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Abstract	  
	  
Objectives:	   Memory	   problems	   are	   reported	   in	   40-­‐60%	   of	   people	   with	   multiple	  
sclerosis	   (MS),	   they	   can	   affect	   independence	   in	   activities	   of	   daily	   living	   and	  may	  
limit	   their	   ability	   to	   benefit	   from	   rehabilitation.	   There	   was	   some	   evidence	   to	  
support	   the	  use	  of	  NeuroPage,	  a	  memory	  aid	   service,	   in	  people	  with	  neurological	  
conditions,	  but	  there	  were	  methodological	  limitations.	  The	  aim	  of	  this	  study	  was	  to	  
evaluate	  the	  effectiveness	  of	  the	  NeuroPage	  service	  for	  people	  with	  MS	  who	  have	  
memory	  problems.	  
	  
Systematic	  Review:	   	  A	  systematic	  review	  on	  external	  memory	  aids	  for	  people	  with	  
MS	  was	   performed.	   Eight	   studies	  were	   included;	   one	   study	   reported	   a	   treatment	  
effect	   on	   subjective	   memory	   functioning;	   one	   on	   mood.	   No	   effect	   was	  
demonstrated	  on	  objective	  memory	  functioning	  or	  quality	  of	  life.	  It	  was	  concluded	  
that	  the	  evidence	  was	  insufficient,	  and	  high	  quality	  trials	  were	  needed.	  
	  
Methods:	  A	  multicentre,	   single-­‐blind	   randomised	   controlled	   crossover	   trial	   design	  
was	  employed.	  People	  with	  MS	  and	  self-­‐reported	  memory	  problems	  were	  recruited	  
into	   the	   trial,	   following	   referral	   from	   MS	   services.	   The	   intervention	   was	  	  
‘NeuroText’,	  a	  service	  that	  sends	  reminder	  messages	  to	  people’s	  mobile	  phones	  at	  
pre-­‐arranged	   times	   via	   the	   existing	   NeuroPage	   system.	   In	   the	   control	   condition	  
participants	  received	  non-­‐memory	  texts,	  containing	  items	  of	  interest,	  such	  as	  news	  
headlines.	  Outcome	  measures	  were	  completed	  using	  postal	  questionnaires.	  t-­‐tests	  
were	   employed	   to	   compare	   intervention	   and	   control	   conditions.	   Semi-­‐structured	  
feedback	  interviews	  were	  performed	  with	  25	  participants.	  
	  
Results:	   Of	   the	   106	   people	   referred	   38	   took	   part.	   They	   were	   aged	   28	   to	   72	  
(mean=48,	   S.D.=11)	   and	   10	   were	   men.	   No	   significant	   differences	   between	  
NeuroText	   and	   control	   were	   detected	   on	   the	   Everyday	  Memory	  Questionnaire	   (t	  
=0.84,	   p=0.41).	   The	   number	   of	   daily	   diary	   items	   forgotten	   in	   the	   NeuroText	  
condition	   was	   significantly	   less	   than	   in	   the	   control	   (9%	   vs.	   31%;	   t=-­‐2.8,	   p=0.01).	  
	   iv	  
Reported	   psychological	   distress	   in	   the	   NeuroText	   condition	   was	   also	   less	   than	  
control	  (t=-­‐3.83,	  p=0.001).	  Seven	  themes	  were	  identified	  from	  participant	  feedback.	  
	  
Conclusions:	   NeuroText	   appears	   to	   be	   help	   people	   with	   MS	   to	   achieve	   their	  
everyday	   tasks	   and	   improve	   mood,	   however	   these	   improvements	   were	   not	  
reflected	  on	   the	  questionnaire	  measure	  of	   the	   frequency	  of	  memory	  problems	   in	  
everyday	  life.	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1	   Background	  
	  
1.1	   Chapter	  Overview	  
This	  chapter	  will	  describe	  the	  context	  in	  which	  the	  research	  has	  taken	  place.	  It	  will	  
begin	   by	   explaining	   what	   multiple	   sclerosis	   (MS)	   is,	   how	   it	   impacts	   the	   central	  
nervous	  system,	  and	  affects	  cognition.	  Memory	  as	  a	  construct	  will	  be	  investigated,	  
followed	   by	   the	   effect	   of	  MS	   on	  memory	   function,	   and	  what	   this	  means	   for	   the	  
individual.	  How	  to	  measure	  memory,	  and	  factors	   that	  should	  be	  considered	  when	  
interpreting	  the	  findings,	  will	  be	  discussed.	  The	  rehabilitation	  of	  memory	  problems	  
will	  be	  introduced,	  with	  a	  particular	  focus	  on	  assistive	  technology,	  followed	  by	  the	  
rationale	  for	  the	  study.	  
	  
1.2	   Multiple	  Sclerosis	  
1.2.1	   What	  is	  Multiple	  Sclerosis?	  
Multiple	  sclerosis	   (MS)	   is	  a	  chronic	   inflammatory,	  demyelinating	  and	  degenerative	  
disease	  of	  the	  central	  nervous	  system	  (CNS).	  Research	  published	  in	  2014	  estimated	  
that	  there	  are	  approximately	  127,000	  people	  with	  MS	  in	  the	  UK,	  and	  6,000	  people	  
newly	   diagnosed	   each	   year	   (I.	   Mackenzie,	   Morant,	   Bloomfield,	   MacDonald,	   &	  
O'riordan,	   2014).	   MS	   is	   the	   most	   common	   non-­‐traumatic	   neurological	   cause	   of	  
disability	  of	  young	  and	  middle-­‐aged	  adults,	  and	  the	  economic	  effects	  of	  the	  disease	  
are	  noticeable	  (Barten,	  Allington,	  Procacci,	  &	  Rivey,	  2010;	  Rao,	  1990).	   	  The	  precise	  
aetiology	  of	  MS	  remains	  unknown;	  however	  it	  is	  generally	  accepted	  that	  MS	  results	  
from	   an	   interaction	   between	   genetic	   predisposition	   and	   environmental	   factors	  
(Grant,	   2009).	  MS	  mostly	   affects	   the	   female	   sex,	  with	   a	  male/female	   ratio	   of	   0.5	  
(World	  Health	  Organization,	  2008).	  People	  with	  MS	  typically	  develop	  symptoms	   in	  
their	   late	   20s,	   experiencing	   visual	   and	   sensory	   disturbances,	   limb	   weakness,	   gait	  
problems,	   and	   bladder	   and	   bowel	   symptoms	   (National	   Clinical	   Guideline	   Centre,	  
2014).	  Partial	  recovery	  may	  occur	  initially,	  but	  over	  time	  people	  develop	  progressive	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disability.	   During	   the	   course	   of	  MS,	   a	   wide	   range	   of	   functional	   impairments	   and	  
disabilities	   can	   develop,	   resulting	   in	   a	   significant	   impact	   on	   the	   quality	   of	   life	   of	  
people	  with	  MS	  and	  their	  families.	  
	  
MS	  is	  most	  commonly	  classified	  into	  four	  subtypes	  reported	  by	  Lublin	  and	  Reingold	  
(1996),	   based	   on	   the	   temporal	   profile.	   Relapsing-­‐remitting	   MS	   (RR)	   is	   the	   most	  
common	   form;	   affecting	   85%	   of	   all	   people	   diagnosed	   (Multiple	   Sclerosis	   Society,	  
2010).	   RR	   is	   characterized	   by	   relapses	   followed	   by	   full	   or	   partial	   recovery	   of	  
impaired	  functions,	  with	  a	  stable	  course	  and	  lack	  of	  progression	  between	  relapses.	  
A	  relapse	   is	  defined	  as	  an	  episode	  of	  neurological	  symptoms	  that	   lasts	  at	   least	  24	  
hours	  and	  happens	  at	  least	  30	  days	  after	  any	  previous	  episode	  began	  (W.	  McDonald	  
et	   al.,	   2001).	   	   People	   often	  make	   a	   good	   recovery	   from	  a	   relapse,	  with	   complete	  
remission,	  however	  around	  half	  of	  all	  relapses	  may	  leave	  some	  lingering	  problems	  
(Vercellino	   et	   al.,	   2009).	   Most	   people	   with	   relapsing	   remitting	   MS	   eventually	  
develop	   secondary	   progressive	  MS,	   around	   65%	   develop	   it	   after	   15	   years	   (Koch,	  
Uyttenboogaart,	   Van	   Harten,	   &	   De	   Keyser,	   2008).	   Secondary	   progressive	   is	  
characterised	   by	   a	   steady	   worsening	   of	   symptoms	   over	   time	   with	   occasional	  
relapses	   and	   minor	   remissions	   (Grant,	   2009).	   A	   smaller	   proportion,	   10-­‐15%	   of	  
individuals	  suffer	  from	  Primary	  progressive	  MS,	  which	  has	  a	  continuous	  and	  gradual	  
worsening	   of	  MS	   symptoms	   with	   no	   distinct	   relapses	   or	   remission	   of	   symptoms.	  
Benign	  MS	  is	  characterised	  by	  little	  disease	  activity,	  and	  is	  reported	  to	  affect	  up	  to	  
10-­‐15%	  of	  people	  with	  MS	  (Mohr	  &	  Cox,	  2001).	  
	  
1.2.2	   How	  does	  MS	  affect	  the	  Central	  Nervous	  System?	  
MS	  is	  a	  progressive	  disease	  of	  the	  CNS	  that	  is	  characterised	  by	  widespread	  lesions,	  
or	   plaques,	   in	   the	   brain	   and	   spinal	   cord	   (Chiaravalloti	   &	  DeLuca,	   2008).	  MS	   is	   an	  
autoimmune	   disease,	   caused	   by	   dysregulation	   of	   the	   immune	   system,	   with	   the	  
formation	   of	   immune	   cells	   specifically	   activated	   against	   CNS	   components	  
(Nocentini,	   Caltagirone,	  &	   Tedeschi,	   2012).	   The	  main	   feature	  of	   this	   disease	   is	   an	  
inflammatory	   process	   resulting	   in	   the	   loss	   of	   the	   myelin	   sheath	   and	   subsequent	  
axonal	   degeneration,	   culminating	   in	   chronic	   multifocal	   sclerotic	   plaques.	   This	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process	  occurs	  preferentially	  in	  the	  white	  matter	  surrounding	  the	  ventricles,	  corpus	  
callosum,	   optic	   nerves,	   brainstem,	   cerebellum	   and	   spinal	   cord	   (Grant,	   2009).	  MS	  
lesions	   predominately	   affect	   white	   matter,	   but	   lesions	   also	   appear	   in	   grey-­‐white	  
matter	   junctions	   and	   grey	   matter	   (Kidd	   et	   al.,	   1999).	   The	   precise	   cause	   of	  
inflammation	   is	   not	   yet	   fully	   understood,	   but	   an	   autoimmune	   response	   directed	  
against	  CNS	  antigens	   is	   suspected	   (Nocentini	  et	  al.,	  2012).	  Due	   to	   the	  widespread	  
development	  of	  plaques,	  MS	  results	  in	  a	  broad	  range	  of	  symptoms,	  including	  motor,	  
cognitive	  and	  neuropsychiatric	  problems	  (Chiaravalloti	  &	  DeLuca,	  2008).	  
	  
1.2.2.1	  How	  does	  MS	  affect	  cognition?	  
Cognitive	   symptoms	   can	   include	   problems	   with	   attention,	   memory,	   learning	   and	  
planning.	   Cognitive	   symptoms	   affect	   up	   to	   60%	   of	   people	   with	  MS	   (E.	   M.	   Rosti-­‐
Otajarvi	  &	  Hamalainen,	  2011),	  and	  because	  the	  disease	  is	  progressive,	  the	  lifetime	  
prevalence	   is	  higher	   than	  60%	   (Mohr	  &	  Cox,	  2001).	   Studies	   into	   the	   symptoms	   in	  
different	   types	  of	  MS	  have	  not	  shown	  clear	  differences	   in	  cognitive	  symptoms	  (D.	  
Miller	   &	   Leary,	   2007).	   	   Cognitive	   dysfunction	   seen	   in	   people	   with	   MS	   is	  
heterogeneous	  and	  occurs	  independently	  of	  physical	  disability	  (Cobble,	  1992;	  Rosti-­‐
Otajärvi	  &	  Hämäläinen,	  2014).	   	  Overt	  dementia	   is	  rare	  in	  people	  with	  MS,	  and	  the	  
more	   common	  clinical	  presentation	   is	  one	  of	   specific	   and	   subtle	   cognitive	  deficits	  
(Fischer,	   2001).	   Cognitive	   variability	   was	   demonstrated	   by	   Rao,	   Hammeke,	  
McQuillen,	   Khatri,	   and	   Lloyd	   (1984),	  who	   studied	  memory	  disturbances	   in	   people	  
with	   MS	   and	   found	   that	   their	   memory	   performance	   was	   highly	   variable,	   when	  
compared	   to	   healthy	   controls.	   Rao	   et	   al.	   (1984)	   suggested	   this	   was	   due	   to	   the	  
variable	   distribution	   of	   plaques	   in	   the	   CNS	   in	   the	   people	  with	  MS.	   The	   degree	   of	  
cognitive	   impairment	   evident	   in	   individuals	   with	   MS	   appears	   to	   be	   unrelated	   to	  
their	  neurological	  disability	  status	  or	  disease	  duration	  (Maurelli	  et	  al.,	  1992;	  Rao	  et	  
al.,	  1991).	  	  
	  
Neuropsychological	   studies	   have	   found	   common	   cognitive	   deficits	   in	  MS,	   despite	  
the	   considerable	   variability	   in	   cognitive	  dysfunction	   seen	   in	  people	  with	  MS	   (Rao,	  
1990,	  1996).	  Intelligence,	  basic	  attention	  and	  basic	  verbal	  skills	  are	  commonly	  intact	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in	   people	   with	   MS	   (Nocentini	   et	   al.,	   2012).	   Memory,	   executive	   dysfunction	   and	  
learning	  dysfunction	  are	  considered	  the	  most	  common	  MS-­‐related	  impairments;	  as	  
is	   slowed	   information	   processing	   speed,	   which	   is	   thought	   to	   underlie	   cognitive	  
problems	   observed	   in	   MS	   (Bravin,	   Kinsella,	   Ong,	   &	   Vowels,	   2000;	   Larner,	   2013;	  
Rosti-­‐Otajärvi	  &	  Hämäläinen,	  2014).	  Complex	  attention	  skills,	  visual-­‐spatial	  learning;	  
visual	  perception	  and	  language	  impairments	  can	  also	  occur	  (Fischer,	  2001;	  Mohr	  &	  
Cox,	  2001).	  
	  
1.3	   Memory	  problems	  and	  MS	  
1.3.1	   Memory	  Systems	  
Memory	   impairment	   is	   one	   of	   the	   most	   common	   sequelae	   of	   brain	   injury	   or	  
disease.	  Many	  different	  patterns	  of	  impairment	  arise	  from	  brain	  damage,	  and	  this	  is	  
reflected	  by	  the	  now	  well-­‐established	  fact	  that	  memory	  is	  not	  a	  unitary	  concept	  or	  
function	   (Evans,	   2004).	   The	  most	   important	   conceptual	   division	   is	   between	   short	  
term	   or	   working	   memory,	   and	   long-­‐term	   memory.	   Working	   memory	   stores	  
information	   temporarily	   for	   a	  matter	  of	   seconds,	  whereas	   long-­‐term	  memory	   is	   a	  
permanent	  repository	  of	  memory	  for	  knowledge	  or	  events	  that	  are	  acquired	  in	  the	  
past,	  i.e.	  from	  a	  few	  minutes	  to	  50	  years	  ago.	  
	  
Working	  memory,	  as	  described	   in	   the	  Baddeley	  and	  Hitch	   (1974)	  multicomponent	  
model,	  is	  thought	  to	  involve	  three	  components:	  the	  phonological	  loop	  holds	  verbal	  
information	   for	   a	   few	   seconds	   or	   whilst	   it	   is	   being	   rehearsed;	   the	   visuospatial	  
sketchpad	  holds	  non-­‐verbal	  material	   in	  the	  same	  way;	  and	  the	  central	  executive	  is	  
the	   attentional	   controller,	  modulating	   the	   interface	   between	   the	   long-­‐term	   store	  
and	  the	  two	  slave	  systems.	  It	  has	  since	  been	  suggested	  that	  a	  good	  account	  of	  the	  
central	   executive	   might	   be	   provided	   by	   the	   supervisory	   attentional	   system	   for	  
executive	  functioning,	  proposed	  by	  Norman	  and	  Shallice	  (1986).	  
	  
Long-­‐term	  memory	  has	  also	  been	  broken	  down	   into	  conceptual	  divisions	  at	   three	  
levels.	  The	  main	  division	  is	  between	  verbal	  and	  non-­‐verbal	  material,	  which	  appears	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to	   result	   from	   hemispheric	   asymmetry	   within	   the	   brain,	   where	   the	   left	   is	   more	  
concerned	  with	  verbal	  processing	  and	  the	  right	  with	  non-­‐verbal	  information	  (Evans,	  
2004).	   The	   second	   division	   is	   between	   declarative	   (explicit)	   and	   non-­‐declarative	  
(implicit)	  systems	  (Squire,	  1992).	  Non-­‐declarative	  memory	  system	  allows	  us	  to	  learn	  
procedures	  without	  conscious	  awareness,	  functioning	  by	  the	  gradual	  acquisition	  of	  
learning	  over	   time	   (Poldrack	   et	   al.,	   2001).	   The	  different	   forms	  of	   implicit	   learning	  
include	   procedural	   learning,	   such	   as	  motor	   skills	   or	   habits;	   priming;	   and	   classical	  
conditioning.	   The	   declarative	   learning	   system	   represents	   knowledge	   and	   includes	  
conscious	   information	   about	   an	   individual’s	   life,	   such	   as	   facts	   and	  events.	   Tulving	  
(1972)	   documented	   the	   third	   conceptual	   division	   of	   declarative	   memory	   into	  
semantic	   and	   episodic	   memory	   systems.	   Semantic	   memory	   stores	   facts	   of	   the	  
world,	  including	  word	  meanings,	  objects,	  people	  and	  encyclopaedic	  facts.	  Semantic	  
knowledge	   is	   therefore	   independent	   of	   context,	   and	   is	   gathered	   though	  multiple	  
exposure	  or	  rehearsal	  of	  the	  material.	  Whereas	  episodic	  memory	  refers	  to	  context-­‐
dependent	   information,	   such	   autobiographical	   events	   or	   information	   linked	   to	   a	  
particular	  time	  or	  place,	  e.g.	  remembering	  what	  you	  did	  yesterday.	  
	  
Recent	  models	   focus	   on	   the	   processes	   involved	   in	  memory	   formation,	   to	   enable	  
researchers	   to	   examine	   how	   component	   processes	   could	   be	   manipulated	   to	  
enhance	   or	   restore	  memory	   functions	   (Skeel	  &	   Edwards,	   2001).	   Skeel	  &	   Edwards	  
(2001)	   proposed	   a	   simple	   taxonomy	   of	   functional	   memory	   processes:	   encoding	  
describes	   the	   unconscious	   or	   effortful	   processes	   by	   which	   information	   or	   motor	  
skills	   are	   initially	   organised	   and	   processed	   for	   immediate	   or	   later	   recall;	  
consolidation	   refers	   to	   mostly	   unconscious	   processes	   by	   which	   memories	   are	  
converted	   from	   temporary,	   active	   processing	   to	   permanent	   storage;	   retrieval	   is	  
effortful	  or	  passive	  process	  where	  previously	  learned	  material	  or	  skills	  are	  recalled.	  
Once	  information	  is	  stored,	  if	  it	  is	  to	  be	  used,	  it	  must	  be	  retrieved.	  The	  two	  principle	  
methods	  of	  retrieval	  are	  recall	  and	  recognition	  (Baddeley,	  2004).	  Recognition	  occurs	  
when	  you	  may	  not	  be	  able	  to	  bring	  to	  mind	  the	  thing	  you	  are	  trying	  to	  remember,	  
but	   instantly	   recognise	   when	   you	   see	   it.	   Recall	   involves	   the	   recollection	   of	  
something	  in	  the	  absence	  of	  the	  thing	  to	  be	  remembered.	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1.3.2	   Prospective	  memory	  
Prospective	   memory,	   remembering	   to	   do	   things	   in	   the	   future,	   is	   distinct	   from	  
retrospective	   memory,	   and	   is	   one	   of	   the	   most	   practically	   important	   uses	   for	  
memory.	  Prospective	  memory	  processes	  allow	  us	  to	  plan	  future	  behaviours	  and	  act	  
on	   these	   at	   the	   appropriate	   time	   (Baddeley,	   2004).	   Ellis	   (1996)	   used	   the	   term	  
‘realising	  delayed	  intentions’,	  for	  these	  tasks.	  There	  are	  several	  types	  of	  prospective	  
memory,	  with	  the	  most	  important	  distinction	  being	  between	  time-­‐based	  and	  event-­‐
based	  tasks	  (Einstein	  &	  McDaniel,	  1990).	  Time-­‐based	  tasks	  involve	  remembering	  to	  
perform	  a	   given	  action	  at	   a	   given	   time	   (e.g.	   phone	  a	   friend	  at	  6pm).	   Event-­‐based	  
tasks	   involve	   remembering	   to	   perform	   an	   action	   in	   the	   appropriate	   circumstance	  
(e.g.	  buy	  milk	  when	  you	  walk	  past	  the	  shop).	  Time-­‐based	  tasks	  are	  considered	  to	  be	  
more	   difficult	   than	   event-­‐based	   tasks,	   because	   the	   association	   aspect	   in	   event-­‐
based	   tasks	   may	   function	   as	   a	   cue	   (Einstein,	   McDaniel,	   Richardson,	   Guynn,	   &	  
Cunfer,	  1995).	  
	  
Prospective	  memory	  could	  be	  deemed	  a	  misleading	   term,	  because	   it	   requires	   the	  
coordinated	   integration	   of	   planning	   skills	   (setting	   the	   intention),	   attention	   and	  
memory	   (recognising	   it	   is	   time	   to	  do	   the	   intended	  action,	   remembering	  what	   the	  
action	  is,	  and	  then	  remembering	  it	  has	  been	  carried	  out)	  (Evans,	  2004).	  Therefore	  it	  
is	  has	  been	  postulated	  that	  prospective	  memory	  functioning	  relies	  on	  attention	  and	  
executive	   functioning	   (Dagenais	   et	   al.,	   2016;	   Fish,	   Manly,	   Kopelman,	   &	   Morris,	  
2015;	  Glisky,	   1996),	   as	  well	   as	   retrospective	  memory	   functioning,	   as	   you	   need	   to	  
recall	  the	  intention	  to	  be	  carried	  out	  (Rendell,	  Jensen,	  &	  Henry,	  2007).	  The	  separate	  
stages	  or	  processes	  involved	  in	  prospective	  memory	  have	  been	  described	  by	  many	  
authors,	   such	   as	   Sohlberg	   and	   Mateer	   (2001)	   who	   suggest	   that	   to	   successfully	  
perform	   the	  prospective	  memory	   task,	   the	  person	  must	  plan	   the	  behaviour;	   keep	  
the	  steps	  required	  to	  accomplish	  this	  in	  mind;	  recall	  the	  task;	  and	  take	  action.	  The	  
most	   recent	   conceptual	   model	   was	   presented	   by	   Zogg,	  Woods,	   Sauceda,	  Wiebe,	  
and	  Simoni	   (2012),	  and	  contains	   five	  components:	   intention	   formation,	  where	  the	  
individual	   forms	  or	  encodes	   the	   intention	   linked	   to	  a	   cue	   (time	  or	  event	   related);	  
retention	   interval,	   is	   the	   typical	   time	   delay	   between	   intention	   formation	   and	  
execution,	   monitoring	   of	   the	   environment	   for	   task-­‐related	   cues	   occur;	   cue	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detection	   and	   intention	   retrieval,	   requires	   the	   individual	   to	   detect	   and	   recognise	  
the	  relevant	  cue	  and	  self-­‐initiate	  retrieval	  of	  appropriate	  intention;	  intention	  recall,	  
successful	   retrieval	   of	   the	   intention	   from	   retrospective	   memory;	   intention	  
execution.	  
	  
1.3.3	   Memory	  problems	  experienced	  in	  MS	  
Approximately	  40-­‐60%	  of	  people	  with	  MS	  have	  memory	  problems	  (Rao	  et	  al.,	  1993).	  
Investigations	  into	  memory	  impairment	  in	  MS	  have	  largely	  focused	  on	  retrospective	  
memory	   (Bravin	   et	   al.,	   2000),	   and	   there	   is	   considerable	   evidence	   that	   MS	   is	  
associated	  with	  impaired	  retrospective	  memory	  (Rendell	  et	  al.,	  2007).	  Thornton	  and	  
Raz	  (1997)	  concluded	  that	  MS	  is	  associated	  with	  significant	  impairment	  on	  all	  three	  
types	  of	  retrospective	  memory:	  short-­‐term,	  long-­‐term	  and	  working	  memory.	  Long-­‐
term	  memory	   is	  one	  of	   the	  most	   consistently	   impaired	   cognitive	   functions	   in	  MS,	  
occurring	   in	   40-­‐65%	  of	   patients	   (Rao	  et	   al.,	   1993).	   Recall	   in	   both	   verbal	   and	  non-­‐
verbal	   categories	   are	   reported	   as	   affected	   by	  MS	   (Grafman,	   Rao,	  &	   Litvan,	   1990;	  
Larner,	   2013;	  Mohr	  &	   Cox,	   2001).	   Although	   retrieval	   of	   verbal	   information	   is	   the	  
problem	   that	  most	   commonly	   interferes	  with	  memory	   function,	   impairments	   can	  
occur	   across	   all	   domains,	   including	  problems	  with	   encoding	   and	   storage	   (Mohr	  &	  
Cox,	   2001).	   Recognition	   memory	   and	   implicit	   learning	   appear	   to	   remain	   intact	  
(Brassington	  &	  Marsh,	  1998).	  
	  
Originally	   it	  was	  thought	  that	  the	  MS-­‐related	  memory	  impairment	  resulted	  from	  a	  
difficulty	  in	  retrieval	  processes,	  however	  recent	  research	  indicates	  that	  the	  primary	  
problem	  is	  in	  the	  learning	  of	  information	  (DeLuca,	  Barbieri-­‐Berger,	  &	  Johnson,	  1994;	  
Thornton,	  Raz,	  &	  Tucker,	  2002).	  This	  deficit	   in	   learning	  new	   information	   results	   in	  
poor	  decision-­‐making	  abilities,	  and	  appears	   to	  affect	  prospective	  memory	  abilities	  
(Nagy	   et	   al.,	   2006;	   Rendell	   et	   al.,	   2007).	   Slow	   processing	   speed,	   susceptibility	   to	  
interference,	   executive	   dysfunction	   and	   perceptual	   deficits	   have	   been	   associated	  
with	   the	   poor	   learning	   abilities	   seen	   in	   people	   with	  MS	   (Chiaravalloti	   &	   DeLuca,	  
2008).	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Specific	   types	   of	  memory	   impairments,	   such	   as	   autobiographical	   and	   prospective	  
memory	  impairment,	  have	  also	  been	  reported	  in	  people	  with	  MS	  (Ernst	  et	  al.,	  2013;	  
Rendell	   et	   al.,	   2007).	   People	   with	  MS	   often	   complain	   of	   forgetfulness	   related	   to	  
prospective	   memory,	   such	   as	   forgetting	   to	   take	   their	   medications,	   rather	   than	  
retrospective	  memory,	   and	   these	  memory	   failures	   greatly	   affect	   their	   daily	   living	  
(Dagenais	  et	  al.,	  2016;	  Demers	  et	  al.,	  2011).	  Prospective	  memory	  in	  people	  with	  MS	  
has	  not	  been	  examined	  to	  the	  same	  extent	  as	  retrospective	  memory	  (Bravin	  et	  al.,	  
2000),	  but	  the	  evidence	  for	  prospective	  memory	   impairment	   in	  people	  with	  MS	   is	  
mounting	   (A.	  Miller,	  Basso,	  Candilis,	   Combs,	  &	  Woods,	  2014).	  Given	   the	  evidence	  
for	  retrospective	  memory	  impairment	  in	  MS,	  it	  is	  logical	  that	  people	  with	  MS	  would	  
also	  have	  deficits	  in	  prospective	  memory.	  This	  is	  because	  prospective	  memory	  tasks	  
involve	   a	   retrospective	   component	   (McDaniel	   &	   Einstein,	   1992).	   	   Research	   has	  
found	   that	   people	   with	   MS	   had	   prospective	   memory	   problems	   (i.e.	   the	  
implementation	  of	  delayed	  intentions),	  as	  well	  as	  the	  retrospective	  memory	  deficits	  
(i.e.	   remembering	   what	   needs	   to	   be	   done)	   associated	   with	   poor	   prospective	  
memory	   performance	   (Dagenais	   et	   al.,	   2016;	   Kardiasmenos,	   Clawson,	   Wilken,	   &	  
Wallin,	  2008;	  Rendell	  et	  al.,	  2007).	  	  
	  
1.3.4	   Impact	  of	  memory	  problems	  
Memory	  problems	  are	  persistent,	   frustrating	  both	   to	  patients	  and	  carers,	   and	  are	  
debilitating	   and	   difficult	   to	   treat	   (Williamson,	   Scott,	   &	   Adams,	   1996).	   Cognitive	  
deficits	  may	  have	  both	  physical	  and	  mental	  effects,	  leading	  to	  symptoms	  of	  fatigue	  
(DeLuca,	   2005),	   and	   severe	   cognitive	   impairment	   presents	   a	   major	   barrier	   to	  
rehabilitation	   programmes	   because	   individuals	   may	   be	   unable	   to	   retain	   advice	  
(Thomas,	   Thomas,	   Hillier,	   Galvin,	   &	   Baker,	   2006).	   Many	   people	   with	   MS	   report	  
feeling	  more	  restricted	  by	  cognitive	   impairments	   than	  by	   limited	  mobility	   (Amato,	  
Zipoli,	  &	  Portaccio,	  2006),	  and	   there	   is	   considerable	  evidence	   indicating	   that	   their	  
quality	  of	  life	  is	  decreased	  (Grima	  et	  al.,	  2000).	  	  
	  
Cognitive	  impairment	  in	  MS	  is	  often	  a	  hidden	  condition,	  which	  brings	  difficulties	  for	  
people	  with	  MS	  in	  terms	  of	  everyday	  functioning,	  which	  contributes	  to	  depression,	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anxiety,	   distress	   and	   fatigue	   (Gilchrist	   &	   Creed,	   1994;	   Sá,	   2008).	   Depression	   is	   a	  
common	  co-­‐morbidity	  in	  people	  with	  MS,	  with	  a	  lifetime	  prevalence	  of	  around	  50%,	  
which	   is	  three	  times	  that	  of	  the	  general	  population;	  and	  higher	  than	  that	  of	  other	  
groups	   of	   chronic	   diseases	   (Bruce	   &	   Arnett,	   2004;	   Feinstein,	   2011;	   Feinstein,	  
O'connor,	  Gray,	  &	  Feinstein,	  1999;	  Minden	  &	  Schiffer,	  1990;	  Thomas	  et	  al.,	  2006).	  
Despite	  the	  high	  rate	  of	  memory	  problems	  and	  depression	  seen	  in	  people	  with	  MS,	  
relatively	   little	   is	   known	   about	   how	   the	   two	   symptoms	   relate	   to	   each	   other.	  
Depression	  may	  worsen	  cognitive	  functioning	  and	  cognitive	  dysfunction	  may	  induce	  
depression	   (Sá,	   2008).	   	   Furthermore,	   the	   cause	   of	   the	   higher	   prevalence	   of	  
depression	   in	   people	   with	   MS	   is	   unclear.	   Explanations	   include	   the	   view	   that	  
depression	  could	  be	  a	  psychological	  reaction	  to	  having	  a	  chronic	  debilitating	  disease	  
(Koch	   et	   al.,	   2014).	   For	   example,	   the	   perceived	   intrusiveness	   of	   MS	   on	   daily	  
activities	  is	  related	  to	  depression	  and	  adjustment	  (Devins	  et	  al.,	  1996),	  as	  is	  loss	  of	  
social	  role	  functioning	  (Pakenham,	  1999).	  	  
	  
Cognitive	   impairments	  may	  also	  negatively	   interfere	  with	  daily	   functioning	   (Engel,	  
Greim,	  &	  Zettl,	  2007;	  Langdon	  &	  Thompson,	  1996),	  participation	  in	  social	  activities	  
(Thomas	  et	  al.,	  2006)	  and	  employment	  status	  (A.	  O'Brien,	  Chiaravalloti,	  Goverover,	  
&	   DeLuca,	   2008;	   Rao	   et	   al.,	   1991).	   Cognitive	   deficits	   detrimentally	   affect	   many	  
aspects	   of	   daily	   life,	   such	   as	   the	   ability	   to	   run	   a	   household	   and	  perform	   self-­‐care	  
tasks,	   including	  medical	   adherence	   (Gulick,	   1998).	   The	   safety	   of	   the	   person	   with	  
memory	   deficits	   can	   also	   be	   compromised,	  making	   them	   vulnerable	   in	   the	   home	  
and	  work.	  Therefore	  cognitively	  impaired	  people	  with	  MS	  are	  more	  socially	  isolated	  
and	  have	  greater	  need	  for	  personal	  assistance	   in	  the	  home	  than	  MS	  patients	  with	  
only	  physical	   activities	   (Rao	  et	   al.,	   1991).	   Prospective	  memory	  plays	   an	   important	  
role	   in	   independent	   functioning,	   and	   is	   crucial	   for	   activities	   of	   daily	   life,	   health	  
needs	   and	   social	   relations	   (McDaniel,	   Einstein,	   &	   Rendell,	   2008),	   and	   Salthouse,	  
Berish,	   and	   Siedlecki	   (2004)	   claim	   that	   prospective	  memory	   is	   a	   more	   important	  
determinant	   of	   the	   ability	   to	   live	   independently	   than	   retrospective	   memory.	  
Therefore	  failures	  of	  prospective	  memory	  are	  embarrassing,	  risky	  to	  the	  individual,	  
and	  hamper	  their	  ability	  to	  function	  independently.	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Cognitive	  deficits	  are	  one	  of	  a	   few	  disease	  manifestations	  predictive	  of	  vocational	  
status	   (Benedict	   et	   al.,	   2005).	   40-­‐80%	   of	   people	   with	   MS	   are	   unemployed,	   and	  
cognitive	  impairment	  is	  a	  large	  contributor	  to	  this	  high	  rate	  (Grønning,	  Hannisdal,	  &	  
Mellgren,	   1990;	   Rao	   et	   al.,	   1991).	   Impairment	   in	   memory,	   executive	   dysfunction	  
and	   poor	   information	   processing	   skills,	   have	   been	   blamed	   for	   this	   difficulty	   in	  
maintaining	   employment	   (Beatty,	   Blanco,	   Wilbanks,	   Paul,	   &	   Hames,	   1995;	  
Parmenter,	   Shucard,	  &	  Shucard,	  2007).	   The	  onset	  of	  MS	   typically	  occurs	   in	   young	  
adulthood,	   when	   individuals	   are	   most	   active	   and	   productive	   in	   many	   aspects	   of	  
their	   lives,	   and	   therefore	   MS	   leads	   to	   the	   loss	   of	   gainful	   employment	   for	   many	  
(Beatty	  et	  al.,	  1995).	  The	  loss	  of	  employment,	  along	  with	  informal	  care,	  accounts	  for	  
up	  to	  60%	  of	  the	  cost	  of	  MS,	  due	  to	  the	  loss	  of	  earnings	  for	  both	  the	  patient	  and	  the	  
carer	  (Whetten-­‐Goldstein,	  Sloan,	  Goldstein,	  &	  Kulas,	  1998).	  Therefore	  impairments	  
in	  memory	  can	  have	  a	  detrimental	  effect	  on	  the	  psychological	  wellbeing	  of	  people	  
and	  others	   around	   them	   (Skeel	  &	   Edwards,	   2001),	   and	  have	   significant	   long-­‐term	  
effects	  for	  patient,	  their	  families	  and	  communities.	  
	  
1.3.5	   Assessment	  of	  Memory	  
Assessment	  of	  memory	  problems	  is	  necessary	  in	  order	  to	  understand	  the	  nature	  of	  
the	  deficits,	  and	  to	  inform	  rehabilitation	  practice	  as	  well	  as	  to	  evaluate	  the	  outcome	  
of	   intervention	  (Mohr	  &	  Cox,	  2001).	  Memory	  assessment	  should	  ideally	  be	  carried	  
out	   immediately	  before	   the	   start	  of	   the	   rehabilitation	  programme,	  and	   should	  be	  
planned,	  carried	  out	  and	   interpreted	   in	  the	  wider	  context	  of	  the	   individual	  person	  
(Bradley,	  Kapur,	  &	  Evans,	  2005).	  	  
	  
Instruments	  that	  assess	  multiple	  domains	  of	  memory	  can	  be	  employed,	  as	  well	  as	  
those	  looking	  specifically	  at	  components	  of	  memory.	  Additionally	  the	  latter	  can	  be	  
in	   the	   form	   of	   formal	   clinician-­‐led	   assessments	   requiring	   the	   client	   to	   perform	  
certain	   tasks,	   or	   they	   can	   be	   self-­‐report	   measures	   completed	   by	   the	   clients	  
themselves	   or	   significant	   others.	   This	   distinction	   can	   be	   termed	   respectively	   as	  
‘objective’	  and	  ‘subjective’	  reports	  of	  memory.	  
	  
	   11	  
The	   primary	   advantage	   of	   administering	   batteries	   of	   tests	   is	   that	   they	   include	   a	  
variety	   of	   memory	   tasks	   (Lezak,	   2004).	   Comprehensive	   batteries	   of	   memory	   are	  
frequently	   employed	   in	   rehabilitation	   settings,	   such	   as,	  Wechsler	  Memory	   Scales	  
(Wechsler,	   1997)	   or	   Rivermead	   Behavioural	   Memory	   Test	   (Wilson,	   Cockburn,	   &	  
Baddeley,	  1985).	  Other	  tests	  focus	  on	  specific	  modalities	  of	  memory,	  e.g.	  verbal	  or	  
visual	  memory;	   types,	   e.g.	   autobiographical,	   or	   prospective	  memory;	   components	  
of	  memory,	  e.g.	  working	  memory;	  or	  processes,	  e.g.	  encoding,	  recall	  or	  recognition.	  
	  
Self-­‐report	  measures	  provide	   invaluable	   information	  regarding	  a	  person’s	  memory	  
functioning,	   and	   highlight	   their	   own	   perception	   of	   the	   level	   at	   which	   they	   are	  
functioning	   and	   the	   impact	   on	   their	   everyday	   life	   (Godfrey,	   Partridge,	   Knight,	   &	  
Bishara,	   1993).	   Inconsistencies	   between	   subjective	   and	   objective	   tests	   are	  
commonly	   reported	   (Goverover	   et	   al.,	   2005).	   This	   inconsistency	   is	   likely	   because	  
everyday	   memory	   problems	   reported	   in	   subjective	   measures	   are	   not	   necessarily	  
solely	   caused	   by	   “memory”	   deficits.	   Therefore	   it	   is	   suggested	   the	   two	   types	   of	  
measures	  assess	  different	  constructs	  (G.	  Cohen,	  1989).	  
	  
1.3.5.1	  Factors	  affecting	  performance	  on	  memory	  measures	  
Memory	   performance	   can	   be	   affected	   by	   other	   cognitive,	   emotional	   and	  
behavioural	   functions	   (Bradley	   et	   al.,	   2005).	   Measured	   memory	   problems	   could	  
actually	  be	  the	  result	  of	  attention	  and	  information	  processing	  deficits,	  or	  executive	  
dysfunction	   (Howieson	   &	   Lezak,	   1995).	   Therefore	   it	   is	   vital	   to	  measure	   attention	  
and	  executive	  functioning,	  alongside	  broad	  measures	  of	  memory.	  
	  
NICE	   guidelines	   state	   that	   anxiety,	   depression,	   difficulty	   sleeping	   and	   fatigue	   can	  
impact	  on	  cognitive	  problems	  (National	  Clinical	  Guidelines	  Centre,	  2014).	  Up	  to	  60%	  
of	   people	   with	   MS	   have	   depression	   (Minden	   &	   Schiffer,	   1991).	   Early	   studies	  
consistently	   failed	   to	   find	   any	   clear	   relation	   between	   depression	   and	   cognitive	  
impairment	  in	  MS	  (Siegert	  &	  Abernethy,	  2005).	  However	  recent	  literature	  suggests	  
that	   depression	   may	   exacerbate	   cognitive	   dysfunction	   (Chiaravalloti	   &	   DeLuca,	  
2008;	   Feinstein,	   2006).	   Some	   studies	   demonstrated	   that	   depression	   has	   a	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detrimental	  impact	  on	  particular	  aspects	  of	  cognitive	  capacity,	  namely	  information	  
processing	   speed,	   working	   memory,	   learning	   and	   executive	   functioning	   (Arnett,	  
Higginson,	  Voss,	  Bender,	  et	  al.,	  1999;	  Douglas	  R	  Denney,	  Sworowski,	  &	  Lynch,	  2005;	  
Gilchrist	   &	   Creed,	   1994;	   Siegert	   &	   Abernethy,	   2005;	   Thornton	   &	   Raz,	   1997).	  
Additionally	   depression	   may	   decrease	   the	   accuracy	   of	   patient-­‐reported	   cognitive	  
impairment	   (Julian,	  Merluzzi,	   &	  Mohr,	   2007).	   Therefore	   it	   is	   common	   practice	   to	  
assess	  mood	  symptoms	  alongside	  neuropsychological	  tests	  (Sá,	  2008).	  
	  
Fatigue	  is	  one	  of	  the	  most	  common	  symptoms	  in	  MS,	  being	  reported	  in	  over	  90%	  of	  
patients	  (Schapiro,	  2002).	  Fatigue	  is	  believed	  to	  influence	  performance	  on	  memory	  
tasks,	  and	  Bryant,	  Chiaravalloti,	  and	  DeLuca	  (2004)	  found	  that	   individuals	  with	  MS	  
showed	   a	   decline	   in	   performance	   on	   a	   working	   memory	   task	   when	   they	   were	  
fatigued.	  Additionally,	   recent	   research	  has	   found	   that	  pain	  may	  degrade	  ability	   to	  
remember	   new	   intentions	   and	   suggests	   that	   pain	   is	   associated	   with	   prospective	  
memory	  dysfunction	  in	  people	  with	  MS	  (A.	  Miller	  et	  al.,	  2014).	  Age	  is	  another	  factor	  
known	  to	  have	  an	  effect	  on	  memory	  tests	   (Chiulli,	  Haaland,	  Larue,	  &	  Garry,	  1995;	  
Savage	   &	   Gouvier,	   1992).	   Therefore	   these	   factors	   should	   be	   considered	   when	  
interpreting	  performance	  on	  memory	  measures.	  
	  
1.4	   Cognitive	  rehabilitation	  for	  people	  with	  MS	  
1.4.1	   Memory	  rehabilitation	  
Neuropsychological	  rehabilitation	  involves	  teaching	  compensatory	  strategies,	  using	  
aids,	  supporting	  patient’s	  awareness	  and	  teaching	  coping	  strategies	  to	  patients	  and	  
their	   significant	   others	   (Rosti-­‐Otajärvi	   &	   Hämäläinen,	   2014).	   The	   ultimate	   aim	   of	  
neuropsychological	   rehabilitation	   is	   to	   alleviate	   the	   impact	   of	   the	   memory	  
impairment	  and	  consequently	  improve	  everyday	  functioning	  (Evans,	  2004).	  
	  
There	   are	   two	   main	   neuropsychological	   approaches	   to	   memory	   rehabilitation:	  
restitution	  and	  compensation	  (Evans,	  2006;	  Sohlberg	  &	  Mateer,	  1989).	  Restitution	  
techniques	   typically	   involve	   repetitive	   practice	   training,	   which	   aims	   to	   target	   a	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person’s	   underlying	  memory	   impairment	   (M.	   O'Brien,	   das	   Nair,	   &	   Lincoln,	   2013).	  
Compensatory	   approaches	   differ	   from	   restitution,	   in	   that	   they	   do	   not	   attempt	   to	  
promote	   recovery	   of	   function,	   and	   instead	   focus	   on	   maximising	   a	   person’s	  
functional	  abilities	  (Sullivan,	  Dehoux,	  &	  Buchanan,	  1989).	  Therefore	  compensatory	  
techniques	  involve	  teaching	  people	  with	  memory	  problems	  to	  bypass	  problems	  by	  
employing	  external	  and	  internal	  memory	  aids	  (Wilson,	  2000).	  	  
	  
The	   majority	   of	   published	   memory	   rehabilitation	   studies	   favour	   the	   use	   of	  
compensatory	   strategies	  over	   restitution	  approaches,	   as	   there	   is	   a	  distinct	   lack	  of	  
evidence	   for	   the	   effectiveness	   of	   restitution	   (Glisky,	   Schacter,	   &	   Tulving,	   1986;	  
Robertson,	   1999;	   Wilson,	   Evans,	   Emslie,	   &	   Malinek,	   1997).	   Cognitive	   problems	  
associated	   with	   MS	   are	   not	   expected	   to	   follow	   a	   natural	   course	   of	   recovery,	   as	  
might	  be	  seen	  in	  people	  with	  acquired	  brain	  injury	  (ABI);	  MS	  is	  more	  likely	  to	  result	  
in	  progressive	  deterioration	  of	  function.	  Therefore,	  restitution	  approaches	  may	  lead	  
to	  initial	  therapeutic	  gains,	  which	  are	  then	  lost	  by	  the	  progressive	  loss	  of	  cognitive	  
function;	   and	   hence	   compensatory	   strategies	   are	   preferable.	   Additionally	  
compensatory	   approaches	   are	   usually	   goal-­‐directed,	   individualised,	   and	   linked	   to	  
function	  (Simmons-­‐Mackie	  &	  Damico,	  1997),	  whereas	  restitution	  techniques	  often	  
have	  limited	  generalizability	  to	  real	  world	  function.	  	  
	  
Compensatory	  approaches	  can	  take	  multiple	  forms:	   internal	  memory	  aids,	  such	  as	  
enhanced	  learning	  and	  mnemonics;	  environmental	  modification;	  and	  external	  aids.	  
Enhanced	   learning	   places	   emphasis	   on	  making	   the	  most	   of	   any	   residual	   learning	  
capacity,	   by	   paying	   more	   attention	   to	   the	   information	   to	   be	   remembered,	   and	  
making	   sure	   you’re	   not	   distracted	   by	   the	   environment.	   Additionally	   more	   time	  
should	   be	   spent	   on	   encoding	   and	   repetition	   of	   the	   information	   needed	   to	  
remember,	   using	   spaced	   and	   varied	   repetition	   (expanded	   rehearsal).	   Errorless	  
learning	  is	  another	  technique	  that	  focuses	  on	  preventing	  people	  from	  making	  errors	  
in	   their	   learning	   process	   (Wilson,	   Baddeley,	   Evans,	  &	   Shiel,	   1994).	   Instead	  of	   trial	  
and	  error,	   information	   is	  presented	   in	   such	  a	  way	   to	  avoid	  or	   significantly	   reduce	  
mistakes	   (Wilson,	   2002).	   PQRST	  and	  Mind	  Maps	   are	   techniques	  useful	   for	   people	  
who	   are	   returning	   to	   formal	   education,	   as	   they	   are	   means	   of	   enhancing	   the	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meaningfulness	   and	   memorability	   of	   information	   to	   be	   learnt	   (Buzan	   &	   Buzan,	  
2000;	  Robinson,	  1970).	  One	  mnemonics	   technique	   is	   the	  method	  of	   loci,	  where	  a	  
route	  around	  a	  familiar	  place	  or	  journey	  with	  specific	   location	  is	  pre-­‐learned.	  Each	  
item	  to	  be	  remembered	  is	  then	  associated	  with	  locations	  on	  the	  route.	  Method	  of	  
loci	  is	  best	  used	  when	  learning	  a	  list,	  and	  takes	  considerable	  practice.	  A	  simpler	  and	  
more	   commonly	   used	  mnemonic	   strategy	   is	  mental	   retracing,	   where	   you	   retrace	  
your	  steps	  in	  order	  to	  remember	  where	  you’ve	  left	  something	  or	  what	  you’ve	  done.	  
Environmental	  modification	   aims	   to	   reduce	   the	  memory	   demands	   placed	   upon	   a	  
person.	   This	   can	   be	   achieved	   by	   using	   signposts,	   labels	   or	   colour-­‐coding	   to	   aid	  
orientation	  to	  the	  environment;	  as	  well	  as	  keeping	  objects	  in	  a	  particular	  place;	  or	  
using	  orientation	  boards.	  
	  
By	   far	   the	   most	   commonly	   used	   strategy	   for	   supporting	   memory	   is	   the	   use	   of	  
external	  aids.	  External	  aids	  used	  in	  a	  compensatory	  fashion	  are	  generally	  viewed	  as	  
a	  means	   to	   reduce	   the	   cognitive	   load	   and	  enable	   successful	   completion	  of	   a	   task	  
(Linden,	  Hawley,	   Blackwood,	   Evans,	  &	  Anderson,	   2014).	   Evans,	  Wilson,	  Needham,	  
and	  Brentnall	   (2003)	   found	  that	  nearly	  70%	  of	  people	  with	  a	  memory	   impairment	  
used	  a	   calendar,	  notebook	  or	  diary.	  External	  memory	  aids	  do	  not	  aim	   to	   improve	  
‘memory’,	  but	   focus	  on	   reducing	   functional	  problems,	  by	  means	  of	   recording	  and	  
accessing	  information	  externally	  (Teasell	  et	  al.,	  2007).	  Examples	  of	  external	  memory	  
aids	  include	  paper-­‐based	  systems	  such	  as	  calendars,	  diaries,	  Filofaxes.	  Another	  form	  
of	   aid	   is	   a	   dosset	   box,	   which	   comprises	   multiple	   sections	   for	   storing	   daily	  
medication	   doses,	   particularly	   helpful	   for	   people	   with	   complicated	   medication	  
regimes.	  
	  
However,	  for	  a	  person	  with	  a	  memory	  impairment	  the	  process	  of	  learning	  to	  use	  an	  
external	  memory	  aid	   is	  not	   straightforward,	  and	   support	   is	  needed	   (Evans,	  2004).	  
Many	  barriers	  exist	   that	  prohibit	   the	  uptake	  of	   compensatory	  memory	   strategies,	  
such	   as	   people	   believing	   they	   will	   “make	   their	   memory	   worse”,	   feeling	   of	  
dependency,	  or	  feeling	  embarrassed	  or	  stupid	  about	  using	  them	  (Baldwin,	  Powell,	  &	  
Lorenc,	  2011;	  Evald,	  2015;	  Wilson	  &	  Watson,	  1996).	  Therefore	  these	  factors	  need	  to	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be	   considered	   when	   implementing	   compensatory	   aids	   with	   people	   with	  memory	  
problems.	  
	  
1.4.1.1	  Assistive	  technology	  for	  memory	  problems	  
There	  is	  a	  rapidly	  growing	  market	  of	  technological	  memory	  aids,	  for	  example	  timers,	  
PDAs,	   smartphones,	   voice	   recorders,	   watches	   with	   alarms	   and	   paging	   devices	  
(Dewar,	   Kopelman,	   Kapur,	   &	  Wilson,	   2014).	   Everyday	   memory	   problems	   seen	   in	  
both	   neurological	   and	   general	   populations	   are	   commonly	   prospective	   memory	  
difficulties	  (Fish,	  Wilson,	  &	  Manly,	  2010),	  and	  technological	  memory	  aids	  commonly	  
focus	   on	   alleviating	   prospective	   memory	   problems	   (Linden	   et	   al.,	   2014).	   An	   aid	  
could	  be	  used	  to	  hold	  information	  concerning	  intended	  actions,	  such	  as	  a	  reminder	  
to	   take	   medication,	   which	   would	   be	   considered	   a	   meta-­‐knowledge	   reminder.	  
Additionally	   the	   content	  of	   a	   reminder	   could	   include	  monitoring	   information,	   e.g.	  
medication	  needs	   to	  be	   refilled,	  or	  out-­‐put	  monitoring	   such	  as,	   “have	  you	   refilled	  
your	   medication”.	   People	   with	   memory	   problems	   have	   an	   inherent	   difficulty	   in	  
developing	   rehabilitation	   strategies,	   because	   by	   definition	   patients	   will	   have	  
difficulty	   remembering	   to	   apply	   compensatory	   techniques	   that	   they	   have	   been	  
taught.	   Technological	   aids	   are	   gaining	   in	   popularity	   because	   they	   counteract	   this	  
problem,	  as	  users	  do	  not	  have	  to	  remember	  to	  use	  the	  device	  (Lannin	  et	  al.,	  2014;	  
Wilson	  et	  al.,	  1997).	  Johnson,	  Bamer,	  Yorkston,	  and	  Amtmann	  (2009)	  administered	  
a	  survey	  to	  over	  1,000	  people	  with	  MS	  and	  found	  that	  approximately	  half	  of	  them	  
used	  electronic	  memory	  aids.	  	  
	  
Assistive	   technology	   for	  memory	   problems	   comes	   in	   a	   variety	   of	   forms,	   including	  
electronic	   organisers,	   pagers,	   mobile	   phones,	   web-­‐based	   scheduling	   and	   voice	  
recorders	   (Linden	  et	  al.,	   2014).	  People	  with	  autobiographical	  memory	  deficits	   can	  
be	  supported	  by	  SenseCam,	  which	  passively	  records	  images	  throughout	  the	  day,	  to	  
act	  as	  a	  pictorial	  memory	  aid	  later	  (Hodges,	  Berry,	  &	  Wood,	  2011).	  Voice	  recorders	  
are	   an	   electronic	   memory	   aid	   that	   can	   replay	   messages	   at	   the	   time	   and	   date	  
specified	   by	   the	   user,	   (Van	   den	   Broek,	   Downes,	   Johnson,	   Dayus,	  &	  Hilton,	   2000).	  	  
Portable	   electronic	   organisers	   (PDA)	   were	   an	   early	   form	   of	   assistive	   technology	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used	   to	   aid	  memory	   function.	   PDAs	   have	   been	   shown	   to	   be	   beneficial	   to	   people	  
with	   traumatic	  brain	   injury	   (TBI)	   (Dowds	  et	  al.,	  2011;	  Gillette	  &	  DePompei,	  2004),	  
and	   specifically	   for	   prospective	   memory	   (Waldron,	   Grimson,	   Carton,	   &	   Blanco-­‐
Campal,	   2012).	   Additionally	   alarms	   can	   be	   used	   as	   electronic	   memory	   aids	   to	  
prompt	  people	  into	  action.	  However,	  cueing	  devices	  alert	  the	  individual	  that	  there	  
is	  something	  they	  need	  to	  do,	  but	  the	  lack	  of	  content	  means	  those	  individuals	  often	  
cannot	   remember	   what	   that	   task	   is,	   and	   therefore	   lack	   functional	   practicality	  
(McKerracher,	   Powell,	   &	   Oyebode,	   2005;	   Zencius,	   Wesolowski,	   Krankowski,	   &	  
Burke,	  1991).	  	  
	  
Much	   of	   the	   research	   on	   electronic	   memory	   aids	   has	   focussed	   on	   NeuroPage	  
(Wilson,	   Emslie,	   Quirk,	   &	   Evans,	   2001;	   Wilson,	   Emslie,	   Quirk,	   Evans,	   &	   Watson,	  
2005;	  Wilson	  et	  al.,	  1997),	  which	   is	  an	  alpha-­‐numeric	  paging	  system	  that	  provides	  
audio/vibration	  alerts	   (Hersh	  &	  Treadgold,	  1994).	  NeuroPage	  now	  also	  sends	  SMS	  
text	   messages	   to	   mobile	   phones,	   as	   well	   as	   pagers.	   Reminders	   are	   externally	  
programmed,	  and	  therefore	  NeuroPage	  does	  not	  require	  training	  or	  learning	  to	  be	  
used	  effectively	  (Kapur,	  Glisky,	  &	  Wilson,	  2004).	  Evidence	  shows	  NeuroPage	  assists	  
people	  with	  memory	   and	   planning	   problems	   following	  ABI,	   in	   achieving	   everyday	  
target	  behaviours,	  relative	  to	  baseline	  (Baldwin	  &	  Powell,	  2015;	  Dewar	  et	  al.,	  2014).	  
NeuroPage	  has	  been	  examined	   for	  use	   in	  participants	  with	  TBI,	  CVA,	  encephalitis,	  
children	   and	   adolescents	   (Emslie,	   Wilson,	   Quirk,	   Evans,	   &	   Watson,	   2007;	   Fish,	  
Manly,	   Emslie,	   Evans,	  &	  Wilson,	   2008;	  Wilson,	   2009;	  Wilson,	   Emslie,	  Quirk,	   et	   al.,	  
2005).	   Fish	   et	   al.	   (2008)	   found	   that	  NeuroPage	  was	   effective	   in	   compensating	   for	  
everyday	  memory	   and	   planning	   problems	   in	   a	  mixed	  ABI	   sample,	   and	   found	   that	  
both	   TBI	   and	   CVA	   groups	   had	   short-­‐term	   benefits.	   The	   TBI	   group	   had	   greater	  
maintenance	   of	   pager-­‐related	   benefits	   associated	   with	   increased	   executive	  
functioning,	  whilst	  CVA	  group	  performance	  returned	  to	  baseline.	   
	  
The	   use	   of	   Google	   Calendar	   as	   a	   cost-­‐effective	   electronic	   memory	   aid	   has	   been	  
investigated	  in	  people	  with	  ABI.	  At	  the	  time,	  Google	  offered	  a	  free	  of	  charge	  service	  
that	   sent	   out	   pre-­‐programmed	   timed	   text	   reminders	   directly	   to	   client’s	   mobile	  
phone.	  Google	  calendar	  was	   found	   to	  be	  more	  effective	   than	  paper-­‐based	  aids	   in	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supporting	   prospective	   intentions	   (A.	   McDonald	   et	   al.,	   2011),	   and	   reducing	   the	  
forgetting	   of	   target	   behaviours	   (Baldwin	   &	   Powell,	   2015).	   Mobile	   phones	   and	  
smartphones	   are	   ubiquitous	   in	   the	   general	   population,	   and	   are	   therefore	  
increasingly	   attractive	   for	   use	   as	   memory	   aids.	   Additionally	   mobile	   phones	   are	  
highly	   portable,	   socially	   acceptable	   and	   cost	   effective	   (Dewar	   et	   al.,	   2014).	   Early	  
mobile	  phone	  studies	  evaluated	  the	   impact	  of	  SMS	  text	  message	  reminders	  to	  act	  
as	  a	  memory	  prompt	  for	  everyday	  tasks,	  planning	  and	  organisation	  skills	  (Stapleton,	  
Adams,	  &	  Atterton,	  2007;	  Wade	  &	  Troy,	  2001).	  	  Smartphone	  technology	  has	  created	  
a	   PDA-­‐style	   memory	   aid	   within	   our	   mobile	   phones.	   The	   reminder	   functions	   on	  
smartphones	   have	   been	   found	   to	   improve	   compliance	   in	   healthcare	   settings	  
(Prasad	   &	   Anand,	   2012),	   and	   everyday	   more	   “apps”	   are	   becoming	   available,	  
including	  reminder	  functions	  that	  can	  even	  remind	  you	  to	  do	  a	  specific	  task	  when	  
you	   arrive	   at	   a	   certain	   location.	   However,	   despite	   this	   advance	   of	   technology,	  
people	  with	  moderate-­‐severe	  cognitive	  impairments	  still	  need	  to	  be	  trained	  in	  how	  
to	   use	   them	   as	   an	   effective	   memory	   aid	   (Svoboda,	   Richards,	   Leach,	   &	   Mertens,	  
2012).	  The	  NeuroPage	  experience	  showed	  that	   its	  effectiveness	  depended	  on	  first	  
establishing	  what	  is	  important	  for	  the	  user,	  programming	  accordingly,	  and	  ensuring	  
that	  the	  person	  actually	  uses	  the	  system	  (Baddeley,	  Eysenck,	  &	  Anderson,	  2014).	  
	  
1.4.2	   Effectiveness	  of	  memory	  rehabilitation	  for	  people	  with	  MS	  
The	  effects	  of	  neuropsychological	  rehabilitation	  in	  people	  with	  MS	  have	  not	  been	  as	  
widely	   studied	   as	   they	   have	   in	   acquired	   brain	   injury,	  where	   the	   advantages	   have	  
been	  more	  extensively	  evaluated	  (Rosti-­‐Otajärvi	  &	  Hämäläinen,	  2014).	  Although	  the	  
findings	  from	  individual	  studies	  appear	  promising,	  reviews	  of	  memory	  rehabilitation	  
in	  people	  with	  MS	  have	   indicated	   that	   the	  effectiveness	  of	  memory	   rehabilitation	  
programmes	  is	  far	  from	  conclusive	  (Carr,	  das	  Nair,	  Schwartz,	  &	  Lincoln,	  2014).	  
	  
A	   recent	   Cochrane	   review	   by	   das	   Nair,	   Ferguson,	   Stark,	   and	   Lincoln	   (2012)	  
evaluated	   the	   effectiveness	   of	   memory	   rehabilitation	   for	   people	   with	   MS.	   Eight	  
studies	   were	   included	   in	   the	   review,	   4	   studies	   included	   teaching	   in	   the	   use	   of	  
internal	  and	  external	  memory	  aids;	  3	  studies	  employed	  computerised	  memory	  and	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attention	  retraining	  packages;	  and	  one	  study	  used	  story	  memory	  technique,	  the	  use	  
of	  imagery	  and	  story	  generation.	  das	  Nair	  et	  al.	  (2012)	  concluded	  that	  there	  was	  no	  
evidence	  to	  support	  the	  effectiveness	  of	  memory	  rehabilitation	  for	  people	  with	  MS.	  
The	   authors	   stated	   that	   the	   findings	  were	   probably	   due	   to	   the	   limited	   quality	   of	  
some	  of	  the	  primary	  studies	  in	  the	  literature	  and	  concluded	  that	  robust	  RCTs,	  with	  
high	   quality	   methodologies	   and	   reporting,	   were	   needed.	   However,	   a	   qualitative	  
meta-­‐synthesis	   of	   group-­‐based	   memory	   rehabilitation	   for	   people	   with	   long-­‐term	  
neurological	  conditions	  found	  that	  programmes	  had	  a	  positive	  impact	  on	  daily	  life.	  
Changes	   were	   seen	   in	   personal,	   inter-­‐personal	   and	   professional	   spheres,	   and	  
therefore	   the	   programme	   gave	   positive	   outcomes	   (das	   Nair,	   Martin,	   &	   Sinclair,	  
2015).	   Similar	   findings	  were	   reported	   in	   an	   individual	   qualitative	   study	  evaluating	  
memory	  rehabilitation	  for	  people	  with	  neurological	  disabilities	  (das	  Nair	  &	  Lincoln,	  
2013).	  	  
	  
External	   memory	   aids	   are	   the	   most	   effective	   and	   widely	   used	   intervention	   for	  
rehabilitation	  of	  memory	  impairments	  (Sohlberg,	  2005;	  Sohlberg	  et	  al.,	  2007).	   In	  a	  
review	  on	  the	  effectiveness	  of	  cognitive	  rehabilitation	  for	  ABI,	  Cicerone	  et	  al.	  (2011)	  
indicated	  there	  was	  evidence	  to	  support	  training	  using	  internal	  and	  external	  aids	  for	  
people	  with	  mild	  memory	   impairments.	  Cicerone	  et	  al.	   (2011)	  also	   recommended	  
that	  people	  with	  moderate	  to	  severe	  memory	  problems	  should	  receive	  training	   in	  
the	   use	   of	   external	   compensatory	   strategies,	   linked	   to	   functional	   activities.	   This	  
notion	   is	   supported	   by	   McKerracher	   et	   al.	   (2005),	   who	   stated	   that	   internal	  
mnemonics	   such	   as	   visual	   imagery,	   tend	   not	   to	   be	  maintained	   or	   translatable	   to	  
real-­‐life	   problems,	   especially	   in	   people	   with	   severe	  memory	   problems.	   Individual	  
studies	   in	   MS	   report	   that	   people	   who	   received	   compensatory	   memory	  
rehabilitation	  reported	  significantly	  less	  emotional	  distress	  than	  those	  who	  received	  
restitution	  (Martin,	  Lincoln,	  &	  das	  Nair,	  2014).	  However,	  a	  recent	  study	  compared	  
the	  restitution	  and	  compensatory	  approaches	  in	  a	  group	  trial	  with	  people	  with	  MS,	  
and	   found	   there	  was	  no	  difference	   in	  outcomes	  measuring	   self-­‐reported	  memory	  
problems,	  mood	  or	  activities	  of	  daily	  living	  (M.	  O'Brien	  et	  al.,	  2013).	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1.5	   Rationale	  for	  current	  study	  
Therefore	   the	   literature	   suggests	   that	   memory	   impairment	   is	   a	   major	   factor	   in	  
determining	   the	   quality	   of	   life	   of	   people	   with	   MS.	   The	   majority	   of	   research	   on	  
electronic	  memory	  aids	  has	  been	  on	  people	  with	  ABI,	  and	  there	  is	  an	  evidence-­‐base	  
for	  their	  effectiveness	  in	  supporting	  everyday	  memory	  functioning	  (Charters,	  Gillett,	  
&	  Simpson,	  2015).	  There	  is	  some	  suggestion	  that	  compensatory	  strategies,	  such	  as	  
memory	  aids,	  could	  be	  effective	  in	  reducing	  everyday	  memory	  problems	  in	  people	  
with	  MS.	  However	  the	  quality	  of	  research	  in	  this	  area,	  and	  cognitive	  rehabilitation	  in	  
general,	  is	  poor.	  Therefore	  the	  next	  chapter	  documents	  a	  systematic	  review	  on	  the	  
effectiveness	  of	  external	  memory	  aids	  for	  people	  with	  MS.	  
	  
NeuroPage	  has	  the	  most	  evidence	  of	  effectiveness	  of	  any	  assistive	  technology,	  and	  
the	   most	   compelling	   evidence	   regarding	   rehabilitation	   of	   prospective	   memory	  
comes	   from	   studies	   using	   automated	   reminders	   for	   specific	   activities	   (Fish	   et	   al.,	  
2010;	   Wilson	   et	   al.,	   2001).	   Although	   there	   are	   increasingly	   sophisticated	  
developments	   in	   assistive	   technology,	   such	   as	   smart	   phones	   and	  mobile	   phones,	  
there	  is	  often	  little	  effort	  to	  assess	  their	  usefulness	  (Baddeley	  et	  al.,	  2014).	  Martin-­‐
Saez,	   Deakins,	   Winson,	   Watson,	   and	   Wilson	   (2011)	   reviewed	   NeuroPage,	  
considering	   more	   recent	   available	   technology,	   e.g.	   smartphones,	   and	   concluded	  
that	  the	  service	  continued	  to	  have	  a	  role	  within	  cognitive	  rehabilitation.	  However,	  
no	   studies	  have	  explicitly	   studied	   the	  effectiveness	  of	  NeuroPage	   for	   people	  with	  
MS,	   and	   they	   have	   all	   compared	   the	   intervention	   to	   usual	   care,	   and	   so	   it	   is	   not	  
understood	   which	   element	   of	   the	   intervention	   is	   most	   useful.	   Furthermore,	   the	  
impact	  of	  NeuroPage	  on	  non-­‐memory	  aspects	  of	  daily	   life	  such	  as	  mood,	  have	  not	  
yet	  been	  evaluated;	  nor	  has	  qualitative	  research	  been	  undertaken	  on	  NeuroPage	  to	  
date.	  Systematic	   reviews,	   such	  as	  A.	  O'Brien	  et	  al.	   (2008),	  have	  stated	   that	   future	  
research	   should	   use	   empirically	   supported	   cognitive	   rehabilitation	   protocols	   and	  
replicate	   interventions	   that	   have	   shown	   effectiveness	   in	   other	   neurological	  
populations	   who	   commonly	   exhibit	   cognitive	   impairments.	   Therefore	   this	   study	  
evaluated	  the	  effectiveness	  of	  the	  well-­‐established	  NeuroPage,	  for	  people	  with	  MS.	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In	  response	  to	  the	  request	  for	  more	  methodologically	  robust	  trials	  (das	  Nair	  et	  al.,	  
2012),	   this	   study	   employed	   a	   randomised	   controlled	   crossover	   design,	   comparing	  
the	  intervention	  to	  an	  active	  control.	  The	  trial	  was	  designed	  to	  evaluate	  feasibility,	  
and	   the	   active	   control	   was	   intended	   to	   explore	   whether	   alerting	   is	   sufficient,	   or	  
whether	  the	  reminder	  content	  is	  necessary	  for	  benefit.	  The	  literature	  suggests	  that	  
attention	  and	  executive	  functioning	  impact	  on	  memory	  performance,	  and	  so	  these	  
abilities	  were	  measured	  at	  baseline.	  Furthermore	  mood,	  everyday	  functioning	  and	  
quality	  of	   life	   are	   impacted	  by	  memory	  problems,	   and	   so	   these	  were	  assessed	  as	  
outcome	  measures,	  alongside	  everyday	  memory	  performance.	  Subjective	  outcome	  
measures	  were	  employed,	   to	   capture	   the	   impact	  of	   the	   intervention	  on	  everyday	  
functioning,	  rather	  than	  memory	  performance	  on	  objective	  measures.	  Additionally,	  
outcome	  measures	  used	  were	  those	  frequently	  employed	  in	  memory	  rehabilitation	  
studies,	   in	   order	   to	   facilitate	   future	   meta-­‐analysis	   of	   pooled	   data	   in	   systematic	  
reviews.	  Finally,	  the	  effectiveness	  of	  memory	  rehabilitation	  has	  been	  largely	  based	  
on	  randomised	  controlled	  trials	  and	  has	  been	  inconclusive,	  however	  patient	  reports	  
based	   on	   qualitative	   studies	   have	   been	   more	   positive.	   Therefore	   following	   trial	  
completion,	  participants	  were	  invited	  to	  take	  part	  in	  feedback	  interviews	  to	  gather	  
their	  perspectives.	  
	  
1.5.1	   Aims	  and	  objectives	  of	  the	  study	  
• Evaluate	  whether	  people	  with	  MS	  who	  used	  NeuroText	  memory	  text	  messages	  
show	   reduced	   subjective	   reports	   of	   memory	   problems	   in	   daily	   life	   in	  
comparison	  with	  social	  text	  messages	  
• Evaluate	  whether	  people	  with	  MS	  who	  used	  NeuroText	  memory	  text	  messages	  
show	   increased	   attainment	   of	   personally	   identified	   target	   behaviours	   in	  
comparison	  with	  social	  text	  messages	  
• Evaluate	  whether	  people	  with	  MS	  who	  used	  NeuroText	  memory	  text	  messages	  
show	  improved	  mood	  and	  quality	  of	  life	  compared	  with	  social	  text	  messages.	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2	   Systematic	   Review:	   External	   memory	   aids	  
for	   memory	   problems	   in	   people	   with	   multiple	  
sclerosis	  
	  
2.1	   Abstract	  
2.1.1	   Background	  
Approximately	   40-­‐60%	   of	   people	   with	   Multiple	   Sclerosis	   (MS)	   have	   memory	  
problems,	  which	  are	  persistent	  and	  impact	  on	  their	  everyday	  functioning,	  mood	  and	  
ability	  to	  respond	  to	  rehabilitation.	  Evidence	  supports	  the	  use	  of	  external	  memory	  
aids	   in	  other	  patient	  groups,	  such	  as	  people	  with	  stroke	  and	  brain	   injury.	  There	   is	  
some	  suggestion	  that	  external	  memory	  aids	  may	  be	  effective	  in	  reducing	  everyday	  
memory	  problems	   in	  people	  with	  MS,	  however	  previous	  reviews	  on	  MS	  have	  only	  
included	  randomised	  controlled	  trials.	  	  Therefore	  this	  review	  included	  research	  that	  
employed	  other	  methodologies.	  
2.1.2	   Objectives	  
The	  aim	  was	  to	  assess	  the	  efficacy	  of	  external	  memory	  aids	  for	  people	  with	  MS	  for	  
improving	  memory	  functioning,	  mood,	  quality	  of	  life	  and	  coping	  strategies.	  
2.1.3	   Search	  methods	  
A	  systematic	  search	  was	  performed	  on	  seven	  electronic	  databases.	  
2.1.4	   Selection	  criteria	  
Intervention	  studies	  with	  at	  least	  75%	  people	  with	  MS	  were	  included.	  Interventions	  
included	   in	   this	   review	   involved	   training	   in	   the	   use	   of	   external	  memory	   aids,	   e.g.	  
diaries,	   and	   personal	   digital	   assistants.	   Studies	   involving	   general	   cognitive	  
rehabilitation	  programmes	  were	  included,	  providing	  they	  explicitly	  covered	  external	  
memory	  aids.	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2.1.5	   Data	  collection	  and	  analysis	  
Primary	   outcome	   measures	   were	   subjective	   reports	   of	   memory	   functioning	   and	  
secondary	   outcome	   measures	   were	   objective	   measures	   of	   memory	   functioning,	  
mood,	  quality	  of	   life	  and	  coping	  strategies.	  Two	  10-­‐point	  scales	  were	  used	  to	  rate	  
the	  quality	  of	   included	  studies:	  the	  SCED	  scale	  for	  single	  case	  experimental	  design	  
studies,	  and	  the	  PEDRO	  scale	  for	  group.	  
2.1.6	   Main	  results	  
Nine	  studies	   involving	  540	  participants	  with	  MS	  were	   included.	  	  The	   interventions	  
varied	   from	   general	   cognitive	   rehabilitation	   programmes	   to	   specific	   training	   on	   a	  
personal	  digital	  assistant.	  One	  single	  case	  experimental	  design	  (mean	  =	  8	  on	  SCED	  
scale)	  and	  eight	  group	  studies	  (mean	  =	  5	  on	  the	  PEDro	  scale)	  were	  included;	  six	  of	  
which	  were	  randomised	  trials.	  One	  study	  reported	  a	  significant	  effect	  of	  treatment	  
on	  subjective	  reports	  of	  memory	  functioning,	  and	  two	  reported	  a	  significant	  effect	  
on	  mood.	  Two	  studies	  reported	  a	  beneficial	  effect	  on	  the	  use	  of	  coping	  strategies.	  
No	  significant	  effect	  of	  intervention	  was	  found	  on	  objective	  measures	  of	  memory	  or	  
quality	  of	  life.	  	  
2.1.7	   Author’s	  conclusions	  
Only	   one	   study	   evaluated	   programmes	   solely	   focusing	   on	   the	   use	   of	   external	  
memory	   aids.	   The	   majority	   of	   studies	   involved	   comprehensive	   cognitive	  
rehabilitation	   programmes,	   and	   thus	  were	   aimed	   at	   tackling	   a	   range	   of	   cognitive	  
deficits.	   The	   methodological	   quality	   of	   included	   studies	   was	   poor.	   In	   conclusion,	  
there	   is	   insufficient	   evidence	   to	   support	   or	   refute	   the	   effectiveness	   of	   external	  
memory	  aids	  for	  improving	  memory	  function	  in	  people	  with	  MS.	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2.2	   Background	  
2.2.1	   Description	  of	  condition	  
Multiple	   Sclerosis	   (MS)	   is	   a	   neurodegenerative	   disease	   characterised	   by	   a	   wide	  
range	  symptoms	  that	  may	  include	  visual,	  motor	  and	  cognitive	  impairments	  (Gentry,	  
2008).	  Cognitive	   impairments,	   such	  as	  dysfunction	   in	  attention,	   executive	  abilities	  
and	  memory,	  are	  common	  in	  people	  with	  MS,	  with	  estimates	  of	  prevalence	  varying	  
from	   43%	   to	   72%	   (Prosiegel	  &	  Michael,	   1993).	  Memory	   problems	   are	   a	   common	  
cognitive	   complaint,	   with	   approximately	   40-­‐60%	   people	   with	   MS	   living	   with	  
memory	  difficulties	  (Rao,	  1995).	  These	  can	  be	  debilitating,	  persistent	  and	  frustrating	  
both	  to	  patients	  and	  carers	  (Williamson	  et	  al.,	  1996).	  
	  
Impairments	   in	   cognitive	   functioning	   are	   related	   to	   low	  mood	   (Gilchrist	  &	   Creed,	  
1994),	   and	   have	   the	   potential	   to	   affect	   independence	   in	   activities	   of	   daily	   living	  
(Langdon	   &	   Thompson,	   1996).	   Severe	   cognitive	   impairment	   presents	   a	   major	  
barrier	  to	  rehabilitation,	  because	  individuals	  may	  be	  unable	  to	  retain	  advice	  or	  have	  
difficulty	   acquiring	   new	   skills	   (Thomas	   et	   al.,	   2006).	   The	   safety	   of	   people	   with	  
memory	   deficits	   can	   also	   be	   compromised,	  making	   them	   vulnerable	   in	   the	   home	  
(e.g.	   forgetting	   to	   turn	   the	   oven	   off)	   and	   at	   work	   (e.g.	   forgetting	   deadlines).	  
Impairments	   in	   memory	   can	   have	   a	   detrimental	   effect	   on	   the	   psychological	  
wellbeing	   of	   people	   and	   others	   around	   them	   (Skeel	   &	   Edwards,	   2001),	   and	   have	  
significant	   long-­‐term	   effects	   on	   a	   person’s	   work	   and	   social	   life	   (Amato,	   Zipoli,	   &	  
Portaccio,	  2008).	  
	  
2.2.2	   Description	  of	  intervention	  
Cognitive	  rehabilitation	  is	  a	  process	  whereby	  people	  with	  neurological	  trauma	  and	  
clinicians	  work	  together	  as	  a	  team	  to	  remediate	  or	  alleviate	  the	  resulting	  cognitive	  
deficits	  (Wilson	  &	  Watson,	  1996).	  Cognitive	  rehabilitation	  aids	  the	  development	  of	  
functional	   independence	   and	   adjustment	   of	   individuals	   with	   brain	   damage	  
(Robertson,	  1993).	  Memory	  rehabilitation	  plays	  a	  large	  part	  in	  the	  management	  of	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people	   with	   memory	   problems	   and	   is	   administered	   as	   part	   of	   a	   comprehensive	  
programme	  or	  as	  an	  independent	  intervention	  (das	  Nair	  &	  Lincoln,	  2012).	  
	  
Cognitive	  rehabilitation	  literature	  is	  divided	  on	  what	  strategies	  work	  best	  for	  people	  
with	  cognitive	  impairment	  (das	  Nair	  et	  al.,	  2012).	  Restoration	  focuses	  on	  improving	  
a	   specific	   cognitive	   function,	   potentially	   forcing	   a	   damaged	  neural	   circuit	   to	  work	  
through	   regeneration.	   Compensation	   focuses	   on	   teaching	   people	   to	   adapt	   to	   the	  
presence	  of	  a	  cognitive	  impairment,	  probably	  employing	  other	  undamaged	  circuits	  
to	   perform	   a	   task	   (H.	   Cohen,	   1999).	   Restitution	   approaches	   typically	   involve	  
retraining	   exercises.	   Compensation	   is	   achieved	   through	   teaching	   people	   to	   use	  
internal	   strategies	   such	   as	   mnemonics,	   or	   external	   strategies	   e.g.	   environmental	  
adaptation	   or	   external	   memory	   aids.	   Wilson	   (2009)	   claimed	   there	   is	   insufficient	  
evidence	   for	   recovery	  of	  memory	   function	  after	   the	   spontaneous	   recovery	  period	  
and	  therefore	  promoted	  the	  use	  of	  compensatory	  strategies.	  Traditionally	  memory	  
rehabilitation	   has	   focussed	   on	   teaching	   people	   to	   use	   compensatory	   strategies.	  
These	   include	  applying/	  using	   	   	   internal	  aids,	   such	  as	  mental	   imagery,	  mnemonics	  
and	   rehearsal;	   or	   external	   memory	   aids,	   such	   as	   diaries,	   lists	   and	   notice	   boards.	  
These	   aids	   aim	   to	   help	   people	   with	   memory	   impairments	   remember	   and	   recall	  
information	  in	  their	  daily	   lives.	  Recently	  technology	  has	  enabled	  the	  use	  of	  paging	  
systems	   (Wilson	   et	   al.,	   2001),	   mobile	   phones	   and	   palmtop	   devices	   to	   reduce	  
prospective	  memory	  problems.	  	  
	  
Cicerone	   et	   al.	   (2005)	   conducted	   a	   narrative	   review	   and	   reported	   cognitive	  
rehabilitation	  to	  be	  beneficial	  for	  treating	  cognitive	  deficits	  following	  brain	  damage.	  
The	   updated	   review	   (Cicerone	   et	   al.,	   2011)	   recommended	   the	   use	   of	   external	  
compensatory	  devices	  for	  people	  with	  memory	  problems	  following	  traumatic	  brain	  
injury	  (TBI)	  or	  stroke;	  while	  another	  review	  (de	  Joode,	  van	  Heugten,	  Verhey,	  &	  van	  
Boxtel,	   2010)	   found	  assistive	   technology,	   such	  as	  personal	   digital	   assistants	   (PDA)	  
reduced	   prospective	  memory	   problems	   after	   acquired	   brain	   injury	   (ABI).	   A	  more	  
recent	   systematic	   review	   (Jamieson,	   Cullen,	   McGee-­‐Lennon,	   Brewster,	   &	   Evans,	  
2014)	  performed	  a	  meta-­‐analysis	  including	  seven	  group	  studies	  and	  concluded	  that	  
there	   was	   strong	   evidence	   for	   the	   efficacy	   of	   prospective	   memory	   prompting	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devices	  for	  people	  with	  ABI	  or	  degenerative	  diseases.	  This	  suggested	  that	  prosthetic	  
technology	   improves	   the	   performance	   of	   everyday	   tasks	   requiring	   memory.	  
Jamieson	  et	  al.	   (2014)	  only	  reviewed	  one	  study	  that	   included	  people	  with	  MS	  and	  
concluded	   that	   there	   was	   a	   specific	   need	   for	   the	   investigation	   of	   technology	   for	  
people	  with	  degenerative	  diseases.	  
	  
Recommendations	  for	  the	  provision	  of	  cognitive	  rehabilitation	  for	  people	  with	  MS	  
have	  largely	  been	  based	  on	  single	  case	  experimental	  designs	  and	  controlled	  clinical	  
trials	   (CCT).	   A	   systematic	   review,	   (A.	   O'Brien	   et	   al.,	   2008),	   concluded	   there	   was	  
insufficient	   evidence	   to	   support	   or	   refute	   the	   effectiveness	   of	   memory	  
rehabilitation	   for	   people	   with	   MS,	   due	   to	   small	   sample	   sizes,	   inadequate	  
randomisation	   and	   blinding	   procedures	   and	   impairment-­‐level	   outcome	  measures.	  
In	   a	   Cochrane	   review	   of	   Neuropsychological	   Rehabilitation	   for	  MS,	   Rosti-­‐Otajärvi	  
and	  Hämäläinen	   (2014)	   found	   that	   cognitive	   training	   improved	  memory	   span	  and	  
working	  memory,	  and	  when	  combined	  with	  other	  neuropsychological	  methods	  also	  
improved	  delayed	  memory.	  However,	  the	  authors	  concluded	  that	  the	  overall	  quality	  
of	   included	   studies	  was	   relatively	  poor	  due	   to	  methodological	   limitations	   and	   the	  
heterogeneity	   of	   interventions	   and	   outcome	   measures.	   Other	   Cochrane	   reviews,	  
such	   as	   das	   Nair	   et	   al.	   (2012)	   and	   Thomas	   et	   al.	   (2006),	   also	   stated	   that	   the	  
literature	   base	   examining	   the	   effectiveness	   of	   memory	   rehabilitation	   for	   people	  
with	  MS	  is	  weak	  and	  of	  poor	  quality,	  and	  concluded	  there	  is	  no	  evidence	  to	  support	  
or	   refute	   the	   effectiveness	   of	   memory	   rehabilitation.	   Furthermore,	   it	   is	   unclear	  
which	  elements	  of	  memory	  rehabilitation	  are	  most	  effective,	  for	  example,	  training,	  
mnemonics	   or	   external	  memory	   aids.	   das	  Nair	   et	   al.	   (2012)	   concluded	   that	  more	  
research	   is	   required	   to	  determine	  whether	  memory	   rehabilitation	   for	  people	  with	  
MS	  is	  effective	  in	  reducing	  memory	  problems.	  
	  
An	  expert	  panel	  underscored	  the	  need	  for	  cognitive	  rehabilitation	  interventions	  for	  
people	   with	   MS	   and	   recommended	   the	   use	   of	   compensatory	   devices	   (Multiple	  
Sclerosis	   Society,	   2006).	   Additionally	   research	   has	   shown	   that	   there	   is	   a	   high	  
frequency	  of	  spontaneous	  utilisation	  of	  strategies	  to	  deal	  with	  cognitive	  difficulties	  
in	  people	  with	  MS,	  with	  the	  most	  common	  being	  the	  use	  of	  external	  memory	  aids	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(Sullivan,	  Edgley,	  &	  Dehoux,	  1990).	  There	  is	  insufficient	  evidence	  to	  support	  the	  use	  
of	  compensation	  strategies	  for	  memory	  problems	  in	  people	  with	  MS	  (das	  Nair	  et	  al.,	  
2012).	   Compensatory	   strategies	   for	   memory	   impairment	   have	   been	  more	   widely	  
examined	   in	  people	  with	   stroke	  or	  TBI.	  Wilson	  et	  al.	   (2001)	  examined	  an	  external	  
memory	  aid,	  NeuroPage,	  which	  sends	  specific	  reminders	  regarding	  important	  tasks	  
to	   patients’	   individual	   pagers	   or	   mobile	   phones.	   NeuroPage	   was	   found	   to	  
significantly	   reduce	   failures	   of	  memory	   in	   people	  with	   brain	   injury	   (Wilson	   et	   al.,	  
2001),	   and	   improvements	   were	   maintained	   at	   follow-­‐up.	   A	   recent	   study	   further	  
supports	   the	   use	   of	   external	   memory	   aids,	   finding	   that	   occupational	   therapy	  
training	   in	   the	  use	  of	   a	   handheld	   computer	   improved	  ABI	   patients’	   daily	  memory	  
function	  more	  than	  standard	  rehabilitation,	  (Lannin	  et	  al.,	  2014).	  	  
	  
2.2.3	   Why	  is	  it	  important	  to	  do	  this	  review	  
There	   is	   some	  suggestion	   that	  external	  memory	  aids	  may	  be	  effective	   in	   reducing	  
everyday	  memory	  problems	  in	  people	  with	  MS	  (das	  Nair	  &	  Lincoln,	  2012).	  A	  recent	  
Cochrane	  review	  (das	  Nair	  et	  al.,	  2012)	  investigated	  the	  evidence	  base	  for	  memory	  
rehabilitation	  for	  people	  with	  MS.	  However,	  most	  of	  the	  literature	  on	  memory	  aids	  
did	  not	  employ	  RCT	  designs,	   and	   so	  was	  not	   included	   in	   the	  Cochrane	   reviews.	  A	  
systematic	   review	   of	   external	   memory	   aids	   for	   cognitive	   problems	   in	   a	   clinical	  
population	   of	  mixed	   aetiologies	   (Gillespie,	   Best,	   &	   O'Neill,	   2012)	   highlighted	   that	  
most	  studies	  have	  been	  qualitative	  or	  single	  subject	  designs.	  Therefore	  the	  present	  
systematic	   review	   evaluated	   research	   that	   employed	   other	   quantitative	  
methodologies,	   such	   as	   quasi-­‐experimental	   designs	   and	   single	   case	   experimental	  
designs,	  as	  well	  as	  RCTs.	  This	  review	  supplements	  Jamieson	  et	  al.’s	  (2014)	  findings	  
by	   evaluating	   the	   effectiveness	   of	   all	   types	   of	   external	   memory	   aids	   not	   just	  
technological;	   specifically	   for	   people	   with	   MS;	   and	   included	   comprehensive	  
cognitive	   rehabilitation	   programmes,	   providing	   the	   use	   of	   memory	   aids	   was	  
included.	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2.3	   Objectives	  
The	  objectives	  were	  to	  test	  the	  following	  two	  hypotheses:	  
1. People	  with	  multiple	   sclerosis	  who	   received	   training	   in	   the	  use	  of	  external	  
memory	  aids	  showed	  better	  outcomes	  in	  their	  subjective	  report	  of	  memory	  
functions	   than	   those	   given	   other	   types	   of	   interventions	   or	   usual	   care	   or	   a	  
placebo	  control.	  
2. People	  with	  multiple	  sclerosis	  who	  received	  training	  on	  the	  use	  of	  external	  
memory	  aids	  had	  better	  objective	  memory	  performance,	  mood	  and	  quality	  
of	   life	   than	   those	   given	   other	   types	   of	   interventions	   or	   usual	   care	   or	   a	  
placebo	  control.	  
	  
2.4	   Methods	  
2.4.1	   Criteria	  for	  considering	  studies	  for	  this	  review	  
2.4.1.1	  Type	  of	  studies	  
Studies	   evaluating	   the	   effectiveness	   of	   interventions	  were	   considered	   for	   review.	  
Therefore,	  randomised	  controlled	  trials	  (RCTs);	  controlled	  clinical	  trials;	  before	  and	  
after	  designs	   and	   single	   case	  experimental	   designs	   (SCED)	  were	   included.	  A	   study	  
was	  deemed	  to	  be	  a	  RCT	  on	  the	  basis	  that	  the	  individuals	  followed	  in	  the	  trial	  were	  
definitely	   or	   probably	   assigned	   prospectively	   to	   one	   of	   two	   (or	  more)	   alternative	  
forms	  of	  health	  care	  using	  random	  allocation	   (Higgins	  &	  Green,	  2013).	  Single	  case	  
experimental	  design	  studies	  were	  distinguished	  from	  descriptive	  case	  reports	  by	  the	  
inclusion	   of	   a	   control	   condition	   either	   through	   multiple	   baseline	   measures	   or	   a	  
separate	  control	  measure	  that	  allowed	  the	  causal	  impact	  of	  the	  treatment	  efficacy	  
to	   be	   inferred,	   as	   in	   reversal/withdrawal	   (A-­‐B-­‐A)	   designs	   (Tate	   et	   al.,	   2008).	   AB	  
design	  SCEDs	  were	  also	  considered.	  Studies	  were	  included	  with	  any	  type	  of	  control	  
group	  (i.e.	  care	  as	  usual,	  standard	  care,	  placebo,	  waiting	  list,	  other	  rehabilitation	  or	  
intervention).	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2.4.1.2	  Type	  of	  participants	  
Studies	  in	  this	  review	  were	  limited	  to	  people	  with	  MS,	  regardless	  of	  clinical	  course	  
or	   length	   of	   time	   since	   diagnosis.	   Therefore	   studies	   that	   included	   participants	  
whose	  memory	   impairments	  resulted	   from	  TBI,	   stroke,	  brain	   tumour	  or	  any	  other	  
brain	  damage	  were	  excluded.	  In	  studies	  with	  mixed	  aetiology	  samples,	  studies	  were	  
included	  if	  the	  sample	  consisted	  of	  75%	  or	  more	  MS	  participants	  or	  a	  subgroup	  of	  
MS	  participants	  could	  be	  identified	  for	  which	  separate	  data	  were	  available.	  Memory	  
impairments	  were	  not	  defined	  in	  advance	  and	  it	  was	  assumed	  that	  people	  receiving	  
training	   on	   the	   use	   of	   external	   memory	   aids	   had	   memory	   impairments.	   Studies	  
were	   included	   if	   participants	   were	   18	   years	   or	   over,	   or	   if	   separate	   data	   were	  
available	  for	  those	  over	  18	  years.	  
	  
2.4.1.3	  Types	  of	  interventions	  
Interventions	   included	  in	  this	  review	  involved	  the	  use	  of,	  or	  training	   in	  the	  use	  of,	  
external	   memory	   aids,	   defined	   as	   any	   external	   means	   of	   compensating	   for	   a	  
memory	   deficit,	   e.g.	   diaries,	   PDAs,	   electronic	   calendars.	   Studies	   involving	   general	  
cognitive	   rehabilitation	   programmes	   covering	   other	   aspects	   of	   cognition,	   such	   as	  
executive	   function	  or	   visual	   perception;	   or	   other	   forms	  of	  memory	   rehabilitation,	  
such	   as	   training	   on	   internal	   strategies,	   were	   included	   provided	   they	   explicitly	  
provided	  training	  on	  the	  use	  of	  external	  memory	  aids.	  Studies	  were	  considered	  to	  
involve	  an	   intervention	   if	   the	   training	   took	  place	  over	  more	   than	  a	   single	   session.	  
Thus,	  single	  session	  experiments	  were	  not	  included.	  Pharmacological	  interventions	  
were	   not	   included.	  Where	   studies	   had	   active	   control	   groups,	   it	  was	   checked	   that	  
these	   groups	   contained	   no	  memory	   content,	   to	   allow	   pure	   comparison	   with	   the	  
treatment	  group.	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2.4.1.4	  Types	  of	  outcomes	  
Primary	  outcomes	  
The	  primary	  outcome	  was	  measures	  that	  directly	  assessed	  the	  degree	  of	  subjective	  
memory	  problems	  in	  everyday	  life.	  If	  more	  than	  one	  outcome	  measure	  was	  used	  to	  
measure	  this	  construct,	  the	  following	  hierarchy	  was	  used:	  
Everyday	   Memory	   Questionnaire	   (EMQ)	   (Sunderland,	   Harris,	   &	   Gleave,	   1984);	  
Cognitive	   Failures	  Questionnaire	   (Broadbent,	   Cooper,	   FitzGerald,	  &	  Parkes,	   1982);	  
Subjective	   Memory	   Questionnaire	   (Davis,	   Cockburn,	   Wade,	   &	   Smith,	   1995);	  
Memory	   Functioning	   Questionnaire	   (Gilewski,	   Zelinski,	   &	   Schaie,	   1990).	   This	   was	  
based	   on	   the	   degree	   to	   which	   the	   measure	   focussed	   on	   memory	   and	   the	  
psychometric	  properties.	  
Secondary	  outcomes	  
Secondary	  outcomes	  were	  measures	  of	  objective	  memory;	  mood;	  quality	  of	  life	  and	  
coping	   strategies	   for	  memory	   problems.	   If	  more	   than	  one	  outcome	  measure	  was	  
used	  to	  measure	  each	  construct,	  the	  following	  hierarchies	  were	  used:	  
i)	   Performance	  on	  memory	  tests	  such	  as,	  Wechsler	  Memory	  Scale	  (Wechsler,	  
1997)	   or	   newer	   versions	   of	   this	   test;	   The	   Cambridge	   Prospective	   Memory	   Test	  
(Wilson,	   Emslie,	   Foley,	   et	   al.,	   2005);	   Doors	   and	   People	   Memory	   Test	   (Baddeley,	  
Emslie,	   &	   Nimmo-­‐Smith,	   1994);	   Rivermead	   Behavioural	   Memory	   Test	   (RBMT)	  
(Wilson	  et	  al.,	  1985)	  or	  newer	  version	  of	  this	  test.	  
	  
ii)	   Mood,	   such	   as	   the	  General	   Health	  Questionnaire	   (GHQ)	   (Goldberg,	   1992);	  
Hospital	  Anxiety	  and	  Depression	  Scale	   (Zigmond	  &	  Snaith,	  1983);	  Beck	  Depression	  
Inventory	   (BDI)	   (Beck,	   Ward,	   &	   Mendelson,	   1961);	   State-­‐Trait	   Anxiety	   Inventory	  
(Spielberger,	  1983).	  
	  
iii)	   Quality	  of	  life,	  such	  as	  MS	  Quality	  of	  Life	  Inventory	  (LaRocca	  et	  al.,	  1996);	  MS	  
Impact	   Scale	   (Hobart,	   Lamping,	   Fitzpatrick,	   Riazi,	   &	   Thompson,	   2001);	   the	   Short	  
Form	  (SF-­‐36)	  (Ware	  &	  Kosinski,	  2001);	  EuroQoL	  (Brooks,	  1996).	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iv)	   Coping	  strategies	  for	  memory	  problems,	  such	  as	  the	  Adaptation	  to	  Memory	  
Difficulties	   Outcome	   Questionnaire	   (AMEDO)	   (Chouliara,	   2013);	   Memory	   Aids	  
Questionnaire	   (MAQ)	   (Wilson	   &	   Moffat,	   1984);	   The	   Strategy	   Subscale	   of	   the	  
Multifactorial	   Memory	   Questionnaire	   (MMQ-­‐Strategy)	   (Troyer	   &	   Rich,	   2002);	  
Internal	   &	   External	   Memory	   Aids	   Questionnaire	   (das	   Nair	   &	   Lincoln,	   2012);	  
Cognitive	  Strategies	  Questionnaire	   (CSQ)	   (Shevil	  &	  Finlayson,	  2010);	  PDA	  Checklist	  
(Gentry,	  2008).	  
	  
Hierarchies	  were	  established	  by	  considering	  the	  relevance	  of	  each	  measure	  to	  each	  
construct	   and	   psychometric	   properties	   in	   people	   with	  MS.	  MS	   specific	   measures	  
were	  placed	  above	  generic	  measures.	  General	  measures	  of	  constructs	  were	  placed	  
above	   specific	   measures.	   If	   no	   psychometric	   properties	   were	   available,	   the	  
hierarchy	  was	  decided	  through	  discussion	  between	  authors.	  
	  
2.4.2	   Search	  methods	  for	  identification	  of	  studies	  
The	   following	   electronic	   databases	   were	   searched	   and	   all	   potential	   studies	   were	  
identified	  by	  the	  reviewer	  (RAG).	  
	  
2.4.2.1	  Electronic	  searches	  
1.	  Cochrane	  Central	  Register	  of	  Controlled	  (CENTRAL)	  (The	  Cochrane	  Library,	  latest	  
issue)	  
2.	  MEDLINE	  (1966	  to	  August	  2014)	  
3.	  EMBASE	  (1980	  to	  August	  2014)	  
4.	   Cumulative	   Index	   to	   Nursing	   and	   Allied	   Health	   Literature	   (CINAHL)	   (1982	   to	  
August	  2014)	  
5.	  PsycInfo	  (1980	  to	  August	  2014)	  
6.	  Web	  of	  Science	  (January	  1981	  to	  August	  2014)	  
7.	  Psycbite	  (2004	  to	  August	  2014)	  
	  
The	  search	  strategy	  used	  and	  modified	  for	  all	  databases	  can	  be	  found	  in	  Appendix	  1.	  
	   31	  
2.4.2.2	  Searching	  other	  resources	  
Citation	  tracking	  of	  primary	  study	  articles	  was	  employed	  and	  the	  reference	  lists	  of	  
identified	   papers	   were	   searched	   for	   further	   relevant	   studies.	   Journals	   covering	  
relevant	   topics	   were	   identified	   and	   the	   contents	   of	   new	   volumes	   were	   hand	  
searched.	   Grey	   literature	   was	   accessed	   by	   searching	   GreyNet	  
(http://www.greynet.org/),	  Mednar	   (http://mednar.com/).	   The	   first	   four	   pages	   of	  
results	  on	  Google	  Scholar	  were	  searched,	  with	  date	   restricted	   from	  2010-­‐present,	  
(http://scholar.google.co.uk/);	  along	  with	  websites	  relevant	  to	  the	  topic	  area,	  such	  
as	   MS	   Society	   (http://mssociety.org.uk/)	   and	   MS	   Trust	   (http://MSTrust.org.uk/).	  
These	  websites	  were	   searched	  using	   combinations	   of	   the	   following	   search	   terms:	  
memory	   (memory;	   cognition;	   remember;	   remembering;	   recall;	   plan;	   planning);	  
multiple	  sclerosis	  (multiple	  sclerosis;	  MS);	  external	  aids	  (memory	  aids;	  external	  aids;	  
reminder	  systems;	  assistive	  technology;	  paging).	  
	  
2.4.3	   Data	  collection	  and	  analysis	  
2.4.3.1	  Selection	  of	  studies	  
The	   review	   primary	   author	   (RAG)	   developed	   the	   search	   strategy,	   following	  
consultation	   with	   a	   university	   librarian	   and	   using	   guidance	   from	   relevant	   past	  
reviews.	   She	   reviewed	   abstracts	   of	   studies	   identified	   by	   this	   strategy	   to	   identify	  
those	  appearing	  pertinent	  and	  systematically	  excluded	  studies	   that	  did	  not	   fit	   the	  
inclusion	   criteria:	   1.	   Less	   than	   75%	   participants	  with	  MS;	   2.	   Study	   design	   did	   not	  
evaluate	   the	   effectiveness	   of	   an	   intervention;	   3.	   Did	   not	   include	   use	   of	   external	  
memory	  aids	  in	  intervention.	  After	  this	  initial	  search,	  duplicate	  papers	  were	  filtered	  
out	  using	  endnote	  software	  (http://endnote.com).	  	  
	  
The	  studies	  that	  met	  the	  criteria	  were	  then	  subject	  to	  a	  full	  text	  review,	  using	  the	  
inclusion	  criteria	  again	  to	  select	  studies.	  Authors	  were	  contacted	  if	  clarification	  was	  
needed	   in	   order	   to	   reach	   the	   decision	   of	   whether	   or	   not	   their	   study	   fitted	   the	  
inclusion	   criteria,	   e.g.	   if	   it	  was	   unclear	  whether	   training	  on	   external	  memory	   aids	  
was	  provided.	  Authors	  were	   also	   contacted	   to	   retrieve	  MS	   subgroup	  data,	  where	  
published	  data	  sets	  were	  of	  mixed	  aetiology	  (less	  than	  75%	  participants	  with	  MS).	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2.4.3.2	  Data	  extraction,	  management	  and	  assessment	  of	  risk	  of	  bias	  
The	  methodological	  quality	  of	  each	  of	  the	  selected	  studies	  was	  assessed	  using	  the	  
PEDro	  or	  SCED	  scales	  (Maher,	  Sherrington,	  Herbert,	  Moseley,	  &	  Elkins,	  2003;	  Tate	  et	  
al.,	  2008).	  The	  main	  measures	  of	  trial	  quality	  were	  whether	  random	  allocation	  had	  
been	  concealed	  and	  whether	  outcomes	  were	  conducted	  blind	   to	  group	  allocation	  
(Maher	   et	   al.,	   2003).	   The	   inclusion	   of	   non-­‐RCTs	   in	   this	   review	   meant	   that	   some	  
studies	   did	   not	   have	   randomisation	   and	   blinding	   procedures,	   and	   these	   were	  
considered	  as	  lower	  quality.	  	  
	  
Data	  for	  the	  review	  were	  extracted	  using	  a	  pre-­‐prepared	  data	  extraction	  form	  that	  
included	  the	  following	  items:	  
Date,	  country	  and	  clinical	  setting	  of	  the	  study	  
Sample	  size	  (percentage	  of	  people	  with	  MS)	  
Numbers	  lost	  to	  follow	  up,	  at	  specific	  time	  points,	  by	  group	  
Adequacy	  of	  matching	  at	  baseline	  between	  groups	  
Inclusion	  and	  exclusion	  criteria	  
Method	  of	  diagnosing	  MS	  and	  memory	  problem	  
Description	   of	   intervention	   and	   control,	   including	   duration,	   frequency,	   intensity,	  
setting,	  and	  individual	  or	  group	  
Demographic	  characteristics	  of	  participants	  (age,	  gender,	  years	  since	  diagnosis,	  type	  
of	  MS,	  years	  of	  education)	  
Outcomes	  measured,	  whether	  primary	  or	  secondary	  and	  when	  they	  were	  recorded	  
Random	  sequence	  generation	  
Allocation	  concealment	  
Blinding	  of	  participants	  and	  personnel	  
Blinding	  of	  outcome	  assessment	  
Intention	  to	  treat	  analysis	  used	  
Incomplete	  data	  
Selective	  reporting	  
Other	  sources	  of	  bias	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Results	  for	  each	  outcome	  
Sample	  size	  justification	  
Reliability,	  validity	  and	  standardisation	  of	  new	  primary	  outcome	  measures	  
Appropriate	  analytical	  techniques	  applied,	  measures	  of	  variability,	  probability	  value	  
Key	  conclusions	  from	  authors	  
	  
These	   characteristics	   were	   judged	   on	   the	   basis	   of	   information	   provided	   in	   the	  
reports	   of	   the	   studies.	   Risk	   was	   assessed	   as	   being	   low,	   high	   or	   unclear	   if	   the	  
information	  available	  was	   insufficient	  to	  make	  this	   judgement,	  on	  the	  basis	  of	  the	  
following	   criteria:	   random	   sequence	   generation;	   allocation	   concealment;	   blinding;	  
incomplete	  outcome	  data;	   selective	   reporting.	   	   Two	  10-­‐point	   scales	  were	  used	   to	  
assess	  methodological	  quality:	  the	  PEDro	  Scale	  (Maher	  et	  al.,	  2003)	  was	  used	  to	  rate	  
the	   group	   studies	   and	   the	   SCED	   scale	   (Tate	  et	   al.,	   2008)	  was	  used	   for	   single	   case	  
experimental	  design	   studies.	   Previous	   research	  has	  established	   that	   there	   is	   good	  
inter-­‐rater	  reliability	  for	  both	  scales	  (Maher	  et	  al.,	  2003;	  Tate	  et	  al.,	  2008).	  	  
	  
Broadening	   the	   inclusion	   criteria	   to	   non-­‐RCT	   designs	   meant	   that	   studies	   without	  
control	  groups	  were	  included	  for	  evaluation	  in	  the	  review.	  Therefore	  it	  was	  decided	  
that	   performing	   a	   meta-­‐analysis	   on	   the	   data	   would	   be	   inappropriate	   and	  
inconsistent	  with	  the	  aims	  of	  the	  study.	  
	  
2.5	   Results	  
2.5.1	   Description	  of	  studies	  
2.5.1.1	  Results	  of	  the	  search	  
The	   search	   strategy	   identified	   1,171	   results	   for	   review.	   Appendix	   2	   provides	   a	  
flowchart	  demonstrating	  the	  search	  process.	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2.5.1.2	  Excluded	  studies	  
In	   total	   1,110	   studies	  were	   excluded	  on	   the	   basis	   of	   the	   criteria.	  During	   title	   and	  
abstract	   screening,	   1,093	   papers	   were	   excluded.	   Of	   these	   792	   studies	   were	  
excluded	   because	   they	   did	   not	   evaluate	   the	   effectiveness	   of	   an	   intervention;	   57	  
because	   the	   sample	   did	   not	   include	   people	   with	   MS;	   and	   244	   did	   not	   instruct	  
participants	  in	  the	  use	  of	  external	  memory	  aids.	  Fifty-­‐two	  duplicates	  were	  removed,	  
leaving	  26	  studies.	  	  
	  
Of	  the	  26	  studies	  that	  received	  full	  text	  review,	  17	  were	  excluded.	  These	  excluded	  
studies	   are	   summarised	   in	   Table	   1.	   Five	   studies	   were	   excluded	   as	   they	   did	   not	  
evaluate	  the	  effectiveness	  of	  an	  intervention	  (Beer	  &	  Kesselring,	  2009;	  das	  Nair	  et	  
al.,	  2012;	  Johnson	  et	  al.,	  2009;	  Kesselring,	  2004;	  E.	  M.	  Rosti-­‐Otajarvi	  &	  Hamalainen,	  
2011);	  eleven	  studies	  did	  not	   instruct	  participants	  on	   the	  use	  of	  external	  memory	  
aids	   (Allen,	  Goldstein,	  Heyman,	  &	  Rondinelli,	   1998;	  Allen,	   Longmore,	  &	  Goldstein,	  
1995;	   Brissart,	   Leroy,	   &	   Debouverie,	   2010;	   Brissart,	   Leroy,	   Morele,	   Baumann,	   &	  
Debouverie,	  2011;	  Brissart	  et	  al.,	  2013;	  Gich	  et	  al.,	  2011;	  Kardiasmenos	  et	  al.,	  2008;	  
Mantynen	  et	  al.,	  2014;	  Ramio	  et	  al.,	  2010;	  Solari	  et	  al.,	  2004;	  Topcular	  et	  al.,	  2010);	  
and	   one	   study	   was	   not	   yet	   published	   and	   data	   were	   not	   yet	   available	   from	   the	  
author	  (Ben	  Ari,	  Hertzman,	  Mosberg-­‐Galili,	  &	  Hellmann,	  2012).	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Table	  1:	  Characteristics	  of	  excluded	  studies	  
Study	  
	  
Reason	  for	  exclusion	  
Allen	  et	  al.	  (1995)	   Did	  not	  use	  external	  memory	  aids	  
Allen	  et	  al.	  (1998)	   Did	  not	  use	  external	  memory	  aids	  
Beer	  and	  Kesselring	  (2009)	   Did	  not	  evaluate	  the	  effectiveness	  of	  an	  intervention	  
Ben	  Ari	  et	  al.	  (2012)	   Conference	  abstract;	  full	  article	  not	  published	  yet;	  data	  not	  
available	  from	  author	  
Brissart	  et	  al.	  (2010)	   Did	  not	  use	  external	  memory	  aids	  
Brissart	  et	  al.	  (2011)	   Did	  not	  use	  external	  memory	  aids	  
Brissart	  et	  al.	  (2013)	   Did	  not	  use	  external	  memory	  aids	  
das	  Nair	  et	  al.	  (2012)	   Did	  not	  evaluate	  the	  effectiveness	  of	  an	  intervention	  
Gich	  et	  al.	  (2011)	   Did	  not	  use	  external	  memory	  aids	  
Johnson	  et	  al.	  (2009)	   Did	  not	  evaluate	  the	  effectiveness	  of	  an	  intervention	  
Kardiasmenos	  et	  al.	  (2008)	   Did	  not	  use	  external	  memory	  aids	  
Kesselring	  (2004)	   Did	  not	  evaluate	  the	  effectiveness	  of	  an	  intervention	  
Mantynen	  et	  al.	  (2014)	   Did	  not	  use	  external	  memory	  aids	  
Ramio	  et	  al.	  (2010)	   Did	  not	  use	  external	  memory	  aids	  
E.	  M.	  Rosti-­‐Otajarvi	  and	  
Hamalainen	  (2011)	  
Did	  not	  evaluate	  the	  effectiveness	  of	  an	  intervention	  
Solari	  et	  al.	  (2004)	   Did	  not	  use	  external	  memory	  aids	  
Topcular	  et	  al.	  (2010)	   Did	  not	  use	  external	  memory	  aids	  	  
	  
	  
2.5.1.3	  Included	  studies	  
The	  remaining	  9	  studies,	  were	  included	  in	  the	  review,	  and	  are	  detailed	  in	  Table	  2.	  
	  
Nine	  studies,	   including	  540	  participants	  with	  MS,	  met	  the	  inclusion	  criteria	  for	  this	  
review	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Gentry,	  2008;	  Jonsson,	  Korfitzen,	  
Heltberg,	  Ravnborg,	  &	  Byskovottosen,	  1993;	  Lincoln,	  Dent,	  &	  Harding,	  2003;	  Lincoln	  
et	   al.,	   2002;	   Shevil	  &	   Finlayson,	   2010;	   Stuifbergen	   et	   al.,	   2012;	   Tesar,	   Bandion,	  &	  
Baumhackl,	  2005).	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Six	  studies	  were	  from	  Europe	  (UK,	  Denmark,	  Austria)	  and	  three	  from	  the	  USA.	  Eight	  
studies	   were	   conducted	   in	   community	   settings	   and	   one	   was	   conducted	   in	   a	  
rehabilitation	  hospital.	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Table	  2:	  Characteristics	  of	  Included	  Studies	  
Study	  
	  
Methods	   Participants	   Interventions	   Outcomes	   Notes	  
Carr	  et	  al.	  
(2014)	  







n=48	  with	  MS	  
Randomised	  (A:24	  B:24)	  
Intention	  to	  treat	  analysis	  used	  
Mean	  age:	  54.3	  
Education	  years:	  14.6	  years	  
Groups	  comparable	  on	  all	  
variables	  
Groups:	  
A:	  Group	  memory	  rehabilitation,	  ten	  
1.5	  hour	  sessions.	  Combination	  of	  
restitution	  and	  compensation	  
strategies.	  
B:	  Waiting	  list	  control	  
Significant	  difference	  
between	  groups	  on	  GHQ-­‐
28	  at	  8	  months.	  
Non-­‐significant	  
differences	  between	  
groups,	  on	  EMQ	  or	  MS-­‐
Impact	  Scale	  at	  4	  or	  8	  
months,	  or	  GHQ-­‐28	  at	  4	  
months.	  
	  
Analysis	  used	  in	  
this	  review:	  A	  vs.	  
B.	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das	  Nair	  and	  
Lincoln	  (2012)	  








n=39	  with	  MS	  
Randomised	  (A:12	  B:17	  C:10)	  
Intention	  to	  treat	  analysis	  used	  
Mean	  age:	  47.2	  years	  
Education	  years:	  14.1	  years	  
Groups	  comparable	  on	  all	  
variables	  
Groups:	  
A:	  Compensation	  –	  how	  to	  use	  
external	  memory	  aids	  and	  taught	  
about	  internal	  memory	  aids	  
B:	  Restitution	  -­‐	  	  taught	  about	  internal	  
memory	  aids,	  exercises	  on	  encoding	  
and	  retrieval	  strategies,	  attention	  
retraining	  
C:	  Attention	  placebo	  –	  self-­‐help	  
group,	  relaxation	  techniques	  




compensation	  and	  control	  
group	  post-­‐treatment,	  on	  
EMQ,	  RBMT-­‐E,	  GHQ	  or	  




Analysis	  used	  in	  
this	  review:	  A	  vs.	  
C	  
	  
Gentry	  (2008)	   Before	  and	  after	  
group	  design	  
n=21	  
Intention	  to	  treat	  analysis	  not	  
used	  
Median	  age:	  50	  years	  
Median	  time	  since	  diagnosis:	  14	  
years	  
A:	  Pretraining,	  usual	  care	  (8	  weeks)	  
B:	  Individual	  format	  intervention	  
training:	  PDA	  installation	  and	  
demonstration	  of	  calendar	  and	  alarm	  
usage;	  enter	  feature	  tasks.	  (3	  weeks,	  
4	  visits:	  2x90	  minutes,	  2x60	  minutes)	  
C:	  Post-­‐training,	  can	  contact	  
administrator	  for	  questions	  (8	  weeks)	  
Non-­‐significant	  change	  
over	  time	  on	  the	  RBMT-­‐E	  
None	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n=40	  with	  MS	  (E:20;	  C:20)	  
hospital	  in-­‐pts	  (16	  +	  16	  
completed)	  
Intention	  to	  treat	  analysis	  not	  
used	  
Mean	  age:	  44.5	  (SD:	  8.3)	  
Education:	  11.5	  (SD:	  2.5)	  
Gender:	  19F,	  21M	  
Groups	  comparable	  on	  all	  
variables,	  except	  visuo-­‐spatial	  
memory	  and	  visual	  perception	  
(E	  group	  more	  impaired)	  
	  
Individual	  goal-­‐directed	  treatment	  
E:	  Compensation	  (internal	  and	  
external	  memory	  aids),	  substitution,	  
direct	  training	  and	  
neuropsychotherapy	  
C:	  Attention	  placebo	  –	  discussion	  and	  
games	  
1-­‐1.5hours	  3	  times	  a	  week;	  mean	  17.2	  
hours	  
	  
Short	  term	  effects:	  	  E	  
significantly	  effected	  
performance	  on	  BDI	  
Long	  term	  effects:	  E	  had	  a	  
significant	  effect	  on	  visuo-­‐
spatial	  and	  memory;	  C	  had	  
significant	  effect	  on	  BDI	  
(more	  depressed	  at	  
second	  follow-­‐up)	  
None	  
Lincoln	  et	  al.	  
(2002)	  








Randomised	  (A:82;	  B:79;	  C:79)	  
Completed	  (A:77;	  B:71;	  C:73)	  
Intention	  to	  treat	  analysis	  used	  
Mean	  age:	  43	  years	  
Age	  left	  education:	  16	  years	  
Groups	  comparable	  on	  all	  
baseline	  variables	  
Individual	  treatment	  
A:	  Only	  baseline	  assessment	  with	  no	  
feedback	  
B:	  Detailed	  cognitive	  assessment	  with	  
feedback	  
C:	  Detailed	  cognitive	  assessment	  with	  
feedback	  and	  training	  on	  internal	  and	  
external	  memory	  aids.	  
No	  significant	  differences	  
between	  groups	  on	  EMQ,	  
GHQ,	  SF-­‐36	  or	  MAQ	  at	  
follow-­‐up	  1	  or	  2	  for	  
patient	  or	  relative	  data	  
Analysis	  used	  in	  
this	  review:	  A	  vs.	  
C	  
	  
	   40	  




Design:	  AB	  Design	  
n=29	  
Mean	  age:	  43	  years	  
Age	  left	  education:	  16	  years	  
Individual	  treatment	  
A:	  Baseline	  
B:	  Detailed	  cognitive	  assessment	  with	  
feedback	  and	  training	  on	  internal	  and	  
external	  memory	  aids.	  
Significant	  reduction	  in	  
the	  frequency	  of	  memory	  
problems	  per	  week	  from	  
















Before	  and	  after	  
group	  design	  
n=41	  
Intention	  to	  treat	  analysis	  not	  
used	  
Mean	  age:	  52.4	  years	  
Time	  since	  diagnosis	  13	  years	  
Group	  format	  
Problem	  solving	  techniques,	  taught	  
internal	  and	  external	  strategies	  and	  
application.	  
5	  session,	  (2	  hours,	  weekly)	  
Significant	  change	  over	  
time	  on	  CSQ	  in	  
effectiveness	  of	  strategies	  
used,	  no	  significant	  effect	  
in	  number	  of	  strategies	  
used.	  Effect	  size	  small.	  
None	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Note:	   Tests	   used:	   EMQ:	   Everyday	   Memory	   Questionnaire;	   GHQ:	   General	   Health	   Questionnaire;	   RMBT-­‐E:	   Rivermead	   Behavioural	   Memory	   Test	   –	   Extended;	   BDI:	   Beck	  
Depression	   Inventory;	   SF-­‐36:	   Short	   Form;	  MAQ:	  Memory	   Aids	  Questionnaire;	   CSQ:	   Cognitive	   Strategies	  Questionnaire;	   DKEFS:	   Delis-­‐Kaplan	   Executive	   Function	   System;	  
Stuifbergen	  et	  
al.	  (2012)	  





Randomised	  (E:36;	  C:27)	  
Completed	  (E:33;	  C:25)	  
Intention	  to	  treat	  analysis	  used	  
Age:	  51-­‐60	  years	  (44%	  of	  
sample);	  36-­‐50	  years	  (43%	  of	  
sample);	  20-­‐35	  years	  (13%	  
sample)	  
Groups	  comparable	  on	  all	  
baseline	  variables	  except	  DKEFS	  
(C	  group	  scored	  higher)	  
Group	  format	  
8	  sessions	  (2	  hour	  sessions	  once	  a	  
week)	  
E:	  Training	  on	  use	  of	  compensatory	  
strategies	  including	  external	  memory	  
aids;	  computer	  assisted	  cognitive	  
training	  programme	  (home	  based	  
practice	  45	  minutes	  3	  times	  a	  week)	  
C:	  Wait	  list	  control	  
Significant	  interaction	  
effect	  of	  group	  and	  time	  










n=19	  (E:10;	  C:9)	  
Mean	  age:	  46	  years	  
Intention	  to	  treat	  analysis	  not	  
used	  
Groups	  comparable	  on	  baseline	  
variables	  
Group	  treatment	  
E:	  12	  one	  hour	  session	  in	  4	  weeks	  
Neuropsychological	  training	  
programme;	  computer	  based	  direct	  
functional	  training	  on	  compensatory	  
strategies:	  internal	  and	  external	  
memory	  supports.	  
C:	  Rehabilitation	  only	  (OT,	  PT,	  ST	  etc.)	  
No	  significant	  group	  x	  
time	  effects	  on	  BDI,	  VLT	  or	  
NVLT.	  
None	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MMQ-­‐Strategy:	   Strategy	   Subscale	   of	   the	   Multifactorial	   Memory	   Questionnaire;	   VLT:	   Verbal	   Learning	   Test;	   NVLT:	   Non-­‐verbal	   Learning	   Test.	   Other	   abbreviations:	   E:	  
Experimental;	  C:	  Control.	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Types	  of	  design	  
Six	   studies	  were	   RCTs	   (Carr	   et	   al.,	   2014;	   das	  Nair	  &	   Lincoln,	   2012;	   Jonsson	   et	   al.,	  
1993;	  Lincoln	  et	  al.,	  2002;	  Stuifbergen	  et	  al.,	  2012;	  Tesar	  et	  al.,	  2005).	  Two	  studies	  
employed	  before	  and	  after	  group	  designs	  (Gentry,	  2008;	  Shevil	  &	  Finlayson,	  2010),	  
and	  one	  study	  was	  a	  single	  case	  experimental	  design	  (SCED)	   (Lincoln	  et	  al.,	  2003).	  
Within	   the	   RCTs,	   the	   method	   of	   generating	   the	   randomisation	   schedule	   was	  
mentioned	  in	  all	  but	  one	  study	  (Tesar	  et	  al.,	  2005).	  Independent	  randomisation	  was	  
reported	  in	  three	  studies	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  
2002)	   and	   two	   studies	   used	   a	   closed	   envelope	   system	   (Jonsson	   et	   al.,	   1993;	  
Stuifbergen	  et	  al.,	  2012).	  Outcomes	  were	  assessed	  by	  an	   individual	  blind	  to	  group	  
allocation	  in	  five	  RCTs	  but	  not	  by	  Tesar	  et	  al.	  (2005).	  The	  SCED	  (Lincoln	  et	  al.,	  2003)	  
employed	  an	  AB	  design	  (where	  A=baseline	  and	  B=intervention)	  for	  29	  participants	  
within	  the	  treatment	  group	  of	  the	  randomised	  controlled	  trial	  (Lincoln	  et	  al.,	  2002).	  	  
	  
Types	  of	  participants	  
The	  diagnosis	  of	  participants	  was	  based	  on	  the	  Poser	  criteria	  (Poser	  et	  al.,	  1983)	  in	  
four	   studies	   (das	   Nair	   &	   Lincoln,	   2012;	   Lincoln	   et	   al.,	   2002;	   Lincoln,	   et	   al.,	   2003;	  
Tesar	   et	   al.,	   2005);	   the	   Jonsson	   et	   al.	   (1993)	   study	   used	   the	   Schumacher	   criteria	  
(Schumacher	  et	  al.,	  1965)	  and	  four	  studies	  relied	  on	  self-­‐reported	  diagnoses	  (Carr	  et	  
al.,	  2014;	  Gentry,	  2008;	  Shevil	  &	  Finlayson,	  2010;	  Stuifbergen	  et	  al.,	  2012).	   	  Seven	  
studies	  had	  mixed	  types	  of	  MS	  [relapsing	  remitting	  MS	  (RRMS),	  primary	  progressive	  
MS	  (PPMS)	  and	  secondary	  progressive	  MS	  (SPMS)]	  (Carr	  et	  al.,	  2014;	  Gentry,	  2008;	  
Lincoln	  et	  al.,	  2002;	  Lincoln	  et	  al.,	  2003;	  Jonsson	  et	  al.,	  1993);	  and	  [RRMS	  and	  SPMS]	  
(das	   Nair	   &	   Lincoln,	   2012;	   Tesar	   et	   al.,	   2005).	   The	   subtypes	   of	   MS	   were	   not	  
described	  by	  Shevil	  and	  Finlayson,	   (2010)	  or	  Stuifbergen	  et	  al.	   (2012).	  The	  sample	  
size	   in	  the	  studies	  varied	  from	  19	  (Tesar	  et	  al.,	  2005)	  to	  240	  (Lincoln	  et	  al.,	  2002);	  
the	   number	   of	   participants	   receiving	   active	   treatment	   similarly	   varied	   from	   10	  
(Tesar	  et	  al.,	  2005)	  to	  82	  (Lincoln	  et	  al.,	  2002).	  The	  majority	  of	  participants	  were	  in	  
their	  mid	  to	  late	  40s,	  with	  mean	  ages	  ranging	  from	  42.1	  years	  (Lincoln	  et	  al.,	  2002)	  
to	   54.3	   years	   (Carr	   et	   al.,	   2014).	   Eight	   studies	   reported	   there	   to	   be	   a	   higher	  
percentage	   of	   women	   than	   men	   in	   their	   samples,	   with	   percentage	   of	   women	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ranging	  from	  88%	  (Stuifbergen	  et	  al.,	  2012)	  to	  47%	  (Jonsson	  et	  al.,	  1993).	  Time	  since	  
diagnosis	  ranged	  from	  a	  mean	  of	  9	  years	  (Tesar	  et	  al.,	  2005)	  to	  15	  years	  (Jonsson	  et	  
al.,	  1993);	  and	  years	  of	  education	  varied	  from	  a	  mean	  of	  11.5	  years	  (Jonsson	  et	  al.,	  
1993)	   to	   the	   majority	   having	   BSc	   or	   postgraduate	   education	   (Stuifbergen	   et	   al.,	  
2012).	  In	  the	  six	  studies	  comparing	  performance	  between	  groups,	  four	  studies	  had	  
groups	  comparable	  at	  baseline	  on	  all	  variables	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  
2012;	   Lincoln	   et	   al.,	   2002;	   Tesar	   et	   al.,	   2005);	   the	   remaining	   two	   studies	   were	  
comparable	   on	   all	   baseline	   variables	   except	   visuo-­‐spatial	   and	   visual	   perception	  
(Jonsson	  et	  al.,	  1993)	  and	  executive	  function	  (Stuifbergen	  et	  al.,	  2012).	  
	  
Types	  of	  interventions	  
Four	   studies	   employed	   individual	   treatment	   (Gentry,	   2008;	   Jonsson	   et	   al.,	   1993;	  
Lincoln	  et	  al.,	  2002;	  Lincoln	  et	  al.,	  2003)	  and	  five	  studies	  used	  group	   interventions	  
(Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Shevil	  &	  Finlayson,	  2010;	  Stuifbergen	  et	  
al.,	  2012;	  Tesar	  et	  al.,	  2005).	  Two	  studies	  ran	  three-­‐group	  comparisons	  (das	  Nair	  &	  
Lincoln,	   2012;	   Lincoln	   et	   al.,	   2002)	   and	   three	   studies	   employed	   two-­‐group	  
comparisons	   (treatment	   vs.	   control)	   (Carr	   et	   al.,	   2014;	   Stuifbergen	   et	   al.,	   2012;	  
Tesar	   et	   al.,	   2005).	   Two	   studies	   evaluated	   the	   performance	   of	   one	   group:	   before	  
treatment	  and	  immediately	  after	  treatment	  (Gentry,	  2008);	  before	  treatment;	  after	  
post-­‐training	   period	   and	   at	   follow-­‐	   up	   (Shevil	   &	   Finlayson,	   2010).	   One	   study	  
evaluated	   performance	   at	   multiple	   time	   points	   at	   baseline	   and	   at	   multiple	   time	  
points	   during	   intervention	   (Lincoln	   et	   al.,	   2003).	   Most	   programmes	   were	   three	  
(Gentry,	  2008)	  to	  ten	  weeks	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012)	  long.	  Two	  
individual	   treatment	   studies	   specified	   that	   the	   time	  period	  was	  a	  maximum	  of	   six	  
months	  post-­‐assessment	   (Lincoln	   et	   al.,	   2002;	   Lincoln	   et	   al.,	   2003).	   Sessions	  were	  
between	   one	   hour	   (Tesar	   et	   al.,	   2005)	   and	   two	   hours	   (Shevil	   &	   Finlayson,	   2010;	  
Stuifbergen	   et	   al.,	   2012),	   and	   participants	   met	   1-­‐3	   times	   a	   week	   in	   all	   studies,	  
except	  two	  where	  it	  depended	  on	  the	  needs	  of	  the	  participant	  (Lincoln	  et	  al.,	  2002;	  
Lincoln	   et	   al.,	   2003).	   Eight	   studies	   employed	   comprehensive	   cognitive	  or	  memory	  
rehabilitation	   programmes,	   which	   all	   included	   teaching	   participants	   how	   to	   use	  
external	  memory	  aids,	  as	  well	  as	  internal	  memory	  strategies.	  Of	  these	  eight	  studies,	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five	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Jonsson	  et	  al.,	  1993;	  Stuifbergen	  et	  
al.,	  2012;	  Tesar	  et	  al.,	  2005)	  ran	  programmes	  that	  also	   included	  cognitive	  training,	  
such	   as	   computerised	   functional	   training	   and	   attention	   retraining.	  One	   study	   also	  
included	  a	   ‘neuropsychotherapy’	  component	   (Jonsson	  et	  al.,	  1993),	  and	  one	  study	  
provided	   psycho-­‐education	   (Shevil	   &	   Finlayson,	   2010).	   Six	   studies	   (Jonsson	   et	   al.,	  
1993;	  Lincoln	  et	  al.,	  2002;	  Lincoln	  et	  al.,	  2003;	  Shevil	  &	  Finlayson,	  2010;	  Stuifbergen	  
et	   al.,	   2012;	   Tesar	   et	   al.,	   2005)	   were	   cognitive	   rehabilitation	   programmes,	   which	  
were	  not	  specific	  to	  memory	  rehabilitation,	  therefore	  the	  amount	  of	  time	  dedicated	  
to	  memory	  rehabilitation,	  let	  alone	  external	  memory	  aids,	  is	  unknown.	  The	  study	  by	  
Gentry	   (2008)	   was	   the	   only	   one	   with	   the	   content	   solely	   confined	   to	   teaching	  
participants	  how	  to	  use	  external	  memory	  aids.	  This	  study	  involved	  the	  installation	  of	  
PDA	  software	  and	  demonstration	  of	  how	  to	  use	  calendar	  and	  alarm	  functions	  on	  a	  
PDA,	  followed	  by	  a	  post-­‐training	  period	  where	  administrative	  support	  was	  available	  
if	  needed.	  	  
	  
2.5.1.4	  Risk	  of	  bias	  in	  included	  studies	  
The	  risk	  of	  bias	  in	  the	  nine	  included	  studies	  was	  mixed,	  with	  high	  risk	  of	  detection	  
bias	  associated	  with	  the	  lack	  of	  blinding	  in	  one	  group	  study	  (Tesar	  et	  al.,	  2005),	  and	  
two	   group	   studies	   at	   high	   risk	   of	   selection,	   detection	   and	   performance	   bias	  
associated	   with	   the	   lack	   of	   a	   control	   group,	   and	   therefore	   absence	   of	  
randomisation,	   allocation	   and	   blinding	   procedures	   (Gentry,	   2008;	   Shevil	   &	  
Finlayson,	  2010).	  The	  risk	  of	  bias	  in	  the	  SCED	  (Lincoln	  et	  al.,	  2003)	  was	  considered	  to	  
be	  generally	   low,	  but	  with	  some	  risk	  of	  observer	  bias	  and	  bias	   in	  determining	   the	  
treatment	   efficacy	   due	   to	   it	   being	   AB	   design.	   The	   risk	   of	   bias	  was	   deemed	   to	   be	  
unclear	  in	  five	  studies,	  due	  to	  lack	  of	  information	  when	  reporting	  the	  methods	  used	  
for	   random	   sequence	   generation	   (Jonsson	   et	   al.,	   1993;	   Stuifbergen	   et	   al.,	   2012;	  
Tesar	  et	   al.,	   2005),	   blinding	   (Jonsson	  et	   al.,	   1993)	   and	  how	   incomplete	  data	  were	  
handled	  (Gentry,	  2008;	  Shevil	  &	  Finlayson,	  2010;	  Tesar	  et	  al.,	  2005).	  	  
	  
The	  methodological	   quality	  of	   group	   studies,	   using	   the	  PEDro	   scale	   (Maher	  et	   al.,	  
2003)	  are	   summarised	   in	  Table	  3,	  and	  single	  case	  experimental	  designs,	  using	   the	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SCED	  scale	  (Tate	  et	  al.,	  2008)	  in	  Table	  4.	  Group	  studies	  received	  a	  mean	  score	  of	  5	  
(S.D.=	  2.51;	  Range	  =	  2-­‐8)	  out	  of	  a	  possible	  10.	  The	  SCED	  scored	  8	  out	  of	  a	  possible	  
10.	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Table	  3:	  Risk	  of	  bias	  table	  for	  group	  studies,	  using	  the	  PEDro	  scale	  (Maher	  et	  al.,	  2003)	  
Criteria	  met	  on	  PEDro	  scale	   Carr	  et	  al.	  
(2014)	  
das	  Nair	  and	  
Lincoln	  (2012)	  








Tesar	  et	  al.	  
(2005)	  
Subjects	  were	  randomly	  
allocated	  into	  groups	  
Y	   Y	   N	   N	   Y	   N	   Y	   N	  
Allocation	  was	  concealed	   Y	   Y	   N	   Y	   Y	   N	   Y	   Y	  
Groups	  matched	  at	  baseline	   Y	   Y	   N	   Y	   Y	   N	   Y	   Y	  
Blinding	  of	  all	  subjects	   N	   N	   N	   N	   N	   N	   N	   N	  
Blinding	  of	  all	  therapists	  who	  
administered	  therapy	  
N	   N	   N	   N	   N	   N	   N	   N	  
Blinding	  of	  all	  assessors	   Y	   Y	   N	   N	   Y	   N	   Y	   N	  
Key	  outcome	  obtained	  from	  
more	  than	  85%	  subjects	  
N	   Y	   Y	   N	   Y	   Y	   Y	   N	  
Subjects	  received	  intended	  
condition	  or	  intention	  to	  treat	  
used	  
Y	   Y	   N	   N	   N	   N	   N	   N	  
Between-­‐group	  statistical	  
comparisons	  reported	  
Y	   Y	   N	   Y	   Y	   N	   Y	   Y	  
Point	  measures	  and	  measures	  
for	  variability	  provided	  
Y	   Y	   Y	   N	   Y	   Y	   Y	   Y	  
TOTAL	   7	   8	   2	   3	   7	   2	   7	   4	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Table	  4:	  Risk	  of	  bias	  table	  for	  single	  participant	  designs	  on	  the	  SCED	  scale	  (Tate	  et	  al.,	  2008)	  
Criteria	  met	  on	  the	  SCED	  scale	   Lincoln	  et	  al.	  (2003)	  
Target	  behaviours	  –	  precise	  and	  repeatable	  measures	   Y	  
3	  phases,	  study	  is	  A-­‐B-­‐A	  or	  multiple	  baseline	   N	  
Baseline	  (pre-­‐treatment).	  Sufficient	  sampling	   Y	  
Treatment	  phase.	  Sufficient	  sampling	   Y	  
Raw	  data	  points	  recorded	   Y	  
Inter-­‐rater	  reliability	  was	  established	  for	  at	  least	  one	  measure	   N	  
Independence	  of	  assessors	   Y	  
Statistical	  analysis	   Y	  
Replication	  either	  across	  subjects,	  therapists	  or	  settings	   Y	  
Evidence	  for	  generalisation	   Y	  
TOTAL	   8	  
	   50	  
Random	  sequence	  generation	  in	  group	  studies	  
Three	  group	  studies	  were	  judged	  to	  have	  a	  low	  risk	  of	  selection	  bias	  on	  the	  basis	  of	  
having	   adequate	   random	   sequence	   generation,	   using	   a	   computerised	   random	  
number	  generator	  by	  an	   independent	  agency	  or	   researcher	   (Carr	  et	  al.,	  2014;	  das	  
Nair	   &	   Lincoln,	   2012;	   Lincoln	   et	   al.,	   2002).	   Three	   studies	   were	   unclear	   in	   their	  
explanation	  of	  random	  sequence	  generation,	  and	  thus	  the	  risk	  of	  bias	  was	  unclear	  
(Jonsson	  et	  al.,	  1993;	  Stuifbergen	  et	  al.,	  2012;	  Tesar	  et	  al.,	  2005).	  Two	  studies	  had	  
no	  control	  group	  and	  therefore	  there	  was	  a	  high	  risk	  of	  selection	  bias	  (Gentry,	  2008;	  
Shevil	  &	  Finlayson,	  2010).	  	  
	  
Allocation	  in	  group	  studies	  
Six	  group	  studies	  were	  judged	  as	  having	  a	  low	  risk	  of	  selection	  bias	  on	  the	  basis	  of	  
adequate	   group	   allocation	   concealment	   using	   a	   computerised	   random	   number	  
generator	   by	   an	   independent	   unit	   (Carr	   et	   al.,	   2014;	   das	   Nair	   &	   Lincoln,	   2012;	  
Lincoln	  et	  al.,	  2002),	  having	  a	  separate	  member	  of	  staff,	  not	  involved	  with	  the	  study	  
to	   complete	   allocation	   (Tesar	   et	   al.,	   2005),	   or	   using	   a	   closed	   envelope	   system	  
(Jonsson	  et	   al.,	   1993;	   Stuifbergen	  et	   al.,	   2012).	   Two	   studies	  had	  no	   control	   group	  
and	   therefore	   there	   was	   a	   high	   risk	   of	   selection	   bias	   (Gentry,	   2008;	   Shevil	   &	  
Finlayson,	  2010).	  	  
	  
Blinding	  in	  group	  studies	  
Four	   group	   studies	  were	   single	   blind	   (Carr	   et	   al.,	   2014;	   das	  Nair	  &	   Lincoln,	   2012;	  
Lincoln	  et	  al.,	  2002;	  Stuifbergen	  et	  al.,	  2012),	   indicating	  a	   low	  risk	  of	  performance	  
and	   detection	   bias.	   Three	   studies	   had	   a	   high	   risk	   of	   bias	   (Gentry,	   2008;	   Shevil	   &	  
Finlayson,	  2010;	  Tesar	  et	  al.,	  2005)	  as	  they	  had	  no	  blinding	  procedures,	  and	  Jonsson	  
et	  al.	  (1993)	  provided	  an	  unclear	  description	  of	  the	  blinding	  procedures	  employed.	  	  
	  
Incomplete	  outcome	  data	  in	  group	  studies	  
Four	  group	  studies	  addressed	  incomplete	  data,	  indicating	  a	  low	  risk	  of	  attrition	  bias.	  
In	  one	  study	  (das	  Nair	  &	  Lincoln,	  2012),	  list-­‐wise	  deletion	  was	  utilised	  and	  baseline	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data	   were	   imputed	   for	   missing	   follow-­‐up	   data.	   In	   another	   study	   (Lincoln	   et	   al.,	  
2002),	   analysis	   covered	   just	   those	   who	   completed	   outcomes,	   however	   it	   also	  
included	  those	  who	  did	  not	  get	  the	  intervention	  as	  planned	  in	  an	  intention	  to	  treat	  
analysis.	  One	  study	  (Stuifbergen	  et	  al.,	  2012),	  replaced	  missing	  values	  with	  the	  last	  
observation	   value	   carried	   forward	   if	   the	   participant	   did	   not	   complete	   later	  
measurements,	  or	   imputed	  if	  an	   intermediate	  value	  was	  missing.	   In	  another	  study	  
(Carr	   et	   al.,	   2014),	   if	   missed	   items	   occurred	   for	   less	   than	   10%	   of	   questions	   in	   a	  
questionnaire,	  the	  missing	  item	  was	  replaced	  with	  the	  mean	  for	  the	  questionnaire.	  
The	  four	  remaining	  studies	  did	  not	  address	  incomplete	  data:	  two	  studies	  did	  not	  use	  
intention-­‐to-­‐treat	   analysis	   after	   reporting	   dropouts	   (Gentry,	   2008;	   Shevil	   &	  
Finlayson,	   2010)	   and	   two	   studies	   provided	   no	   explanation	   of	   how	   drop	   out	   data	  
were	   dealt	  with	   (Jonsson	   et	   al.,	   1993;	   Tesar	   et	   al.,	   2005),	   thus	   the	   risk	   of	   bias	   is	  
unclear.	  
	  
Selective	  reporting	  in	  group	  studies	  
There	  was	  no	  selective	  reporting	  in	  any	  of	  the	  nine	  studies,	  indicating	  a	  low	  risk	  of	  
reporting	  bias	  
	  
Risk	  of	  bias	  in	  SCED	  
The	  risk	  of	  bias	  in	  the	  one	  SCED	  study	  was	  generally	  low	  (Lincoln	  et	  al.,	  2003).	  The	  
measure	   of	   target	   behaviours	   was	   specified	   and	   the	   variability	   in	   behaviour	   was	  
established	   through	   sufficient	   sampling	   during	   baseline	   and	   treatment	   phase.	  
Verification	   of	   treatment	   efficacy	  was	   demonstrated	   using	   statistical	   analysis	   and	  
generalisation	   was	   assured	   through	   replication	   across	   subjects	   and	   transfer	   to	  
beyond	   target	   behaviours.	   However	   there	   was	   a	   high	   risk	   of	   bias	   in	   determining	  
treatment	  efficacy	  as	  an	  AB	  design	  was	  used.	  There	  was	  also	  a	  high	  risk	  of	  observer	  
bias,	  as	  inter-­‐rater	  reliability	  was	  not	  established	  for	  measures.	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2.5.2	   Effects	  of	  interventions	  
Parametric	   and	   nonparametric	   statistical	   analyses	  were	   used	   to	   compare	   groups.	  
Significance	  testing	  was	  reported	  in	  all	  studies,	  however	  the	  appropriate	  measures	  
of	  variability	  were	  not.	  	  
	  
2.5.2.1	  Outcome	  1:	  Subjective	  Memory	  Measures	  
Four	  studies	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  2002;	  Lincoln	  
et	  al.,	  2003)	  used	  subjective	  measures	  of	  participants’	  memory	   functioning.	  Three	  
studies	  used	  the	  EMQ	  (Sunderland	  et	  al.,	  1984)	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  
2012;	  Lincoln	  et	  al.,	  2002)	  and	  one	  study	  used	  diaries	  to	  record	  specific	  instances	  of	  
memory	  difficulties	   that	   interfered	  with	  daily	   life	   (Lincoln	  et	  al.,	   2003).	  One	   study	  
(Lincoln	  et	  al.,	  2003)	  found	  a	  significant	  effect	  of	  treatment	  on	  subjective	  memory	  
functioning,	   demonstrated	   by	   a	   significant	   reduction	   (p<0.01)	   in	   the	   frequency	   of	  
reported	   memory	   problems	   per	   week	   from	   baseline	   to	   intervention.	   Subgroup	  
analysis	  of	  MS	  participants	  from	  das	  Nair	  and	  Lincoln,	  (2012)	  detected	  no	  significant	  
effect	  of	  treatment;	  Carr	  et	  al.	  (2014)	  and	  Lincoln	  et	  al.	  (2002)	  found	  no	  significant	  
treatment	  effect.	  
	  
2.5.2.2	  Outcome	  2:	  Objective	  Memory	  Measures	  
Two	  studies	  (das	  Nair	  &	  Lincoln,	  2012;	  Gentry,	  2008)	  included	  objective	  measures	  of	  
memory;	   both	   used	   the	   RBMT-­‐E	   (Wilson	   et	   al.,	   1985).	   	   Subgroup	   analysis	   of	  MS	  
participants	   from	   das	   Nair	   and	   Lincoln	   (2012)	   showed	   no	   significant	   effect	   of	  
treatment;	  Gentry	  (2008)	  also	  found	  no	  significant	  long-­‐term	  effect.	  
	  
2.5.2.3	  Outcome	  3:	  Mood	  
Five	  studies	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Jonsson	  et	  al.,	  1993;	  Lincoln	  
et	   al.,	   2002;	   Tesar	   et	   al.,	   2005)	   included	   measures	   of	   participants’	   mood.	   All	  
measured	  mood	  both	   immediately	  after	   treatment	  and	   long-­‐term.	  Three	  of	   these	  
studies	  used	  the	  GHQ	  (Goldberg,	  1992)	  (Carr	  et	  al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  
Lincoln	  et	  al.,	  2002)	  and	  two	  used	  the	  BDI	  (Beck	  et	  al.,	  1987)	  (Jonsson	  et	  al.,	  1993;	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Tesar	  et	  al.,	  2005).	  A	  significant	  effect	  of	  intervention	  was	  found	  at	  long-­‐term	  follow	  
up	  in	  one	  study	  (Carr	  et	  al.,	  2014).	  Jonsson	  et	  al.	  (1993)	  found	  a	  significant	  effect	  of	  
treatment	  on	  mood,	  however	   it	  was	  due	  to	  the	  control	  group	  worsening	   in	  mood	  
over	  time.	  
	  
2.5.2.4	  Outcome	  4:	  Quality	  of	  Life	  
Two	  studies	   included	  a	  measure	  of	  quality	  of	   life	   (Carr	  et	  al.,	   2014;	   Lincoln	  et	  al.,	  
2002),	  using	  the	  MS	  Impact	  Scale	  (Hobart	  et	  al.,	  2001)	  (Carr	  et	  al.,	  2014),	  and	  the	  SF-­‐
36	  (Ware	  &	  Kosinski,	  2001)	  (Lincoln	  et	  al.,	  2002).	  No	  effect	  of	  treatment	  on	  quality	  
of	  life	  was	  found	  either	  immediately	  or	  long-­‐term.	  
	  
2.5.2.5	  Outcome	  5:	  Coping	  strategies	  for	  memory	  problems	  
Four	  studies	  (das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  2002;	  Shevil	  &	  Finlayson,	  2010;	  
Stuifbergen	  et	  al.,	  2012)	  used	  measures	  of	  coping	  strategies	  for	  memory	  problems.	  
One	  study	   (Shevil	  &	  Finlayson,	  2010)	   found	  a	  significant	   treatment	  effect	   (p<0.05)	  
on	  the	  effectiveness	  of	  strategies	  used	  on	  the	  CSQ,	  but	  no	  significant	  effect	  on	  the	  
number	   of	   strategies	   used.	   One	   study	   (Stuifbergen	   et	   al.,	   2012)	   detected	   a	  
significant	  treatment	  effect	  (p<0.01)	  on	  the	  use	  of	  compensatory	  strategies	  on	  the	  
MMQ-­‐Strategy	   (Troyer	   &	   Rick,	   2002).	   No	   significant	   treatment	   effect	   on	   coping	  
strategies	   was	   reported	   in	   two	   studies	   (das	   Nair	   &	   Lincoln,	   2012;	   Lincoln	   et	   al.,	  
2002)	  on	  the	  Internal	  and	  External	  Memory	  Aids	  Questionnaire	  (das	  Nair	  &	  Lincoln,	  
2012)	  and	  the	  Memory	  Aids	  Questionnaire	  (MAQ)	  (Wilson	  &	  Moffat,	  1984)	  (Lincoln	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2.6	   Discussion	  
2.6.1	   Summary	  of	  main	  results	  
Despite	  evidence	  demonstrating	  the	  existence	  of	  memory	  problems	  in	  people	  with	  
MS	  and	  the	  associated	  everyday	  problems,	  literature	  examining	  the	  effectiveness	  of	  
external	  memory	  aids	  on	  alleviating	  memory	  problems	  in	  people	  with	  MS	  remains	  
weak.	  This	   review	   included	  a	  variety	  of	   study	  designs,	   in	  an	  attempt	   to	   collate	  all	  
available	  evidence	   to	  evaluate	  whether	  people	  with	  MS	  who	   received	   training	  on	  
the	   use	   of	   external	   memory	   aids	   showed	   better	   outcomes	   in	   their	   memory	  
functions,	   mood	   and	   quality	   of	   life,	   than	   those	   who	   did	   not.	   Broadening	   the	  
inclusion	   criteria	   to	   non-­‐RCT	   designs	   meant	   that	   studies	   without	   control	   groups	  
were	  included	  for	  evaluation.	  However,	  few	  additional	  studies	  were	  identified	  that	  
were	  not	  included	  in	  previous	  reviews	  confined	  to	  RCTs.	  	  
	  
Nine	   studies	   were	   included	   in	   this	   review;	   six	   studies	   were	   RCTs;	   two	   employed	  
before	   and	   after	   group	   designs;	   and	   one	   was	   a	   SCED.	   One	   study	   specifically	  
evaluated	  an	  external	  memory	  aid;	  the	  others	  were	  either	  memory	  rehabilitation	  or	  
cognitive	   rehabilitation	   studies	   that	   included	   a	   component	   attending	   to	   external	  
memory	   aids.	   These	   studies	   were	   published	   between	   1993	   and	   2014	   and	   the	  
majority	   were	   of	   poor	   quality;	   lacking	   detailed	   description	   of	   the	   randomisation	  
procedures,	  blinding	  and	  dealing	  with	  incomplete	  outcome	  data.	  Although	  the	  one	  
SCED	  (Lincoln	  et	  al.,	  2003)	  scored	  8	  out	  of	  10	  for	  methodological	  quality,	  the	  mean	  
for	  group	  studies	  was	  only	  5	  out	  of	  10.	  Only	  five	  of	  the	  included	  studies	  evaluated	  
participant	  outcomes	  using	  ecologically	  valid	  memory	  measures	   (Carr	  et	  al.,	  2014;	  
das	  Nair	  &	  Lincoln,	  2012;	  Gentry,	  2008;	  Lincoln	  et	  al.,	  2002;	  Lincoln	  et	  al.,	  2003);	  five	  
studies	  included	  measures	  of	  participants’	  mood,	  and	  only	  two	  assessed	  quality	  of	  
life.	  	  
	  
The	   evidence	   for	   the	   effectiveness	   of	   teaching	   people	   with	   MS	   to	   use	   external	  
memory	  aids	  to	   improve	  everyday	  memory	  functioning	  was	  limited,	  with	  only	  one	  
study	   reporting	  an	   improvement	  on	  a	   subjective	  memory	  measure	   (Lincoln	  et	   al.,	  
2003),	   and	   none	   demonstrating	   benefits	   on	   objective	   measures	   of	   memory.	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However	   it	   should	   be	   noted	   that	   only	   four	   studies	   employed	   subjective	  memory	  
measures,	   and	   only	   two	   used	   objective	  memory	  measures.	   Five	   studies	   assessed	  
participants’	   mood,	   though	   only	   two	   studies	   reported	   positive	   results	   following	  
intervention	   (Carr	   et	   al.,	   2014;	   Jonsson	   et	   al.,	   1993),	   and	   no	   studies	   reported	   an	  
effect	   on	   quality	   of	   life.	   Five	   studies	   assessed	   the	   use	   of	   coping	   strategies	   for	  
memory	   problems,	   with	   two	   reporting	   beneficial	   effects	   of	   treatment	   (Shevil	   &	  
Finlayson,	  2010;	  Stuifbergen	  et	  al.,	  2012).	  	  
	  
There	   are	   several	   limitations	   of	   this	   review	   that	   need	   to	   be	   considered.	   Despite	  
systematically	   searching	   seven	   electronic	   databases	   it	   is	   possible	   that	   not	   all	  
relevant	   studies	   were	   identified.	   Studies,	   particularly	   SCEDs	   may	   have	   been	  
published	   in	   journals	   that	  were	   not	   searched	   by	   the	   databases,	   or	  may	   not	   have	  
been	   identified	   with	   the	   search	   strategy	   used.	   Due	   to	   the	   nature	   of	   memory	  
problems	  affecting	  many	  areas	  of	   life,	   it	   is	  possible	  that	  some	  relevant	  articles	  did	  
not	  use	  words	  applied	  in	  the	  search	  strategy.	  For	  example	  if	  an	  article	  were	  named	  
‘problems	  at	  work’,	  it	  would	  not	  have	  been	  included.	  Selection	  was	  also	  performed	  
by	   only	   one	   author,	   which	   reduces	   the	   likelihood	   that	   errors	   are	   detected,	  
compared	  to	  employing	  a	  review	  team.	  Another	  issue	  that	  should	  be	  considered	  is	  
the	   change	   in	   the	  way	  SCEDs	  are	   classified.	   This	   review	  classifies	   SCEDs	  using	   the	  
SCED	  scale	  (Tate	  et	  al.,	  2008),	  which	  included	  AB	  designs,	  such	  as	  the	  Lincoln	  et	  al.	  
(2003)	  study.	  A	  revised	  classification	  system	  has	  since	  been	  developed,	  the	  RoBiNT	  
Scale	   (Tate	   et	   al.,	   2013)	  which	   states	   that	   AB	   designs	   should	   not	   be	   classified	   as	  
SCEDS	  due	  to	  the	  inability	  to	  determine	  cause	  and	  effect,	  with	  the	  absence	  of	  ABA	  
reversal	  or	  multiple	  baseline	  designs.	  Therefore	  it	  should	  be	  noted	  that	  the	  included	  
SCED	   (Lincoln	   et	   al.,	   2003)	   does	   not	   provide	   staggered	   baselines	   to	   support	  
determining	  the	  impact	  of	  the	  intervention.	  
	  
This	  review	  evaluated	  the	  evidence	  for	  the	  use	  of	  external	  memory	  aids	  for	  people	  
with	   MS,	   however	   only	   one	   study	   provided	   data	   on	   participants	   that	   had	   solely	  
received	   dedicated	   training	   in	   the	   use	   of	   external	   memory	   aids.	   The	   majority	   of	  
studies	   involved	   comprehensive	   cognitive	   rehabilitation	   programmes,	   and	   thus	  
were	   aimed	   at	   tackling	   a	   range	   of	   cognitive	   deficits.	   Therefore	   it	   is	   difficult	   to	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deduce	  how	  much	   time	  was	   spent	  on	  memory	   rehabilitation	   in	  general,	   let	   alone	  
external	   memory	   aids	   specifically.	   Consequently,	   the	   results	   of	   this	   review	  
suggested	   that	   there	   was	   no	   evidence	   to	   support	   or	   refute	   the	   effectiveness	   of	  
external	  memory	  aids	  on	  subjective	  or	  objective	  reports	  of	  memory	  function.	  
	  
2.6.2	   Quality	  of	  the	  evidence	  
The	   literature	   base	   investigating	   the	   effectiveness	   of	   external	   memory	   aids	   for	  
people	   with	  MS	   is	   poor.	   Only	   six	   RCTs	   were	   identified,	   of	   these	   five	   were	   single	  
blind,	  although	  it	  should	  be	  noted	  that	  the	  Jonsson	  et	  al.	  (1993)	  paper	  stated	  that	  
blinding	   was	   problematic	   as	   patients	   could	   easily	   unmask	   their	   allocation	   in	  
conversation.	  Due	  to	  the	  nature	  of	  the	  studies	  considered,	  it	  was	  unlikely	  that	  those	  
giving	  the	  intervention	  could	  be	  blind	  to	  group	  allocation.	  Masking	  the	  participants	  
to	  the	  group	  allocation	  was	  also	  not	  likely	  to	  be	  possible.	  Eight	  of	  the	  nine	  studies	  
were	  published	  after	  the	  publication	  of	  the	  CONSORT	  statement	  (Moher,	  Schulz,	  &	  
Altman,	   2003),	   however	   these	   guidelines	   were	   not	   followed	   in	   the	   majority	   of	  
included	  studies.	  The	  randomisation	  protocol	  was	  unclear	  in	  three	  studies	  (Jonsson	  
et	  al.,	  1993;	  Stuifbergen	  et	  al.,	  2012;	  Tesar	  et	  al.,	  2005).	  All	  RCTs	  appeared	  to	  have	  
adequate	   allocation	   concealment.	   Inclusion	   and	   exclusion	   criteria	   were	   generally	  
defined	   well	   and	   all	   described	   the	   flow	   of	   participants	   through	   the	   study.	   The	  
description	  of	  interventions	  and	  control	  conditions	  were	  inadequate	  in	  the	  majority	  
of	  studies	  and	  the	  choice	  of	  outcome	  measures	  used	  was	  extremely	  poor,	  with	  only	  
four	   studies	   employing	   ecologically	   valid	   memory	   measures.	   Feedback	   from	  
participants	  was	  only	  obtained	   in	  one	  study	   (Tesar	  et	  al.,	  2005);	   responses	   to	   this	  
questionnaire	  were	  positive.	  
	  
2.6.3	   Potential	  biases	  in	  the	  review	  process	  
Two	  of	  the	  review	  authors	  were	  lead	  investigators	  in	  four	  included	  studies	  (Carr	  et	  
al.,	  2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  2002;	  Lincoln	  et	  al.,	  2003).	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2.6.4	   Agreement	  and	  disagreement	  with	  other	  studies	  or	  reviews	  
This	   review	   adds	   to	   the	   recent	   Cochrane	   review	   on	   memory	   rehabilitation	   for	  
people	  with	  MS	   (das	  Nair	  et	  al.,	  2012)	  by	   including	   five	  extra	  studies:	   two	  studies	  
published	  since	  the	  review	  and	  three	  non-­‐RCT	  designs.	  This	   review	  also	  evaluated	  
only	   the	   treatment	   compared	   to	   control	   conditions	   in	   two	   previously	   included	  
studies	  (das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  2002).	  When	  conducting	  this	  review	  
there	  was	  the	  assumption	  that	  broadening	  the	  criteria	   to	   include	  non-­‐RCTs	  would	  
yield	  results	  that	  had	  been	  excluded	  from	  previous	  Cochrane	  reviews.	  However	  only	  
two	   before	   and	   after	   designs	   and	   one	   SCED	   were	   identified.	   Our	   findings	  
complement	   the	   das	  Nair	   et	   al.	   (2012)	   and	   Rosti-­‐Otajärvi	   and	  Hämäläinen	   (2014)	  
Cochrane	   reviews,	   which	   both	   concluded	   that	   there	   was	   no	   evidence	   to	   suggest	  
that	  memory	  rehabilitation	  was	  more	  effective	  than	  a	  control.	  This	  review	  supports	  
the	  opinion	  from	  both	  previous	  reviews	  that	  studies	  evaluating	  the	  effectiveness	  of	  
memory	   rehabilitation	   are	   of	   poor	   quality.	   This	   review	   also	   complements	   the	  
findings	  of	  the	  Thomas	  et	  al.	  (2006)	  Cochrane	  review	  on	  psychological	  interventions	  
for	   MS,	   showing	   that	   interventions	   designed	   to	   help	   people	   with	   cognitive	  
impairments	   were	   inconclusive.	   Although	   this	   review	   does	   not	   support	   the	  
conclusions	  of	  recent	  reviews	  of	  neuropsychological	  rehabilitation	  (Cicerone	  et	  al.,	  
2011;	  de	  Joode	  et	  al.,	  2010)	  in	  their	  recommendations	  of	  the	  use	  of	  compensatory	  
aids	   for	   people	   experiencing	   memory	   problems,	   it	   does	   support	   a	   recent	   review	  
(Jamieson	  et	  al.,	  2014)	  that	  concluded	  there	  is	  still	  a	  specific	  need	  for	  investigations	  
of	  technology	  for	  people	  with	  degenerative	  diseases.	  
	  
2.7	   Conclusions	  
2.7.1	   Implications	  for	  practice	  
People	   with	   MS	   frequently	   report	   problems	   with	   their	   memory	   in	   everyday	   life.	  
Training	   in	   the	   use	   of	   external	   memory	   aids	   is	   offered	   to	   some	   people	   during	  
memory	   rehabilitation	   programmes,	   however	   their	   effectiveness	   has	   not	   been	  
determined.	   Studies	   with	   people	   with	   other	   types	   of	   brain	   damage,	   such	   as	   TBI,	  
have	  provided	   some	  evidence	   for	   the	  effectiveness	  of	  external	  memory	  aids.	   This	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review,	   however,	   examined	   the	   literature	   for	   people	   with	   MS	   and	   found	   no	  
evidence	   to	   support	   or	   refute	   that	   external	   memory	   aids	   improved	   everyday	  
memory	  function,	  mood	  or	  quality	  of	  life.	  One	  problem	  with	  small	  RCTs	  is	  that	  they	  
do	  not	  take	  into	  account	  intra-­‐group	  variability,	  which	  is	  assumed	  to	  be	  controlled	  
through	  the	  randomisation	  process.	  This	  is	  the	  case	  for	  fully-­‐powered	  RCTs,	  but	  not	  
small	   ones.	   Therefore,	   clinicians	   are	   encouraged	   to	   use	   single	   case	   experimental	  
design	   methodology	   to	   evaluate	   the	   effectiveness	   of	   any	   interventions	   they	   are	  
providing	  in	  clinical	  practice	  for	  memory	  problems	  with	  people	  with	  MS.	  
	  
2.7.2	   Implication	  for	  research	  
The	  evidence	  base	  for	  the	  effectiveness	  of	  external	  memory	  aids	  for	  people	  with	  MS	  
was	  poor,	  both	  quantitatively	  and	  qualitatively.	  Only	   six	  RCTs	  were	   identified	  and	  
the	   majority	   of	   these	   had	   small	   sample	   sizes.	   In	   addition	   there	   were	   only	   two	  
studies	   using	   other	   experimental	   designs,	   such	   as	   CCTs,	   before	   and	   after	   group	  
designs,	   and	   single	   case	   experimental	   designs.	   These	   studies	   failed	   to	   use	  
appropriate	   ecologically	   valid	   outcome	   measures	   necessary	   to	   establish	  
generalisation	   of	   benefits	   in	   practice.	   Most	   of	   the	   studies	   failed	   to	   follow	   the	  
CONSORT	  guidelines	   (Moher	  et	  al.,	  2003),	   thus	   limiting	   the	  ability	   to	  evaluate	   the	  
accuracy	  of	  their	  findings.	  Therefore	  it	  is	  suggested	  that	  more	  high	  quality	  research	  
is	  necessary	  to	  provide	  conclusive	  evidence	  as	  to	  whether	  external	  memory	  aids	  are	  
effective	  at	  reducing	  memory	  problems	  for	  people	  with	  MS.	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3	   Methods	  
	  
3.1	   Chapter	  Overview	  
This	   chapter	   summarises	   the	   methodology	   of	   a	   crossover	   RCT	   study	   including	  
approval	   process,	   recruitment	   and	   design.	   The	   baseline	   and	   outcome	   measures	  
used	  are	  described,	  as	  is	  the	  feedback	  interview	  process.	  Data	  collection	  and	  choice	  
of	  analyses	  are	  explained.	  
3.2	   Approvals	  
Ethical	   approval	   was	   granted	   by	   the	   NRES	   Committee	   East	   Midlands	   –	  
Northampton,	   reference	   number	   13/EM/0324.	   The	   study	   was	   accepted	   for	  
inclusion	   on	   the	  National	   Institute	   for	  Health	   Research	   Clinical	   Research	  Network	  
(NIHR	   CRN)	   Portfolio	   and	   allocated	   to	   the	   Nervous	   System	   Disorders	   Speciality	  
Group.	   Research	   and	   Design	   (R&D)	   approvals	   were	   granted	   by	   Nottingham	  
University	  Hospitals	  NHS	  Trust;	  Nottinghamshire	  Healthcare	  NHS	  Trust;	  Cambridge	  
University	   Hospitals	   NHS	   Foundation	   Trust;	   Cambridgeshire	   Community	   Services	  
NHS	   Trust	   and	   Peterborough	   and	   Stamford	   Hospitals	   NHS	   Foundation	   Trust.	   See	  
Appendices	  3	  &	  4	  for	  approval	  letters.	  
	  
3.3	   Study	  Design	  
The	   study	   was	   a	   multicentre	   feasibility	   and	   phase	   II	   efficacy	   study	   of	   a	   complex	  
intervention.	  The	  study	  was	  conducted	  between	  November	  2013	  and	  October	  2015,	  
and	  took	  place	  across	  5	  NHS	  trusts	  in	  Nottinghamshire	  and	  Cambridgeshire.	  A	  single	  
blind,	   crossover	   randomised	   controlled	   trial	   (RCT)	  was	   used	   to	   ascertain	  whether	  
the	  use	  of	  memory	  reminders	  using	  NeuroText	  was	  effective	   in	  reducing	  everyday	  
memory	  problems,	  and	  improving	  mood	  and	  quality	  of	  life	  in	  people	  with	  memory	  
problems	   acquired	   though	  MS.	   Treatment	   efficacy	  was	   determined	   by	   comparing	  
treatment	  and	  an	  attention	  control	  condition	  on	  a	  range	  of	  measures.	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In	  addition,	  there	  was	  a	  qualitative	  component	  in	  which	  interviews	  were	  conducted	  
with	   participants	   to	   capture	   participants’	   perspectives	   and	   experiences.	   The	  
interviews	  sought	  to	  gather	  information	  from	  the	  participants	  on	  perceived	  benefits	  
or	  drawbacks	  of	  the	  NeuroText	  messages.	  
	  
3.4	   Participants	  
3.4.1	   Inclusion	  criteria	  
Participants	  were	  included	  if	  they:	  
1. had	   a	   diagnosis	   of	   multiple	   sclerosis	   (including	   relapsing,	   remitting,	  
secondary	  progressive,	  	  primary	  progressive	  and	  benign),	  as	  determined	  by	  
the	  referring	  clinician	  
2. had	  self-­‐reported	  memory	  problems,	  defined	  as	  a	   score	  more	   than	  20	  on	  
the	   participant	   version	   of	   the	   frequency	   scale	   of	   the	   Everyday	   Memory	  
Questionnaire	   (EMQ)(Sunderland	  et	  al.,	  1984);	   to	  ensure	   that	  participants	  
had	   everyday	   memory	   problems	   and	   were	   therefore	   representative	   of	  
those	  who	   could	   receive	   this	   intervention	   in	   clinical	   practice.	   This	   cut-­‐off	  
was	  determined	   from	  a	   rehabilitation	   study	   (ReMIND)(das	  Nair	  &	  Lincoln,	  
2012)	  as	  1	  S.D.	  below	  the	  total	  mean	  and	  higher	  to	  include	  those	  with	  self-­‐
reported	  memory	  problems	  
3. were	   able	   to	   read	   and	   respond	   to	   potential	   requested	   messages	  
independently,	  as	  determined	  	  by	  self-­‐report	  
4. were	  aged	  18	  years	  or	  older,	  to	  allow	  consent	  
5. were	   more	   than	   12	   months	   since	   diagnosis,	   to	   allow	   time	   to	   adapt	   to	  
diagnosis,	  as	  determined	  by	  self-­‐report	  




3.4.2	   Exclusion	  criteria	  
Participants	  were	  excluded	  if	  they:	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1. had	  cognitive,	  visual	  or	  motor	   impairment,	  such	  that	  they	  were	  unable	  to	  
use	  a	  pager	  or	  mobile	  phone,	  as	  determined	  by	  self-­‐report	  
2. had	  another	  concurrent	  neurological	  diagnosis,	  e.g.	  epilepsy,	  to	  ensure	  that	  
the	  memory	  problem	  was	  due	  to	  MS,	  as	  determined	  by	  self-­‐report	  
3. had	  a	  concurrent	  severe	  medical/psychiatric	  diagnosis,	  to	  ensure	  they	  were	  
likely	  to	  engage	  in	  treatment,	  as	  determined	  by	  self-­‐report	   	  
4. were	   concurrently	   taking	   part	   in	   other	   psychological	   research	   studies,	   to	  
ensure	  any	  changes	  in	  outcomes	  were	  not	  impacted	  by	  other	  interventions,	  
as	  determined	  by	  self-­‐report	  	  
5. people	   who	   did	   not	   understand	   English,	   as	   no	   translation	   service	   was	  
available	  
	  
3.4.3	   Recruitment	  
Participants	  were	   recruited	   from	  various	  MS	   services	   across	  Nottinghamshire	   and	  
Cambridgeshire.	  Referrals	  were	  made	  through	  Nottingham	  University	  Hospitals	  NHS	  
Trust	  from	  MS	  Clinics	  and	  CLRN	  research	  nurses;	  Nottinghamshire	  Healthcare	  NHS	  
Trust	   from	  a	   community	   rehabilitation	   team;	   Cambridge	  University	  Hospitals	  NHS	  
Foundation	  Trust	   from	  MS	  nurse	  clinics;	  Cambridgeshire	  Community	  Services	  NHS	  
Trust	   from	   community	  MS	  nurses	   and	   Peterborough	   and	   Stamford	  Hospitals	  NHS	  
Foundation	   Trust	   from	   Neurology	   outpatient	   clinics	   and	   MS	   nurses.	   Some	  
participants	  were	  self-­‐referred	  through	  charity	  event.	  
	  
Services	   were	   provided	   with	   details	   of	   the	   study,	   and	   asked	   to	   forward	   this	  
information	  to	  potential	  participants.	  	  
	  
i) For	  all	  participants	  recruited	  before	  1st	  September	  2014:	  
Potential	   participants	  were	   approached	   by	   a	  member	   of	   their	   clinical	   care	  
team,	   explaining	  what	  was	   involved	   in	   the	   trial,	   and	   given	   an	   invitation	   to	  
study	   letter	   (version	  1),	  participant	   information	  sheet	   (PIS),	   consent	   forms,	  
the	   EMQ,	   and	   a	   stamped	   addressed	   envelope.	   See	   appendix	   5	   for	   these	  
documents.	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After	  reading	  the	  Participant	  Information	  sheet,	  potential	  participants	  and	  a	  
relative	  or	  carer	  completed	  the	  consent	  forms,	  the	  EMQ	  and	  contact	  details	  
form	  (pg.2	  of	  invitation	  to	  study	  letter)	  and	  returned	  in	  the	  envelope,	  if	  they	  
wished	  to	  take	  part	  in	  the	  study.	  
	  
Upon	   receipt	   of	   the	   above,	   the	   eligibility	   of	   the	   potential	   participant	   was	  
checked	  using	  the	  completed	  EMQ.	  If	  potential	  participants	  scored	  above	  20,	  
participants	   were	   invited	   to	   continue	   into	   the	   study.	   The	   researcher	  
contacted	  the	  potential	  participants	  by	  telephone,	  using	  the	  details	  provided	  
on	   the	   contact	   details	   form.	   The	   researcher	   confirmed	   that	   the	   potential	  
participant	  had	  received	  and	  read	  the	  PIS	  and	  offered	  a	  chance	  for	  them	  to	  
ask	  any	  questions	  about	  the	  study.	  A	  date	  was	  organised	  to	  set	  up	  a	  visit	  for	  
baseline	  assessment.	  
	  
ii) For	  all	  participants	  recruited	  from	  1st	  September	  2014:	  
• Potential	   participants	  were	   approached	   by	   a	  member	   of	   their	   clinical	   care	  
team,	   explaining	  what	  was	   involved	   in	   the	   trial,	   and	   given	   an	   invitation	   to	  
study	   letter	  (version	  2)	  see	  Appendix	  6,	  participant	   information	  sheet	  (PIS),	  
consent	  forms,	  and	  a	  stamped	  addressed	  envelope.	  
	  
• If	   the	   potential	   participant	  was	   interested	   in	   taking	   part	   in	   the	   study	   they	  
could	  choose	  to	  either	  complete	  the	  contact	  details	  form	  (pg.	  2	  of	  invitation	  
to	  study	  letter)	  and	  send	  it	  themselves,	  or	  their	  clinician	  offered	  to	  complete	  
the	   form	  and	  send	   it	   to	   the	   researcher	   for	   them.	  Due	   to	   the	  nature	  of	   the	  
potential	   participants’	   memory	   problems	   they	   were	   liable	   to	   forget	   to	  
complete	   and	   send	   the	   form,	   and	   therefore	   clinicians	   could	   aid	   their	  
recruitment	   by	   offering	   this	   service.	   After	   reading	   the	   Participant	  
Information	   sheet,	   potential	   participants	   and	   a	   relative	   or	   carer	   read	   and	  
completed	  the	  consent	  forms.	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The	   contact	   details	   form	   requested	   permission	   that	   the	   researcher	   could	  
contact	   the	  potential	  participant	  by	   telephone	   regarding	   taking	  part	   in	   the	  
research,	  and	  ask	  them	  questions	  about	  their	  memory.	  Upon	  receipt	  of	  the	  
contact	   details	   form	   the	   researcher	   contacted	   potential	   participants	   by	  
telephone,	   using	   the	   details	   provided.	   The	   researcher	   confirmed	   that	   the	  
potential	   participant	   had	   received	   and	   read	   the	   PIS	   and	   completed	   and	  
offered	   a	   chance	   for	   them	   to	   ask	   any	   questions	   about	   the	   study.	   The	  
researcher	   then	   checked	   the	   eligibility	   of	   the	   potential	   participant	   by	  
administering	   the	   EMQ.	   If	   potential	   participants	   scored	   above	   20,	  
participants	   were	   invited	   to	   continue	   into	   the	   study,	   and	   a	   date	   was	  
organised	  to	  set	  up	  a	  visit	  for	  baseline	  assessment.	  	  
	  
At	   the	   beginning	   of	   the	   baseline	   visit	   the	   researcher	   discussed	   the	   study	   and	  
explained	  that	  entry	  to	  the	  study	  was	  voluntary	  and	  that	  their	  treatment	  and	  care	  
would	   not	   be	   affected	   by	   their	   decision.	   It	   was	   also	   explained	   that	   they	   could	  
withdraw	  at	  any	  time	  but	  attempts	  would	  be	  made	  to	  avoid	  this	  occurrence.	  In	  the	  
event	  of	  their	  withdrawal	  it	  was	  explained	  that	  their	  data	  collected	  so	  far	  could	  not	  
be	  erased	  and	  we	  would	  seek	  consent	  to	  use	  the	  data	   in	  the	  final	  analyses	  where	  
appropriate.	   The	   participant	   had	   the	   opportunity	   to	   ask	   any	   questions	   about	   the	  
study.	  
	  
The	  researcher	  then	  checked	  that	  participants	  had	  signed	  their	  consent	  forms,	  and	  
the	  researcher	  countersigned	  them.	  Baseline	  assessment	  then	  began.	  
	  
For	   those	  who	  did	  not	  meet	   the	   inclusion	  criteria	  on	   the	  EMQ,	  e.g.	   scoring	  below	  
20,	  the	  researcher	  explained	  that	  they	  were	  not	  eligible	  to	  take	  part	  in	  the	  trial,	  and	  
so	  they	  would	  not	  be	  invited	  to	  continue.	  
	  
3.5	   Group	  allocation	  
Random	   allocation	   on	   a	   1:1	   ratio	   was	   carried	   out	   by	   an	   independent	   research	  
assistant,	   using	   a	   web-­‐based	   randomisation	   number	   generator,	   prepared	   in	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advance	   of	   the	   study.	   The	   independent	   research	   assistant	   in	   the	   Division	   of	  
Rehabilitation	  and	  Ageing	  (University	  of	  Nottingham),	  was	  blind	  to	  the	  participants	  
recruited	   and	   held	   the	   randomisation	   schedule.	   Once	   participants	  were	   recruited	  
and	  had	  completed	  baseline	  assessment,	  the	  researcher	  contacted	  the	  independent	  
research	  assistant	  by	  email	  and	  provided	  initials	  and	  date	  of	  birth	  of	  the	  participant.	  
The	   independent	   research	   assistant	   holding	   the	   randomisation	   schedule	   then	  
disclosed	  group	  allocation	  of	   the	  participant.	  This	  ensured	  allocation	  concealment	  
from	   those	   recruiting	  participants.	   Participants	  were	   randomly	   allocated	   to	   either	  
the	  intervention	  condition	  first	  (group	  1)	  or	  control	  condition	  first	  (group	  2).	  Due	  to	  
the	   nature	   of	   the	   intervention,	   both	   researcher	   and	   participants	   were	   aware	   of	  
which	  group	  they	  had	  been	  allocated	  to.	  
	  
3.6	   Intervention	  
During	   the	   intervention	   phase,	   participants	   received	   NeuroText	   memory	   text	  
messages	  for	  2	  months.	  	  
	  
NeuroText	   is	   a	   service	   that	   simply	   sends	   reminder	   messages	   to	   people’s	   mobile	  
phones	  or	  pager.	  These	  messages	  are	  tailor	  made	  and	  sent	  at	  pre-­‐arranged	  times	  to	  
prompt	   people	   to	   do	   the	   things	   they	   would	   otherwise	   forget	   to	   do.	   During	   the	  
baseline	   home	   visit,	   participants	   identified	   problems	   such	   as	   ‘I	   forget	   to	   lock	   the	  
back	  door’	  or	  ‘I	  forget	  to	  take	  my	  medication’	  and	  agreed	  on	  reminders	  that	  would	  
be	  helpful,	  which	  they	  then	  received	  by	  text	  at	   their	  chosen	  times	  and	  frequency.	  
Only	  messages	  requested	  or	  agreed	  by	  participants	  were	  selected	  for	  transmission.	  
Participants	  also	  chose	  the	  wording	  of	  the	  messages	  and	  were	  free	  to	  modify	  these	  
as	   necessary	   during	   the	   trial.	   An	   example	   NeuroText	   timetable	   can	   be	   found	   in	  
Appendix	  7.	  
	  
NeuroText	   runs	   through	   the	   existing	   NeuroPage	   service	   at	   the	   Oliver	   Zangwill	  
Centre	   for	   Neuropsychological	   Rehabilitation	   (OZC)	   in	   Ely,	   UK.	   The	   Neuropage	  
service	  is	  owned	  by	  Cambridgeshire	  Community	  Services	  NHS	  Trust.	  Throughout	  the	  
trial	   the	   intervention	  was	  named	   ‘NeuroText’	   for	   clarity,	   in	   light	   of	   the	   increasing	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use	  of	  texts	  on	  mobile	  phones,	  and	  the	  decreasing	  use	  of	  pagers.	  The	  intervention	  
was	  run	  by	  the	  researcher,	  who	  had	  been	  given	  training	   in	  the	  use	  of	  NeuroPage.	  
The	   lists	  of	  reminders	  were	  entered	  onto	  the	  computer	  at	  OZC	  by	  the	  researcher,	  
and	  then	  the	  computer	  automatically	  sent	  out	  the	  messages	  at	  the	  correct	  time	  and	  
dates.	  The	  procedures	  for	  the	  intervention	  are	  well	  established	  and	  have	  been	  used	  
in	  previous	  trials	  (Wilson	  et	  al.,	  2001;	  Wilson	  et	  al.,	  1997).	  
	  
Those	   who	   wished	   to	   receive	   the	   messages	   to	   a	   pager	   rather	   than	   their	   mobile	  
phone	  were	   given	   a	   demonstration	   by	   the	   researcher.	   Participants	   using	   a	   pager	  
needed	  to	  provide	  details	  of	  their	  address	  and	  the	  addresses	  of	  anywhere	  they	  are	  
likely	   to	   be	   using	   the	   service	   (e.g.	   work),	   to	   the	   Neuropage	   service	   to	   ensure	  
network	  coverage.	  They	  also	  needed	  to	  provide	  a	  contact	  number	  in	  the	  case	  of	  any	  
service	  issues.	  	  
	  
Two	   days	   after	   the	   start	   of	   intervention	   participants	   were	   contacted	   by	   the	  
researcher	  by	  text	  to	  check	  that	  the	  NeuroText	  messages	  were	  coming	  through,	  and	  
that	   they	  were	   happy	  with	   them.	   The	  NeuroText	  messages	  were	   programmed	   to	  
run	   for	   2	   months	   using	   the	   rota	   agreed	   during	   the	   baseline	   home	   visit,	   unless	  
participant	  requested	  any	  modifications,	  which	  were	  put	  in	  place	  upon	  receipt.	  
	  
Any	  other	  rehabilitation,	  e.g.	  occupational	   therapy	  or	  physiotherapy,	  continued	  as	  
usual	   for	   all	   patients.	   Any	   medication,	   including	   MS	   modifying	   drugs	   and	   anti-­‐
depressants	  were	  prescribed	  as	  usual	  for	  all	  patients.	  
	  
3.7	   Control	  
During	   the	   control	   phase,	   participants	   received	   non-­‐memory	   text	  messages	   for	   2	  
months.	  
	  
The	  control	   condition	  was	  a	   text	  messages	   containing	  non-­‐memory	  content,	   from	  
RSS	  feeds	  participants	  were	   interested	   in,	  e.g.	  headlines	  on	  sports,	  current	  affairs,	  
or	   entertainment	   news,	   or	   quotes.	   During	   the	   baseline	   home	   visit,	   participants	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identified	   the	   type	  of	  non-­‐memory	  messages	   they	  would	  be	  happy	   to	   receive	  e.g.	  
football	  and	  current	  affairs.	  Participants	  were	  free	  to	  modify	  these	  during	  the	  trial.	  
It	  was	  explained	  that	  the	  non-­‐memory	  messages	  would	  be	  transmitted	  at	  the	  same	  
times	  and	  frequency	  as	  the	  NeuroText	  messages,	  unless	  requested	  otherwise.	  Links	  
of	  chosen	  RSS	  feeds	  were	  programmed	  into	  the	  NeuroPage	  computer	  at	  OZC,	  and	  
posts	  from	  allocated	  RSS	  feeds	  were	  automatically	  sent	  out	  at	  the	  correct	  time	  ad	  
dates.	  An	  example	  control	  timetable	  can	  be	  found	  in	  Appendix	  8.	  
	  
Two	  days	  after	  the	  start	  of	  the	  control	  condition	  participants	  were	  contacted	  by	  the	  
researcher	  by	   text	   to	   check	   the	   control	  messages	  were	   coming	   through,	   and	   that	  
they	  were	  happy	  with	  them.	  The	  control	  messages	  were	  programmed	  to	  run	  for	  2	  
months,	   using	   the	   rota	   agreed	   during	   baseline	   visit,	   unless	   participant	   requested	  
any	  modifications,	  which	  were	  put	  in	  place	  upon	  receipt.	  	  
	  
Any	  other	  rehabilitation,	  e.g.	  occupational	   therapy	  or	  physiotherapy,	  continued	  as	  
usual	   for	   all	   patients.	   Any	   medication,	   including	   MS	   modifying	   drugs	   and	   anti-­‐
depressants	  were	  prescribed	  as	  usual	  for	  all	  patients.	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3.8	   Flowchart	  
Figure	  1:	  Participant	  flow	  through	  the	  study	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3.9	   Baseline	  Assessments	  
Baseline	  assessment	  was	  completed	  at	  a	  place	  convenient	  for	  the	  participant.	  This	  
process	  was	  carried	  out	  over	  1-­‐3	  sessions,	  according	   to	  patient	  choice	  and	  ability.	  
For	  example,	  if	  a	  patient	  had	  fatigue	  on	  an	  assessment	  day	  they	  may	  have	  wished	  to	  
spread	  that	  session	  over	  two	  visits,	  rather	  than	  one.	  
	  
Following	   the	   consent	   procedures	   detailed	   above,	   participants	   were	   offered	   a	  
choice	   of	   receiving	   text	   messages	   to	   provided	   pagers	   or	   participants’	   mobile	  
phones.	  Participants	  and	   their	   relatives	  or	  carers	  were	  asked	   to	  describe	  a	   typical	  
week	  to	  elicit	  problems	  that	  they	  needed	  help	  with	  and	  identify	  target	  reminders.	  
Participants	  could	  also	  look	  over	  a	  list	  of	  common	  reminders	  to	  see	  if	  they	  thought	  
any	  of	  them	  would	  be	  useful.	  In	  addition,	  suitable	  control	  messages	  were	  identified	  
through	  discussion	  with	  the	  participant.	  Rotas	  were	  drawn	  up	  for	  both	  conditions.	  
The	  outline	  schedule	  can	  be	  found	  in	  Appendix	  9.	  
	  
Self-­‐reported	  demographic	   information	   and	  details	   of	   type	  of	  MS	  and	   years	   since	  
diagnosis	  were	  recorded	  on	  the	  Demographic	  Record	  Form,	  which	  can	  be	  found	  in	  
Appendix	   10.	   In	   some	   cases	   demographic	   categories	   were	   collapsed	   to	   provide	  
more	   concise	   categorisation:	   Responses	   in	   the	   “Partnership”	   category	   endorsing	  
“Separated	  but	  still	  legally	  married	  or	  civil	  partnership;	  divorced	  or	  legally	  dissolved	  
civil	   partnership;	   widowed	   or	   surviving	   partner	   from	   civil	   partnership”	   were	  
categorised	   as	   “No	   longer	   married	   or	   in	   civil	   partnership”.	   In	   the	   open	   ended	  
“Beliefs”	   section	   responses	   were	   collapsed	   e.g.	   “Christian”	   and	   “Catholic”	   were	  
grouped	  together	  as	  “Christian”;	  “Agnostic”	  and	  “None”	  were	  grouped	  as	  “None”;	  
and	   “Spiritual”,	   “Humanist”,	   “Jehovah	  Witness”	  were	   grouped	   as	   “Other”.	   “Years	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A	   baseline	   cognitive	   assessment	   was	   conducted	   to	   document	   the	   nature	   of	   the	  
memory	   impairment	   and	   to	   record	   factors	   that	   may	   be	   related	   to	   treatment	  
response.	  
	  
3.9.1	   Rationale	  for	  tools	  selected	  
3.9.1.1	  Everyday	  Memory	  Questionnaire	  
The	  Everyday	  Memory	  Questionnaire	  (EMQ)(Sunderland,	  Harris,	  &	  Baddeley,	  1983)	  
is	  a	  self-­‐rating	  scale,	  designed	  to	  assess	  memory	  functioning	  in	  everyday	  life	  (Tate,	  
2010).	  The	  questionnaire	  consists	  of	  28	   items,	  each	  describing	  everyday	  activities,	  
which	  may	  involve	  memory	  failure.	  A	  5-­‐point	  scale	  was	  used:	  0	  (once	  or	  less	  in	  the	  
last	  month);	  1	  (more	  than	  once	  a	  month	  but	  less	  than	  once	  a	  week);	  2	  (about	  once	  a	  
week);	  3	  (more	  than	  once	  a	  week	  but	  less	  than	  once	  a	  day);	  4	  (once	  or	  more	  a	  day)	  
(Lincoln	  et	  al.,	  2002).	  Items	  of	  the	  EMQ	  sample	  a	  range	  of	  potential	  memory	  failures	  
in	   everyday	   situations,	   seemingly	   covering	   episodic	   memory	   for	   verbal	   and	  
visuospatial	   material,	   procedural	   memory,	   and	   prospective	   memory,	   e.g.	  
“completely	  forgetting	  to	  do	  things	  you	  said	  you	  would	  do,	  and	  things	  you	  planned	  
to	   do”.	   Informant	   and	   self-­‐report	   versions	   are	   available,	   which	   contain	   the	   same	  
items,	  but	  are	  phrased	  as	  appropriate.	  The	  self-­‐report	  version	  of	  the	  EMQ	  was	  used	  
at	  baseline	  as	  a	  screening	  measure.	  
	  
The	  EMQ	  was	  developed	  as	  a	  subjective	  measure	  of	  memory	  failure	  in	  everyday	  life	  
(Sunderland	   et	   al.,	   1983).	   Sunderland	   and	   colleagues	   constructed	   the	   EMQ	   in	  
response	   to	   clinical	   needs,	   questioning	   the	   ecological	   validity	   of	   laboratory-­‐based	  
memory	   tests	   to	   evaluate	   the	   effectiveness	   of	   therapy	   programmes	   for	   memory	  
disorders	  (Tate,	  2010).	  The	  list	  of	  items	  were	  assembled	  to	  include	  a	  wide	  range	  of	  
memory	  failures;	  that	  would	  be	  the	  types	  of	  error	  that	  the	  majority	  of	  subjects	  had	  
the	  opportunity	  to	  make	  in	  their	  daily	  lives,	  and	  would	  include	  cognitive	  difficulties	  
(Sunderland	   et	   al.,	   1983).	   Some	   of	   the	   items	   might	   not	   normally	   be	   classed	   as	  
memory	   failures,	   but	   a	   memory	   failure	   could	   be	   the	   root	   of	   the	   problem,	   for	  
example,	   ‘finding	   a	   television	   story	   difficult	   to	   follow’.	   The	   EMQ	   was	   initially	  
developed	   for	   use	  with	   survivors	   of	   head	   injury	   and	   has	   since	   been	   refined	  with	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both	   non-­‐clinical	   and	   clinical	   samples,	   including	   people	   with	   MS	   (Lincoln,	   et	   al.,	  
2002;	   Richardson,	   1996;	   Richardson	   &	   Chan,	   1995).	   The	   original	   questionnaire	  
consisted	   of	   35	   items,	   which	   was	   reduced	   to	   the	   more	   commonly	   used	   28-­‐item	  
version	   to	   increase	   validity	   and	   facilitate	   self-­‐administration,	   (Sunderland	   et	   al.,	  
1984).	   The	   response	   scale	   has	   also	   been	   changed	   over	   time,	   from	   relative	  
frequencies	  (‘sometimes’)	  with	  a	  9-­‐point	  sale,	  to	  absolute	  values	  (e.g.	  ‘about	  once	  a	  
week’)	  on	  a	  5-­‐point	  scale	  (Tinson	  &	  Lincoln,	  1987).	  
	  
The	  EMQ	  has	  good	  face	  validity,	  assesses	  real-­‐life	  situations	  and	   is	  used	   in	  clinical	  
practice	  (das	  Nair	  &	  Lincoln,	  2012).	  Concurrent	  validity	  was	  demonstrated	  between	  
the	   EMQ	   and	   a	   similar	   rating	   of	   everyday	   memory,	   the	   Subjective	   Memory	  
Questionnaire	  (Goldstein	  &	  Polkey,	  1992).	  Concurrent	  validity	  of	  the	  EMQ	  has	  also	  
been	   established	  when	   examined	  with	  Wechsler	  Memory	   Scale	   (WMS)(Wechsler,	  
1945)	  and	  Rivermead	  Behavioural	  Memory	  Test	  (RBMT)(Efklides	  et	  al.,	  2002;	  Wilson	  
et	   al.,	   1985).	   Efklides	   et	   al.	   (2002)	   also	   reported	   internal	   consistency	   indices	   of	  
α=.889.	   Several	   factor	   analyses	   have	   been	   performed	   on	   the	   EMQ,	   including	   one	  
using	   a	   non-­‐clinical	   population	   that	   found	   the	   28-­‐item	   EMQ	   to	   consistently	  
differentiate	   between	   two	   systems	   of	   memory	   and	   attention,	   with	   some	  
differentiation	  of	  visual	  and	  verbal	  systems	  (Royle	  &	  Lincoln,	  2008).	  	  
	  
3.9.1.2	  Doors	  &	  People	  
The	  Doors	  and	  People	  Test	   (Baddeley	  et	  al.,	  1994)	   is	  a	  broadly	  based	  test	  of	   long-­‐
term	   memory.	   This	   battery	   of	   four	   tests	   yields	   a	   single	   age-­‐scaled	   overall	   score	  
which	  can	  be	  ‘unpacked’	  to	  give	  individual	  measures	  of	  visual	  and	  verbal	  memory,	  
recall	   and	   recognition	   and	   forgetting,	   allowing	   the	   tester	   to	   assess	   patterns	   of	  
deficit	  (Evans,	  Wilson,	  &	  Emslie,	  1996).	  The	  test	  uses	  learning	  of	  names	  and	  shapes,	  
over	   a	   series	   of	   repeated	   trials.	   The	   recognition	   tasks	   use	   the	   forced	   choice	  
technique,	  where	  participants	  have	  to	  choose	  a	  target	  from	  three	  distractors,	  which	  
eliminates	  problems	  with	  response	  bias	  that	  can	  affect	  tests	  using	  a	  yes-­‐no	  format	  
(Evans,	   2004).	   The	   Doors	   test	   examines	   visual	   recognition;	   the	   stimuli	   have	   been	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carefully	   designed	   to	   minimize	   any	   verbal	   mediation,	   as	   the	   distractor	   items	   are	  
similar	  in	  most	  of	  the	  gross	  characteristics	  of	  the	  target	  (Evans,	  2004).	  
	  
The	   Doors	   and	   People	   test	   provides	   an	   analytic	   overview	   of	   long-­‐term	   explicit	  
memory,	  and	  is	  designed	  for	  use	  both	  as	  a	  clinical	  and	  research	  tool.	  The	  test	  was	  
designed	   principally	   to	   provide	   an	   improved	   measure	   of	   nonverbal	   episodic	  
memory	   that	  would	   be	   acceptable	   to	   a	  wide	   range	   of	   subjects	   (Bradley	  &	   Kapur,	  
2004).	   The	   developers	   wished	   to	   provide	   a	   test	   that	   was	   easy	   to	   administer,	  
unstressful	   to	   the	   patient,	   and	   could	   be	   performed	   on	   a	   wide	   range	   of	   subjects.	  
They	  also	  wished	  to	  abolish	  floor	  and	  ceiling	  effects	  and	  provide	  material	  with	  high	  
face	  validity.	  
	  
Ecological	  validity	  is	  suggested	  through	  the	  justification	  of	  use	  of	  test	  materials,	  i.e.	  
names	  are	  used	  as	  forgetting	  names	  could	  be	  an	  everyday	  memory	  problem.	  Face	  
validity	  is	  assumed	  as	  material	  is	  chosen	  to	  be	  purely	  verbal	  or	  visual,	  i.e.	  doors	  are	  
hard	  to	  verbally	  encode	  and	  names	  allow	  minimal	  visual	  encoding.	  The	  Doors	  and	  
People	  has	  a	  theoretical	  basis	  focusing	  on	  the	  fractioning	  of	  memory,	  and	  thus	  has	  
content	  validity.	  The	  sensitivity	  of	  the	  test	  to	  detect	  memory	  impairment	  has	  been	  
demonstrated	  in	  people	  with	  early	  stage	  Alzheimer’s	  disease	  (Greene,	  Baddeley,	  &	  
Hodges,	  1996);	  and	  there	   is	  evidence	  of	   the	  test’s	  ability	   to	  differentiate	  between	  
modality	   specific	   memory	   impairments	   (Morris,	   Abrahams,	   Baddeley,	   &	   Polkey,	  
1995).	  	  	  
	  
One	  benefit	   of	   using	   the	  Doors	   and	  People	  with	  people	  with	  MS,	  who	   commonly	  
experience	  fatigue,	  is	  that	  it	  is	  relatively	  short	  in	  length	  compared	  to	  other	  memory	  
batteries,	  and	  usually	  well	  tolerated	  due	  to	  the	  mixture	  of	  stimuli.	  The	  amount	  and	  
complexity	   of	   drawing	   and	   writing	   required	   is	   low,	   which	   makes	   it	   suitable	   for	  
people	  with	  MS,	  who	  often	  have	  impaired	  motor	  skills.	  
	  
In	  the	  case	  that	  participants	  scored	  a	  raw	  score	   lower	  than	  that	  referred	  to	   in	  the	  
normative	  tables,	  the	  scaled	  score	  was	  given	  as	  1	  point	  below	  the	  minimum	  scaled	  
score	  value	  in	  the	  table.	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3.9.1.3	  	   Hayling	  &	  Brixton	  
The	  Hayling	  and	  Brixton	  tests	  (Burgess	  &	  Shallice,	  1997)	  are	  measures	  of	  executive	  
functions	   (EF),	   specifically	   behavioural	   regulation.	   The	   Hayling	   Test	   evaluates	  
initiation	  speed	  and	  response	  suppression,	  and	  the	  Brixton	  Test	  is	  a	  rule	  detection	  
and	   rule	   following	   task.	  During	   the	  Hayling	   test	   participants	   have	   to	   complete	   30	  
sentences	   from	   which	   the	   last	   word	   was	   omitted.	   In	   the	   first	   half	   (initiation	  
condition)	   they	   complete	   the	   sentences	   with	   a	   word	   that	   makes	   sense.	   In	   the	  
second	  half	   (inhibition	  condition),	  participants	  have	  to	  provide	  a	  word	  that	  makes	  
no	  sense	  in	  the	  context	  of	  the	  sentence	  (e.g.	  London	  is	  a	  very	  busy	  ‘banana’)	  (Gurd,	  
Kischka,	   &	  Marshall,	   2010).	   	   This	   section	   yields	   two	   scores,	   an	   error	   score	   and	   a	  
measure	  of	   response	   speed.	   In	  addition	  all	   three	   scores	   can	  be	   combined	   into	  an	  
overall	   score.	   The	   Brixton	   test	   is	   a	   nonverbal	   task	   of	   set	   attainment	   and	   rule	  
detection.	   Participants	   are	   shown	   a	   56-­‐page	   stimulus	   book.	   All	   pages	   contain	   10	  
circles	   in	   two	   rows	   of	   five.	   Only	   one	   circle	   is	   filled	   in	   on	   each	   page	   and	   the	  
participant	  has	  to	  predict	  where	  the	  next	  filled	  circle	  will	  be	  on	  the	  next	  page,	  based	  
on	  previous	  pages	  (Gurd	  et	  al.,	  2010).	  The	  test	  does	  not	  require	  verbal	  responses,	  as	  
the	  patient	   points	   to	   the	  position.	   The	   score	   is	   the	  number	  of	   errors	  made.	   Both	  
tasks	  are	  easy	  to	  administer	  and	  are	  well	  tolerated	  by	  patients.	  	  
	  
The	   Hayling	   and	   Brixton	   tests	   were	   developed	   to	   be	   sensitive	   to	   symptoms	   of	  
executive	   disturbance.	   The	  Brixton	   test	  was	   based	  on	   the	  Wisconsin	   Card	   Sorting	  
Task	   (WCST)	   (Milner,	   1963).	   However	   in	   contrast	   to	   the	   WCST,	   the	   rule	   that	   is	  
currently	  in	  operation	  cannot	  be	  triggered	  by	  any	  perceptually	  salient	  aspect	  of	  the	  
stimuli	   (Strauss,	   Sherman,	   &	   Spreen,	   2006).	   Significant	   judgement	   is	   required	   for	  
assigning	  Hayling	  responses	  to	  particular	  categories.	  A	  study	  by	  Andrés	  and	  Van	  der	  
Linden	   (2000)	   assessed	   interrater	   reliability	   and	   found	   that	   two	   raters	   agreed	   on	  
76.5%	  of	  1425	  responses.	  Studies	  evaluating	  the	  relationship	  between	  performance	  
on	   the	   Hayling	   and	   Brixton	   tests	   found	   that	   the	   correlation	   was	   low	   (Bielak,	  
Mansueti,	  Strauss,	  &	  Dixon,	  2006;	  de	  Frias,	  Dixon,	  &	  Strauss,	  2006).	  Therefore,	  it	  is	  
thought	   that	   the	  two	  tests	  most	   likely	  measure	  different	  cognitive	  processes.	  This	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notion	   is	  supported	  by	  multiple	  studies,	  showing	  dissociations	  (Burgess	  &	  Shallice,	  
1994;	  Temple	  &	  Sanfilippo,	  2003).	  
	  
Performance	  on	  the	  Hayling	  is	  impaired	  in	  a	  variety	  of	  conditions	  thought	  to	  disrupt	  
EF,	  including	  Alzheimer’s	  disease	  and	  Parkinson’s	  disease	  (Bouquet,	  Bonnaud,	  &	  Gil,	  
2003;	  Collette,	  Van	  der	  Linden,	  Delrue,	  &	  Salmon,	  2002).	  There	  is	  some	  evidence	  of	  
ecological	  validity.	   In	  patients	  with	  schizophrenia,	   social	   impulsivity	   symptoms	  are	  
moderately	  linked	  to	  performance	  on	  the	  Hayling	  sentence	  completion	  task	  (Chan,	  
Chen,	   Cheung,	  &	  Cheung,	   2004).	   The	  Brixton	   test	   is	   related	   to	  other	  measures	  of	  
executive	   function.	   Marczewski,	   de	   Linden,	   and	   Laroi	   (2001)	   found	   moderately	  
strong	  correlations	  between	  the	  Brixton	  and	  Tower	  of	  London	  Tests	  in	  patients	  with	  
schizophrenia	  (Strauss	  et	  al.,	  2006).	   Impaired	  performance	  on	  the	  Brixton	  test	  has	  
also	  been	   reported	   in	  disorders	   thought	   to	  compromise	  EF,	   such	  as	   schizophrenia	  
(Marczewski	  et	  al.,	  2001).	  	  
	  
The	   benefit	   of	   using	   the	   Hayling	   and	   Brixton	   tests	   with	   people	   with	   MS,	   who	  
commonly	  experience	  fatigue,	  is	  that	  is	  relatively	  short	  compared	  to	  EF	  batteries.	  	  	  
	  
3.9.1.4	  Test	  of	  Everyday	  Attention	  
The	  Test	  of	  Everyday	  Attention	  (TEA)(Robertson,	  Ward,	  Ridgeway,	  &	  Nimmo-­‐Smith,	  
1994)	   is	   a	   battery	   of	   eight	   tasks	   intended	   to	   measure	   attentional	   processes	   in	  
adults.	   Age-­‐scaled	   scores	   are	   derived	   for	   each	   subtest;	   therefore	   the	   TEA	   can	   be	  
used	  analytically	   to	   identify	  patterns	  of	  deficit.	  The	   test	   is	  presented	  as	  a	  pretend	  
trip	   to	   Philadelphia,	   during	   which	   the	   participant	   performs	   a	   series	   of	   tasks	  
appropriate	  to	  the	  context	  (Strauss	  et	  al.,	  2006).	  	  
	  
Selective	  attention	   is	  tested	   in	  three	  subtasks:	  Map	  Search,	  Telephone	  Search	  and	  
Elevator	  counting	  with	  distraction.	  On	  the	  Map	  search	  task	  participants	  search	  for	  
symbols	   on	   a	   map	   amongst	   distractors	   for	   two	   minutes.	   Telephone	   Search	   task	  
requires	   participants	   to	   circle	   key	   symbols	  while	   searching	   entries	   in	   a	   simulated	  
telephone	  directory,	  amongst	  distractors.	  Elevator	  Counting	  with	  distraction	  (ECD)	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asks	  participants	  to	  count	  the	   low	  tones	  and	  ignore	  the	  high	  tones.	  ECD	  also	  tests	  
working	  memory.	  
	  
Sustained	   attention	   is	  measured	   in	   three	   subtasks:	   Elevator	   Counting,	   Telephone	  
Search	  while	  Counting	  and	  Lottery.	  On	  the	  Elevator	  Counting	  task	  participants	  are	  
instructed	  to	  pretend	  they	  are	  in	  an	  elevator	  where	  the	  floor-­‐indicator	  in	  broken.	  To	  
establish	  what	  floor	  they	  are	  on	  they	  must	  count	  a	  series	  of	  tape-­‐presented	  tones.	  
During	  Telephone	  Search	  while	  Counting	  (TSC)	  participants	  must	  again	  search	  in	  the	  
telephone	   directory	   while	   simultaneously	   counting	   strings	   of	   tones.	   TSC	   also	  
measures	   divided	   attention	   when	   compared	   to	   Telephone	   Search	   performance.	  
Lottery	  asks	  participants	  to	   listen	  to	  a	  tape	  with	  a	  series	  of	  consecutive	   letter	  and	  
numbers,	   and	   write	   down	   letters	   that	   precede	   the	   target	   ‘55’,	   which	   occur	  
infrequently	  in	  this	  10	  minute	  long	  test.	  	  
	  
Attentional	   switching	   is	   assessed	   in	   two	   subtasks:	   Visual	   Elevator	   and	   Elevator	  
Counting	   with	   Reversal.	   Visual	   Elevator	   is	   self-­‐paced	   and	   requires	   participants	   to	  
count	  up	   and	  down	  when	   specific	   signals	   (arrows)	   are	  presented	  amongst	   stimuli	  
(elevator	  doors).	  Elevator	  Counting	  with	  Reversal	  (ECR)	  uses	  the	  same	  paradigm	  as	  
Visual	  Elevator	  but	  presents	  stimuli	  aurally	  rather	  than	  visually,	  presented	  at	  a	  fixed	  
speed.	  ECR	  also	  tests	  working	  memory.	  
	  
The	  TEA	  is	  one	  of	  the	  few	  tests	  based	  on	  an	  established	  theory	  of	  attention	  (Bate,	  
Mathias,	  &	  Crawford,	  2001),	  the	  attentional	  model	  of	  Posner	  and	  Petersen	  (1989).	  
This	   proposes	   three	   attentional	   systems:	   orientation,	   vigilance	   and	   selection.	   A	  
factor	   analysis	   on	   the	  performance	  of	   the	  normative	   reference	   group	  on	   the	   TEA	  
revealed	  three	  factors	  that	  correspond	  closely	  to	  three	  attention	  concepts	  (Evans	  et	  
al.,	  1996).	  Thus	  the	  TEA	  has	  high	  construct	  validity.	  TEA	  subtests	  have	  been	  shown	  
to	  significantly	  correlate	  with	  many	  other	  tests	  of	  attention	  and	  EF,	  such	  as	  Trails,	  
Digits	   Backward,	   Stroop,	   Word	   Fluency,	   Modified	   Six	   Elements	   Text	   and	   PASAT	  
(Bate	  et	  al.,	  2001;	  Chan,	  Hoosain,	  &	  Lee,	  2002).	  The	  reliability	  of	  all	  TEA	  subtests	  is	  
good,	  with	   the	  exception	  of	   Telephone	  Search	  while	  Counting.	   The	  validity	  of	   the	  
TEA	   has	   been	   studied	   in	   stroke	   patients,	   patients	   with	   Alzheimer’s	   disease	   and	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head-­‐injured	  patients	  and	  can	  be	  judged	  satisfactory	  (Evans	  et	  al.,	  1996;	  Gurd	  et	  al.,	  
2010).	  Overall	  the	  TEA	  appears	  to	  be	  useful	  in	  discriminating	  patients	  with	  cognitive	  
deficits	  from	  controls,	  (Strauss	  et	  al.,	  2006).	  	  
	  
The	  TEA	  was	  developed	  with	  the	  intention	  of	  creating	  a	  clinically	  valid	  tool	  of	  high	  
ecological	   validity.	   The	   TEA	   is	   acceptable	   to	   patients,	   and	   has	   high	   face	   validity	  
(Evans	   et	   al.,	   1996).	   Robertson	   et	   al.	   (1994)	   examined	   relationships	   between	   TEA	  
subtests	   and	  measures	  of	   functional	   status	   in	   stroke	  patients	   and	   found	   the	  Map	  
Search	   and	   Elevator	   Counting	   subtests	   were	   moderately	   correlated	   with	   two	  
measures	  of	  activities	  of	  daily	  living.	  It	  was	  noted	  that	  other	  conventional	  measures	  
of	   attention	   did	   not	   correlate	   consistently	   with	   these	   functional	   measures.	   In	  
another	  study	  Elevator	  Counting	  with	  Distraction	  exhibited	  a	  high	  correlation	  with	  
functional	  status,	  in	  a	  MS	  sample	  (Higginson,	  Arnett,	  &	  Voss,	  2000).	  
	  
In	  the	  case	  that	  participants	  scored	  a	  raw	  score	   lower	  than	  that	  referred	  to	   in	  the	  
normative	  tables,	  the	  scaled	  score	  was	  given	  as	  1	  point	  below	  the	  minimum	  scaled	  
score	  value	  in	  the	  table.	  
	  
3.10	   Outcome	  assessments	  
At	  the	  end	  of	  each	  condition	  participants	  and	  their	  carers	  or	  relatives	  were	  asked	  to	  
fill	  out	  the	  outcome	  measures.	  The	  researcher	  posted	  the	  questionnaires	  two	  days	  
prior	  to	  the	  end	  of	  the	  participant’s	  condition.	  A	  pre-­‐paid	  addressed	  envelope	  was	  
enclosed.	  A	  copy	  of	  the	  participant	  questionnaire	  can	  be	  found	  in	  Appendix	  11.	  	  
	  
i) For	  all	  participants	  recruited	  before	  1st	  September	  2014:	  
• Two	   weeks	   were	   granted	   for	   outcome	   measure	   completion	   between	  
conditions.	  These	  two	  weeks	  also	  served	  as	  a	  washout	  period	  between	  
conditions.	  
ii) For	  all	  participants	  recruited	  from	  1st	  September	  2014:	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• Three	  weeks	  were	   granted	   for	   outcome	  measure	   completion	   between	  
conditions.	  These	  three	  weeks	  also	  served	  as	  a	  washout	  period	  between	  
conditions.	  
	  
Additionally,	  for	  the	  final	  two	  weeks	  of	  each	  condition,	  participants	  were	  asked	  to	  
fill	   out	  daily	   diaries,	   in	  which	   they	   recorded	   the	   frequency	  of	   forgetting	   the	   tasks	  
they	  received	  reminders	   for.	  The	  researcher	  posted	  the	  daily	  diary	  4	  days	  prior	  to	  
their	   start	   date.	   A	   pre-­‐paid	   addressed	   envelope	   was	   enclosed.	   Two	   days	   into	  
expected	   daily	   diary	   completion,	   the	   participant	   is	   sent	   a	   text	   by	   the	   researcher	  
checking	   that	   they	  have	  received	  the	  daily	  diary	  and	  that	   they	  were	  completing	   it	  
without	  concern.	  An	  example	  of	  a	  daily	  diary	  is	  shown	  in	  Appendix	  12.	  	  
	  
The	   researcher	   sent	   a	   follow-­‐up	   text	   2	   weeks	   after	   each	   condition	   ended	   if	  
completed	  questionnaires	  had	  not	   yet	  been	   received.	   If	   participants	   self-­‐reported	  
that	   they	   were	   unable	   to	   complete	   the	   questionnaires,	   help	   was	   offered	   by	   the	  
researcher	  to	  administer	  the	  primary	  outcome	  measure	  (EMQ	  frequency)	  over	  the	  
phone.	  After	  that	  point	  no	  further	  action	  was	  taken.	  
	  
	  
3.10.1	   Rationale	  for	  assessments	  selected	  
3.10.1.1	   Everyday	  Memory	  Questionnaire	  
See	   section	   3.9.1.1	   above	   for	   details	   of	   the	   EMQ.	   The	   participant	   version	   of	   the	  
EMQ-­‐28	  was	  the	  primary	  outcome	  measure.	  The	  self-­‐report	  and	  informant	  (relative	  
or	  carer)	  versions	  were	  used	  as	  outcome	  measures.	  A	  lower	  total	  score	  on	  the	  EMQ	  
(participant	  and	  relative)	  indicates	  lower	  frequency	  of	  reported	  memory	  problems.	  
Studies	  which	  have	  included	  subjective	  reports	  of	  memory	  completed	  by	  significant	  
others	   have	   found	   that	   carers	   report	   higher	   frequency	   of	   problems	   than	  patients	  
(Beatty	  &	  Monson,	  1996;	  McIntosh‐Michaelis	  et	  al.,	  1991).	  Therefore	  inclusion	  of	  
the	   informant	   version	   provides	   an	   alternative	   perspective	   of	   memory	   problems	  
faced.	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Importance	   of	   memory	   problems	   were	   also	   rated	   in	   addition	   to	   frequency	   of	  
problems,	  in	  the	  form	  of	  a	  saliency	  scale	  (K.	  Mackenzie,	  2014).	  The	  importance	  scale	  
was	  added	  to	  include	  the	  reporting	  of	  how	  much	  importance	  a	  person	  might	  place	  
on	  a	  particular	  symptom.	  The	  authors	  suggested	  the	  addition	  had	  potential	  to	  add	  
clinically	   useful	   information	   to	   the	   measure	   while	   remaining	   relatively	   short	  
(Mackenzie,	  2014).	  
	  
3.10.1.2	   General	  Health	  Questionnaire	  
	  
The	   General	   Health	   Questionnaire	   (GHQ)(Goldberg	   &	   Williams,	   1988)	   is	   a	   self-­‐
administered	   questionnaire,	   measuring	   common	   mental	   health	   problems	   of	  
depression,	  anxiety,	  somatic	  symptoms	  and	  social	  withdrawal.	  GHQ-­‐30	  has	  30	  items	  
and	  uses	  a	  4-­‐point	  Likert	  scale.	  A	  lower	  total	  score	  on	  GHQ	  indicates	  fewer	  reported	  
mood	  problems.	  
	  
The	  GHQ	  was	  developed	  as	  a	  60-­‐item	  screening	  tool	  to	  detect	  those	  likely	  to	  have	  
or	   be	   at	   risk	   of	   developing	   psychiatric	   disorders.	   The	   30-­‐item	   version	   is	   easy	   to	  
complete	  and	  was	  chosen	  because	  of	   time	  considerations.	  This	  shorted	  version	  of	  
the	   GHQ	   was	   balanced	   for	   overall	   agreement	   set	   and	   had	   items	   endorsed	   by	  
‘physically	  ill’	  respondents	  removed	  (Goldberg	  &	  Williams,	  1988).	  There	  are	  multiple	  
ways	  to	  score	  the	  GHQ,	  but	  using	  the	  4-­‐point	  Likert	  scale	  (0-­‐1-­‐2-­‐3)	  provides	  a	  wider	  
and	  smoother	  score	  distribution	  (Goldberg	  &	  Williams,	  1988),	  and	  is	  therefore	  more	  
sensitive	   to	   change.	   The	   30-­‐item	   version	   does	   not	   have	   questions	   about	   suicide	  
which	  makes	  it	  better	  than	  GHQ-­‐28	  for	  postal	  administration.	  
	  
The	  GHQ	  has	  been	  translated	  into	  38	  different	  languages,	  testament	  to	  the	  validity	  
and	  reliability	  of	  the	  questionnaire	  (Jackson,	  2007).	  The	  GHQ-­‐30	  is	  the	  version	  that	  
has	   been	   most	   widely	   validated,	   with	   the	   median	   value	   for	   sensitivity	   across	  
diagnosis-­‐specific	  coefficients	  being	  81%,	  and	  21	  of	  29	  studies	  yielded	  values	  within	  
10%	   of	   this	   figure	   (Goldberg	   &	   Williams,	   1988).	   Sensitivity	   for	   detecting	   major	  
depression	  was	  the	  highest,	  at	  88%	  (Goldberg	  &	  Williams,	  1988).	  Factor	  analyses	  of	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the	  GHQ-­‐30	   indicate	   an	   impressive	   degree	   of	   consistency	   of	   the	   factor	   structure,	  
and	   the	   identification	  of	   five	   distinct	   factors	   corresponding	   to	   anxiety,	   feelings	   of	  
incompetence,	   depression,	   difficulty	   in	   coping	   and	   social	   dysfunction	   (Huppert,	  
Walters,	  Day,	  &	  Elliott,	  1989).	  
	  
3.10.1.3	   EQ-­‐5D	  	  
The	   EQ-­‐5D	   is	   a	   standardised	  measure	   of	   health	   status	   developed	   by	   the	   EuroQol	  
Group	   in	   order	   to	   provide	   a	   simple	   generic	   measure	   of	   health	   for	   clinical	   and	  
economic	  appraisal	  (The	  EuroQol	  Group,	  1990).	  The	  EQ-­‐5D	  consists	  of	  a	  ‘descriptive	  
system’	  comprising	  the	  following	  5	  dimensions:	  mobility,	  self-­‐care,	  usual	  activities,	  
pain/discomfort	   and	   anxiety/depression.	   A	   visual	   analogue	   scale	   follows	   where	  
participants	  are	  asked	  to	  record	  their	  health	  on	  a	  vertical	  scale	  where	  endpoints	  are	  
labelled	  ‘Best	   imaginable	  health	  state’	  and	  ‘worst	   imaginable	  health	  state’.	  On	  the	  
EQ-­‐5D-­‐3L	   each	   dimension	   has	   3	   levels:	   no	   problem,	   some	   problems,	   extreme	  
problems.	  A	   lower	   score	  on	   each	   item	   (1-­‐5)	   indicates	   better	   quality	   of	   life;	   and	   a	  
higher	  score	  on	  the	  Visual	  Analogue	  Scale	  indicates	  better	  quality	  of	  life.	  Cumulative	  
scoring	  is	  not	  used	  on	  the	  EQ-­‐5D.	  ‘Health	  states’	  can	  be	  referred	  to	  in	  terms	  of	  a	  5-­‐
digit	   code,	   for	   example	   11111	   would	   indicate	   no	   problems	   on	   any	   of	   the	   5	  
dimensions.	   Additionally	   health	   states	   can	   be	   converted	   into	   a	   single	   summary	  
index.	  
	  
The	  National	  Institute	  for	  Health	  and	  Care	  Excellence	  (NICE)	  recommends	  the	  EQ-­‐5D	  
(NICE,	   2008),	   and	   it	   is	   validated	   in	  many	   different	   patient	   populations.	   Construct	  
validity	  has	  been	  demonstrated	  in	  a	  study	  of	  people	  with	  dementia	  (Aguirre,	  Kang,	  
Hoare,	  Edwards,	  &	  Orrell,	  2016).	  
	  
3.10.1.4	   Adaptation	  to	  Memory	  Difficulties	  Outcome	  Questionnaire	  
The	  Adaptation	  to	  Memory	  Difficulties	  Outcome	  questionnaire	  (AMEDO)(Chouliara,	  
2013)	   is	   a	   brief	   and	   simple	  measure	   tailored	   to	   the	   characteristics	   and	   needs	   of	  
neurologically	   impaired	   adults.	   The	   AMEDO	   consists	   of	   2	   parts:	   Part	   A	   asks	  
questions	  about	  how	  participants	  cope	  with	  their	  memory	  problems,	  ranked	  on	  a	  4-­‐
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point	   Likert	   scale;	   Part	   B	   includes	   checklists	   of	   memory	   aids	   used,	   followed	   by	  
questions	   relating	   to	  how	  participants	  use	   them,	   ranked	  on	  a	  4-­‐point	  Likert	   scale,	  
for	   example	   “Using	   external	   memory	   aids	   is	   part	   of	   my	   everyday	   life”.	   A	   higher	  
score	   on	  AMEDO	  part	   A	   indicates	   better	   coping	   strategies	   for	  memory	   problems;	  
higher	  scores	  on	  Parts	  B1	  and	  B2	   indicate	  better	  use	  of	  external	  and	   internal	  aids	  
respectively.	  
	  
The	  AMEDO	  was	  designed	  as	  an	  outcome	  measure	  specific	  to	  the	  effects	  of	  memory	  
rehabilitation,	  to	  complement	  memory	  batteries	  and	  established	  generic	  measures	  
(Chouliara,	   2013).	   It	  was	   developed	   as	   a	   response	   to	   qualitative	   feedback	   from	   a	  
rehabilitation	  programme	   (ReMIND)(das	  Nair	  &	   Lincoln,	   2012).	   Participants	   in	   the	  
ReMIND	   study	   reported	   improvements	   in	   domains	   that	   were	   not	   covered	   by	  
existing	  questionnaires	  assessing	   the	  outcome	  of	  memory	   rehabilitation	   in	  people	  
with	   neurological	   disabilities.	   During	   development	   of	   the	   AMEDO,	   the	   criteria	   of	  
face	   validity,	   response	   distribution	   and	   construct	   validity	   were	   applied.	   Principal	  
component	  analysis	  indicated	  that	  the	  questionnaire	  captured	  most	  of	  the	  content	  
areas	   it	   was	   designed	   to	   cover,	   and	   construct	   validity	   was	   assumed	   (Chouliara,	  
2013).	   Part	   A	   of	   the	   questionnaire	   comprises	   of	   three	   components:	   memory	  
knowledge;	   control;	   and	   emotional	   adjustment.	   These	   factors	  were	   confirmed	   by	  
evaluation	  of	   item-­‐convergent	   validity	   and	  high	   internal	   consistency	  estimates	   for	  
all	  subscales	  were	  found.	  
	  
3.10.1.5	   Daily	  diary	  
The	  daily	  diary	  is	  a	  self-­‐defined	  outcome	  measure	  relating	  to	  participants’	  everyday	  
memory	   problems,	   and	   has	   been	   used	   in	   previous	   studies	   evaluating	   NeuroPage	  
(Fish	  et	  al.,	  2008;	  Wilson	  et	  al.,	  2001;	  Wilson	  et	  al.,	  1997).	  
	  
A	   daily	   diary	  was	   devised	   for	   each	  participant	   based	  on	   the	   earlier	   discussions	   at	  
baseline	   assessment,	   relating	   to	   current	   everyday	   memory	   failures	   and	   the	  
reminders	  they	  wished	  to	  receive	  during	  the	  intervention	  condition.	  For	  example,	  if	  
participants	  wished	   to	   receive	   reminders	   to	   take	   their	  medication,	   the	  daily	   diary	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would	  ask	  how	  many	  times	  they	  forgot	  to	  take	  their	  medication	  each	  day.	  For	  each	  
participant	  the	  content	  of	  the	  daily	  diary	  was	  the	  same	  in	  both	  conditions,	  as	  non-­‐
memory	   messages	   were	   transmitted	   at	   the	   same	   times	   and	   frequency	   as	   the	  
NeuroText	  messages,	  unless	  requested	  otherwise.	  
	  
3.11	   Feedback	  Interviews	  
All	   participants	  were	   contacted	   by	   the	   researcher	   at	   least	   two	  months	   after	   trial	  
completion	   and	   invited	   to	   take	   part	   in	   a	   feedback	   interview.	   Two	   attempts	  were	  
made	   at	   contact	   by	   telephone.	   If	   participants	   agreed	   to	   take	   part,	   they	   were	  
informed	   that	   it	  would	   be	   audio	   recorded,	   in	   order	   to	   record	   their	   views	   in	   their	  
words.	  	  	  	  
	  
Semi-­‐structured	   interviews	   were	   conducted	   to	   capture	   participants’	   perspectives	  
and	   experiences,	   and	   to	   inform	   further	   improvements	   of	   the	   programme.	   This	  
interview	  was	  used	  to	  gather	  supplementary	   information	  from	  the	  participants	  on	  
the	  perceived	  benefits	  (what	  they	  felt	  worked	  well/what	  they	  liked)	  or	  draw-­‐backs	  
(what	  did	  not	  go	  well/what	  did	  not	  like)	  of	  the	  NeuroText	  messages,	  and	  potential	  
improvements.	   They	   were	   also	   asked	   about	   the	   perceived	   effects	   of	   the	   control	  
messages,	  and	  potential	   improvements.	  The	   interview	  schedule	  was	  based	  on	   the	  
one	   used	   in	   the	   ReMemBrIn	   trial	   (das	   Nair,	   Lincoln,	   &	   Ftizsimmons,	   2015).	  
Questions	   were	   open-­‐ended,	   with	   the	   aim	   of	   eliciting	   as	   much	   information	   as	  
possible	   about	   peoples’	   experiences	   of	   the	   intervention.	   The	   semi-­‐structured	  
interview	  schedule	  is	  detailed	  in	  Appendix	  13.	  
	  
Interviews	  were	  conducted	  over	  the	  telephone.	  This	  was	  due	  to	  the	  flexible	  nature	  
of	  organising	  a	  phone	  call	  with	  participants	  at	  their	  preferred	  time,	  compared	  to	  the	  
impracticality	   of	   organising	   geographically-­‐spread	   home	   visits,	   when	   these	   short	  
interviews	   could	   be	   done	   equally	   well	   over	   the	   phone.	   Interviews	   were	   audio	  
recorded.	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3.12	   Data	  collection	  and	  entry	  
Baseline	   data	   were	   anonymised,	   scored	   and	   entered	   into	   a	   password	   protected	  
database	   by	   the	   researcher.	   Personal	   participant	   details,	   e.g.	   name,	   address	   and	  
date	   of	   birth	   were	   entered	   into	   a	   separate	   password	   protected	   database	   by	   the	  
researcher.	  
3.12.1	   RCT	  Outcomes	  
Outcome	  measures	  were	  scored	  and	  entered	   into	  a	  password	  protected	  database	  
by	  a	  person	  blind	   to	   the	  study	  and	   response.	  They	  were	  blind	   to	  group	  allocation	  
and	   did	   not	   have	   any	   contact	   with	   study	   participants.	   Outcome	   measures	   were	  
marked	  with	  ID	  numbers	  by	  the	  researcher	  prior	  to	  being	  posted	  to	  participants,	  to	  
ensure	  blinding.	  The	  researcher	  performed	  10%	  accuracy	  checking.	  	  
	  
3.12.2	   Feedback	  interviews	  
Interviews	   were	   digitally	   recorded	   using	   WebEx	   for	   the	   health	   sector	  
teleconferencing	  services,	  to	  ensure	  secure	  recording.	  Interviews	  were	  recorded	  by	  
the	   researcher	   and	   transcribed	   verbatim	   by	   two	   independent	   researchers.	  
Transcriptions	  were	  checked	  by	  the	  researcher	  for	  accuracy.	  	  
	  
3.13	   Data	  analyses	  
Statistical	   analyses	   were	   carried	   out	   by	   the	   researcher,	   using	   IBM	   SPSS	   Statistics	  
version	  22.0.	  
	  
3.13.1	   Baseline	  	  
The	   demographic	   characteristics	   were	   separated	   first	   into	   groups	   (1	   and	   2),	   and	  
then	  into	  continuous	  and	  categorical	  variables.	  Categorical	  variables	  were	  reported	  
using	   percentages,	   and	   continuous	   reporting	   the	   mean,	   standard	   deviation	   and	  
range	  of	  the	  groups.	  The	  distribution	  of	  baseline	  data	  was	  assessed	  for	  normality	  by	  
checking	  whether	   the	   value	   of	   the	   skewness	   statistic	  was	   greater	   than	   twice	   the	  
value	  of	  its	  standard	  error	  (Coolican,	  2014).	  Where	  the	  skew	  was	  twice	  the	  standard	  
	   82	  
error,	   non-­‐parametric	   procedures	   were	   applied,	   otherwise	   the	   mean,	   standard	  
deviation	   and	   range	   were	   reported	   for	   all	   measures.	   If	   the	   majority	   of	   variables	  
included	   in	   the	   analyses	   were	   of	   normal	   distribution	   parametric	   statistics	   were	  
employed.	   Participants	   were	   randomly	   allocated	   to	   the	   two	   groups,	   so	   any	  
differences	   between	   groups	   were	   due	   to	   chance;	   therefore	   a	   statistical	   test	   to	  
determine	  whether	  differences	  were	  due	  to	  chance	  was	  not	  employed.	  	  
	  
3.13.2	   Feasibility	  
The	  number	  of	  referrals	  and	  recruitments	  from	  each	  NHS	  trust	  were	  reported,	  and	  
the	  percentages	  of	  converted	  referrals	  were	  calculated.	  Reasons	  for	  exclusions	  and	  
dropouts	   were	   described.	   The	   number	   and	   percentage	   of	   outcome	   measures	  
returned	   were	   calculated,	   as	   were	   the	   completion	   rates	   of	   individual	   scales,	   e.g.	  
EMQ.	  
	  
The	   frequency	   and	   types	   of	   intervention	   and	   control	   messages	   requested	   by	  
participants	  were	  calculated.	  	  
	  
3.13.3	   Effectiveness	  of	  intervention	  
The	  distribution	  of	  outcome	  data	  was	  assessed	  for	  normality	  by	  checking	  whether	  
the	  value	  of	  the	  skewness	  statistic	  was	  greater	  than	  twice	  the	  value	  of	  its	  standard	  
error	   (Coolican,	   2014).	   Where	   the	   skew	   was	   twice	   the	   standard	   error,	   non-­‐
parametric	  procedures	  were	  applied,	  otherwise	  the	  mean,	  standard	  deviation	  and	  
range	  were	  reported	  for	  all	  measures.	  
	  
Intention-­‐to-­‐treat	  analysis	  was	  used	  throughout	  the	  trial,	  such	  that	  an	  estimate	  of	  
likely	   health	   benefits	   of	   the	   intervention	   in	   clinical	   practice	   may	   be	   provided.	  
Therefore	   all	   data	   was	   categorised	   as	   the	   group	   in	   which	   participants	   were	  
randomised	   into.	   The	   study	  was	   an	   AB/BA	   crossover,	   therefore	   group	   1	   received	  
NeuroText	  first,	  control	  second;	  group	  2	  received	  control	  first,	  NeuroText	  second.	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There	  are	  many	  ways	   to	  approach	   the	  analysis	  of	   crossover	   trials.	   The	  analysis	  of	  
crossover	   trials	   should	   take	  advantage	  of	   the	  within-­‐participants	  design	  and	  use	  a	  
form	  of	  paired	  analysis	  (Elbourne	  et	  al.,	  2002).	  Therefore	  within-­‐group	  comparisons	  
were	  employed.	  For	  all	  outcome	  measures,	  scores	  from	  both	  groups	  1	  and	  2	  were	  
combined	   to	   get	   a	   dataset	   for	   performance	   after	   the	   NeuroText	   condition,	   and	  
control	  condition.	  Therefore	  the	  NeuroText	  data	  was	  collated	  using	  scores	  (Group	  1	  
condition	   1	   +	   Group	   2	   condition	   2);	   and	   control	   was	   calculated	   using	   (Group	   1	  
condition	   2	   +	   Group	   2	   condition	   1).	   Grouping	   the	   scores	   from	   each	   condition	  
(NeuroText	   and	   control),	   regardless	   of	   which	   order	   they	   received	   conditions,	  
increases	  the	  sample	  size,	  and	  therefore	  the	  power.	  
	  
The	   appropriate	   analysis	   of	   data	   from	  an	  AB/BA	   trial	   is	   a	   paired	   t-­‐test	   (Higgins	  &	  
Green,	   2013).	   Paired-­‐samples	   t-­‐tests	   (Senn,	   2002)	   were	   employed,	   to	   compare	  
combined	   performance	   after	   the	   NeuroText	   and	   control	   conditions.	   A	   significant	  
difference	   in	   performance	   between	   conditions	   was	   determined	   as	   p<0.05.	   Effect	  
sizes	  were	  also	  estimated	  using	  Cohen’s	  d,	  by	  calculating	  mean	  difference	  divided	  
by	   standard	   deviation	   of	   difference	   (Cohen,	   1988;	   Field,	   2013).	   Effect	   size	   was	  
classified	  as	  follows:	  0.2	  small;	  0.5	  moderate;	  0.8	  large.	  
	  
When	   employing	  within-­‐subject	   analyses	   on	   data	   from	   an	   AB/BA	   trial,	   additional	  
checks	   for	   carryover	   or	   period	   effects	   should	   be	   performed,	   (Higgins	   &	   Green,	  
2013).	   This	   is	   to	   ensure	   that	   there	   was	   no	   “carryover”	   of	   effects	   from	   the	   first	  
condition	  into	  the	  second;	  and	  that	  the	  order	  in	  which	  condition	  were	  received	  had	  
no	  impact	  on	  participant	  outcomes.	  Carryover	  effects	  were	  tested	  by	  comparing	  the	  
sum	   of	   values	   over	   both	   conditions,	   between	   groups	   1	   and	   2	   (Jones	  &	   Kenward,	  
2014).	  Period	  effects	  were	  tested	  by	  comparing	  the	  difference	  between	  NeuroText	  
and	  control	  condition	  scores,	  between	  groups	  1	  and	  2	  (Jones	  &	  Kenward,	  2014).	  The	  
data	  was	  checked	  for	  carryover	  and	  period	  effects	  using	  independent	  t-­‐tests.	  
	  
In	  addition,	  a	  within-­‐subject	  analysis	  was	  also	  performed	  using	  change	  data	  on	  the	  
EMQ-­‐participant	   frequency	   subscale.	   Change	   data	   was	   calculated	   using	   the	  
combined	  data	  at	   three	  time-­‐points:	  baseline	   [B],	  after	  condition	  1	   [T1],	  and	  after	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condition	  2	  [T2],	  to	  enable	  comparison	  between	  change	  with	  NeuroText	  and	  change	  
with	  control	  for	  each	  participant.	  Therefore	  change	  with	  NeuroText	  was	  calculated	  
as	  (Group	  1	  T1-­‐B)	  +	  (Group	  2	  T2-­‐T1).	  Change	  with	  control	  was	  calculated	  as	  (Group	  1	  
T2-­‐T1)	  +	  (Group	  2	  T1-­‐B).	  A	  paired/related-­‐samples	  t-­‐test	  was	  employed	  to	  compare	  
the	   two	   sets	   of	   data.	   A	   significant	   difference	   in	   performance	   between	   conditions	  
was	  determined	  as	  p<0.05.	  
	  
3.13.3.1	   Sample	  size	  estimation	  
A	   feasibility	   analysis	   was	   performed,	   as	   no	   previous	   trials	   of	   this	   nature	   were	  
identified,	  and	  therefore	  there	  was	  no	  previous	  data	  on	  rates	  of	  consent,	  number	  
who	   completed	   treatment,	   or	   outcome	   assessments.	   In	   order	   to	   determine	   the	  
sample	   size,	   a	   12-­‐point	   difference	   on	   the	   Everyday	   Memory	   Questionnaire	   was	  
identified	  as	  clinically	   important	  during	   the	  ReMemBrIn	  Trial	   (das	  Nair,	   Lincoln,	  et	  
al.,	   2015),	   and	   a	   sigma	   value	   of	   16.4	   was	   identified	   from	   Carr	   et	   al.	   (2014).	  
Calculating	  the	  sample	  size	  using	  these	  values	  equated	  to	  a	  required	  sample	  size	  of	  
30	  in	  each	  group	  (α=0.05).	  Therefore,	  considering	  a	  10%	  allowance	  for	  dropouts,	  at	  
least	  66	  participants	  were	  planned	  to	  be	  recruited	  in	  this	  study.	  
	  
Post-­‐hoc	  sample	  size	  estimation	  was	  calculated,	  to	  advise	  for	  a	  future	  full-­‐powered	  
RCT.	  
	  
3.13.4	   Feedback	  interviews	  
Data	   were	   obtained	   using	   the	   semi-­‐structured	   feedback	   interviews,	   and	   the	  
transcripts	  were	  coded	  and	  analysed	  thematically.	  NVivo	  10	  for	  Windows	  was	  used	  
to	  store	  and	  organise	  the	  data.	  
	  
Thematic	  analysis	  was	  initially	  considered	  because	  it	  is	  a	  flexible	  approach,	  and	  not	  
bound	  to	  any	  theoretical	  position	  (Braun	  &	  Clarke,	  2006).	  However,	  the	  purpose	  of	  
the	   interviews	  was	   to	  examine	  participant	   feedback	  on	   their	   experience	  of	   taking	  
part	  in	  the	  trial,	  and	  to	  provide	  suggestions	  for	  improvement.	  The	  semi-­‐structured	  
interview	   schedule	   was	   designed	   specifically	   to	   capture	   these	   key	   questions.	  
	   85	  
Therefore	   it	   was	   anticipated	   that	   the	   data	   would	   cover	   similar,	   specific	   topics	   in	  
response	   to	   the	   interview	  questions,	   and	   it	  was	   deemed	   that	   framework	   analysis	  
(FA)	  would	  therefore	  be	  a	  more	  appropriate	  method.	  
	  
FA	  is	  becoming	  an	  increasingly	  popular	  approach	  to	  the	  management	  and	  analysis	  
of	  qualitative	  data	  in	  health	  research,	  and	  is	  most	  commonly	  used	  for	  the	  thematic	  
analysis	  of	  semi-­‐structured	   interview	  transcripts	   (Gale,	  Heath,	  Cameron,	  Rashid,	  &	  
Redwood,	  2013).	  FA	  sits	   closely	  with	   thematic	  analysis	   in	   its	  approach,	   identifying	  
commonalities	   and	   differences	   in	   the	   data,	   then	   focusing	   on	   the	   relationships	  
between	  difference	  parts	  of	  the	  data,	  to	  cluster	  into	  themes	  (Gale	  et	  al.,	  2013).	  FA	  
also	   is	   not	   aligned	   to	   a	   particular	   epistemological	   or	   theoretical	   approach.	   The	  
defining	  feature	  of	  FA	  if	  the	  matrix	  output	  or	  rows	  (cases),	  columns	  (codes)	  and	  cells	  
of	   summarised	   data,	   which	   provide	   structure	   into	   which	   the	   researcher	   can	  
systematically	   reduce	   the	   data,	   to	   analyse	   it	   by	   case	   or	   code	   (Ritchie,	   Lewis,	  
Nicholls,	  &	  Ormston,	  2013).	  This	   layout	  allows	  the	  researcher	  to	  perform	  in-­‐depth	  
analyses	  of	  themes	  across	  the	  dataset,	  whilst	  retaining	  the	  context	  of	  participants’	  
views.	   Furthermore	   FA	   allows	   the	   researcher	   to	   maintain	   an	   effective	   and	  
transparent	   audit	   trail,	   as	   management	   and	   analysis	   take	   place	   simultaneously	  
(Smith	  &	  Firth,	  2011).	  An	  example	  of	  the	  framework	  matrix	  used	  in	  this	  study	  can	  be	  
found	  in	  Appendix	  14.	  
	  
The	  procedure	  for	  FA	  described	  by	  Gale	  et	  al.	  (2013)	  was	  followed.	  Gale	  et	  al.	  (2013)	  
outline	   seven	   stages	   of	   FA:	   (i)	   transcription,	  where	   audio	   recording	   is	   transcribed	  
verbatim;	   (ii)	   familiarisation	   with	   the	   interview,	   by	   re-­‐listening	   or	   re-­‐reading	  
transcripts	  and	  noting	  impressions;	  (iii)	  coding,	  carefully	  reading	  transcripts	  line-­‐by-­‐
line	  and	  paraphrasing	  important	  passages	  and	  labelling	  with	  codes;	  (iv)	  developing	  a	  
working	   analytical	   framework,	   codes	   were	   grouped	   together	   into	   clearly	   defined	  
categories	   over	   several	   iterations;	   (v)	   applying	   the	   analytical	   framework,	   indexing	  
transcripts	  using	  categories	  and	  codes;	  (vi)	  charting	  data	  into	  the	  framework	  matrix,	  
a	  spread	  sheet	  is	  used	  to	  generate	  a	  matrix	  and	  data	  are	  charted	  onto	  the	  matrix;	  
(vii)	   interpreting	   the	   data,	   characteristics	   of	   data	   and	   connections	   between	  
categories	  are	  identified	  to	  form	  themes	  and	  sub-­‐themes.	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Themes	   were	   defined	   as	   important	   aspects	   of	   data	   that	   broadly	   related	   to	   the	  
interview	   questions,	   and	   were	   representative	   of	   patterned	   responses	   within	   the	  
data	   set,	   and	   that	   appeared	   with	   some	   frequency	   (Braun	   &	   Clarke,	   2006).	   The	  
degree	   of	   frequency	   was	   not	   predefined.	   Themes	   identified	   were	   coded	   and	  
analysed	  at	  a	   semantic/explicit	   level.	  A	  mixture	  of	  deductive	  and	   inductive	  coding	  
was	  employed	   in	   this	   study,	  where	   some	  codes	  were	  pre-­‐defined	   in	   line	  with	   the	  
interview	   questions.	   However	   inductive	   coding	   also	   occurred,	   to	   include	  
unexpected	  perspectives	  (Gale	  et	  al.,	  2013).	  In	  our	  write	  up,	  we	  opted	  not	  to	  ‘count’	  
the	  number	  of	   times	  a	  construct	  or	   theme	  was	  endorsed	  by	  participants,	  because	  
we	  felt	  that	  this	  would	  suggest	  a	  level	  of	  accuracy,	  which	  such	  an	  analysis	  does	  not	  
purport	   to	   do.	   Instead,	   we	   chose	   to	   describe	   the	   endorsement	   in	   general	   terms,	  
such	  as,	  ‘several	  participants’	  or	  ‘a	  few…’	  
	  
Saturation	  was	   assumed	  when	   the	   emergence	   of	   new	   themes	   stopped	   and	   code	  
definitions	  were	   stable	   (Guest,	  Bunce,	  &	   Johnson,	  2006).	   Saturation	  was	  assessed	  
and	  agreed	  by	   two	  researchers,	  and	  data	  collection	   in	   the	   form	  of	   interviews	  was	  
stopped.	  	  
	  
FA	   was	   carried	   out	   by	   the	   researcher,	   under	   the	   supervision	   of	   an	   experienced	  
qualitative	   researcher,	   to	   ensure	   quality.	   Multiple	   iterations	   of	   the	   framework	  
matrix	  were	  co-­‐reviewed,	  to	  confirm	  themes	  and	  sub-­‐themes	  were	  valid.	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4	   Quantitative	  Results	  
	  
4.1	   Chapter	  Overview	  
This	  chapter	  will	  begin	  by	  describing	  the	  demographic	  characteristics	  and	  baseline	  
performance	   of	   the	   sample.	   Recruitment	   rates,	   return	   of	   outcome	  measures	   and	  
attrition	  will	  be	  reported.	  The	  content	  of	  the	  intervention	  will	  be	  discussed,	  and	  the	  
outcomes	  of	  the	  intervention	  and	  control	  will	  be	  compared.	  
	  
4.2	   Feasibility	  Study	  
4.2.1	   Description	  of	  the	  sample	  
One-­‐hundred-­‐and-­‐seven	   people	  were	   referred	   to	   the	   trial	   and	   of	   these	   103	  were	  
assessed	   for	   eligibility;	   4	   people	   could	   not	   be	   reached	   for	   assessment	   using	   the	  
contact	   details	   provided	   by	   the	   referrers.	   53	   people	   were	   excluded.	   	   Of	   those	  
excluded,	   8	   people	   did	   not	   score	   above	   the	   cut-­‐off	   on	   the	   EMQ,	   4	   had	   a	   severe	  
motor	  or	  cognitive	  impairment	  and	  41	  did	  not	  want	  to	  take	  part	  and	  so	  did	  not	  give	  
consent.	  Figure	  2	  shows	  the	  flow	  of	  participants	  through	  the	  trial.	  
	  
Fifty	  people	  were	  recruited	  to	  the	  feasibility	  trial.	  25	  people	  were	  randomised	  into	  
group	  1	  to	  receive	  NeuroText	  first	  then	  control;	  25	  in	  group	  2	  to	  receive	  control	  first	  
then	  NeuroText.	  The	  demographic	  characteristics	  of	  the	  participants	  are	  described	  
in	  tables	  5	  and	  6.	  	  
	  
Table	  5:	  Demographic	  characteristics	  of	  participants	  on	  continuous	  variables	  
	   Group	  1	  	   Group	  2	  	  
	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	  
Age	   25	   50.96	   11.96	   28-­‐72	   25	   48.12	   10.31	   30-­‐72	  
Years	  since	  diagnosis	   25	   11.86	   8.97	   1-­‐37	   25	   10.30	   9.48	   1-­‐33	  
Years	  since	  last	  relapse	   14	   1.29	   1.54	   0-­‐6	   19	   2.26	   2.28	   0-­‐9	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Table	  6:	  Demographic	  characteristics	  of	  participants	  on	  categorical	  variables	  
	   	   Group	  1	  	   Group	  2	  
	   	   n	   %	   n	   %	  
Gender	   Men	   11	   44	   7	   28	  




Primary	  progressive	   7	   28	   3	   12	  
Secondary	  progressive	   7	   28	   6	   24	  
Relapsing	  remitting	   9	   36	   15	   60	  
Benign	   1	   4	   0	   0	  
Missing	   1	   4	   1	   4	  
NHS	  Trust	   Nottingham	  University	  Hospitals	   7	   28	   13	   58	  
Nottingham	  CityCare	  Partnership	   3	   12	   4	   16	  
Cambridge	  University	  Hospitals	   2	   8	   1	   4	  
Cambridgeshire	  Community	  Services	   8	   32	   4	   16	  
Peterborough	  &	  Stamford	  Hospitals	   5	   20	   3	   12	  
Education	   1-­‐4	  GCSEs	  or	  NVQ	  L1	   2	   8	   3	   12	  
5+	  GCSEs	  or	  NVQ	  L2	   10	   40	   6	   24	  
2+	  A	  Levels	  or	  NVQ	  L3	   1	   4	   5	   20	  
Degree	  or	  Higher	  degree	   8	   32	   7	   28	  
Professional	  Qualification	   1	   4	   0	   0	  
Vocational	  qualifications	   3	   12	   4	   16	  
Occupation	   Higher	   managerial,	   administrative	   and	  
professional	  occupations	  
2	   8	   3	   12	  
Intermediate	  occupations	   2	   8	   2	   8	  
Routine	  and	  manual	  occupations	   0	   0	   1	   4	  
Never	   worked	   and	   long-­‐term	  
unemployed	  
0	   0	   4	   16	  
Disability	  retirement/	  retirement	   21	   84	   15	   60	  
Occupation	  
Type	  
Full	  time	   3	   12	   2	   8	  
Part	  Time	   1	   4	   7	   28	  
Unemployed	   21	   84	   16	   64	  
Partnership	   Never	  married	  or	  civil	  partnership	   2	   8	   3	   12	  
Married	  or	  civil	  partnership	   19	   76	   17	   68	  
No	  longer	  married	  or	  civil	  partnership	   4	   16	   5	   20	  
Ethnicity	   White	   23	   92	   24	   96	  
	   89	  
Mixed/Multiple	  ethnic	  groups	   0	   0	   1	   4	  
Black/African/Caribbean/Black	  British	   2	   8	   0	   0	  
Beliefs	   Christian	   8	   32	   15	   60	  
Other	   2	   8	   1	   4	  
None	   15	   60	   9	   36	  
	  
Group	   1	   and	   group	   2	   are	   comparable	   for	   the	   majority	   of	   demographic	  
characteristics.	  Group	  2	  had	  a	  higher	  percentage	  of	  women;	  people	  with	  relapsing	  
remitting	   MS;	   and	   participants	   from	   Nottingham	   University	   Hospitals	   NHS	   Trust,	  
compared	   to	   group	   1.	   Group	   1	   had	   a	   higher	   percentage	   of	   people	   with	   primary	  
progressive	  MS;	  participants	   from	  Cambridgeshire	  Community	  Services	  NHS	  Trust;	  
unemployed/retired	  people;	  and	  people	  with	  no	  beliefs.	  
	  
4.2.2	   Baseline	  characteristics	  
The	   distribution	   of	   scores	   on	   baseline	   measures	   were	   checked	   to	   determine	  
whether	   they	   had	   normal	   distributions.	   The	   majority	   of	   measures	   had	   normal	  
distribution	   and	   so	   parametric	   statistics	   are	   reported	   in	   table	   7.	   Skew	   values	   for	  
each	  subtest	  are	  reported	  in	  Appendix	  15.	  
	  
Table	  7:	  Distribution	  of	  scores	  on	  baseline	  measures	  
	   Group	  1	  	   Group	  2	  	  
	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	  
EMQ	  Total	  Score	   25	   49.9	   16.2	   21-­‐86	   25	   52.0	   17.8	   21-­‐98	  
Doors	  &	  People	  Test	   	   	   	   	   	   	  
People	   25	   7.7	   3.2	   1-­‐13	   25	   6.8	   3.4	   1-­‐13	  
Doors	   24	   7.6	   3.8	   1-­‐14	   25	   6.0	   3.1	   1-­‐11	  
Shapes	   24	   8.6	   4.8	   0-­‐16	   25	   8.3	   3.7	   0-­‐14	  
Names	   24	   8.1	   4.4	   0-­‐15	   25	   10.3	   4.4	   1-­‐16	  
Overall	  Score	   24	   7.6	   4.2	   0-­‐15	   25	   9.0	   8.3	   0-­‐36	  
Combined	   visual	  
memory	  
24	   8.1	   3.9	   2-­‐15	   25	   6.7	   3.4	   2-­‐13	  
Combined	   verbal	  
memory	  
24	   7.7	   3.8	   2-­‐14	   25	   8.3	   3.9	   14	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Combined	  recall	   24	   8.1	   3.8	   2-­‐14	   25	   7.1	   3.6	   2-­‐14	  
Combined	  recognition	   24	   7.8	   4.1	   2-­‐14	   25	   7.9	   3.9	   2-­‐14	  
Verbal	  forgetting	   24	   8.8	   3.1	   3-­‐13	   25	   10.1	   2.5	   5-­‐14	  
Visual	  forgetting	   24	   9.9	   1.8	   6-­‐12	   25	   9.2	   2.8	   2-­‐12	  
Hayling	  &	  Brixton	  
Hayling	  error	   25	   5.4	   2.3	   1-­‐8	   25	   5.3	   2.1	   1-­‐8	  
Hayling	  overall	   25	   4.7	   1.8	   1-­‐7	   25	   5.0	   1.6	   1-­‐7	  
Brixton	   25	   4.8	   2.4	   1-­‐10	   25	   5.0	   2.2	   1-­‐9	  
Test	  of	  Everyday	  Attention	   	   	   	   	   	   	  
Map	  search	  1	   22	   7.2	   3.3	   0-­‐12	   25	   6.5	   3.4	   0-­‐12	  
Map	  search	  2	   22	   6.7	   3.2	   0-­‐11	   25	   6.2	   3.4	   0-­‐13	  
Elevator	  counting	   25	   6.6	   0.6	   5-­‐7	   25	   6.9	   0.4	   6-­‐7	  
Elevator	  counting	  with	  
distraction	  
25	   9.4	   2.9	   5-­‐13	   24	   10.3	   2.3	   6-­‐13	  
Visual	  elevator	  1	   23	   8.7	   3.2	   3-­‐15	   24	   9.3	   2.9	   3-­‐14	  
Visual	  elevator	  2	   22	   7.8	   3.5	   0-­‐13	   24	   8.0	   3.1	   0-­‐15	  
Elevator	  counting	  with	  
reversal	  
20	   9.6	   3.6	   5-­‐18	   22	   9.4	   3.5	   2-­‐15	  
Telephone	  search	   23	   7.5	   3.2	   0-­‐12	   25	   7.7	   3.4	   0-­‐15	  
Telephone	   search	  
while	  counting	  
23	   8.0	   3.5	   0-­‐15	   25	   8.2	   3.7	   0-­‐15	  
Lottery	   25	   8.0	   3.8	   1-­‐13	   24	   8.9	   3.7	   1-­‐13	  
Note:	  Tests	  used:	  EMQ:	  Everyday	  Memory	  Questionnaire	  
	  
All	  Hayling	  &	  Brixton	   scores	  had	  non-­‐normal	  distributions,	   and	   so	  non-­‐parametric	  
statistics	  are	  reported	  in	  table	  8.	  	  
	  
Table	  8:	  Distribution	  of	  scores	  on	  Hayling	  &	  Brixton	  tests	  at	  baseline	  
	   Group	  1	  	   Group	  2	  	  
	   n	   Median	   I.Q.R.	   n	   Mean	   I.Q.R.	  
Hayling	  Error	   25	   6	   4.5-­‐6	   25	   6	   4.5-­‐6	  
Hayling	  Overall	   25	   6	   3.5-­‐6	   25	   6	   4-­‐6	  
Brixton	   25	   5	   2.5-­‐6.5	   25	   6	   3.5-­‐6.5	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The	  two	  groups	  were	  comparable	  across	  all	  baseline	  measures.	  Scores	  on	  the	  Doors	  
&	   People	   subtests	   were	   in	   the	   low-­‐average	   to	   average	   memory	   ability	   range.	  
Performance	   on	   the	   Hayling	   &	   Brixton	   tests	   in	   both	   groups	   showed	   average	  
executive	   functioning.	  Overall	   scores	  on	  the	  Test	  of	  Everyday	  Attention	  were	   low-­‐
average	   in	  attention	   for	  both	  groups.	  Participants	  scored	   in	   the	  average	  range	   for	  
the	  Elevator	  counting	  with	  distraction	  (ECD)	  subtest	  measuring	  selective	  attention,	  
and	  Elevator	  counting	  with	  reversal	  (ECR),	  which	  measures	  attention	  switching.	  
	  
4.2.3	   Feasibility	  measures	  
4.2.3.1	  Recruitment	  
One	  hundred	   and	   seven	   people	  were	   referred	   from	  MS	  Clinicians.	   Table	   9	   shows	  
referral	  and	  inclusion	  to	  study	  figures	  for	  each	  of	  the	  NHS	  trusts.	  
	  
Table	  9:	  Referral	  and	  inclusion	  figures	  by	  Trust	  








31	   20	   65	  
Nottingham	  CityCare	  
Partnership	  
13	   7	   54	  
Cambridge	  
University	  Hospitals	  
3	   3	   100	  
Cambridgeshire	  
Community	  Services	  
42	   12	   29	  
Peterborough	   &	  
Stamford	  Hospitals	  
18	   8	   44	  
Total	   107	   50	   47	  
	  
The	  majority	  of	  referrals	  were	  made	  from	  Cambridgeshire	  Community	  Services	  NHS	  
Trust,	   however	   they	   had	   the	   lowest	   conversion	   rate	   for	   inclusion	   in	   the	   study.	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Cambridge	  University	  Hospitals	  NHS	  Trust	  had	  100%	  conversion	  rate,	  but	   referred	  
the	   lowest	  number	  of	  potential	  participants.	  Nottingham	  University	  Hospitals	  NHS	  
Trust	  had	  the	  highest	  number	  of	  included	  participants	  in	  the	  study.	  	  
	  	  
4.2.3.2	  Return	  of	  Outcome	  measures	  
The	  number	  of	  each	  of	  the	  outcome	  questionnaires	  returned	  after	  first	  and	  second	  
conditions	   are	   detailed	   below	   in	   table	   10.	   Figure	   2	   also	   demonstrates	   outcome	  
measure	  return.	  
	  
Table	  10:	  Return	  of	  outcome	  questionnaires	  
	   Outcomes	   Group	  1	   Group	  2	  
First	  Condition	   Questionnaire	  participant	  n	  (%)	   21	  (84)	   19	  (83)	  
Questionnaire	  relative	  n	  (%)	   17	  (68)	   12	  (52)	  
Daily	  Diary	  n	  (%)	   19	  (76)	   15	  (65)	  
Second	  Condition	   Questionnaire	  participant	  n	  (%)	   17	  (71)	   14	  (61)	  
Questionnaire	  relative	  n	  (%)	   15	  (63)	   10	  (43)	  
Daily	  Diary	  n	  (%)	   13	  (54)	   11	  (48)	  
	  
Group	  1	  had	  a	  slightly	  higher	  return	  rate	  than	  group	  2	  across	  all	  outcome	  measures	  
and	  conditions.	  Return	  rates	  decreased	  from	  condition	  1	  to	  condition	  2.	  
	  
Table	   11	   provides	   a	   breakdown	   of	   completion	   rates	   for	   individual	   outcome	  
measures	  within	  the	  booklets.	  
	  
Table	  11:	  Completion	  of	  individual	  sections	  of	  outcome	  measures	  
	   Outcomes	   Group	  1	   Group	  2	  
First	  Condition	   EMQ	  Frequency	  participant	  n(%)	   21	  (84)	   18	  (78)	  
EMQ	  Importance	  participant	  n(%)	   18	  (72)	   15	  (65)	  
GHQ	  n(%)	   19	  (76)	   16	  (70)	  
AMEDO	  Part	  A	  n(%)	   19(76)	   15	  (65)	  
EQ5d	  n(%)	   19(76)	   15	  (65)	  
EQ5d	  VAS	  n(%)	   18	  (72)	   14	  (61)	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EMQ	  relative	  n(%)	   17	  (68)	   11	  (48)	  
Second	  Condition	   EMQ	  Frequency	  participant	  n(%)	   17	  (71)	   14	  (61)	  
EMQ	  Importance	  participant	  n(%)	   16	  (67)	   13	  (57)	  
GHQ	  n(%)	   16	  (67)	   13	  (57)	  
AMEDO	  Part	  A	  n(%)	   16	  (67)	   13	  (57)	  
EQ5d	  n(%)	   16	  (67)	   13	  (57)	  
EQ5d	  VAS	  n(%)	   15	  (63)	   13	  (57)	  
EMQ	  relative	  n(%)	   14	  (58)	   9	  (39)	  
Note:	   Tests	   used:	   EMQ:	   Everyday	   Memory	   Questionnaire;	   GHQ:	   General	   Health	   Questionnaire;	  
AMEDO:	  Adaptation	  to	  Memory	  Difficulties	  Outcomes	  Questionnaire.	  
	  
The	  completion	  rates	  of	  individual	  outcome	  measures	  were	  similar	  to	  those	  of	  the	  
overall	  outcome	  returns.	  Group	  1	  had	  a	  higher	  completion	  rate	  than	  group	  2,	  and	  
completion	  rates	  decreased	  over	  time.	  
	  
Five	  participants	  requested	  phone	  assistance	  after	  their	  first	  condition,	  2	  in	  group	  1	  
and	  3	  in	  group	  2;	  two	  after	  their	  second	  condition,	  1	  from	  each	  group.	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Figure	  2:	  Flow	  of	  participants	  through	  the	  feasibility	  study	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4.2.3.3	  Attrition	  
Two	  participants	  were	  considered	  dropouts	  due	  to	  the	  researcher	  not	  being	  able	  to	  
contact	   them	  after	   they	  had	   consented	   into	   the	   study.	   Technological	  problems	  at	  
the	  beginning	  of	  the	  trial	  meant	  that	  ten	  participants	  did	  not	  receive	  the	  control	  as	  
planned.	   Therefore,	   the	   trial	   was	   temporarily	   halted	   and	   the	   technological	  
difficulties	   were	   resolved.	   Additionally	   adjustments	   to	   the	   protocol	   were	  
implemented	   to	   boost	   recruitment	   and	   outcome	   return,	   and	   then	   the	   trial	   was	  
restarted	   with	   these	   changes	   in	   place,	   as	   agreed	   by	   the	   ethics	   committee.	   See	  
Appendix	  16	  for	  the	  approval	  letter.	  	  
	  
Therefore,	  outcomes	  analysis	  was	  conducted	  on	  38	  participants	  who	  were	  recruited	  
after	  problems	  with	  delivery	  of	  control	  condition	  were	  rectified,	  and	  in	  line	  with	  the	  
new	  protocol.	  	  
	  
4.3	   Randomised	  controlled	  trial	  
4.3.1	   Description	  of	  the	  sample	  
After	  restarting	  the	  trial	  38	  people	  were	  included,	  17	  participants	  randomised	  into	  
group	  1	  and	  received	  NeuroText	  first	  then	  control;	  21	  were	  in	  group	  2	  and	  received	  
control	  first	  then	  NeuroText.	  	  
	  
The	  demographic	  characteristics	  of	  the	  participants	  are	  described	  in	  tables	  12	  and	  
13.	  	  
	  
Table	  12:	  Demographic	  characteristics	  of	  participants	  on	  continuous	  variables	  
	   Group	  1	  	   Group	  2	  	  
	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	  
Age	   17	   48.8	   12.9	   28-­‐72	   21	   46.7	   9.7	   30-­‐65	  
Years	  since	  diagnosis	   17	   10.6	   9.8	   1-­‐37	   21	   9.7	   9.4	   1-­‐33	  
Years	  since	  last	  relapse	   11	   1.4	   1.7	   0-­‐6	   17	   2.1	   2.3	   0-­‐9	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Table	  13:	  Demographic	  characteristics	  of	  participants	  on	  categorical	  variables	  
	   	   Group	  1	  	   Group	  2	  
	   	   n	   %	   n	   %	  
Gender	   Men	   6	   35	   4	   19	  
Women	   11	   65	   17	   81	  
Type	   of	  
multiple	  
sclerosis	  
Primary	  progressive	   3	   18	   1	   5	  
Secondary	  progressive	   5	   29	   5	   24	  
Relapsing	  remitting	   8	   47	   14	   66	  
Benign	   1	   6	   0	   0	  
Missing	   0	   0	   1	   5	  
NHS	  Trust	   Nottingham	  University	  Hospitals	   6	   35	   13	   62	  
Nottingham	  CityCare	  Partnership	   2	   12	   1	   5	  
Cambridge	  University	  Hospitals	   1	   6	   1	   5	  
Cambridgeshire	  Community	  Services	   3	   18	   3	   14	  
Peterborough	  &	  Stamford	  Hospitals	   5	   29	   3	   14	  
Education	   1-­‐4	  GCSEs	  or	  NVQ	  L1	   2	   12	   2	   9	  
5+	  GCSEs	  or	  NVQ	  L2	   6	   35	   6	   29	  
2+	  A	  Levels	  or	  NVQ	  L3	   1	   6	   3	   14	  
Degree	  or	  Higher	  degree	   5	   29	   6	   29	  
Vocational	  qualifications	   3	   18	   4	   19	  
Occupation	   Higher	   managerial,	   administrative	   and	  
professional	  occupations	  
2	   12	   3	   14	  
Intermediate	  occupations	   2	   12	   2	   10	  
Routine	  and	  manual	  occupations	   0	   0	   1	   5	  
Never	   worked	   and	   long-­‐term	  
unemployed	  
0	   0	   3	   14	  
Disability	  retirement/	  retirement	   13	   76	   12	   57	  
Occupation	  
Type	  
Full	  time	   3	   18	   2	   9	  
Part	  Time	   1	   6	   6	   29	  
Unemployed	   13	   76	   13	   62	  
Partnership	   Never	  married	  or	  civil	  partnership	   2	   12	   2	   10	  
Married	  or	  civil	  partnership	   13	   76	   15	   71	  
No	  longer	  married	  or	  civil	  partnership	   2	   12	   4	   19	  
Ethnicity	   White	   17	   100	   21	   100	  
Beliefs	   Christian	   4	   23	   12	   57	  
Other	   1	   6	   1	   5	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None	   12	   71	   8	   38	  
	  
Group	   1	   and	   group	   2	   were	   comparable	   for	   the	   majority	   of	   demographic	  
characteristics.	  Group	  2	  had	  a	  higher	  percentage	  of	  females;	  people	  with	  relapsing	  
remitting	   MS;	   and	   participants	   from	   Nottingham	   University	   Hospitals	   NHS	   Trust,	  
compared	   to	   group	   1.	   Group	   1	   had	   a	   higher	   percentage	   of	   people	   with	   primary	  
progressive	  MS;	   participants	   from	  Peterborough	  &	   Stamford	  Hospitals	  NHS	   Trust;	  
unemployed/retired	  people;	  and	  people	  with	  no	  beliefs.	  
	  
4.3.2	   Baseline	  characteristics	  
The	   distribution	   of	   scores	   on	   baseline	   measures	   were	   checked	   to	   determine	  
whether	   they	   had	   normal	   distributions.	   The	   majority	   of	   measures	   had	   normal	  
distribution	  and	  so	  parametric	  statistics	  are	  reported	   in	  table	  14.	   	  Skew	  values	  for	  
each	  subtest	  are	  reported	  in	  Appendix	  17.	  
	  
Table	  14:	  Distribution	  of	  scores	  on	  baseline	  measures	  
	   Group	  1	  	   Group	  2	  
	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	  
EMQ	  Total	  Score	   17	   51.6	   17.8	   32-­‐86	   21	   53.3	   18.2	   21-­‐99	  
Doors	  &	  People	  Test	   	   	   	   	   	   	  
People	   17	   7.8	   3.6	   1-­‐13	   21	   7.3	   3.5	   1-­‐13	  
Doors	   17	   7.3	   4.3	   1-­‐14	   21	   6.4	   2.9	   1-­‐11	  
Shapes	   17	   9.0	   5.3	   0-­‐16	   21	   8.8	   3.7	   0-­‐14	  
Names	   17	   7.4	   4.5	   0-­‐15	   21	   10.4	   4.1	   1-­‐16	  
Overall	  Score	   17	   7.7	   4.6	   0-­‐15	   21	   8.9	   7.6	   0-­‐36	  
Combined	   visual	  
memory	  
17	   8.3	   4.5	   2-­‐15	   21	   7.4	   3.3	   2-­‐13	  
Combined	   verbal	  
memory	  
17	   7.4	   4.0	   2-­‐14	   21	   8.7	   3.9	   2-­‐14	  
Combined	  recall	   17	   8.4	   4.1	   2-­‐14	   21	   7.9	   3.5	   2-­‐14	  
Combined	  recognition	   17	   7.4	   4.4	   2-­‐14	   21	   8.2	   3.8	   2-­‐14	  
Verbal	  forgetting	   17	   8.8	   2.8	   4-­‐13	   21	   10.1	   2.4	   5-­‐13	  
Visual	  forgetting	   17	   9.9	   1.6	   6-­‐11	   21	   9.2	   2.9	   2-­‐12	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Hayling	  &	  Brixton	  
Hayling	  error	   17	   5.8	   2.0	   1-­‐8	   21	   5.6	   1.8	   1-­‐8	  
Hayling	  overall	   17	   5.0	   1.7	   1-­‐7	   21	   5.1	   1.4	   1-­‐6	  
Brixton	   17	   5.2	   2.7	   1-­‐10	   21	   5.1	   2.3	   1-­‐9	  
Test	  of	  Everyday	  Attention	  
Map	  search	  1	   15	   7.1	   3.4	   0-­‐12	   21	   7.0	   3.4	   0-­‐12	  
Map	  search	  2	   15	   6.9	   3.0	   0-­‐11	   21	   6.5	   3.4	   0-­‐13	  
Elevator	  counting	   17	   6.5	   0.7	   5-­‐7	   21	   6.9	   0.4	   6-­‐7	  
Elevator	  counting	  with	  
distraction	  
17	   9.2	   3.0	   5-­‐13	   21	   10.6	   2.3	   6-­‐13	  
Visual	  elevator	  1	   16	   8.8	   3.6	   3-­‐15	   20	   9.9	   2.4	   5-­‐14	  
Visual	  elevator	  2	   16	   7.8	   4.0	   0-­‐13	   20	   8.3	   2.8	   2-­‐15	  
Elevator	  counting	  with	  
reversal	  
13	   10.9	   3.7	   5-­‐18	   19	   9.6	   3.7	   2-­‐15	  
Telephone	  search	   16	   7.6	   3.5	   0-­‐12	   21	   8.1	   3.4	   0-­‐15	  
Telephone	   search	  
while	  counting	  
16	   8.2	   3.7	   0-­‐15	   21	   8.6	   3.6	   0-­‐15	  
Lottery	   17	   7.8	   4.1	   1-­‐13	   20	   9.6	   3.3	   4-­‐13	  
Note:	  Tests	  used:	  EMQ:	  Everyday	  Memory	  Questionnaire.	  
	  
All	   Hayling	   scores	   had	   non-­‐normal	   distributions,	   and	   so	   non-­‐parametric	   statistics	  
are	  reported	  in	  table	  15.	  	  
	  
Table	  15:	  Distribution	  of	  scores	  on	  Hayling	  &	  Brixton	  tests	  at	  baseline	  
	   Group	  1	  	   Group	  2	  	  
	   n	   Median	   I.Q.R.	   n	   Mean	   I.Q.R.	  
Hayling	  Error	   17	   6	   6-­‐7	   21	   6	   5-­‐6.5	  
Hayling	  Overall	   17	   6	   3.5-­‐6	   21	   6	   4-­‐6	  
	  
The	  two	  groups	  were	  comparable	  across	  all	  baseline	  measures.	  Scores	  on	  the	  Doors	  
&	   People	   subtests	   were	   in	   the	   low-­‐average	   to	   average	   memory	   ability	   range.	  
Performance	   on	   the	   Hayling	   &	   Brixton	   tests	   in	   both	   groups	   showed	   average	  
executive	   functioning.	  Overall	   scores	  on	  the	  Test	  of	  Everyday	  Attention	  were	   low-­‐
average	   in	  attention	   for	  both	  groups.	  Participants	  scored	   in	   the	  average	  range	   for	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the	  Elevator	  counting	  with	  distraction	  (ECD)	  subtest	  measuring	  selective	  attention;	  
and	  Elevator	  counting	  with	  reversal	  (ECR),	  which	  measures	  attention	  switching.	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4.3.3	   Participant	  Flow	  
All	  38	  participants	  received	  the	  intervention	  and	  control	  as	  planned.	  No	  participants	  
dropped	  out	  part	  way	   through	   intervention	  phase.	  One	  participant	  withdrew	  part	  
way	  through	  the	  control	  condition.	  Figure	  3	  demonstrates	  the	  flow	  of	  participants	  
through	  the	  study.	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Figure	  3:	  Flow	  of	  participants	  through	  the	  RCT	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4.3.4	   Content	  of	  Intervention	  
A	   total	   of	   885	   reminder	   messages	   per	   week	   were	   requested	   in	   the	   NeuroText	  
conditions,	  and	  788	  control	  messages.	  The	   frequency	  and	  type	  of	   reminders	  were	  
evaluated	  in	  table	  16	  below.	  
	  
Table	  16:	  Most	  frequently	  requested	  text	  messages	  
	   Group	  1	   Group	  2	  
NeuroText	  Condition:	  
Requested	  content	  (%)	  
Medication	  (36)	   Medication	  (47)	  
Toilet	  (10)	   Today	  is	  (11)	  
Drink	  (8)	   Check	  calendar/diary	  (8)	  
Eat	  meal	  (7)	   Charge	  phone	  (6)	  
Check	  calendar/diary	  (6)	   Eat	  meal	  (4)	  
Today	  is	  (4)	   Prepare	  food	  (3)	  
Control	  Condition:	  
Requested	  content	  (%)	  
Current	  affairs	  (68)	   Current	  affairs	  (51)	  
Sports	  news	  (15)	   Specific	  news	  (36)	  
Specific	  news	  (13)	   Sports	  news	  (13)	  
Quotes	  (4)	   	  
	  
NeuroText	   messages	   regarding	   medication	   were	   the	   most	   commonly	   requested	  
reminder	  in	  the	  NeuroText	  condition.	  Reminders	  for	  the	  day	  of	  the	  week;	  check	  the	  
calendar/diary	   and	   eat	   meal	   were	   also	   frequently	   requested	   in	   the	   NeuroText	  
condition.	  Messages	  requesting	  current	  affairs	  headlines	  were	  the	  most	  frequently	  
requested	  in	  the	  control	  condition.	  
	  
4.3.5	   Outcomes	  of	  RCT	  
The	   distribution	   of	   scores	   on	   the	   outcome	   questionnaires	   were	   checked	   to	  
determine	  whether	   they	   had	   normal	   distributions.	   The	  majority	   of	   subscales	   had	  
normal	   distribution	   and	   so	   parametric	   statistics	   are	   reported	   in	   table	   17.	   	   Skew	  
values	  for	  each	  measure	  are	  reported	  in	  Appendix	  18.	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Group	  1=	  (NeuroText,	  Control);	  Group	  2=	  (Control,	  NeuroText)	  
Table	  17:	  RCT	  outcome	  data	  
Measure	   Group	   NeuroText	   Control	   Combined	  NeuroText	  	   Combined	  Control	  




Group1	   13	   44.4	   22.7	   12-­‐75	   12	   36.1	   21.0	   4-­‐76	   27	   40.3	   22.9	   1-­‐83	   29	   40.7	   21.3	   4-­‐90	  




Group1	   11	   70.9	   17.4	   35-­‐98	   11	   71.8	   16.3	   51-­‐104	   24	   73.5	   17.0	   35-­‐100	   25	   71.4	   16.7	   36-­‐104	  
Group2	   13	   75.6	   17.1	   37-­‐100	   14	   76.4	   17.3	   36-­‐99	  
GHQ	  total	   Group1	   11	   37.1	   9.5	   24-­‐61	   11	   44.6	   18.4	   22-­‐77	   24	   31.9	   12.6	   8-­‐61	   26	   39.7	   16.2	   21-­‐77	  
Group2	   13	   27.5	   13.5	   8-­‐55	   15	   36.1	   13.9	   21-­‐68	  
AMEDO	  Part	  
A	  total	  
Group	  	   11	   37.1	   8.9	   19-­‐48	   11	   39.2	   8.3	   25-­‐51	   24	   38.5	   7.9	   19-­‐52	   25	   38.5	   6.7	   25-­‐51	  
Group2	   13	   39.7	   7.1	   28-­‐52	   14	   38.0	   5.5	   32-­‐51	  
AMEDO	  Part	  
B1	  
Group1	   11	   13.8	   2.7	   10-­‐16	   11	   14.1	   2.6	   8-­‐16	   24	   14.2	   2.7	   9-­‐20	   25	   13.7	   3.2	   3-­‐16	  
Group2	   13	   14.5	   3.0	   9-­‐20	   14	   13.4	   3.6	   3-­‐16	  
AMEDO	  Part	  
B2	  
Group1	   10	   12.6	   3.3	   6-­‐16	   10	   12.6	   3.7	   4-­‐16	   22	   11.2	   37	   4-­‐16	   21	   12.2	   3.7	   4-­‐16	  
Group2	   12	   10.1	   3.7	   4-­‐16	   11	   11.8	   3.9	   4-­‐16	  
EQ5d	  1	   Group1	   11	   2.2	   0.4	   2-­‐3	   10	   2.1	   0.3	   2-­‐3	   24	   2.0	   0.4	   1-­‐3	   24	   1.9	   0.5	   1-­‐3	  
Group2	   13	   1.9	   0.3	   1-­‐2	   14	   1.7	   0.5	   1-­‐2	  
EQ5d	  2	   Group1	   11	   1.7	   0.5	   1-­‐2	   11	   2.0	   0.6	   1-­‐3	   24	   1.6	   0.5	   1-­‐2	   25	   1.6	   0.6	   1-­‐3	  
Group2	   13	   1.5	   0.5	   1-­‐2	   14	   1.4	   0.5	   1-­‐2	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Measure	   Group	   NeuroText	   Control	   Combined	  NeuroText	  	   Combined	  Control	  
n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	   n	   Mean	   SD	   Range	  
EQ5d	  3	   Group1	   11	   2.2	   0.4	   2-­‐3	   11	   2.3	   0.8	   1-­‐3	   24	   2.0	   0.4	   1-­‐3	   25	   2.0	   0.7	   1-­‐3	  
Group2	   13	   1.9	   0.3	   1-­‐2	   14	   1.7	   0.5	   1-­‐2	  
EQ5d	  4	   Group1	   11	   2.5	   0.5	   2-­‐3	   11	   2.7	   0.5	   2-­‐3	   24	   2.3	   0.6	   1-­‐3	   25	   2.2	   0.7	   1-­‐3	  
Group2	   13	   2.1	   0.6	   1-­‐3	   14	   1.9	   0.5	   1-­‐3	  
EQ5d	  5	   Group1	   11	   1.8	   0.6	   1-­‐3	   11	   2.0	   0.6	   1-­‐3	   24	   1.6	   0.6	   1-­‐3	   25	   1.8	   0.6	   1-­‐3	  
Group2	   13	   1.5	   0.5	   1-­‐2	   14	   1.6	   0.5	   1-­‐2	  
EQ5d	  VAS	   Group1	   10	   42.5	   24.3	   17-­‐86	   10	   32.9	   21.5	   9-­‐80	   23	   53.2	   26.4	   14-­‐100	   24	   44.5	   22.5	   9-­‐92	  




Group1	   11	   37.6	   21.2	   0-­‐70	   9	   30.0	   16.3	   1-­‐56	   20	   35.0	   19.7	   0-­‐71	   20	   33.2	   18.9	   1-­‐91	  




Group1	   11	   68.6	   20.9	   30-­‐93	   9	   66.8	   17.0	   37-­‐97	   20	   70.5	   17.0	   30-­‐93	   20	   63.4	   17.2	   31-­‐97	  
Group2	   9	   72.7	   11.3	   57-­‐87	   11	   60.6	   17.6	   31-­‐81	  
Daily	  Diary	   Group1	   14	   14.1	   16.3	   0-­‐53	   9	   15.1	   12.6	   0-­‐37	   20	   8.8	   9.9	   0-­‐53	   20	   30.0	   33.9	   0-­‐100	  
Group2	   11	   8.0	   9.4	   0-­‐30	   14	   39.5	   37.7	   0-­‐100	  
Note:	  Tests	  used:	  EMQ-­‐p:	  Everyday	  Memory	  Questionnaire	  participant-­‐rated;	  GHQ:	  General	  Health	  Questionnaire;	  AMEDO:	  Adaptation	  to	  Memory	  Difficulties	  Outcomes	  
Questionnaire;	  EMQ-­‐r:	  Everyday	  Memory	  Questionnaire	  relative-­‐rated.	  Daily	  diary	  scores	  were	  %	  target	  behaviours	  forgotten.	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Paired-­‐samples	   t-­‐tests	   were	   employed	   to	   compare	   outcome	   scores	   in	   the	  
NeuroText	  and	  control	  conditions.	  These	  results	  are	  displayed	  in	  table	  18.	  
	  
Table	  18:	  Comparison	  between	  combined	  treatment	  and	  control	  
Measure	   t	   df	   p	   Cohen’s	  d	  
EMQ-­‐p	  Frequency	  total	   0.12	   24	   0.90	   0.02	  
EMQ-­‐p	  Importance	  total	   -­‐0.85	   20	   0.41	   -­‐0.15	  
GHQ	  total	   -­‐3.83	   20	   0.001*	   -­‐0.84	  
AMEDO	  Part	  A	  total	   0.23	   20	   0.82	   0.05	  
AMEDO	  Part	  B1	   1.11	   20	   0.28	   0.24	  
AMEDO	  Part	  B2	   -­‐1.92	   17	   0.07	   -­‐0.45	  
EQ5d	  1	   1.83	   19	   0.08	   0.41	  
EQ5d	  2	   -­‐0.44	   20	   0.67	   -­‐0.10	  
EQ5d	  3	   0.33	   20	   0.75	   0.07	  
EQ5d	  4	   0.44	   20	   0.67	   0.10	  
EQ5d	  5	   -­‐2.17	   20	   0.04*	   -­‐0.47	  
EQ5d	  VAS	   2.03	   19	   0.06	   0.45	  
EMQ-­‐r	  Frequency	  total	   -­‐1.66	   16	   0.12	   -­‐0.40	  
EMQ-­‐r	  Importance	  total	   0.84	   16	   0.41	   0.20	  
Daily	  Diary	   -­‐2.88	   19	   0.01*	   -­‐0.64	  
*treatment	  effect	  
Note:	  Tests	  used:	  EMQ-­‐p:	  Everyday	  Memory	  Questionnaire	  participant-­‐rated;	  GHQ:	  General	  Health	  
Questionnaire;	   AMEDO:	   Adaptation	   to	   Memory	   Difficulties	   Outcomes	   Questionnaire;	   EMQ-­‐r:	  
Everyday	   Memory	   Questionnaire	   relative-­‐rated.	   Daily	   diary	   scores	   were	   %	   target	   behaviours	  
forgotten.	  
	  
Significant	  differences	   (p<0.05)	  were	   found	  on	   the	  GHQ,	  EQ5d	  question	   regarding	  
anxiety	   &	   depression,	   and	   the	   daily	   diary.	   Therefore	   while	   receiving	   NeuroText	  
participants’	   had	   less	   psychological	   distress	   and	   a	   lower	   frequency	   of	   forgetting	  
everyday	   target	   behaviours,	   compared	   to	   control.	   There	   were	   no	   significant	  
differences	   between	   the	   treatment	   and	   control	   on	  measures	   of	   general	   everyday	  
memory	  problems	  rated	  by	  participants	  or	  significant	  other;	  adaptation	  to	  memory	  
difficulties;	  and	  quality	  of	  life	  questions	  regarding	  perceived	  health	  status,	  mobility,	  
self-­‐care,	  usual	  activities	  and	  pain.	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Effect	  sizes	  were	  calculated	  using	  Cohen’s	  d.	  A	  large	  effect	  size	  was	  found	  for	  scores	  
on	  the	  GHQ,	  and	  moderate	  effect	  size	  for	  the	  daily	  diary;	  AMEDO	  internal	  memory	  
aids	  subscale;	  EQ5d	  anxiety	  &	  depression	  question	  and	  EQ5d	  VAS	  of	  health.	  
	  
GHQ	  and	  daily	  diary	  scores	  from	  the	  first	  and	  second	  conditions	  are	  portrayed	  for	  
both	  groups	  in	  figures	  4	  and	  5,	  respectively.	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Figure	  5:	  Mean	  total	  scores	  on	  the	  daily	  diary	  
	  
	  
The	  data	  was	   checked	   for	   carryover	  and	  period	  effects	  using	   independent	   t-­‐tests,	  
and	  results	  are	  reported	  in	  table	  19.	  There	  was	  a	  significant	  period	  effect	  for	  scores	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Table	  19:	  Carryover	  and	  period	  effects	  checks	  using	  independent	  t-­‐tests	  
	   	   Test	  for	  carryover	  effect	   Test	  for	  period	  effect	  
Measure	   Group	   Sum	   of	   both	  
condition	  
t	   df	   p	   Difference	  
between	  
condition	  
t	   df	   p	  
EMQ	   Frequency	  
participant	  total	  
Group	  1	   81.6	   -­‐0.23	   23	   0.82	   7.4	   -­‐1.62	   23	   0.12	  
Group	  2	   77.8	   -­‐4.9	  
EMQ	  Importance	  total	   Group	  1	   144.7	   0.51	   19	   0.62	   -­‐2.7	   0.13	   19	   0.99	  
Group	  2	   152.1	   -­‐2.6	  
GHQ	  total	   Group	  1	   83.3	   -­‐1.71	   19	   0.10	   -­‐6.7	   -­‐0.51	   19	   0.62	  
Group	  2	   62.5	   -­‐8.8	  
AMEDO	  Part	  A	  total	   Group	  1	   77.2	   -­‐0.13	   19	   0.90	   -­‐2.8	   2.31	   19	   0.03*	  
Group	  2	   76.4	   2.6	  
AMEDO	  Part	  B1	   Group1	   27.8	   -­‐0.22	   19	   0.83	   0.4	   0.51	   19	   0.62	  
Group2	   27.3	   1.3	  
AMEDO	  Part	  B2	   Group1	   26.0	   -­‐1.58	   16	   0.14	   -­‐1.8	   0.44	   16	   0.67	  
Group2	   21.7	   -­‐1.1	  
EQ5d	  1	   Group1	   4.4	   -­‐2.25	   18	   0.04*	   0.1	   0.24	   18	   0.81	  
Group2	   3.7	   0.2	  
EQ5d	  2	   Group1	   3.6	   -­‐1.53	   19	   0.14	   -­‐0.2	   1.43	   19	   0.17	  
Group2	   2.9	   0.1	  
EQ5d	  3	   Group1	   4.4	   -­‐2.12	   19	   0.047*	   0.0	   0.28	   19	   0.79	  
Group2	   3.8	   0.1	  
EQ5d	  4	   Group1	   5.2	   -­‐2.73	   19	   0.01*	   -­‐0.1	   1.29	   19	   0.21	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Group2	   4.0	   0.2	  
EQ5d	  5	   Group1	   3.7	   -­‐1.26	   19	   0.22	   -­‐0.1	   -­‐0.78	   19	   0.45	  
Group2	   3.1	   -­‐0.3	  
EQ5d	  VAS	   Group	  1	   66.8	   2.34	   18	   0.03*	   6.3	   0.51	   18	   0.62	  
Group	  2	   108.8	   11.0	  
EMQ-­‐r	  Frequency	  total	   Group1	   60.4	   0.60	   15	   0.56	   -­‐0.1	   -­‐1.59	   15	   0.13	  
Group2	   71.2	   -­‐7.9	  
EMQ-­‐r	  Importance	  total	   Group1	   132.0	   0.63	   15	   0.54	   0.3	   0.72	   15	   0.48	  
Group2	   139.8	   5.6	  
Daily	  Diary	   Group1	   24.8	   1.57	   18	   0.13	   -­‐5.4	   -­‐2.13	   18	   0.047*	  
Group2	   51.6	   -­‐35.6	  
*carryover/period	  effect	  
Note:	  Tests	  used:	  EMQ-­‐p:	  Everyday	  Memory	  Questionnaire	  participant-­‐rated;	  GHQ:	  General	  Health	  Questionnaire;	  AMEDO:	  Adaptation	  to	  Memory	  Difficulties	  
Outcomes	  Questionnaire;	  EMQ-­‐r:	  Everyday	  Memory	  Questionnaire	  relative-­‐rated.	  Daily	  diary	  scores	  were	  %	  target	  behaviours	  forgotten.	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EMQ-­‐p	   frequency	   subscale	   scores	   are	   demonstrated	   graphically	   across	   the	   three	  
time-­‐points	  in	  figure	  6.	  
	  
Figure	  6:	  Mean	  total	  scores	  on	  the	  EMQ	  participant	  frequency	  subscale	  
	  
	  
Change	  scores	  were	  calculated	  using	  baseline,	  NeuroText	  and	  control	  scores	  on	  the	  
EMQ	  frequency	  subscale.	  Change	  scores	  are	  demonstrated	  in	  table	  20.	  
	  
Table	  20:	  EMQ	  participant	  frequency	  total	  change	  scores	  
	   Mean	   S.D.	   Range	   t	   df	   p	   Cohen’s	  d	  
Change	  with	  treatment	   -­‐4.6	   16.8	   -­‐48-­‐43	   0.84	   24	   0.41	   0.17	  
Change	  with	  control	   -­‐8.9	   16.4	   -­‐47-­‐22	  
	  
There	  was	  no	   significance	  difference	  between	  change	  with	   treatment	  and	  change	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4.3.6	   Sample	  size	  and	  power	  
	  
Using	   the	   GHQ	   dataset	   from	   this	   trial,	   the	   estimated	   sample	   size	   needed	   for	   full	  
powered	   future	   trial	   is	   54	   participants	   per	   group.	   Therefore,	   considering	   a	   10%	  
allowance	  for	  dropouts,	  119	  participants	  would	  need	  to	  be	  recruited.	  Alternatively	  
using	  the	  Daily	  Diary	  dataset	  from	  this	  trial,	   the	  estimated	  sample	  size	  needed	  for	  
full	  powered	  future	  trial	  is	  17	  participants	  per	  group.	  Therefore,	  considering	  a	  10%	  
allowance	   for	   dropouts,	   37	   participants	   would	   need	   to	   be	   recruited.	   These	  
estimations	  were	  calculated	  using	  the	  Sealed	  Envelope	  Ltd.	  website	  (2012).	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5	   Qualitative	  Results	  
	  
5.1	   Chapter	  Summary	  
This	  chapter	  describes	  the	  demographic	  characteristics	  of	  the	  participants	  that	  took	  
part	  in	  the	  feedback	  interviews.	  The	  foci,	  themes,	  and	  sub-­‐themes	  are	  explored	  and	  
supported	  by	  participant	  quotes.	  
5.2	   Feedback	  interviews	  
Feedback	   interviews	  were	  carried	  out	  with	  25	  participants,	  and	  their	  demographic	  
characteristics	   are	   presented	   in	   table	   21	   below.	   All	   participants	   agreed	   to	   the	  
interview	  being	  audio	  recorded.	  	  
Table	  21:	  Demographic	  characteristics	  of	  participants	  in	  feedback	  interviews	  





1	   NeuroText	   62	   Male	   Primary	  Progressive	   4	   White	  British	  
3	   NeuroText	   60	   Male	   Secondary	  Progressive	   5	   White	  British	  
4	   NeuroText	   50	   Male	   Secondary	  Progressive	   23	  
Black/African/Caribbean
/Black	  British	  
7	   Control	   72	   Male	   Primary	  Progressive	   10	   White	  British	  
8	   NeuroText	   52	   Female	   Unsure	   16	   White	  British	  
9	   NeuroText	   67	   Male	   Primary	  Progressive	   16	   White	  British	  
10	   NeuroText	   61	   Female	   Primary	  Progressive	   19	   White	  British	  
11	   NeuroText	   40	   Male	   Primary	  Progressive	   19	  
Black/African/Caribbean
/Black	  British	  
12	   NeuroText	   52	   Female	   Relapsing	  Remitting	   15	   White	  British	  
14	   Control	   32	   Female	   Relapsing	  Remitting	   1	   White	  British	  
15	   NeuroText	   67	   Male	   Secondary	  Progressive	   21	   White	  British	  
16	   Control	   53	   Female	   Relapsing	  Remitting	   3	   White	  British	  
17	   Control	   65	   Female	   Secondary	  Progressive	   33	   White	  British	  
19	   Control	   49	   Male	   Relapsing	  Remitting	   9	   White	  British	  
20	   NeuroText	   50	   Male	   Primary	  Progressive	   2	   White	  British	  
21	   Control	   55	   Male	   Secondary	  Progressive	   31	   White	  British	  
22	   NeuroText	   42	   Male	   Primary	  Progressive	   4	   White	  British	  
23	   Control	   36	   Female	   Relapsing	  Remitting	   5	   White	  British	  
26	   Control	   30	   Female	   Relapsing	  Remitting	   5	   White	  British	  
27	   Control	   34	   Female	   Relapsing	  Remitting	   10	   White	  British	  
29	   Control	   46	   Female	   Unsure	   1	   White	  British	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30	   Control	   47	   Female	   Relapsing	  Remitting	   2	   White	  British	  
31	   NeuroText	   38	   Female	   Relapsing	  Remitting	   1	   White	  British	  
32	   Control	   47	   Female	   Relapsing	  Remitting	   8	   White	  British	  
33	   NeuroText	   56	   Female	   Relapsing	  Remitting	   13	   White	  British	  
	  
Themes	   were	   grouped	   by	   3	   foci:	   NeuroText	   messages,	   Control	   messages	   and	  
Overall	  experience	  of	  participating	  in	  study.	  Seven	  major	  themes	  were	  identified:	  (i)	  
perceived	   usefulness	   of	   NeuroText,	   (ii)	   NeuroText	   ending,	   (iii)	   potential	  
improvements	   to	   NeuroText,	   (iv)	   potential	   usefulness	   of	   control,	   (v)	   control	   not	  
useful,	  (vi)	  positive	  experience	  of	  study,	  (vii)	  a	  few	  concerns	  with	  participation.	  Foci,	  
themes	  and	  sub-­‐themes	  are	  summarised	  in	  figure	  7.	  
Figure	  7:	  Theme	  summary	  
Foci	   Themes	   Sub-­‐themes	  
NeuroText	  messages	  
Perceived	  usefulness	  of	  
NeuroText	  
Memory	  related	  improvements	  
Improved	  ability	  to	  manage	  mood	  
Improved	  fatigue	  management	  
NeuroText	  ending	  
Benefit	  remained	  







	   	   	  
Control	  messages	  
Potential	  usefulness	  of	  
control	  
Acting	  as	  a	  prompt	  
"Gave	  me	  a	  lift"	  
Encouraged	  engagement	  





	   	   	  
Overall	  experience	  
of	  participating	  in	  
study	  




A	  few	  concerns	  with	  
participation	  




Themes	  are	  explored	  below	  with	  excerpts	  from	  the	  transcripts,	  which	  highlight	  the	  
participants’	  experiences.	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5.2	   Reminder	  messages	  
5.2.1	   Perceived	  usefulness	  of	  NeuroText	  
5.2.1.1	  Memory-­‐related	  improvements	  
The	   most	   highly	   endorsed	   notion	   throughout	   the	   feedback	   interviews	   was	   that	  
receiving	   the	   NeuroText	   reminder	   messages	   helped	   participants	   achieve	   their	  
everyday	  target	  behaviours,	  which	  they	  would	  have	  normally	  forgotten	  to	  do,	  such	  
as,	  attending	  appointments,	  turning	  the	  oven	  off,	  or	  taking	  out	  the	  bins.	  
“They	  were	  good	  because	  when	  I	  got	  them	  I	  put	  the	  bins	  out	  because	  
I	   remembered…	   I	  usually	   forget	   that	   I’ve	  got	  a	   full	  bin	  and	   I’d	  have	  
like	  black	  bags	  and	  stuff	  and	  I	  have	  to	  wait	  another	  week	  for	  them	  to	  
come	  again,	   it	  helped	  me,	   thinking	   ‘Oh	  yes,	   I’ve	  got	   the	   text	   to	  put	  
the	  bins	  out’,	  things	  like	  that.	  	  That	  was	  useful.”	  (ID	  27)	  
Many	   participants	   found	   the	   reminder	   messages	   helpful	   because	   it	   meant	   they	  
adhered	   to	   their	   medicine	   regimes,	   which	   made	   their	   physical	   condition	   more	  
stable.	  	  
“Yes,	   well	   yes	   and	   as	   I	   say	   it	   just	   meant	   that	   the	   reminders	   were	  
about	   reminding	  me	   to	   take	   tablets	  at	  a	   certain	   time,	   it	   just	  meant	  
that	   I	   didn’t	   miss	   those	   tablets,	   it	   just	   made	   my	   sort	   of	   condition	  
more	  stable.”	  (ID	  22)	  
“‘Take	  your	  medication’,	  ‘Pick	  the	  child	  up	  from	  school’.	  	  Yeah	  it	  was	  
great.	  	  I	  haven’t	  missed	  any	  of	  my	  injections…	  they	  saved	  me	  missing	  
my	  injection.	  	  I	  think	  I	  missed	  it	  once	  in	  the	  whole	  time	  and	  I	  usually	  
miss	  it	  a	  lot.	  I	  didn’t	  miss	  any	  medication.	  Yeah.”	  (ID	  23)	  
In	   all	   these	   instances,	   the	   participants	   report	   a	   direct	   connection	   between	   the	  
content	   of	   the	   text	   message	   (e.g.,	   ‘take	   your	   medication’)	   and	   there	   is	   some	  
indication	  of	  the	  timing	  of	  the	  action	  to	  be	  completed	  (e.g.,	  ‘…when	  I	  got	  them	  I	  put	  
the	  bins	  out…’).	  After	  receiving	  the	  NeuroText	  reminder	  messages	  for	  a	  while,	  some	  
participants,	   however,	   reported	   that	   the	   process	   of	   receiving	   the	   messages	   was	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acting	   as	   a	   prompt.	   When	   the	   “beep”	   of	   a	   message	   came	   through,	   they	   would	  
observe	  the	  time	  and	  anticipate	  the	  content	  of	  the	  message.	  
	  “They	  were	  very	  repetitive,	  but	  that	  was	  kind	  of	  good	  because	  that,	  
sometimes	  I	  would	  think	  ‘Oh,	  I	  know	  what	  that	  is,	  I’ve	  got	  to	  do	  this’.	  
So,	  they	  did	  work.	  They	  did	  work	  extremely	  well.”	  (ID	  29)	  
“When	  it	  was	  half	  past	  seven,	  or	  eight	  o’clock,	  the	  texts	  would	  come	  
through,	  I	  think	  it	  was	  eight	  o’clock	  and	  I	  would	  think,	  even	  with	  that	  
little	   ‘beep’	   ‘I’ve	  got	   to	  check	   the	  diary!	   I’ve	  got	   to	  check	   the	  diary,	  
you	  know?”	  (ID	  31)	  
In	  fact,	  some	  participants	  did	  not	  even	  feel	  the	  need	  to	  read	  the	  reminder	  message,	  
because	  the	  previous	  repetition	  of	  the	  messages	  meant	  that	  they	  knew	  what	  they	  
had	  to	  do	  when	  the	  message	  came	  through.	  
“Well	  it	  got	  to	  a	  stage	  where	  I	  wasn’t	  even	  looking	  at	  the	  reminders	  
as	  they	  came	  in	  to	  remind	  me	  to	  do	  a	  particular	  thing,	  it	  was	  almost	  
like	  well,	  what	   time	   is	   it,	  well	   that	   reminder	  will	   be	   for...	   so	   it	  was	  
almost	  jogging	  my	  memory,	  I	  didn’t	  actually,	  necessarily	  need	  to	  read	  
the	  reminder…because	  I	  knew	  roughly	  what	  the	  reminder	  would	  be	  
about.’	  (ID	  22)	  
As	   mentioned,	   some	   text	   messages	   prompted	   a	   reactive	   response	   from	   the	  
participants,	   e.g.,	   taking	   medications	   when	   prompted.	   However,	   for	   some	  
participants,	  the	  reminder	  messages	  appeared	  to	  get	  them	  into	  a	  routine.	  	  
	  “To	   start	   with	   it	   was	   unusual,	   but	   then	   every	   time	   a	   text	   came	  
through,	  I	  know	  what	  it	  was	  going	  to	  say,	  because	  I	  got	  used	  to	  the	  
times	   and	   everything	   of	   what	   it	   was	   going	   to	   say	   and	   it,	   yeah	   the	  
times,	  the	  dates...	  It’s	  brilliant,	  I	  tell	  you.”	  (ID	  9)	  
Again,	   there	   is	   a	   suggestion	   that	   this	   action	  was	   in	   response	   to	   the	   prompt,	   not	  
necessarily	  the	  content	  (‘I	  know	  what	   it	  was	  going	  to	  say’),	  but	  there	  is	  a	  sense	  of	  
routine	  formation	  here	  (‘I	  got	  used	  to	  the	  times…’).	  Interestingly,	  some	  participants	  
started	  anticipating	  when	  the	  message	  would	  come	  through,	  and	  even	  perform	  the	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behaviour	   just	   before	   receiving	   the	  message.	   This	   response	  was	  most	   commonly	  
seen	  with	  regard	  to	  taking	  medication.	  
“It	  was	  a	  nice	  surprise	  because	  I’d	  forgot	  all	  about	  it.	  Some	  mornings	  
I’d	   err,	   some	   mornings	   I’d	   remember	   it	   was	   coming	   and	   if	   I’d	  
remembered,	   I	   would	   take	   the	   medication	   before	   it	   comes	   and	   I	  
would	  think	  ’Yes,	  I	  took	  it,	  thank	  you.’”	  (ID	  19)	  
“What	  I	  found	  was	  that	  the	  text	  would	  go	  off	  and	  I	  would	  think	  ‘Oh	  I	  
need	   to	   take	  my	   tablets’,	   just	   about	   the	   same	   time,	   so	   I	   got	   into	   a	  
habit	  of	  knowing	  the	  times	  I	  should	  be	  taking	  them.”	  (ID	  33)	  
The	  fact	  that	  participants	  were	  achieving	  their	  target	  behaviours,	  and	  had	  more	  of	  a	  
daily	  routine,	  enabled	  the	  participants	  to	  feel	  more	  organised	  and	  focussed	  on	  what	  
they	  needed	  to	  do.	  
	  “Well,	   it	   generally	   just	  helped	  me	  get	  a	   lot	  better	  organised	   than	   I	  
had	  previously	  been	  and	  focussed	  me	  a	  bit	  better	  on,	  yeah	  I	  did	  have	  
problems	  from	  time	  to	  time	  for	  different	  varied	  reasons	  and	  when	  I	  
know	   I’m	   going	   to	   have	   a	   problem	   or	   I	   think	   I	   might	   be	   having	   a	  
problem	   I	   can	   take	  action	   to	   lessen	   the	   impact	  of	   it…	   just	   keep	  me	  
focussed	   on	   you	   know	   sort	   of	   doing	   what	   I	   knew	   I	   had	   to	   do	   but	  
often	  wouldn’t,	  you	  know	  if	  you’re	  just	  left	  to	  your	  own	  devices	  and	  
you	  think	  you	  know	  right	   I	  must	  check	  my	  to	  do	   list	  you	  would	   just	  
procrastinate	  all	  day	  long	  and	  wouldn’t	  get	  it	  done.”	  (ID	  3)	  
Participants	   reported	   that	   the	   reminders	  made	   their	   day	  more	   structured,	   which	  
allowed	  them	  to	  plan	  ahead.	  
“Yeah,	   it	  was	   fine,	   it	  was	   absolutely,	   it	  was	   okay,	   it	  was	   helping	   to	  
sort	  of	  structure	  the	  day	  a	  little	  bit	  better,	  so	  it	  worked	  very	  well.”	  (ID	  
22)	  
“Well	  they	  were	  good	  because	  it	  gives	  you	  time	  to	  plan	  ahead	  sort	  of	  
thing	   and	   know	   that	   you’ve	   either	   got	   to	   get	   there	   and	   arrange	  
whatever	  you	  need	  to	  do,	  you	  know	  if	  you	  have	  looking	  ahead,	  you	  
know	  that	  you	  have	  some	  warning,	  sort	  of	  thing.”	  (ID	  33)	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Furthermore,	   in	   association	   with	   their	   improved	   planning	   abilities,	   participants	  
reported	  spontaneously	  employing	  other	  memory	  strategies	  into	  their	  everyday	  life	  
during	  the	  study,	  including	  external	  memory	  aids.	  Using	  aids	  such	  as,	  calendars	  for	  
appointments	  and	  creating	   lists,	   allowed	  participants	   to	  enhance	   the	  benefit	   they	  
experienced	  from	  the	  reminder	  messages.	  
	  “I	  do	  tend	  to	  write	  things	  down,	   like	  when	  I	  go	  shopping	  I	  do	  write	  
my	   list	   and	   actually	   remember	   to	   take	   it…And	   I	   write	   things,	  
everything	  is	  on	  the	  calendar	  and	  I	  do	  check	  the	  calendar	  every	  day	  
to	  see	  what’s	  going	  on,	  even	  in	  advance	  if	  it’s	  written	  in	  the	  calendar,	  
like	   dental	   appointments,	   hospital	   appointments,	   children’s	   things	  
like	   school	   lunches,	   it’s	  all	  written	  on	   the	  calendar	  and	   I	  do	   look	  at	  
the	   calendar	   in	   the	  mornings	   to	   see	  what	   I’m	  doing	   to	  make	   sure	   I	  
don’t	  forget	  to	  do	  anything.	  	  So	  yeah	  it	  has	  been	  a	  great.”	  (ID	  10)	  
“It	  was	  great.	  	  It	  was	  really,	  really	  it	  really	  helped	  me,	  encouraged	  me	  
to	  check	  the	  diary…	  we	  went	  and	  got	  a	  magnetic	  calendar	  to	  put	  on	  
the	   fridge,	   so	   it’s	   in	  my	   face,	  all	   the	  appointments,	   like	   I’ve	  got	   the	  
doctor’s	  next	  week,	  then	  I’m	  going	  to	  Wales	  next	  Friday…but	  I	  need	  
this	  in	  my	  face	  and	  I	  go	  to	  the	  fridge	  every	  day	  so…”	  (ID	  31)	  
One	   participant	   also	   reported	   using	   internal	   strategies,	   such	   as	   consciously	  
increasing	  concentration.	  
“Yes,	   but	   it	   was	   helping	   me	   concentrate,	   let’s	   say	   that	   for	   some	  
unknown	  reason	   I	  needed	  a	  pencil	   and	  some	  additional	  medication	  
so	   getting	   back	   to	   the	   analogy	   that	   I’m	   going	   from	   the	   living	   room	  
into	  the	  kitchen…	  there	  should	  be	  two	  things,	   I	  was	  trying	  things	   in	  
my	   head	   that	  when	   I	  was	   actually	   holding	   on	   to	  my	   Zimmer	   I	  was	  
putting	  two	  fingers	  together	  so	  I’d	  got	  to	  remember	  I	  was	  going	  in	  for	  
two	  things,	  not	  one,	  so	  that	  sort	  of	   thing	  again	  sort	  of	  helped	  me.”	  
(ID	  7)	  
A	  portion	  of	  participants	  disclosed	   that	  prior	   to	   the	   trial	   they	  had	  often	   forgotten	  
what	   day	   of	   the	   week	   it	   was.	   Therefore	   they	   found	   that	   reminders	   saying,	   e.g.	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“Good	   morning,	   today	   is	   Tuesday”,	   gave	   them	   something	   to	   refer	   back	   to	   and	  
oriented	  them	  to	  the	  day	  and	  place	  in	  the	  week.	  
“That	   was	   nice	   because	   I	   didn’t	   have	   to	   um	   search	   around	   for…	  
because	  sometimes	  I	  really	  have	  no	  idea,	  so	  that	  was	  nice.	  	  I	  knew	  it	  
was	  Wednesday	  and	  in	  my	  mind	  I	  kind	  of	  knew	  what	  I	  had	  to	  do	  that	  
day…	  Because	  it	  is	  like	  waking	  up	  and	  not	  knowing	  where	  you	  are	  in	  
time,	  rather	  than	  geographically.	  Um	  it	   is	  easier	   if	  you	  wake	  up	  and	  
immediately,	   or	   soon	   you	   know	   exactly	   what	   date	   it	   is,	   you	   know	  
what	  you	  have	  got	  to	  do	  that	  day	  and	  you	  know.”	  (ID	  8)	  
“Yeah	  the	  day	  and	  the	  date,	  was	  always	  handy…	  Yeah	  because	  as	  you	  
probably	   realised	  when	   you’re	   on	   holiday	   it’s	   impossible,	   it’s	   really	  
hard	   remember	   what	   day	   it	   is	   anyway,	   you	   have	   nothing	   to	   refer	  
back	   to	   and	   that’s	   always	   the,	   I	   always	   think	   it’s	   a	   Friday,	   I	   think	  
that’s	  wishful	  thinking.”	  (ID	  12)	  
Knowing	   what	   day	   of	   the	   week	   it	   was	   meant	   that	   participants	   knew	   what	   they	  
needed	  to	  do,	  or	  where	  they	  were	  supposed	  to	  be.	  
“Because	  I	  could	  tell	  what	  day	  it	  was	  and	  know	  what	  was	  happening.	  
When	   the	   children	  were	   going	   to	   college	   or	   school	   or	  whatever.	   	   I	  
could	  work	  that	  out	  when	  I	  knew	  what	  day	  it	  was…	  Normally	  I	  usually	  
phone	  my	  mother	  up	  on	  a	  Sunday	  and	  if	  I	  didn’t	  know	  it	  was	  Sunday	  
then	  I	  would	  never	  phone	  her,	  she	  kept	  going	  ‘Oh,	  that	  because	  you	  
know	  what	  day	  it	  is’.”	  (ID	  30)	  
	  
5.2.1.2	  Improved	  ability	  to	  manage	  mood	  
A	  large	  proportion	  of	  participants	  reported	  that	  they	  were	  coping	  better	  as	  a	  result	  
of	   the	   reminder	   messages.	   The	   fact	   that	   participants	   were	   not	   forgetting	   things	  
made	  them	  feel	  less	  anxious	  and	  frustrated.	  	  
	  “I	  knew	  it	  was	  Wednesday	  and	  in	  my	  mind	  I	  kind	  of	  knew	  what	  I	  had	  
to	  do	  that	  day.	  Um,	  because	  I	  do	  regular	  things,	  I	  go	  to	  the	  MS	  Centre	  
twice	   a	  week	   and	   so	   it	  was	  nice	   to	   know	   that	   I	  was	  on	   track	   and	   I	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wasn’t	   forgetting	   things…	   It	   makes	   you	   feel	   less	   anxious	   about	  
things…yes.	  That	  is	  the	  best	  I	  can	  describe	  it	  I’m	  afraid.”	  (ID	  8)	  
Not	  forgetting	  things	  meant	  that	  participants	  were	  being	  kinder	  to	  themselves;	  they	  
stopped	  accusing	  themselves	  of	  having	  a	  ‘bad	  memory’,	  or	  being	  useless.	  
“I	   didn’t	   constantly	   feel	   like	   I’ve	   got	   a	   bad	   memory.	   You	   know,	   I	  
didn’t	   get	  annoyed	  at	  myself,	   if	   I	   hadn’t	  done	   this	  or	   I	  hadn’t	  done	  
that	   and	   yeah…	   	   It	   stops	   the	   frustration	   I	   suppose…	   I’m	   quite	   a	  
positive	  person,	  but	  just	  sometimes	  it’s	  frustrating	  and	  embarrassing	  
having	  to	  feel,	  not	  low,	  but	  I	  suppose	  you	  just	  feel	  a	  bit	  ‘Oh!’	  because	  
you	   try,	   I	   always	   give	  myself,	   I	   give	   100%,	   so	   when	  my	   100%	  was	  
nowhere	   near	   good	   enough	   to	   even	   do	   simple	   tasks,	   it	   feels	   quite	  
frustrating…	   It	   helped	  me	  physically	   and	  mentally,	   it	  made	  me	   feel	  
not	  quite	  so	  useless	  and	  forgetful	  and	  frustrated.”	  (ID	  23)	  
Furthermore,	   participants	   felt	   reassured	   that	   they	   were	   not	   going	   to	   forget	   any	  
important	  appointments,	  or	  arrangements	  with	  other	  people.	  Often	  the	  reminders	  
gave	  participants	  a	  chance	  to	  acknowledge	  that	   they	  had	  already	  remembered	  an	  
intended	   action,	   but	   perhaps	  more	   poignantly,	   the	   reminders	   acted	   as	   a	   reliable	  
safety	  net	  for	  those	  times	  when	  they	  would	  have	  otherwise	  forgotten.	  
	  “Oh	  just	  much	  better	  knowing	  that	  you	  can	  rely	  on	  it	  and	  it’ll	  come	  
through	   and	   you	   then	   go	   and	   take,	   or	  whatever	   the	   reminder	  was	  
about.	  	  It	  definitely,	  definitely	  was	  helpful…	  Um,	  I	  think	  knowing	  that	  
you	  can,	   that	   it’s	   something	   that	  you	  don’t	  have	   to	   remember.	  Cos	  
without	   it,	  there	   is	  no	  shadow	  of	  a	  doubt,	   I	  wouldn’t	  remember.	  So	  
it’s	  like	  your,	  it’s	  a	  crutch	  really	  and	  you	  know	  you	  can	  rely	  on	  it	  ‘cos	  
it’s	  always	  going	  to	  come	  through.”	  (ID	  32)	  
This	  meant	  that	  the	  participants	  felt	  like	  they	  were	  more	  in	  control	  of	  their	  life	  and	  
more	  secure	  in	  their	  organisational	  abilities,	  because	  they	  were	  remembering	  what	  
they	  needed	  to,	  and	  knew	  what	  was	  happening.	  
	  “It	   was	   good	   because	   it	   was	   useful	   to	  me	   that	   I	   knew	   in	  my	   own	  
mind,	  what	  was	  coming	  up	  and	  what	   I	  needed	  to	  do…	  Yes,	   it	  made	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me	  feel	  that	  I	  was	  probably	  more	  in	  control	  of	  things	  because…	  that	  
I’d	   remembered	   what	   was	   going	   to	   happen.	   I	   remembered	   what	   I	  
should	  be	  doing.”	  (ID	  15)	  
“[Made	   me	   feel]	   in	   control.	   I	   know	   it	   sounds	   daft,	   but	   it’s	   a	   little	  
thing,	   but	   because	   I	   remember	   to	   check,	   you	   know	   it’s	   like	   ‘Wow!	  
Check	  me	  out!’”	  (ID	  16)	  
“A	  bit	  more	  in	  control.	  Even	  though	  someone	  else	  was	  telling	  me	  to	  
do	   it,	   yeah,	   it	  was	  definitely	  more	   control,	   but	   it	  wasn’t	   a	   constant	  
reminder	   that	   I’d	   forgotten	   something	   or	   that	   I’d	   not	   done	  
something...	   Yeah,	   it	   made	   me	   feel	   a	   bit	   better	   within	   myself	  
because,	  yeah	  more	  in	  control	  and	  not	  constantly	  forgetting	  things.”	  
(ID	  23)	  
Not	  having	  to	  worry	  about	  forgetting	  important	  things	  at	  work	  or	  home	  meant	  that	  
participants	  felt	  less	  stressed.	  
	  “It’s	  a	  lot	  more	  positive	  so,	  you	  feel	  less	  stressed	  about	  work,	  so	  you	  
don’t	   have	   to	  worry	   about	  writing	   stuff	   down	   all	   the	   time…	   It	   just	  
allowed	  me	   to	  kind	  of	   focus	  my	   thoughts	  on	  other	   sort	  of	   random,	  
non-­‐routine	  tasks…just	  helped	  alleviate	  some	  stress	  about	  not	  having	  
to	  worry	  about	  particular	  tasks	  or	  had	  I	  done	  a	  particular	  task	  or	  had	  
I	  remembered	  to	  take	  tablets	  or	  whatever	  at	  the	  required	  time.”	  (ID	  
22)	  
	  “You’re	  then	  less	  stressed	  about,	  you	  know,	  it’s	   just	  something	  you	  
can	   cross	   off	   your	   list	   because	   you	   know	   you	   are	   going	   to	   get	   a	  
reminder.	   	   So	   you	   know,	   I’ve	   never	   got	   to	   worry	   about	   it.	   I	   know	  
that’s	  always	  going	  to	  come	  through	  and	  you’re	  less	  stressed	  cos	  you	  
know	  that	  it’s	  going	  to	  stop	  you	  from,	  from	  forgetting	  something	  like	  
your	  meds,	  which	  are	  really	  important.”	  (ID	  32)	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Additionally,	   the	   reminders	   alleviated	   stress	   by	   reducing	   the	   amount	   of	   time	  
wasting,	  where	  participants	  previously	  would	  have	   to	  backtrack	  because	   they	  had	  
forgotten	  to	  do	  something	  significant.	  
“So	   it	  must	  have	   saved	  me	  miles	  and	  miles	  of	   going	   into	   town	  and	  
coming	  home	  and	  forgetting	  that	  I	  needed	  to	  go	  into	  town,	  cause	  I’d	  
get	  a	   text	  at	   the	  end	  which	  would	   say	   ‘Do	  you	  need	  anything	   from	  
town?’	  and	  I	  thought	  ‘Oh	  yes	  I	  do’	  and	  it	  was	  great…	  They	  saved	  me	  a	  
lot	  of	  money	  with	  fuel.	  	  They	  saved	  me	  time,	  they	  saved	  me	  rushing.”	  
(ID	  23)	  
	  
5.2.1.3	  Improved	  fatigue	  management	  
As	  mentioned	  before,	  participants	  reported	  how	  the	  reminders	  led	  to	  an	  improved	  
ability	   to	   plan	   and	   organise	   their	   days.	   They	   also	   talked	   about	   how	   their	   energy	  
levels	   would	   quickly	   deteriorate,	   and	   how	   the	   reminders	   helped	   them	   to	   pace	  
themselves	   better,	   and	   plan	   their	   schedule	   accordingly.	   Therefore	   this	   enabled	  
them	  to	  more	  effectively	  self-­‐manage	  their	  fatigue.	  
“The	  fatal	  thing	  with	  MS	  is	  you	  know	  when	  you	  feel	  quite	  good	  you	  
tend	   to	  do	   too	  much	  and	  over	   tire	   yourself	   and	  everything	  goes	   to	  
rack	  and	  ruin	  very	  quickly	  if	  you’re	  not	  careful	  and	  that	  can	  last	  for	  a	  
few	  days,	  so	  now	  I	  am	  much	  more	  careful	  about	  committing	  to	  what	  
I	  do	  in	  terms	  of	  physical	  things	  and	  mental	  activities,	  so	  that	  I’m	  sort	  
of	  getting	  enough...	  pacing	  myself	  generally	  a	  lot	  better.”	  (ID	  3)	  
“Well	   it	  was	  useful	   in	  the	  amount	  I’ve	  got	  my	  motivation	  that	  turns	  
around	  to	  me	  and	  says	  I’ve	  got	  this,	  this	  and	  this	  to	  do	  and	  then	  I’ve	  
got	   my	   actual	   energy	   levels	   which	   unfortunately	   the	   two	   do	   not	  
equal	  each	  other	  so	  I	  have	  to	  make	  some	  conscious	  decisions	  ‘what	  
am	  I	  going	  to	  do	  and	  what	  am	  I	  going	  to	  sort	  of	  leave	  out’	  so	  it	  was	  
drawing	   me	   to	   think	   what	   actually	   I	   should	   do	   and	   it	   was	   re-­‐
emphasizing	  my	  to	  do	   list,	  was	  something	  that	   I	  must	  pay	  attention	  
to	  so	  it	  was	  definitely	  helping	  me.”	  (ID	  7)	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“I	  do	  like	  to	  know	  what	  I’ve	  go	  ahead	  of	  me,	  so	  that	  I	  can	  try	  and	  plan	  
my	  energy	   levels	  accordingly.	  Um	  and	  know	   if	   I’ve	  got	   time	   to	  stop	  
off	  and	  get	  a	  pint	  of	  milk,	  or	  whatever,	  rather	  than	  running	  round	  or	  
just	  sitting	  down	  on	  the	  sofa	  and	  then	  sometimes	  I	  find	  I	  am	  not	  able	  
to	  get	  up	  again,	  whereas	  if	  I	  keep	  sort	  of	  wandering	  a	  little	  bit	  in	  the	  
house,	   I	  know	  I’ve,	   I	  am	  alright	  to	  go	  out	   if	   I	  need	  to…	  But	  with	  my	  
MS,	  if	  I	  sit	  down,	  sometimes	  that’s	  it.	  	  I	  sit	  down	  and	  that’s	  it	  for	  the	  
day,	  so	  it’s	  helpful	  to	  have	  a	  mental	  image	  or	  plan	  of	  what	  I	  need	  to	  
do.”	  (ID	  8)	  
	  
5.2.2	   NeuroText	  ending	  
5.2.2.1	  Benefit	  remained	  
The	  majority	   of	   participants	   talked	   about	   how	   they	   responded	   to	   the	   NeuroText	  
reminders	   finishing.	   Many	   of	   them	   reported	   that	   the	   benefit	   of	   the	   reminders	  
remained	   even	   when	   they	   had	   stopped.	   Spontaneous	   implementation	   of	   other	  
external	  memory	  aids	  helped	  some	  participants	  to	  maintain	  the	  benefits,	  including	  
using	   reminder	   functions	   on	   their	   mobile	   phones,	   or	   using	   paper-­‐based	   or	  
electronic	  calendars.	  	  
“Yes,	   I	   had	   to	   after	   the	   messages	   stopped	   because	   I	   did	   start	  
forgetting	   things	  again…	   I	   thought	   if	   I	  wrote	   things	  down	  and	  stuck	  
them	  on	  the	  fridge	  because	  I’m	  always	  in	  and	  out	  of	  the	  fridge	  and	  I	  
would	  see	  the	  messages	  that	  I’d	  written	  to	  myself.”	  (ID	  10)	  
Some	  participants	  tried	  to	  replicate	  the	  NeuroText,	  by	  setting	  up	  alerts	  containing	  
the	  same	  content	  at	  the	  same	  time,	  just	  using	  a	  different	  platform.	  
	  “Well	   I	  was	  going	  to	  say	  since	  it	  stopped	  I	   left	  a	  bit	  of	  a	  gap	  so	  I’ve	  
now	  found	  I’m	  recording	  reminders	  to	  myself	  a	  lot	  more	  than	  I	  used	  
to	  on	  my	  mobile	  phone,	  so	  I’m	  doing	  similar	  to	  what	  you	  were	  doing	  
for	  me,	  for	  myself.”	  (ID	  3)	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  “I’ve	  set	  up	  reminders,	  sort	  of	  daily	  tasks	  that	   I	  have	  to	  complete…	  
Its	  been	  very	  positive,	  as	  I	  say	  its	  just	  allowed	  me	  from	  those	  original	  
text	  message	  alerts	  to	  kind	  of	  set	  up	  something	  similar	  with	  my	  work	  
based	  calendar	  to	  kind	  of	  send	  myself	  text	  alerts,	  well	  not	  text	  alerts	  
but	  email	  alerts.”	  (ID	  22)	  
Other	   participants	   found	   that	   the	   routine	   created	   by	   receiving	   NeuroText	   was	  
maintained	  even	  once	  the	  reminders	  were	  no	  longer	  being	  received.	  Therefore	  they	  
were	  still	  performing	  target	  behaviours	  at	  the	  intended	  time.	  
“I	  enjoyed	  having	  them	  texted,	  it	  was	  a	  reminder	  to	  take	  me	  meds	  at	  
the	  start	  of	  the	  day.	  	  Even	  when	  they	  finished…when	  they	  finished	  I	  
still	  got	  into	  a	  routine	  of	  taking	  them	  in	  the	  morning.	  	  Occasionally	  I	  
still	  forget,	  but	  normally	  I	  remember	  that	  because	  I	  was	  taking	  them	  
religiously	  at	  the	  time	  when	  I	  got	  the	  messages,	  I	  remembered	  what	  
it	  was.”	  (ID	  19)	  
Interestingly,	  participants	  reported	  that	  they	  would	  notice	  the	  time	  of	  day,	  think	  of	  
the	  message	   they	  would	  have	  been	  receiving,	  what	   the	  content	  would	  have	  been	  
and	  then	  act;	  rather	  than	  simply	  thinking	  of	  what	  they	  should	  have	  been	  doing	  at	  
that	  particular	  time,	  and	  acting	  on	  it.	  
	  “I	   found	  the	  repetition,	  sort	  of	   ingrains	   it	  within	  my	  mind,	  when	  at	  
certain	   times	  of	   the	  day	   I	  knew	  that	   the	  phone	  was	  about	   the	  ring,	  
and	   when	   it	   rang,	   it	   was	   going	   to	   remind	   me	   for	   my	   evening	  
Amitriptyline,	   or	  my,	   or	  my	  morning	   tablets	   and	   things	   throughout	  
the	  day.	  So,	  I	  think	  that	  stayed	  with	  me	  and	  it	  is	  still	  the	  same	  now…	  
Yep.”	  (ID	  15)	  
“Then	   I	   got	   into	   the	  habit	  of	   taking	   them	  as	   soon	  as	   I	   had	   the	   text	  
message	  and	  now	  that	  I	  am	  not	  getting	  the	  text	  messages,	  I	  think	  ‘Oh	  
this	  is	  the	  time	  I	  would	  get	  my	  text	  message!’	  so	  I	  take	  my	  tablet!...	  
You	   know,	   98%	   of	   the	   time,	   I	   do	   take	   them	   when	   I	   should.	   	   All	  
because	  of	  those	  messages.”	  (ID	  16)	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5.2.2.2	  Stopped	  achieving	  target	  behaviours	  
For	   some	   participants,	   once	   they	   stopped	   receiving	   reminders,	   they	   reverted	   to	  
baseline	  and	  forgot	  to	  perform	  their	  target	  behaviours	  again.	  	  
	  “When	  would	  it	  be,	  Monday…	  Putting	  the	  bins	  out	  on	  Tuesday,	  that	  
was	  really,	  really	  good	  because	  I’ve	  started	  forgetting	  again	  already.	  	  
I	   don’t	   know	   really,	   that	   was	   all	   that	   I	   did,	   but	   I	   did	   enjoy	   it	   and	  
helped	  with	  the	  bins.”	  (ID	  27)	  
Furthermore,	   the	   fact	   that	   they	  had	  started	  to	   forget	   their	   intended	  actions	  again	  
appeared	  to	  dismay	  participants.	  
“I	  miss	  my	  Wednesday	  night	  one.	  It’s	  the	  thing	  of…	  I	  miss	  them	  and	  I	  
forget	  things…Yep,	  exactly	  how	  they	  were	  before!”	  (ID	  23)	  
“I	  mean	  I	  found	  now	  that	  I	  haven’t	  got	  them	  that	  I’ll	  sometimes	  get	  
to	  like	  twelve	  o’clock	  and	  I’ll	  think	  ‘Blow,	  I	  haven’t	  taken	  my	  first	  one’	  
and	  I’m	  due	  my	  second	  one,	  so	  it’s	   just…	  it	  does	  have	  an	  impact	  on	  
your	  day.”	  (ID	  29)	  
5.2.2.3	  Concerns	  
Since	  they	  had	  started	  to	  forget	  again,	  numerous	  participants	  reported	  ‘missing’	  the	  
messages	  once	  they	  had	  finished,	  and	  that	  they	  would	  have	  liked	  them	  to	  continue.	  	  
	  “I	  was	  expecting	  them	  and	  thought	  they	  would	  be	  useful	  to	  carry	  on,	  
because	  they	  were	  useful	  to	  have…	  I	  miss	  them.”	  (ID	  1)	  
	  “Oh	   that	   study	   was	  marvellous!	   I	   didn’t	   forget	   nothing,	   you	   know	  
when	   the	  –	   ‘cos	   I	  was	  getting	   the	  message	  every	  day,	   to	   check	   the	  
diary…	  It	  was	  great	  and	  I	  am	  lost	  now	  I	  haven’t	  got	  it…	  Yes.	  Big	  time,	  I	  
do	  miss	  them.”	  (ID	  31)	  
In	  fact,	  some	  participants	  appeared	  to	  have	  an	  emotional	  response	  to	  the	  cessation	  
of	  NeuroText.	  
“It	  did	  sort	  of	  brighten	  me	  up	  quite	  a	  lot	  really	  although	  I	  was	  going	  
through	  quite	  a	  bad	  patch,	  but	   I	  did	   find	   it	  useful.	   I	  was	  quite	  sorry	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when	  they	  stopped	  actually,	  so	  you	  know	  but	  as	  I	  say	  that’s	  how	  life	  
goes	  on,	  I	  was	  really	  quite	  happy	  to	  receive	  them.”	  (ID	  7)	  
Several	  participants	   thought	  NeuroText	  was	  so	  useful	   that	   they	  enquired	  whether	  
NeuroText	  would	  be	  available	  outside	  of	  the	  study.	  
“It	  was	  actually	  really	  useful	  and	  really	  nice	  and	  I	  think	  that	  it	  would	  
be	  something	   that	  was	  very	  useful	   if	  you	  could	  eventually	  come	  up	  
with	  something	  I	  would	  definitely	  be	  interested.”	  (ID	  4)	  
“No,	  I	  want	  them	  to	  keep	  it	  on.	  I	  don’t	  want	  them	  to	  be	  just	  a	  study!”	  
(ID	  31)	  
	  
5.2.3	   Potential	  improvements	  to	  NeuroText	  
5.2.3.1	  Mostly	  nothing	  
The	  vast	  majority	  of	  participants	  were	  happy	  with	  NeuroText	  as	   it	  was,	   thought	   it	  
was	  useful,	  and	  did	  not	  recommend	  any	  changes.	  	  
“No	  I	  think	  they	  were	  the	  right	  ones	  for	  me	  and	  worked	  well	  and	  as	  I	  
say	   I	   am	   to	   a	   large	   extent	   am	   replicating	   those	   with	   my	   own	  
diarisation	  in	  the	  mobile	  phone.”	  (ID	  3)	  
“Not	   particularly	   no.	   	   I	   thought	   the	   reminders	  were	   quite	   useful	   in	  
the	  format	  that	  they	  were	  because	   I	  was	  expecting	  them	  and	  knew	  
what	  to	  expect.” (ID	  15) 
“No,	   I	   thought	  they	  were	   fantastic	  as	   they	  were.	   	  They	  were	  direct,	  
straight	   to	   the	  point	  and	   they	  gave	  me	  an	  order	  and	   I	  obeyed.”	   (ID	  
16)	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5.2.3.2	  Tailored	  adjustments	  
A	   couple	   of	   participants	   thought	   that	  making	   the	   reminders	  more	   specific	   to	   the	  
individual	   would	   make	   them	   more	   useful;	   this	   was	   usually	   regarding	   specific	  
appointments.	  
	  “I	   suppose	   if	   they	   could	   be	   personalised	   to	   me,	   that	   would	   have	  
made	  them	  more	  useful.”	  (ID	  8)	  
“I	  suppose	  it	  has	  to	  be	  more	  tailored	  to	  the	  individual	  and	  say	  ‘You’ve	  
got	   an	   appointment	   at	   2	   o’clock	   this	   afternoon’	   text	   at	   1’oclock…	  
Maybe,	   be	   more	   specific	   about	   the	   appointment.	   	   Instead	   of	   just	  
checking	  your	  diary,	   ‘You	  have	  a	  hospital	  appointment’,	  or	   ’You	  are	  
going	  to	  the	  theatre’,	  or	  to	  tell	  you	  exactly	  what	  the	  appointment	  is.”	  
(ID	  17)	  
Others	   suggested	   that	   reducing	   the	   frequency	   of	   reminders,	   or	   limiting	   the	   days	  
they	  received	  specific	  messages,	  would	  have	  been	  helpful	  for	  them.	  
	  “What	  I	  was	  thinking	  was	  if	  instead	  of	  having	  them	  as	  regularly	  as	  I	  
was	   getting	   them	   they	   were	   maybe	   even	   spread	   out	   and	   not	   as	  
frequently	  as	  I	  was	  getting	  they	  would	  have	  been	  helpful.”	  (ID	  4)	  
“Chores	  throughout	  the	  day,	  because	  some	  days	  wouldn’t	  have	  been	  
the	  same,	  say	  sort	  of	  a	  weekend	  you	  know	  I	  probably	  wouldn’t	  have	  
done	   the	  washing	  and	  different	   things,	   so	   those	  ones,	  not	  always.”	  
(ID	  29)	  
A	  few	  participants	  thought	  that	  reducing	  the	  overlap	  with	  other	  reminder	  services	  
would	  be	  an	  improvement.	  Again,	  this	  was	  mostly	  regarding	  appointments,	  and	  the	  
automated	  reminder	  services	  that	  have	  been	  recently	  introduced.	  
“They	  were	  okay	  but	  they	  are	  not	  so	  important	  because	  [the	  doctors]	  
telephone	  me	  with	   text	  messages	   anyway,	   they	   send	  me	  messages	  
the	   day	   before	   anyway,	   a	   text	  message,	   so	   I	   already	   get	  messages	  
from	  them,	  so	  they’re	  not	  so	  important.”	  (ID	  1)	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“Having	  said	  that,	  the	  physio	  has	  now	  started	  using	  a	  text	  reminder	  
scheme,	  so	  I	  think	  in	  my	  life,	  my	  experience,	  more	  and	  more	  people	  
seem	  to	  be	  using	  a	  system	  similar	  to	  what	  you	  are	  talking	  about.”	  (ID	  
33)	  
It	   should	   be	   noted	   that	   most	   of	   the	   participants	   who	   suggested	   the	   above	  
improvements	   did	   acknowledge	   that	   they	   could	   have	   altered	   their	   NeuroText	  
messages	  to	  reflect	  these	  recommendations,	  at	  any	  time	  in	  the	  trial.	  
	  
5.3	   Control	  Messages	  
5.3.1	   Potential	  usefulness	  of	  control	  
5.3.1.1	  Acting	  as	  prompt	  (control)	  
Several	  participants	  reported	  that	  the	  control	  (non-­‐reminder)	  messages	  acted	  as	  a	  
prompt.	  Participants	  recognised	  that	  when	  a	  control	  message	  came	  through	  to	  their	  
phone,	  it	  was	  at	  the	  same	  time	  as	  they	  had	  previously	  received	  a	  reminder,	  or	  had	  
previously	  performed	  a	  target	  behaviour	  as	  a	  result	  of	  a	  reminder.	  Therefore,	   this	  
response	   of	   the	   control	   acting	   as	   a	   prompt	  was	   observed	   if	   the	   participants	   had	  
already	  received	  the	  NeuroText	  messages	  in	  the	  previous	  condition.	  
“I	   thought	   they	  were	   round	  about	   the	   time	  when	   I	  was	  waiting	   for	  
the	  calls.	  I	  was	  waiting	  for	  the	  headline,	  I	  was	  waiting	  for	  the	  calls	  to	  
come	   and	   err…the	   headline	   came	   in	   place	   of	   a	   call	   about	  
medication.”	  (ID	  15)	  
“But	   after	   a	   little	   while	   I	   realised	   that	   as	   a	   reminder,	   that	   I	   would	  
have	  been	  checking	  my	  medications,	  so	  I	  took	  me	  medication.	  I	  kind	  
of	   triggered	   me	   memory…	   I	   was	   like	   ‘Oh,	   something	   about	   the	  
weather,	   oh,	   I	   haven’t	   taken	   me	   meds	   yet,	   I’d	   best	   go	   and	   take	  
them.’”	  (ID	  19)	  
For	   some	   participants,	   their	   response	   to	   this	   prompt	   was	   to	   perform	   the	   target	  
behaviour,	  for	  example,	  take	  their	  medication.	  However,	  for	  other	  participants,	  the	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priming	  effect	  reduced	  as	  time	  went	  on,	  and	  the	  control	  messages	  ceased	  to	  act	  as	  
a	  prompt.	  
“Yeah	  well	  partly	  when	  I	  was	  on	  the	  placebo	  one,	   I	  would	  open	  the	  
message	   and	   just	   see,	   just	   look	   at	  my	  phone	  and	   it	  would	   say	  BBC	  
whatever,	   and	   I	   would	   think	   	   ‘Oh	   yeah	   that’s	   meant	   to	   be	   for	  my	  
tablets	  and	  then…’	  in	  the	  beginning,	  but	  as	  time	  went	  on,	  I	  would	  just	  
look	  at	  it	  and	  I	  wouldn’t	  think	  what	  it’s	  actually	  reminding	  me	  about.	  	  
My	  brain	  would	  kind	  of	  switch	  off	  on	  it.”	  (ID	  32)	  
Additionally,	  some	  people	  did	  not	  make	  the	  connection	  between	  the	  timing	  of	  the	  
reminder	  messages,	  and	  the	  control	  messages	  at	  all.	  
“I	  wasn’t	  at	  all.	   I	   thought	  they	  were	   just	   random,	  annoying	  texts…	   I	  
hadn’t	  made	  that	  connection.”	  (ID	  33)	  
	  
5.3.1.2	  Gave	  me	  a	  lift	  
Another	   positive	   response	   reported	   by	   some	   participants,	   was	   that	   receiving	   the	  
control	  messages	  gave	  them	  an	  on-­‐the-­‐spot	  mood	  lift.	  	  
“Um	  they	  cheered	  me	  up!	  They	  cheered	  me	  up	  in	  the	  morning	  and	  I	  
had	  something	  to	  smile	  about	  before	  I	  had	  to	  face	  the	  world…	  it	  was	  
just	  something	  nice	  before	  I	  had	  to	  start	  fighting	  the	  world	  again…	  I	  
really	  did	  like	  that	  because	  they	  cheered	  me	  up	  even	  though	  I	  didn’t	  
realise	   I	   needed	   cheering	   up,	   if	   you	   know	  what	   I	  mean…	   I’ve	   been	  
through	  a	  bit	  of	  a	  rough	  time	  the	   last	  sort	  of	  six,	  eight	  months,	  but	  
yeah,	  that	  made	  it	  slightly	  better	  for	  me.”	  (ID	  8)	  
No	  I	  was	  quite	  happy	  with	  them	  to	  be	  honest	  with	  you.	  It	  was	  a	  nice	  
surprise	  to	  have	  them	  coming	  through	  to	  start	  off	  with.”	  (ID	  19)	  
“Erm,	   well	   they	   really	   gave	   me	   a	   lift	   actually,	   you	   know,	   some	   of	  
them	  were	  really	  good…”	  (ID	  16)	  
One	   participant	   even	   stated	   they	   would	   enjoy	   receiving	   the	   control	   messages	  
outside	  of	  the	  trial	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  “No	  not	  really	   just	  really,	   just	  to	  say	  that	   if	  you	  were	  going	  to	  start	  
doing	   something	   like	   this	   in	   which	   you	   would	   focus	   on	   particular	  
sports,	  particular	  teams	  and	  stuff	  like	  that	  I	  would	  be	  very	  interested	  
yeah.	  “	  (ID	  4)	  
 
5.3.1.3	  Encouraged	  engagement	  
Several	  participants	  reported	  enjoying	  receiving	  the	  control	  messages,	  and	  finding	  
the	  content	  interesting	  to	  read.	  	  
	  “I	   enjoyed	   having	   them	   come	   through	   still	   and	   then	   some	   of	   the	  
results	   that	  came	  through	   I	  was	   really	   interested	   in	  and	   I	  had	  been	  
following	  and	  some	  of	  those	  I	  wasn’t,	  so	  it	  was	  nice	  being	  able	  to	  you	  
know	  make	  the	  choice	  to	  what	  I	   listened	  to	  and	  what	  to	  follow	  and	  
what	  not.”	  (ID	  4)	  
In	  particular,	  participants	  who	  received	  current	  affairs	  or	  sport	  headlines,	  liked	  the	  
fact	  that	  they	  were	  more	  up-­‐to-­‐date	  with	  the	  news,	  than	   if	   they	  had	  not	  received	  
the	  messages.	  
“Err,	  absolutely	  brilliant	  because	  I	  might	  have	  missed	  something	  and	  
then	   you’ve	   sent	   it	   through,	  whatever	   it	  was,	   of	   course	   that	   keeps	  
you,	  you	  remember	  it.”	  (ID	  9)	  
“It’s	   little	   pointers	   in	   that	   of	   oh	   that’s	   interesting	   and	   that’s	  
interesting	  and	  they	  were	  really	  good,	  I	  liked	  those	  and	  that	  because,	  
like	  now	  I	  haven’t	  put	  the	  TV	  on,	  you	  know	  all	  morning	  since	  I’ve	  got	  
up	  and	  stuff	  and	  so	  by	  having	  those	  little	  pointers	  are	  brilliant,	  you’re	  
like	  ‘ahh	  that’s	  nice’.” (ID	  11)	  
The	  control	  messages	  encouraged	  engagement	  for	  some	  participants,	  who	  followed	  
the	  Internet	  link	  from	  the	  headline,	  to	  the	  full	  news	  article.	  	  
	  “If	   something	   caught	  my	  eye,	  which	   it	  quite	  often	  did	  because	   the	  
Guardian	  put	  some	  really	  good	  stuff	  out	  sometimes,	  I	  obviously	  went	  
on	   to	   that	   and	   really	   quite	   enjoyed	   it…	   And	   of	   course	   there	   were	  
certain	  headlines	  that	  were	  catching	  my	  attention.”	  (ID	  7)	  
	  	   135	  
One	  participant	  reported	  that	  they	  would	  follow	  the	  link	  to	  the	  full	  article,	  and	  then	  
go	  on	  to	  read	  further	  articles.	  
“Yes,	  definitely	  so	  if	  I	  got	  a	  message	  of	  a	  score	  or	  something	  and	  then	  
I’d	  go	  online	  and	  look	  further	  at	  what	  it	  was,	  what	  the	  message	  was,	  
and	  they	  were	  good	  for	  that	  you	  know…	  what	  it	  does	  you’d	  get	  them	  
through	   and	   you’d	   look,	   it	   just	   makes	   you	   look	   more	   in	   depth	   at	  
whatever	  it	  was	  and	  you’d	  find	  other	  stuff	  you	  know.	  It’s	  just	  like	  on	  
a	  search	  engine,	  it	  was	  good…	  just	  encouraged	  more	  activity	  and	  for	  
you	  to	  look	  at	  more	  stuff	  and	  things	  like	  that.”	  (ID	  11)	  
Another	  participant	  found	  that	  the	  news	  headlines	  made	  him	  attend	  more	  closely	  
to	  articles	  in	  his	  newspaper,	  and	  read	  them	  in	  more	  depth.	  
“Well,	  I	  received	  the	  news	  headlines	  and	  then,	  it	  was	  about	  the	  time	  
in	  the	  morning	  when	   I	  get	  my	  morning	  paper,	  so	  as	   I	  went	  through	  
my	   morning	   paper,	   I’d	   be	   looking	   for	   headlines	   that	   matched	  
something	  that	  you	  had	  tried	  to	  put	  across	  to	  me…	  I	  suppose	  it	  made	  
me	  more,	  look	  at	  it	  in	  depth	  for	  anything	  coming	  up.	  Instead	  of	  just	  
accepting	  the	  headline,	   I	  would	  read	  what	  was	  behind	  the	  headline	  
and	  why	  it	  was	  presented.”	  (ID	  15)	  
Additionally,	   a	   couple	   of	   participants	   reported	   feeling	   that	   the	   control	   messages	  
made	  them	  feel	  a	  bit	  more	  connected	  to	  the	  outside	  world.	  
“Well	   they	  were	   just	   funny,	  or	  they	  made	  me	  think	  about	  what	  the	  
messages	  were,	   the	   news	   ones	   and	   I	   said	   I	   thought	   ‘Oh,	   I	   wonder	  
where	  she’s	  got	  that	  from,	  I’d	  like	  to	  read	  that’.	  	  You	  know,	  but	  they	  
did	   give	  me	   a	   bit	   of	   a	   lift	   and	   for	   some	   strange	   reason	   I	   don’t	   feel	  
alone!	  	  Weird!”	  (ID	  16)	  
“I	  think	  the	  news	  and	  sports	  information	  didn’t	  really,	  I	  keep	  myself	  
quite	  informed	  anyway	  so	  it,	  they	  were	  nice	  to	  receive	  from	  a	  feeling	  
of	  involved	  sort	  of	  situation	  but	  didn’t	  really	  do	  an	  awful	  lot	  in	  terms	  
of...	  the	  main	  ones	  were	  sort	  of	  the	  action	  to	  check	  my	  to	  do	  list,	  not	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to	  procrastinate	  and	  get	  on	  and	  get	  things	  done,	  were	  much	  stronger	  
in	  terms	  of	  in	  pact	  on	  me,	  yeah.”	  (ID	  3)	  
	  
5.3.2	   Control	  not	  useful	  
5.3.2.1	  No	  purpose	  
Many	  participants	  felt	  that	  the	  control	  messages	  were	  not	  serving	  any	  purpose,	  and	  
that	  they	  did	  not	  particularly	  enjoy	  receiving	  them.	  
“Not	  particularly	  useful	   for	  anything	   really.	  Most	  of	   them	   I	   thought	  
‘what?!	  	  What	  is	  this	  about?’	  Yeah,	  it	  weren’t	  particularly	  relevant	  or	  
anything.	  No.”	  (ID	  17)	  
“I	   just	   lost	   interest	   in	   it	  you	  know	  what	   I	  mean,	  that’s	  all,	   I	   just	   lost	  
interest.	  No	  weren’t	  too	  keen	  on	  those	  ones	  at	  all.”	  (ID	  21)	  
Participants	   reported	   ignoring	   the	   control	   messages,	   particularly	   after	   they	   had	  
been	  receiving	  them	  after	  a	  while.	  
“A	  lot	  of	  the	  time	  I	  would	  just	  have	  a	  look	  and	  I	  wouldn’t,	  even	  follow	  
the	   link	   through.	  Maybe	   because	   of	   time,	   that	   you	   know,	   I’ve	   got	  
quite	  a	  busy	  household	  and	  you	  know,	   I	  wouldn’t	  have	   the	   time	   to	  
erm,	  to	  actually	  look	  at	  them.”	  (ID	  29)	  
“After	   a	   while	   it	   came	   up	   ‘Oh,	   ok’	   and	   I	   didn’t	   really	   acknowledge	  
what	  it	  was	  reminding	  me	  of.	  So	  I	  just	  would	  look	  at	  it	  and	  then	  just	  
ignore	  it.”	  (ID	  32)	  
The	  control	  messages	  were	  deemed	  useless	  by	  many	  participants,	  and	  they	  pointed	  
out	  that	  the	  messages	  were	  not	  effective	  in	  reminding	  them	  to	  perform	  tasks.	  
	  “Yes.	  The	  one	  that,	   I	  know	  one	  of	  the	  reminders	  was	  on	  a	  Monday	  
night	  to	  make	  sure	  the	  bins	  were	  out	  and	  that	  would	  come	  through	  
and	  when	  I	  was	  on	  a	  placebo	  I	  didn’t	  even	  remember	  that	  that	  was	  
what	  it	  was	  for.”	  (ID	  32)	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Some	  participants	  stated	  outright	  that	  the	  NeuroText	  reminders	  were	  more	  useful	  
than	  the	  control	  messages.	  
“Didn’t	  really	  do	  an	  awful	  lot	  in	  terms	  of...	  The	  main	  ones	  were	  sort	  
of	  the	  action	  to	  check	  my	  to	  do	  list,	  not	  to	  procrastinate	  and	  get	  on	  
and	  get	  things	  done,	  were	  much	  stronger	  in	  terms	  of	  in	  pact	  on	  me,	  
yeah…	  Erm,	  I	  think	  as	  time	  went	  on	  they	  became	  more	  of	  a	  nuisance	  
than	  a	  benefit.”	  (ID	  3)	  
“Well,	  I’d	  read	  them	  and	  some	  of	  them	  were	  a	  little	  bit	  funny	  so	  I’d	  
laugh	  and	  just	  put	  my	  phone	  and	  I’d	  just	  carry	  on	  and	  then	  I’d	  think	  
‘Bloody	  hell,	  me	   tablet!’	   you	  know,	   so	  although	   I	   enjoyed	   receiving	  
them,	   they	  didn’t	   really	   get	  me	   trained	  as	   such,	  as	   the	  more	  direct	  
ones	  which	  worked	  brilliant.”	  (ID	  16)	  
	  
5.3.2.2	  Confusing	  
Initially	   the	  control	  messages	  confused	  some	  participants,	  as	   they	  were	  unsure	  of	  
the	  origin	  of	  the	  messages.	  	  
“It	  was	  quite	  funny	  actually	  because	  I	  kept	  forgetting	  that	  you	  were	  
sending	  these	  messages	  and	  I	  thought	  ‘what	  on	  earth	  is	  that’ then	  I	  
sort	  of	  twigged	  and	  thought	  ‘yeah	  I	  know	  what	  it	  is’.”	  (ID	  10)	  
“To	  be	  honest	  with	  you,	  the	  first	   lot	  was	  to	  do	  with	  the	  news	  and	   I	  
kept	   on	   thinking	   ‘what	   it	   this	  weird	   thing	   sending	  me	   things	   to	   do	  
with	  the	  news?’	  And	  then	  after	  about	  the	  fifth	  one	  did	  I	  think,	  ‘Oh,	  I	  
know	  what	  it	  is’.”	  (ID	  14)	  
One	  participant	  pointed	  out	  that	  if	  they	  had	  identified	  those	  “random	  texts”	  as	  the	  
trial	  control	  messages,	  they	  would	  have	  found	  them	  less	  annoying.	  
“Yeah,	  I	  think	  if	  I’d	  known	  why	  I	  was	  getting	  all	  these	  random	  texts,	  
then	   I	   would	   have	   found	   them	   less	   annoying	   because	   they	   kept	  
coming	   through	   and	   they	   didn’t	   seem	   to	   relate	   to	   anything	   I	   was	  
involved	   in	   and	   I	   started	   at	   one	   stage	   to	   think	   that	  my	   phone	   had	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been	  hacked,	  or	  my	  emails	  had	  been,	  or	  that	  something	  wrong	  was	  
going	  on	  and	  I	  think	  at	  one	  stage	  I	  did	  actually	  ring	  you	  and	  ask	  about	  
them,	  or	  did	  you	  contact	  me...”	  (ID	  33)	  
	  
5.3.2.3	  Distracting	  
The	   content	   of	   the	   control	   messages	   distracted	   some	   participants	   directly	   away	  
from	  their	  target	  behaviours,	  for	  instance,	  where	  they	  found	  themselves	  involved	  in	  
a	  news	  story,	  rather	  than	  taking	  their	  medication.	  
	  “I	   found	  me	  mind	  wondering	   once	   I’d	   read	   ‘em,	  wondering	  where	  
they	  were	  from	  and	  you	  know,	  so,	  the	  more	  direct	  ones	  worked	  far	  
better	  for	  me	  and	  they	  were	  the	  ones	  that	  trained	  me…	  I	  did	  notice	  
the	   timing	   and	   I	   knew	   I’d	   got	   to	   take	  me	   tablets,	   or	   I’d	   got	   to	   be	  
doing	  something	  and	   they	  worked	   to	  a	  degree,	  but	  not	  as	  much	  as	  
the	  direct	  ones.	  Because	  as	  I	  say,	  I	  got	  that	  distracted	  reading	  them	  I	  
thought	  ‘Oh,	  I	  wonder	  where	  she	  got	  this	  from,	  I	  love	  to	  read	  that	  in	  
full’	  do	  you	  know	  what	  I	  mean?”	  (ID	  16)	  
“My	  brain	  would	  kind	  of	  switch	  off	  on	  it.	  So	  I	  would	  just	  look	  at	  it	  and	  
think,	  ‘Oh	  yeah,	  BBC	  whatever’	  and	  sometimes	  whatever	  the	  current	  
affairs	   thing	  was,	   it	  might	   be	   that	   that	   actually	   interested	  me,	   so	   I	  
would	  be	  on	  my	  phone	  looking	  at	  it	  and	  by	  the	  time	  I	  came	  off	  it,	  I’d	  
forgotten	  about	  [target	  behaviour]	  anyway.”	  (ID	  32)	  
	  
5.3.2.4	  Irritating	  
Many	  participants	  reported	  finding	  the	  control	  messages	  irritating.	  Some	  found	  that	  
they	  already	  knew	  the	  content	  of	  the	  news	  headlines,	  or	  that	  they	  did	  not	  find	  them	  
relevant.	  
“Yeah,	   they	   were	   just	   general	   information	   that	   generally	   I	   knew	  
anyway	  or	  wasn’t	  particularly	  exciting	  for	  me.”	  (ID3)	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“I	   really	   don’t	   know	  with	   that	   one	   because	   I	   read	   the,	   I	   go	   on	   the	  
newspaper	  every	  day,	  so	  I	  didn’t,	  if	  I	  wasn’t	  going	  on	  the	  newspaper	  
then	  maybe,	  but	  because	  I	  go	  on	  the	  newspaper	  every	  day,	  I	  wasn’t	  
gaining	  anything	  from	  it.	  	  I	  know	  that	  sounds	  bad,	  what	  I	  am	  saying,	  
but	  I	  am	  being	  very	  honest	  about.”	  (ID	  14)	  
“Well	  I	  think	  the	  new	  news	  because	  I	  used	  to	  look	  at	  it	  anyway.”	  (ID	  
20)	  
Other	  participants	  found	  that	  the	  control	  messages	  were	  too	  repetitive,	  in	  terms	  of	  
content.	  
	  “To	   be	   honest	   with	   you,	   the	   news	   ones,	   I	   thought	   they	   were	  
repetitive,	  to	  say	  the	  same	  story	  time	  and	  time	  again.”	  (ID	  14)	  
	  “No,	  not	  really.	  I	  think	  they	  repeated	  quite	  often.”	  (ID	  32)	  
“So	   I	   found	   the	   other	   one,	   the	   entertainment	   news	   one	   quite	  
frustrating	  and	  annoying,	  but	  hey	  ho…	  It	  just	  seemed	  to	  be	  the	  same	  
stuff	   being	   sent	   and	   it	   was	   sort	   of,	   I	   felt	   it	   became	   a	   bit	   of	   an	  
inconvenience,	  but	  it	  was	  all	  part	  of	  the	  trial,	  so…”	  (ID	  26)	  
However,	  despite	   the	  perceived	  negative	  elements	  of	   the	  control	  messages,	  most	  
participants	   demonstrated	   that	   they	   understood	   the	   purpose	   of	   the	   control	  
messages	  in	  the	  study,	  and	  therefore	  accepted	  them.	  
	  
5.4	   Overall	  Experience	  of	  participating	  in	  study	  
5.4.1	   Positive	  experience	  of	  study	  
5.4.1.1	  Participation	  
Response	   to	   participation	   in	   the	   study	   was	   overwhelmingly	   positive,	   and	   overall	  
participants	  were	  pleased	  to	  have	  been	  involved	  in	  the	  study.	  
	  “They	   did	   [help]!	   	   They	   really	   did.	   It	   was	   a	   positive	   experience	   all	  
ways	  round.”	  (ID	  16)	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“Yeah,	   I	   was	   really	   pleased	   with	   what	   you	   did,	   I	   tell	   you.	   I	   can’t	  
remember	  everything	  now,	  but	  I	  got	  them	  on	  me	  phone.”	  (ID	  9)	  
“It	   would	   be	   nice	   to	   know	   that	   I’ve	   helped	   someone	   achieve	  
something.”	  (ID	  8)	  
The	   study	   provided	   comfort	   for	   participants,	   and	   some	   expressed	   gratitude	   for	  
taking	  part.	  
“Yeah	  because	  [husband’s]	  memory’s	  not	  that	  great	  these	  days	  and	  I	  
said	  mine	  is	  better	  than	  yours	  now.	  So	  yes,	  it	  has	  helped	  me	  an	  awful	  
lot	  and	  I’m	  grateful	  that	  I’ve	  been	  on	  the	  trial.”	  (ID	  10)	  
“No,	  thank	  you	  for…	  thank	  you	  for	  helping	  me.	  You	  have	  helped	  me	  a	  
lot,	  even	  though	  it	  was	  only	  a	  little	  thing.	  It	  made	  a	  great	  difference	  
to	  me,	  so	  thank	  you	  very	  much	  Rachel.”	  (ID	  19)	  
One	   participant	   disclosed	   that	   they	   normally	   dislike	   engaging	   with	   health	  
professionals	   because	   it	   highlights	   the	   fact	   he	   has	   MS,	   which	   makes	   him	   feel	  
disheartened.	  However,	  his	  participation	  in	  the	  study	  allowed	  him	  to	  acknowledge	  
he	  had	  MS,	  and	  that	  he	  was	  not	  alone	  in	  the	  journey.	  
“I	  don’t	  actually	  like	  going	  to	  see	  health	  professionals	  if	  I	  can	  help	  it	  
because,	   it	   sort	   of	   draws	   attention	   that	   there	   is	   something	   wrong	  
with	  me…	  so	  I	  sometimes	  can	  find	  if	  I	  say	  the	  doctors	  been	  to	  see	  me	  
or	  some	  other	  person	  I	  sort	  of	  feel	  quite	  down	  afterwards	  but	  I	  was	  
finding	   that	  actually	  getting	   these	   text	  messages	  was	  actually	  make	  
me	   think	   ‘oh	   right	   I’ve	   got	   MS	   I’m	   not	   alone	   in	   this’	   because	  
somebody	   else	   is	   actually	   contacting	   me	   although	   it	   being	   a	   text	  
message	  but	   it,	   I	  was	  actually	  getting	  quite	  a	  big	  degree	  of	  comfort	  
actually	   getting	   these	   text	   messages	   sent	   so	   umm	   but	   that	   is	  
definitely	  an	  additional	  point	  and	  a	  very	  real	  one	  to	  me.”	  (ID	  7)	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5.4.1.2	  Enjoyed	  assessment	  
An	  unanticipated	   response	   to	  participation	  was	   that	   several	   participants	   reported	  
enjoying	  the	  baseline	  assessments,	  and	  finding	  the	  tests	  interesting.	  
	  “Was	   brilliant,	   really	   brilliant…Well	   all	   the	   information	   you	   taught	  
me	  about	  the	  shapes	  and	  everything	  and	  what	  I	  decide	  on,	  you	  know	  
whether	  any	  are	  right	  and	  everything.	  Then	  the	  first	  stage	  and	  all	  the	  
different	   images	   that	   you	   gave	   me,	   was	   one	   the	   same,	   or	   smaller	  
than	  the	  other.	  	  With	  squares,	  circle…	  yeah.”	  (ID	  9)	  
“I	  don’t	  know	  what	  that	  was,	  but	  it	  was	  interesting,	  it	  was	  interesting	  
to	  do.	  	  I	  can’t	  really	  remember	  what	  the	  other	  tests	  you	  did,	  I	  know	  
the	  one	  with	  the	  doors	  because	  that	  was	  really	  exciting.”	  (ID	  11)	  
“Ok,	   initially	   for	   the	   assessment	   phase	   of	   it,	   I	   found	   it	   really	  
interesting	   because	   I	   do	   assessments	   of	   a	   similar	   nature,	   so	   it	  was	  
very	  good,	  very	  useful	  to	  see	  it	  from	  the	  other	  side	  of	  the	  fence.”	  (ID	  
33)	  
Specifically,	   one	   participant	   likened	   the	   tests	   to	   “brain	   training”	   and	   enjoyed	   the	  
fact	  that	  the	  assessment	  required	  him	  to	  exercise	  his	  brain.	  
“Well	  it	  was	  quite	  interesting	  because	  I	  was	  thinking	  about	  stuff	  and	  
using	  my	  brain,	  bits	  of	  my	  brain	  that	  I	  haven’t	  used	  for	  ages.	  	  It	  was	  
quite	  difficult	  but	  I	  really	  enjoyed	  it	  and	  you	  don’t	  realise,	  you	  see	  I	  
don’t	   know	   if	   it’s	   because	   I	   have	   MS	   or	   not	   or	   whether	   I’m	   a	   bit	  
stupid	  or	  not	  but	  you	  don’t	  know	  how	  difficult	  certain	  things	  are,	  but	  
once	  you	  get	  used	  to	  it.	  You	  know	  we	  started	  doing	  those	  looking	  at	  
doors…	  I	  think	  it	  was	  and	  going	  over	  it,	  the	  more	  you	  go	  over	  it,	   it’s	  
like	  brain	  training,	  the	  more	  you	  do	  it	  the	  better	  you	  become	  at	  it.”	  
(ID	  11)	  
Furthermore,	  for	  some,	  the	  assessment	  provided	  validation	  that	  their	  memory	  was	  
not	  as	  impaired	  as	  they	  had	  originally	  thought.	  
“Yes!	   It	  was	   completely	   the	  opposite	   to	  what	   I	  would	  normally	   say	  
when	  I	  was	  actually	  doing	  a	  practical,	  completely	  different.	  I	  was	  ‘Ok,	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I’m	  not	   that	  bad	  actually’.	   It	  was	  good,	   it	  was	  a	  bit	  of	  a	   confidence	  
boost.”	  (ID	  14)	  
	  “I	   actually	   enjoyed	   it.	   I	   enjoyed	   knowing	   I	   wasn’t	   as	   bad	   as	   I	  
thought.”	  (ID	  8)	  
	  
5.4.2	   A	  few	  concerns	  with	  participation	  
Despite	   the	   positive	   reaction	   to	   participation	   in	   the	   study,	   a	   few	   concerns	   were	  
raised.	  Initially	  one	  participant	  was	  apprehensive	  about	  what	  level	  of	  commitment	  
would	  be	  expected.	  
“And	  err...	  And	  the	  commitment,	  what	  the	  level	  of	  commitment	  was,	  
but	  yea	  it	  was	  fine	  yeah	  I	  didn’t	  find	  it	  too	  arduous	  and	  my	  son	  luckily	  
was	  happy	  to	  take	  part	  in	  it	  as	  well.”	  (ID	  3)	  
The	  same	  participant	  was	  also	  initially	  nervous	  about	  the	  prospect	  of	  finding	  out	  his	  
level	  of	  cognitive	  impairment.	   	  
“I	  think	  it	  was	  sort	  of	  what,	  what	  might	  be	  found	  out	  about	  my	  good	  
or	  bad	  memory	  traits.”	  (ID	  3)	  
One	   participant	   reported	   that	   she	   did	   not	   find	   any	   benefit	   of	   taking	   part	   in	   the	  
study,	  however	  she	  did	  not	  mind	  taking	  part.	  
“It	  was	  fine,	  but	  it	  made	  no	  difference	  because	  they	  were	  items	  that	  I	  
hadn’t	  forgotten.	  You	  know	  you	  think,	   if	   I’d	  forgotten	  it	  would	  have	  
been	   a	   blessing,	   but	   because	   I	   wasn’t	   forgetting	   those	   particular	  
items,	  it	  wasn’t	  a	  big	  deal	  to	  me…	  I	  didn’t	  find	  it	  beneficial.”	  (ID	  14)	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6	  Discussion	  
	  
6.1	  Chapter	  overview	  
This	   chapter	  will	   first	   assess	   the	   feasibility	   of	   running	   the	   study	  with	   people	  with	  
multiple	   sclerosis.	   The	   findings	   of	   the	   randomised	   control	   trial	   and	   the	   feedback	  
interviews	  will	  then	  be	  discussed.	  Findings	  will	  be	  considered	  in	  the	  greater	  context	  
of	   the	   literature,	   and	   the	   limitations	   of	   the	   present	   study	   will	   be	   reviewed.	   The	  
implications	  for	  future	  research	  and	  clinical	  practice	  will	  be	  considered.	  	  
6.2	  Summary	  of	  the	  study	  
The	   aims	   of	   the	   study	   were	   to	   evaluate	   whether	   receiving	   NeuroText	   messages	  
reduced	   everyday	  memory	   problems;	   increased	   attainment	   of	   target	   behaviours;	  
and	  improved	  mood	  and	  quality	  of	  life,	  compared	  to	  receiving	  control	  messages.	  A	  
phase	   II	   exploratory	   RCT	   was	   successfully	   employed	   across	   multiple	   sites,	   to	  
evaluate	   the	  effectiveness	  of	   the	   intervention.	   The	   feasibility	  of	   the	   study	  design,	  
intervention,	   control	   and	  outcomes	  was	   assessed.	   The	  primary	   outcome	  measure	  
was	  the	  EMQ;	  quantitative	  measures	  of	  attainment	  of	  target	  behaviours,	  mood	  and	  
quality	   of	   life	   were	   also	   employed.	   Feedback	   interviews	   were	   analysed	   using	  
framework	  analysis	  to	  generate	  themes.	  	  
	  
6.3	  Discussion	  of	  findings	  
6.3.1	  Feasibility	  	  
6.3.1.1	  Recruitment	  
The	   trial	   was	   conducted	   over	   24	   months	   (November	   2013	   –	   October	   2015),	  
however	  recruitment	  took	  place	  within	  12	  months	  of	  this	  period	  (April	  2014	  -­‐	  March	  
2015).	   Potential	   PIs	   for	   the	  original	   four	   sites	  were	   identified	   prior	   to	   ethical	   and	  
R&D	   approval	   in	   preparation	   for	   recruitment;	   however	   the	   final	   approval	   was	  
gained	   at	   the	   end	   of	   November,	   and	   progress	   was	   very	   slow	   over	   the	   Christmas	  
holidays	  and	  in	  January.	  Meetings	  were	  set	  up	  early	  2014	  to	  ensure	  PIs	  had	  all	  the	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appropriate	   documentation	   and	   were	   clear	   on	   the	   referral	   procedures.	   The	   first	  
participant	  was	  recruited	  into	  the	  study	  in	  April	  2014.	  
	  
Referring	   clinicians	   appeared	   to	   recognise	   the	   potential	   of	   the	   study	   and	   seemed	  
keen	  to	  refer	  patients	  who	  met	  the	   inclusion	  criteria.	  Throughout	  the	  recruitment	  
period	  PIs	  were	   contacted	  monthly	   about	   referral	   and	   recruitment	   rates,	   and	   the	  
researcher	  attended	  periodic	  meetings	  at	  PIs’	  places	  of	  work	  to	  refresh	   interest	   in	  
the	  study	  amongst	  clinical	  teams.	  However	  referral	  rates	  remained	  slow,	  and	  it	  was	  
clear	  protocol	  amendments	  were	  necessary	   to	  boost	   recruitment,	   therefore	  when	  
the	   trial	  was	  halted	  due	   to	   technological	   problems,	   amendments	  were	  made	  and	  
gained	   ethical	   approval.	   The	   protocol	   changes	   allowed	   clinicians	   to	   aid	   the	  
completion	  of	  contact	  details	  forms	  and	  send	  them	  to	  the	  researcher	  on	  behalf	  of	  
participants,	   meaning	   that	   participants	   with	   memory	   problems	   didn’t	   have	   to	  
remember	   to	   complete	   and	   send	   them	   independently.	   Additionally	   the	   screening	  
measure	  was	  administered	  over	  the	  phone.	  These	  changes	  reduced	  the	  amount	  of	  
time	   and	   effort	   needed	   to	   make	   a	   referral	   by	   both	   clinicians	   and	   their	   patients.	  
Furthermore,	  an	  additional	   site	  was	  added	  and	  recruitment	  dates	  were	  extended.	  
Additional	  actions	  boosted	  recruitment:	  CRN	  research	  nurses	  referred	  at	  two	  sites;	  
researcher	  attendance	  at	  MS	  clinics,	  MS	  Society	  research	  morning	  and	  further	  team	  
meetings.	   These	   implemented	   measures	   were	   successful,	   and	   therefore	   the	  
majority	  of	  referrals	  and	  recruits	  were	  made	  between	  September	  2014	  and	  March	  
2015.	   Therefore	   if	   a	   definitive	   trial	   was	   to	   be	   performed,	   the	   amended	   protocol	  
should	  be	  employed.	  
	  
One	  hundred	  and	  three	  people	  with	  MS	  were	  assessed	  for	  eligibility,	  and	  of	  these	  
50	  consented	  into	  the	  study.	  Of	  the	  53	  excluded,	  the	  majority	  ‘did	  not	  want	  to	  take	  
part’,	  most	   commonly	   this	  was	  because	   they	  experienced	  memory	  problems,	   e.g.	  
forgetting	  names,	  but	  not	  prospective	  memory	  problems.	  It	  would	  have	  been	  useful	  
if	   clinicians,	   prior	   to	   referring,	   had	   employed	   a	   prospective	   memory	   screening	  
measure,	  e.g.	  the	  Cambridge	  Prospective	  Memory	  Test	  (Wilson,	  Emslie,	  Foley,	  et	  al.,	  
2005).	   However,	   this	   would	   be	   an	   additional	   task	   that	   clinicians	   would	   have	   to	  
perform,	  which	  may	  have	  slowed	  recruitment	  rates	  further.	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The	  second	  most	  frequent	  reason	  for	  not	  wanting	  to	  take	  part	  was	  that	  they	  used	  
effective	  reminders	  already;	  others	  included	  time-­‐pressures	  and	  not	  wanting	  to	  use	  
a	  mobile	  phone	  or	  pager.	  Those	  excluded	  due	  to	  scoring	  below	  cut-­‐off	  on	  the	  EMQ,	  
i.e.	   having	   few	  memory	   problems,	   probably	  would	   not	   have	   benefitted	   from	   the	  
intervention.	  As	  participants	  were	  required	  to	  give	  informed	  consent	  to	  participate,	  
there	   may	   have	   been	   a	   bias	   towards	   people	   who	   recognised	   their	   difficulties.	  
However,	  these	  are	  likely	  to	  reflect	  the	  people	  who	  would	  use	  the	  service	  if	  offered	  
in	  clinical	  practice;	  and	  those	  excluded	  would	  be	  unlikely	  to	  use	  the	  service.	  
	  
Participants	   appeared	   to	   enjoy	   the	   baseline	   visits,	   particularly	   the	   opportunity	   to	  
discuss	   their	  memory	   problems	  with	   a	   new,	   engaged	   person.	   For	   the	  majority	   of	  
participants	  baseline	  assessment	  took	  approximately	  3	  hours,	  split	  over	  two	  visits,	  
with	   the	   exception	   of	   one	   that	   took	   4	   hours	   over	   3	   sessions.	   The	   majority	   of	  
participants	   requested	   home	   visits,	   a	   few	   wished	   to	   meet	   at	   their	   hospital.	   The	  
cognitive	   tests	   were	   well	   received	   by	   most,	   and	   tolerated	   by	   all.	   Therefore	   the	  
assessment	  battery	  was	  acceptable	  and	  could	  be	  used	  in	  a	  definitive	  trial	  
	  
All	  participants	  appeared	   to	  understand	   the	  crossover	  design,	  and	  were	  willing	   to	  
be	   randomised.	   Two	   participants	   were	   considered	   dropouts	   after	   baseline	   and	  
consent,	   because	   the	   researcher	   was	   unable	   to	   contact	   them	   again	   using	   the	  
provided	  contact	  details.	  The	  retention	  rate	  was	  98%	  of	  those	  who	  took	  part	  in	  the	  
trial,	  and	  94%	  of	  those	  who	  consented	  into	  the	  trial.	  Therefore	  the	  study	  design	  was	  
deemed	  acceptable	  and	   feasible	   for	  people	  with	  MS,	  and	  could	  be	  used	   in	   future	  
trials.	  
	  
6.3.1.2	  Suitability	  of	  intervention	  	  
NeuroText	  proved	  feasible	  to	  deliver	  and	  all	  participants	  were	  able	  to	  comply	  with	  
the	   intervention.	   No	   participants	   dropped	   out	   whilst	   receiving	   NeuroText,	   and	  
informal	  feedback	  throughout	  the	  trial	  was	  overwhelmingly	  positive.	  Rotas	  for	  the	  
time	   and	   frequency	   of	   the	   reminder	   deliveries	   were	   agreed	   during	   the	   baseline	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home	  visits,	   and	  most	  participants	  did	  not	  make	  adjustments	   at	   any	  point	   during	  
the	  trial.	  The	  content	  of	  the	  NeuroText	  messages	  were	  in	  capital	  letters	  by	  default;	  
some	   participants	   thought	   this	   was	   useful,	   some	   would	   have	   preferred	   the	  
messages	   to	   be	   in	   lowercase.	   It	   is	   recommended	   that	   both	   options	   are	   made	  
available	  in	  future	  trials.	  
	  
6.3.1.3	  Suitability	  of	  control	  
Development	   of	   the	   control	   condition	   began	  with	   researching	   examples	   of	   social	  
text	   with	   non-­‐memory	   content.	   It	   was	   decided	   that	   these	   would	   include	   news	  
headlines,	   depending	   on	   interest,	   e.g.	   sport,	   current	   affairs,	   quotes.	   Headlines	  
would	  be	   accompanied	  by	  URL	   links	   to	   the	   full	   corresponding	   article.	   Considering	  
the	  number	  of	  control	  messages	  that	  were	  sent	  out	  to	  each	  participant	  during	  the	  
control	   condition,	   it	   became	   clear	   that	   each	   individual	   message	   could	   not	   be	  
manually	   typed	   in,	   unless	   participants	   were	   happy	   to	   receive	   the	   same	   content	  
multiple	   times,	   as	   expected	   in	   the	   NeuroText	   condition.	   Therefore	   a	   range	   of	  
potential	   RSS	   feeds	   were	   identified	   and	   offered	   to	   participants,	   who	   chose	   a	  
maximum	   of	   three	   feeds	   to	   receive	   content	   from.	   Consequently	   this	   led	   to	   the	  
development	  and	  introduction	  of	  new	  RSS	  feed	  software	  to	  the	  NeuroPage	  service	  
at	  the	  Oliver	  Zangwill	  Centre.	  
	  
Technological	  problems	  were	  experienced	  with	  the	  control	  at	  the	  beginning	  of	  the	  
trial	  because	  faulty	  RSS	   feeds	  were	  not	  consistently	  or	  reliably	  sending	  content	  to	  
the	  NeuroPage	  system,	  and	  so	  control	  messages	  could	  not	  be	  populated	  and	  sent	  at	  
the	   requested	   times.	   Only	   participants	   who	   had	   requested	   content	   from	   these	  
particular	  feeds	  were	  affected.	  However,	  once	  the	  problem	  was	  identified,	  the	  trial	  
was	   halted,	   faulty	   RSS	   feeds	   were	   deleted	   and	   replaced	   with	   functioning	  
alternatives	   if	   possible,	   and	   the	   trial	   restarted.	  Only	   participants	   starting	   the	   trial	  
from	   this	   point	   onwards	   were	   included	   in	   the	   outcome	   analyses.	   Once	   restarted	  
there	  were	  still	  some	  reports	  that	  although	  participants	  were	  receiving	  messages	  at	  
the	  correct	  time	  and	  frequency,	  the	  content	  was	  repetitive.	  This	  arose	  from	  the	  RSS	  
feeds	  not	  having	  adequate	  new	  material.	  However	  due	  to	  the	  fact	  messages	  were	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still	  being	  received	  as	  planned,	  the	  control	  was	  considered	  received	  as	  planned.	  It	  is	  
advisable	   that	   in	   future	   studies	   only	   RSS	   feeds	   from	   trusted	   news	   websites	   are	  
employed,	  e.g.	  BBC,	  the	  Guardian,	  or	  ESPN.	  	  
	  
Once	   the	   trail	   restarted,	   the	   control	   condition	   proved	   feasible	   to	   deliver	   and	  
participants	   were	   able	   to	   comply	   with	   the	   control.	   One	   participant	   dropped	   out	  
whilst	   receiving	   the	   control,	   because	   they	   did	   not	   find	   it	   useful	   and	   could	   not	  
understand	  why	  they	  were	  receiving	  the	  control	  messages,	  despite	  the	  researcher	  
explaining	  the	  trial	  design	  to	  them	  on	  many	  occasions.	  
	  
Control	   messages	   were	   sent	   at	   the	   same	   times	   and	   frequency	   as	   reminder	  
messages,	   to	   enable	   a	   direct	   comparison	   across	   conditions.	   A	   minority	   of	  
participants	   requested	   that	   the	   number	   of	   control	   messages	   was	   reduced,	   and	  
therefore	  they	  received	  slightly	  fewer	  messages	  in	  the	  control	  condition,	  compared	  
to	   NeuroText	   condition.	   Therefore	   this	  meant	   that	   the	   frequency,	   as	   well	   as	   the	  
content,	  was	  different	  between	  conditions,	  and	  could	  have	  potentially	  impacted	  on	  
the	  interpretation	  of	  findings,	  e.g.	   if	  the	  control	  messages	  were	  less	  effective	  than	  
NeuroText	   because	   participants	   received	   fewer	  messages.	   Some	   participants	   also	  
reported	   that	   they	  were	   initially	  unsure	  about	   the	  origin	  of	   the	  control	  messages.	  
This	  was	  despite	  the	  sender	  having	  the	  same	  number,	  and	  the	  researcher	  checking	  
participants	  had	  started	  receiving	  them.	  In	  future	  trials	  it	  is	  recommended	  that	  the	  
researcher	   telephones	  participants,	   rather	   than	   text	  messaging,	   to	   check	   they	  are	  
receiving	   the	   messages	   and	   understand	   their	   origin.	   A	   few	   participants	   reported	  
being	   unable	   to	   open	   the	  URL	   links	   in	   the	   control	  messages,	   but	   this	  was	   due	   to	  
limitations	   of	   their	   personal	   mobile	   phone.	   Therefore	   in	   future	   studies	   mobile	  
phones	  should	  be	  checked	  for	  compatibility	  prior	  to	  randomisation.	  
	  
6.3.1.4	  Outcomes	  
Following	  the	  first	  condition	  over	  80%	  of	  participant	  outcome	  questionnaires	  were	  
returned	  and	  rates	  were	  comparable	  in	  both	  groups.	  Return	  rates	  of	  the	  daily	  diary	  
and	   relative	   questionnaires	   were	   slightly	   lower	   than	   the	   participant	   outcome	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questionnaires,	   for	  group	  1	   (76%;	  68%),	  and	  considerably	   lower	   for	  group	  2	   (65%;	  
52%).	   The	   daily	   diary	   had	   to	   be	   completed	   over	   a	   week,	   whereas	   the	   outcome	  
questionnaire	  could	  be	  completed	  in	  one	  sitting	  and	  returned	  immediately.	  Hence	  
the	   lower	   rates	   of	   daily	   diary	   return	   could	   be	   due	   to	   the	   prolonged	   attention	  
necessary	   for	   completion	   and	   return.	   It	   is	   recommended	   that	   an	   additional	   text	  
message	   be	   sent	   to	   participants	   on	   the	   final	   day	   of	   filling	   out	   the	   daily	   diary,	   to	  
remind	   them	   to	   post	   it.	   Low-­‐rates	   of	   carers/friend	   questionnaire	   completion	  was	  
commonly	   because	   participants	   could	   not	   identify	   someone	   to	   complete,	   and	  
frequently	   participants	   reported	   that	   their	   carers	   underplayed	   their	   level	   of	  
impairment.	  K.	  Mackenzie	  (2014)	  reported	  similar	  findings,	  where	  patients	  with	  MS	  
reported	  significantly	  more	  problems	  than	  carers	  on	  the	  EMQ.	  This	  could	  be	  due	  to	  
the	  disruption	  in	  family	  functioning	  and	  friendship,	  associated	  with	  MS	  (Thomas	  et	  
al.,	  2006).	  Therefore	  future	  trials	  may	  consider	  not	  using	  the	  carer/friend	  outcome	  
questionnaire.	  	  
	  
The	  completion	  rates	  for	  the	  individual	  scales,	  e.g.	  EMQ,	  were	  lower	  than	  the	  rate	  
of	   outcome	   return,	   as	   participants	   did	   not	   always	   complete	   all	   sections	   of	   the	  
questionnaire	   before	   returning	   them	   to	   the	   research	   team.	   Participants	   reported	  
that	  completing	  the	  outcome	  measures	  was	  challenging.	  Some	  participants	  found	  it	  
hard	   to	   describe	   the	   frequency	   of	   memory	   problems	   on	   the	   EMQ,	   or	   practicing	  
meta-­‐memory;	   others	   found	   that	   the	   questionnaire	   was	   too	   long	   or	   ‘too	   hard’.	  
Therefore	  in	  future	  trials	  it	  may	  be	  beneficial	  to	  shorten	  the	  outcome	  questionnaire,	  
or	   employ	   an	   independent	   researcher	   to	   aid	   questionnaire	   completion.	   Some	  
participants	  claimed	  that	  the	  poor	  response	  rate	  was	  due	  to	  low	  mood	  or	  a	  relapse	  
of	  physical	  symptoms,	  and	  many	  lost	  or	  forgot	  to	  post	  the	  questionnaires.	  A	  couple	  
of	  participants	   returned	   their	  daily	  diaries	  before	   the	   last	  day	  of	   the	  diary;	  hence	  
they	   completed	   the	  daily	   diary	   in	   advance.	   To	  prevent	   this	   from	  occurring,	   a	   text	  
message	  could	  be	  sent	  each	  day	  to	  remind	  them	  to	  complete	  only	  that	  day.	  
	  
The	   majority	   of	   participants	   completed	   the	   primary	   outcome	   measure,	   EMQ-­‐
frequency,	  however	  the	  EMQ-­‐importance	  scale	  and	  the	  EQ5d	  visual	  analogue	  scale	  
(VAS)	   were	   most	   commonly	   incomplete.	   Therefore	   for	   future	   trials,	   it	   is	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recommended	   that	   the	   EMQ-­‐importance	   scale	   be	   omitted	   from	   the	   outcome	  
questionnaire,	  as	  the	  frequency	  scale	  is	  sufficient.	  It	   is	  suspected	  that	  the	  reduced	  
completion	   of	   the	   EQ5d	   VAS	   was	   because	   it	   was	   presented	   at	   the	   end	   of	   the	  
questionnaire,	   and	   in	   a	   visually	   different	   format	   to	   the	   other	   items.	   Therefore	   in	  
future,	  placing	  it	  earlier	  in	  the	  questionnaire,	  and	  perhaps	  adding	  a	  tick-­‐box	  at	  the	  
bottom	  to	  say	  they	  have	  marked	  the	  VAS,	  would	  increase	  completion	  rates.	  
	  
Return	   rates	   decreased	   from	   condition	   1	   to	   condition	   2	   on	   all	   measures.	   Future	  
trials	  could	  perhaps	  run	  a	  parallel	  arm	  RCT	  to	  alleviate	  this	  problem.	  However,	  this	  
would	   require	   a	   larger	   sample	   size.	   If	   participants	   did	   not	   return	   their	   outcome	  
questionnaire	  within	  2	  weeks,	  they	  were	  offered	  help	  or	  administration	  by	  phone,	  
to	   prevent	   missing	   data.	   Five	   participants	   requested	   this	   help	   following	   the	   first	  
condition,	  two	  after	  the	  second.	  The	  researcher	  therefore	  populated	  the	  outcome	  
measure;	  meaning	   scoring	   was	   un-­‐blinded,	   as	   the	   researcher	   was	   aware	   of	   their	  
group	  allocation.	  	  Therefore	  future	  studies	  need	  an	  independent	  research	  assistant	  
to	  check	  and	  help	  participants	  to	  complete	  outcome	  questionnaires.	  
	  
6.3.2	  Effectiveness	  of	  intervention	  
The	   two	   groups	   were	   comparable	   on	   all	   baseline	   measures.	   The	   sample	   had	   a	  
higher	   percentage	   of	   women	   than	   men,	   which	   is	   representative	   of	   the	   MS	  
population	   (World	   Health	  Organisation,	   2008).	   The	  majority	   of	   participants	   (68%)	  
were	   unemployed	   or	   retired	   since	   the	   onset	   of	   the	  multiple	   sclerosis,	   suggesting	  
that	   the	   progression	   of	   the	   disease	   had	   already	   affected	   them	   cognitively	   or	  
physically	  to	  the	  degree	  they	  could	  no	  longer	  work.	  
	  
6.3.2.1	  Neuropsychology	  of	  sample	  
Baseline	   performance	   on	   cognitive	   measures	   suggested	   participants	   had	   low-­‐
average	  to	  average	  memory	  ability	  and	  average	  executive	  functioning.	  Participants	  
overall	  had	  low-­‐average	  attention,	  with	  average	  abilities	   in	  selective	  attention	  and	  
attention	  switching.	  It	  should	  however	  be	  noted	  that	  only	  42	  of	  the	  50	  participants	  
undertook	  the	  attention	  switching	  subtest,	  the	  remaining	  eight	  found	  it	  too	  difficult	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to	  proceed	  after	  the	  test	  examples.	  Marking	  these	  participants	  with	  a	  score	  of	  ‘0’	  in	  
these	   subtests	   was	   considered,	   however	   they	   did	   not	   wish	   to	   take	   part	   in	   the	  
subtest,	   and	   so	   their	   score	   could	   not	   be	   accurately	   estimated.	   Therefore	   if	   these	  
participants	  had	  been	  able	  to	  complete	  the	  subtest,	  the	  average	  performance	  score	  
of	  the	  sample	  would	  most	  likely	  have	  been	  lower.	  
	  
In	   summary,	   the	   neuropsychological	   profile	   of	   participants	   overall	   appears	   to	   be	  
slightly	   below	   average;	   and	   suggests	   that	   their	   everyday	   memory	   problems	   are	  
most	   likely	   associated	   with	   reduced	   memory	   and	   attention	   functioning.	   This	  
supports	   existing	   literature	   that	   many	   people	   with	   MS	   have	   memory	   problems	  
(Rosti-­‐Otajärvi	  &	  Hämäläinen,	  2014)	   ,	   and	   impairments	   in	   complex	  attention	   skills	  
(Fischer,	   2001;	   Mohr	   &	   Cox,	   2001).	   Executive	   dysfunction	   is	   commonly	   seen	   in	  
people	  with	  MS	  (Rosti-­‐Otajärvi	  &	  Hämäläinen,	  2014),	  but	  was	  not	  demonstrated	  in	  
this	   sample.	   One	   explanation	   could	   be	   that	   the	   prospective	   memory	   problems	  
witnessed	   in	   the	   sample	   are	   due	   to	   retrospective	  memory	   problems,	   rather	   than	  
prospective	  memory,	  which	  depend	  on	  executive	  functioning.	  However	  the	  lack	  of	  
demonstrated	   executive	   dysfunction	   is	   probably	   due	   to	   the	   limited	   range	   of	  
assessments	  used.	  
	  
6.3.2.2	  RCT	  findings	  
The	   most	   frequently	   requested	   reminders	   in	   the	   NeuroText	   condition	   were	  
regarding	  medication,	  which	  is	  what	  was	  found	  in	  Martin-­‐Saez	  et	  al.	  (2011)	  study	  on	  
NeuroPage;	  and	  in	  the	  control	  condition	  were	  current	  affairs	  headlines.	  Therefore	  it	  
was	  anticipated	  that	  the	  NeuroText	  messages	  would	  be	  more	  effective	  in	  reducing	  
everyday	  memory	  problems;	  as	  well	  as	   increased	  attainment	  of	  target	  behaviours,	  
which	  were	  related	  to	  the	  reminders	  requested.	  	  
	  
No	   significant	   difference	   was	   found	   on	   the	   EMQ	   between	   conditions,	   suggesting	  
that	   the	   content	   of	   the	   messages	   may	   not	   be	   important	   in	   impacting	   general	  
everyday	  memory	  problems.	  This	  might	   indicate	   that	   the	   fact	   they	  get	  a	  message	  
alert	   is	   the	   most	   important	   aspect	   acting	   as	   a	   reminder,	   rather	   than	   what	   the	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message	   says.	   This	   could	   be	   seen	   to	   support	   the	   Fish	   et	   al.	   (2007)	   study,	   where	  
participants	  were	  sent	  content-­‐free	  messages	  to	  act	  as	  a	  prompt	  to	  participants	  to	  
remember	  their	  intentions,	  and	  hence	  improve	  prospective	  memory	  functioning.	  
	  
However,	   there	   was	   a	   moderate	   effect	   size	   and	   significant	   difference	   between	  
conditions	   on	   the	   daily	   diary;	   demonstrating	   that	   participants	   showed	   improved	  
attainment	  of	   target	  behaviour	  when	  receiving	  NeuroText	  messages,	  compared	  to	  
controls.	   This	   discrepancy	   suggests	   that	   the	   utility	   of	   NeuroText	   lies	   in	   its	  
compensation	   for	   discrete	   recall	   of	   specific	   tasks,	   rather	   than	   an	   ability	   to	  
compensate	   for	   memory	   dysfunction,	   as	   suggested	   by	   Lannin	   et	   al.	   (2014),	   with	  
regard	   to	   personal	   digital	   assistants.	   Therefore	   the	   findings	   are	   probably	   due	   to	  
limitations	   of	   the	   EMQ,	   including	   the	   fact	   it	   is	   a	   general	   measure	   of	   everyday	  
memory,	  and	   is	  unlikely	  to	  pick	  up	  changes	   in	  prospective	  memory	  functioning.	   In	  
future	   studies	   it	   would	   be	   useful	   to	   use	   an	   outcome	   measure	   of	   prospective	  
memory,	  e.g.	  the	  Cambridge	  Prospective	  Memory	  Test	  (Wilson	  et	  al.,	  2005).	  These	  
findings	   are	   similar	   to	   three	   studies	   evaluating	  memory	   rehabilitation	   for	   people	  
with	  MS,	   where	   no	   significant	   difference	   was	   reported	   on	   the	   EMQ	   (Carr	   et	   al.,	  
2014;	  das	  Nair	  &	  Lincoln,	  2012;	  Lincoln	  et	  al.,	  2002).	  However,	  the	  EMQ	  was	  used	  
because	   there	   was	   no	   appropriate	   alternative	   measure	   of	   everyday	   memory	  
available	   (Carr	   et	   al.,	   2014).	   A	   significant	   reduction	   in	   the	   frequency	   of	   memory	  
problems,	  following	  memory	  rehabilitation,	  was	  captured	  on	  a	  daily	  diary	  in	  Lincoln	  
et	  al.	  (2003).	  	  
	  
A	  large	  effect	  size	  and	  significant	  difference	  between	  groups	  was	  found	  on	  the	  GHQ,	  
where	   participants	   reported	   fewer	   symptoms	   of	   psychological	   distress	   whilst	  
receiving	   NeuroText,	   than	   when	   receiving	   control	   messages.	   Langdon	   and	  
Thompson	  (1996)	  stated	  that	  cognitive	  impairments	  negatively	  interfere	  with	  daily	  
functioning.	   This	   would	   suggest	   that	   receiving	   the	   reminder	   messages	   improved	  
their	   mood,	   potentially	   because	   they	   were	   remembering	   to	   do	   the	   things	   they	  
needed	   to	   do,	   and	   so	   their	   everyday	   life	   was	   easier.	   The	   implication	   would	  
therefore	  be	  that	  the	  content	  of	  the	  NeuroText	  reminder	  messages	  were	  having	  a	  
greater	   impact	   than	   the	   control	   content.	   Furthermore,	   these	   findings	   were	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complemented	  by	  a	  moderate	  effect	  size	  and	  significant	  difference	  on	  the	  subscale	  
assessing	   anxiety	   and	   depressive	   symptoms	   on	   the	   EQ5d.	   Therefore	   receiving	  
NeuroText	   alleviated	   psychological	   distress	   in	   participants,	   compared	   to	   control,	  
supporting	   the	   findings	   of	   Carr	   et	   al.	   (2014),	   who	   found	   that	   group	   memory	  
rehabilitation	  significantly	  improved	  mood	  compared	  to	  control.	  
	  
No	   differences	   between	   conditions	   were	   found	   on	   the	   mobility,	   self-­‐care,	   usual	  
activities	   and	   pain	   subscales	   of	   the	   EQ5d,	   or	   on	   the	   AMEDO	   scales	   measuring	  
adaptation	  to	  memory	  difficulties	  scales.	  	  The	  AMEDO	  was	  developed	  as	  a	  measure	  
of	   memory	   rehabilitation	   outcomes,	   and	   so	   it	   is	   surprising	   that	   there	   was	   no	  
reported	  impact	  on	  this	  questionnaire.	  This	  could	  perhaps	  be	  explained	  because	  the	  
items	   on	   the	   questionnaire	   would	   be	   impacted	   by	   a	   comprehensive	   research	  
programme	   that	   aims	   to	   educate	   and	   provide	   a	   toolkit	   for	   a	   variety	   of	   memory	  
problems.	   However	   NeuroText	   aimed	   to	   tackle	   specific	   prospective	   memory	  
problems,	   and	   so	   participants	   were	   unlikely	   to	   endorse	   questions	   such	   as,	   “I	  
understand	  how	  memory	  works”	  or	  “I	  have	  a	  range	  of	  internal	  memory	  aids	  that	  I	  
can	  use	  for	  different	  tasks”.	  
	  
Carryover	  and	  period	  effects	  are	  a	  common	  issue	  associated	  with	  crossover	  designs.	  
A	  3-­‐week	  washout	  period	  between	  conditions	  was	  employed	  in	  the	  study	  design	  to	  
ensure	   any	   benefit	   from	   the	   first	   condition	   was	   not	   carried-­‐over	   to	   the	   second	  
condition.	  A	  carryover	  effect	  was	  detected	  on	  four	  of	  the	  EQ5d	  items,	  therefore	  a	  
longer	   wash-­‐out	   period	   is	   recommended	   for	   future	   studies.	   Alternatively	   using	   a	  
parallel	  arm	  RCT	  would	  eliminate	  this	  risk.	  A	  period	  effect	  was	  found	  on	  the	  AMEDO	  
part	   A,	   and	   the	   daily	   diary.	   The	   period	   effect	   associated	   with	   the	   daily	   diary	  
suggested	  that	  groups	  reported	  fewer	  incidents	  of	  forgetting	  over	  time,	  regardless	  
of	  condition.	  However,	  on	  closer	  inspection,	  the	  large	  reduction	  of	  forgetting	  from	  
the	  control	  to	  NeuroText	  conditions	  in	  Group	  2,	  accounts	  for	  the	  significant	  period	  
effect.	   Furthermore,	   it	   appears	   that	  Group	   1’s	   rate	   of	   forgetting	   did	   not	   increase	  
much	   after	   moving	   from	   the	   NeuroText	   to	   control	   conditions,	   which	   might	  
demonstrate	  that	  the	  benefit	  of	  NeuroText	  was	  maintained	  through	  to	  their	  second	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condition.	  This	  would	  add	  to	  the	  explanation	  of	  why	  a	  period	  effect	  was	  detected;	  
but	  perhaps	  more	  importantly	  suggest	  there	  was	  a	  carryover	  effect.	  	  
	  
6.3.2.3	  Feedback	  interviews	  
Feedback	   interviews	   were	   carried	   out	   with	   25	   participants.	   Participants	   were	  
contacted	  after	  trial	  completion	  and	  invited	  to	  interview.	  Feedback	  interviews	  were	  
performed	   over	   the	   telephone,	   rather	   than	   face-­‐to-­‐face,	   as	   there	   is	   evidence	  
suggesting	  that	  the	  two	  modes	  of	   interview	  can	  yield	  the	  same	  results	   	  (Sturges	  &	  
Hanrahan,	   2004).	   Furthermore,	   previous	   home-­‐visits	   and	   multiple	   incidents	   of	  
communication	   had	   allowed	   for	   rapport	   building	   between	   the	   researcher	   and	  
participants;	   therefore	   it	  was	  deemed	   that	  participants	  would	   feel	   comfortable	   to	  
share	  their	  views	  over	  the	  phone,	  and	  that	  the	  researcher	  had	  sufficient	  insight	  to	  
interpret	   those	  views.	  However,	  because	   the	   researcher	  performed	  the	   interview,	  
there	  is	  increased	  risk	  of	  social	  desirability	  bias.	  
	  
Seven	   major	   themes	   were	   identified	   from	   the	   transcripts	   of	   the	   feedback	  
interviews.	  Regarding	  NeuroText	  messages:	  perceived	  usefulness,	  messages	  ending,	  
potential	   improvements;	   Control	   messages:	   potential	   usefulness	   of	   control,	   not	  
useful;	   and	   Overall	   experience	   of	   participating	   in	   the	   study:	   all	   positive,	   a	   few	  
concerns.	  
	  
The	   NeuroText-­‐related	   sub-­‐theme	   ‘everyday	   memory	   related	   improvements’	  
included	   participants’	   experiences	   of	   achieving	   target	   behaviours	   and	   improved	  
planning	   and	  organisation	   skills,	  which	   largely	   reflect	   the	  daily	   diary	   findings,	   and	  
findings	   from	   another	   qualitative	   memory	   rehabilitation	   study	   for	   people	   with	  
neurological	   disabilities	   (das	  Nair	  &	   Lincoln,	   2013;	   das	  Nair,	  Martin,	   et	   al.,	   2015).	  
Furthermore	   the	   sub-­‐theme	   ‘improved	   ability	   to	   manage	   mood’	   was	   identified,	  
which	  contained	  concepts	  of	  coping	  better	  e.g.	  through	  being	  kinder	  to	  themselves,	  
and	  improved	  control	  over	  their	   life,	  which	  could	  potentially	  explain	  the	  alleviated	  
psychiatric	  distress	  portrayed	  in	  the	  GHQ	  results	  after	  NeuroText.	  Improvements	  in	  
managing	  fatigue	  were	  also	  reported,	   in	  association	  with	   improved	  ability	  to	  plan.	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Evidence	   supporting	   improvements	   in	   mood	   and	   fatigue	   after	   memory	  
rehabilitation	   have	   recently	   been	   established	   in	   a	  meta-­‐synthesis	   of	   group-­‐based	  
memory	   rehabilitation	   (das	   Nair,	   Martin,	   et	   al.,	   2015).	   Additional	   findings	   were	  
uncovered	   from	  the	   transcripts,	   such	  as	   reports	   that	   the	  benefits	   from	  NeuroText	  
remained	   for	   some	   after	   the	   messages	   finished,	   either	   through	   an	   established	  
routine,	   or	   implementation	   of	   replacement	   aids.	   This	   experimentation	  with	   other	  
replacement	  memory	  aids	  was	  not	  supported	  by	  the	  AMEDO	  results	  in	  the	  current	  
study,	  but	  was	  also	  reported	  in	  the	  das	  Nair	  and	  Lincoln	  (2013)	  study.	  These	  findings	  
suggest	   that	   some	   people	  might	   only	   need	   to	   receive	   NeuroText	  messages	   for	   a	  
short	  period	  of	   time,	   such	  as	   two	  months,	  and	  can	   then	  effectively	  use	   their	  own	  
reminders.	  Furthermore	  people	  may	  only	  need	   the	   initial	  baseline	  visit	   to	   identify	  
appropriate	   reminders	  with	   a	   therapist,	   and	   then	   could	   potentially	   set	   their	   own	  
reminders.	  Other	  participants	  reported	  missing	  the	  messages,	  and	  so	  these	  are	  the	  
subgroup	  that	  would	  benefit	  from	  longer-­‐term	  use	  of	  NeuroText.	  
	  
Themes	   regarding	   messages	   acting	   as	   prompts	   appeared	   with	   regard	   to	   both	  
NeuroText	  messages	  and	  control	  messages.	  Therefore	  the	  notion	  that	  the	  message	  
content	   may	   not	   be	   important	   cannot	   be	   ignored.	   However,	   it	   seems	   that	   the	  
control	   messages	   acted	   as	   prompts	   once	   participants	   had	   already	   received	  
NeuroText	  messages,	   and	   that	   the	  NeuroText	  messages	   had	   themselves	   acted	   as	  
prompts	  first.	  It	  was	  common	  for	  participants	  to	  report	  that	  when	  a	  control	  acted	  as	  
a	  prompt,	   they	  observed	   the	   time,	   thought	  about	  what	   reminder	   text	   they	  would	  
have	   received	   at	   that	   time,	   and	   what	   reminder	   it	   contained;	   rather	   than	   simply	  
thinking	   about	   what	   task	   they	   should	   be	   doing	   at	   that	   time.	   Only	   one	   person	  
reported	   that	   the	   control	   messages	   acted	   as	   prompts,	   without	   having	   received	  
NeuroText	   first.	   Therefore	   it	   is	   probable	   that	   the	   content	   of	   the	   message	   is	  
important	   initially,	   and	   then	   if	   a	   routine	   is	   established,	   the	   content	   could	   be	  
removed.	  This	  carryover	  effect	  from	  NeuroText	  to	  control	  condition	  supports	  what	  
was	   hypothesised	   to	   have	   occurred	   with	   the	   maintained	   target	   behaviour	  
performance	  on	  daily	  diary	  scores.	  However	   this	  would	  not	  work	   for	  everyone,	  as	  
many	  participants	  explicitly	  said	  that	  NeuroText	  was	  more	  effective	  for	  them	  than	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the	  control,	  and	  many	  more	  did	  not	   find	   that	   the	  benefit	   remained	   in	   the	  control	  
condition.	  
	  
Interestingly	   the	   feedback	   interviews	   uncovered	   unanticipated	   responses	   to	   the	  
control,	  such	  as	  short-­‐term	  improvements	  in	  mood,	  and	  encouraging	  engagement.	  
Sub-­‐themes	   regarding	   negative	   aspects	   of	   the	   control	   were	   also	   found,	   such	   as	  
irritating	   and	   confusing.	   Some	  participants	   found	   the	   control	  messages	   distracted	  
them	   away	   from	   their	   desired	   target	   behaviour,	   which	   could	   put	   them	   at	   a	  
disadvantage,	  compared	  to	  NeuroText.	  
	  
Overall	   participation	   was	   deemed	   positive,	   with	   participants	   enjoying	   being	  
involved,	   and	   finding	   the	   baseline	   assessments	   interesting.	   All	   participants	   were	  
interested	  in	  receiving	  a	  results	  summary,	  and	  many	  asked	  to	  be	  notified	  of	  similar	  
future	   studies.	   Feasibility	   issues	   were	   touched	   on,	   where	   most	   participants	  
suggested	   nothing	   needed	   to	   be	   changed	   to	   the	   NeuroText	   messages,	   others	  
suggested	   a	   few	   tailored	   adjustments,	   e.g.	   reduce	   frequency.	   Therefore	   it	   is	  
recommended	  that	  the	  researcher	  should	  contact	  the	  participants	  more	  frequently	  
throughout	  the	  trial	  to	  ask	  whether	  they	  wish	  to	  modify	  the	  reminder	  scheme.	  
	  
6.4	  Limitations	  of	  the	  study	  
6.4.1	  Issues	  with	  study	  design	  
The	  RCT	  methodology	  was	  chosen	  primarily	  as	   it	   is	  the	  most	  robust	  design	  for	  the	  
evaluation	  of	  interventions	  (Higgins	  &	  Green,	  2013),	  and	  to	  ensure	  the	  study	  could	  
be	   included	   in	   future	   systematic	   reviews	   and	   meta-­‐analyses.	   Furthermore,	   the	  
design	   allowed	   the	   comparison	   of	   the	   intervention	   to	   an	   active	   control,	   with	  
randomisation,	  allocation	  concealment	  and	  blinding,	  to	  eliminate	  bias.	  A	  commonly	  
reported	  issue	  with	  RCTs	  is	  that	  the	  personal	  story	  of	  participants	   is	   lost,	  however	  
the	   qualitative	   feedback	   element	   of	   this	   study	   recaptured	   participants’	  
perspectives.	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There	   is	   some	  confusion	   in	   the	   literature	  around	   the	   terms	   ‘feasibility’	   and	   ‘pilot’	  
when	   describing	   a	   study,	   where	   some	   authors	   use	   the	   terms	   interchangeably	  
(Thabane	   et	   al.,	   2010),	   whilst	   others	   define	   them	   as	   separate	   (Arain,	   Campbell,	  
Cooper,	  &	  Lancaster,	  2010;	  Lancaster,	  Dodd,	  &	  Williamson,	  2004).	  Whitehead,	  Sully,	  
and	   Campbell	   (2014)	   performed	   a	   literature	   review	   aimed	   at	   defining	   the	  
relationship	  between	  the	  two	  terms.	  They	  found	  that	  the	  distinguishing	  features	  of	  
a	  pilot	  study	  were	  that	  they	  mimic	  the	  design	  of	  future	  larger	  trials,	  and	  therefore	  
have	  stricter	  methodology;	  focus	  on	  the	  trial	  processes;	  and	  are	  a	  small	  version	  of	  
the	  main	  study	  (Whitehead	  et	  al.,	  2014).	  The	  authors	  also	  report	  that	  pilot	  studies	  
can	   also	   test	   the	   feasibility	   of	   a	   larger	   study,	   as	   well	   as	   investigating	   the	   trial	  
procedures,	   and	   therefore	   it	   could	   be	   said	   that	   pilot	   studies	   are	   also	   feasibility	  
studies	  (Whitehead	  et	  al.,	  2014).	  They	  conclude	  that	  a	  pilot	  study	  is	  a	  special	  type	  of	  
feasibility	   study,	   which	   plans	   for	   future	   trials	   and	   mimics	   the	   definitive	   trial;	  
therefore	  the	  current	  study	  is	  considered	  a	  pilot	  trial.	  
	  
The	   RCT	   crossover	   design	   of	   this	   study	  was	   deemed	   feasible.	   However	   crossover	  
designs	   run	   the	   risk	  of	   carryover	  effects	   from	   the	   first	   condition	   to	   the	   second.	  A	  
washout	   period	   of	   3	   weeks	   was	   employed	   to	   reduce	   any	   carryover,	   however	   it	  
appears	  that	  this	  may	  have	  not	  been	  successful.	  Therefore	  a	  longer	  washout	  period	  
between	  conditions	  would	  be	  recommended,	  although	  this	  could	  increase	  the	  rate	  
of	  dropout	  between	  conditions.	  Due	  to	  the	  degenerative	  nature	  of	  MS,	  it	  is	  possible	  
that	   crossover	  designs	  are	   inappropriate,	   and	   that	  only	  data	   from	   the	   first	  period	  
should	  be	  used	  (Qizilbash	  et	  al.,	  1998).	  Although,	  each	  participant	  only	  took	  part	  in	  
the	   study	   for	   six	  months,	   and	   the	   randomisation	   should	  have	  meant	   that	   disease	  
progression	  was	  equally	  likely	  across	  groups.	  Perhaps	  a	  better	  alternative	  for	  future	  
trials	   would	   be	   to	   employ	   a	   parallel	   arm	   RCT	   design.	   However,	   one	   benefit	   of	  
crossover	   trials	   is	   that	  participants	  experience	  both	   conditions,	   and	   can	   therefore	  
express	  a	  preference	  for	  or	  against	  the	  treatment.	  Another	  benefit	  is	  that	  because	  
each	   patient	   receives	   both	   conditions,	   crossover	   trials	   usually	   require	   half	   the	  
number	   of	   participants	   to	   produce	   the	   same	   precision	   as	   a	   parallel	   group	   trial	  
(Elbourne	  et	  al.,	  2002).	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Despite	   efforts	   to	   boost	   recruitment,	   the	   sample	   size	   estimate	   of	   66	   was	   not	  
reached,	  due	  to	  a	  saturation	  of	  eligible	  referrals	  at	  many	  sites	  and	  the	  timeframe	  of	  
the	   study.	   Therefore	   more	   sites,	   or	   multiple	   referring	   clinicians	   at	   each	   site,	   are	  
recommended	  in	  future.	  Additionally,	  recruiting	  from	  local	  charity	  branches,	  such	  as	  
the	  MS	   Society,	   is	   recommended	   to	   boost	   recruitment.	   Therefore	   the	   study	   was	  
underpowered	  to	  evaluate	  the	  effectiveness	  of	  the	  intervention.	  Recruitment	  rates	  
in	   clinical	   research	   are	   unpredictable,	   and	   so	   often	   are	   lower	   than	   anticipated	  
(Pringle	   &	   Churchill,	   1995).	   However,	   the	   results	   will	   serve	   as	   pilot	   data	   for	   a	  
potentially	  larger	  multi-­‐centre	  study.	  
	  
6.4.2	  Issues	  with	  intervention	  
Due	   to	   the	   nature	   of	   the	   intervention	   being	   carried	   out	   over	   two	   months	   in	  
participants’	  personal	  lives,	  adherence	  remains	  unknown.	  A	  literature	  review	  on	  the	  
non-­‐use	   of	   assistive	   technology	   devices	   reported	   high	   rates	   of	   non-­‐adherence	  
(Wessels,	   Dijcks,	   Soede,	   Gelderblom,	   &	   De	  Witte,	   2003).	   Therefore	   it	   is	   probable	  
that	  some	  reminder	  messages	  went	  unread,	  and	  that	  mobile	  phones	  were	  switched	  
off	   or	   on	   silent	  mode.	   However,	   due	   to	   the	   study	   design,	   these	   events	  may	   also	  
have	  occurred	  in	  the	  control	  condition,	  and	  were	  therefore	  counterbalanced.	  
	  
6.4.3	  Issues	  with	  outcomes	  
The	  lack	  of	  inclusion	  of	  a	  baseline	  prospective	  memory	  test	  was	  a	  limitation,	  none	  
were	  used,	  as	  they	  have	  lower	  validity	  than	  chosen	  tests	  (Roche,	  Fleming,	  &	  Shum,	  
2002).	  However,	  it	  would	  be	  useful	  to	  measure	  prospective	  memory	  as	  part	  of	  the	  
baseline	  assessment,	  using,	  e.g.	  the	  Cambridge	  Prospective	  Memory	  Test	  (Wilson	  et	  
al.,	  2005)	  or	  subtests	  of	  the	  RBMT	  (Wilson	  et	  al.,	  1985)	  in	  future	  studies.	  
	  
The	   outcome	  measures	   employed	   were	   chosen	   on	   the	   basis	   of	   being	   subjective,	  
self-­‐report	   tools,	  which	  were	  ecologically	   valid.	  However	   subjective	  measures	   rely	  
on	   participants’	   ability	   to	   report	   recent	   or	   current	   status,	   which	   required	   intact	  
meta-­‐memory	  skills,	  and	   these	  are	   likely	   to	  be	   impaired	   in	   the	  sample	  population	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(Beatty	   &	   Monson,	   1991).	   Therefore,	   participant	   questionnaires	   might	   be	  
inaccurate	   as	   a	   measure	   of	   incidence	   of	   memory	   failures.	   People	   with	   worse	  
memories	   might	   be	   worse	   at	   recalling	   instance	   of	   memory	   failure	   and	   give	  
themselves	   low	  frequency	  ratings	   (Sunderland	  et	  al.,	  1983).	  However,	  despite	   this	  
limitation,	  this	  form	  of	  assessment	  is	  the	  most	  appropriate	  for	  the	  study.	  
	  
Another	  limitation	  is	  that	  the	  outcome	  measures	  were	  employed	  because	  they	  are	  
well-­‐established	   measures	   in	   memory	   rehabilitation	   studies,	   with	   good	  
psychometric	   properties.	   Therefore	   findings	   from	   this	   study	   are	  more	   likely	   to	  be	  
included	  in	  systematic	  reviews	  and	  pooled	  together	  in	  a	  meta-­‐analysis.	  However,	  it	  
appears	   that	   the	   EMQ	  probably	   is	   not	   sensitive	   to	   change	   in	   the	   achievement	   of	  
target	  behaviours,	  and	  you	  would	  not	  expect	  to	  see	  changes	  in	  the	  majority	  of	  items	  
with	   this	   intervention,	   e.g.	   recognising	   faces.	   Changes	   important	   to	   the	   individual	  
are	  often	   lost	  on	  global	  measures,	   and	   improvements	   too	   small	   to	  be	   statistically	  
significant	   may	   still	   be	   important	   to	   the	   patient	   (Hanssen,	   Šaltytė	   Benth,	   Beiske,	  
Landrø,	   &	   Hessen,	   2015;	   Khan,	   Pallant,	   &	   Turner-­‐Stokes,	   2008;	   Royle	   &	   Lincoln,	  
2008).	  However,	  the	  EMQ	  was	  used	  because	  there	  was	  no	  appropriate	  alternative	  
available	  with	   good	  psychometric	   properties,	   (Carr	   et	   al.,	   2014).	   In	   future	   trials	   it	  
would	  be	  useful	   to	   include	   a	   subjective	  measure	  of	   prospective	  memory,	   such	   as	  
the	  Comprehensive	  Assessment	  of	  Prospective	  Memory	  (Roche	  et	  al.,	  2002),	  which	  
measures	  the	  specific,	  everyday	  PM	  lapses.	  This	  recommendation	  is	  despite	  the	  fact	  
that	  psychometric	  properties	  have	  not	  yet	  been	  determined.	  
	  
Some	  participants	  did	  not	   return	  the	  outcome	  questionnaires,	  and	  this	  must	   raise	  
doubts	   over	   how	   representative	   the	   results	   were.	   It	   is	   likely	   that	   those	   with	   the	  
worst	  memories	  were	  under-­‐represented	  as	  they	  often	  lost	  or	  forgot	  to	  return	  the	  
outcome	   questionnaires.	   Hence,	   it	   is	   possible	   that	   this	   could	   have	   biased	   the	  
results,	   however	   this	   would	   be	   expected	   in	   both	   conditions,	   and	   so	   would	   be	  
counterbalanced.	   Some	   who	   did	   not	   feel	   able	   to	   complete	   the	   questionnaires	  
reported	  that	  this	  was	  due	  to	  low	  mood.	  Therefore	  screening	  for	  mood	  problems	  at	  
baseline	  could	   increase	  outcome	  return,	  but	  could	  mean	  that	   the	  sample	  was	  not	  
representative	   of	   the	   population,	   where	   the	   lifetime	   prevalence	   of	   depression	   is	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50%	   in	   people	   with	   MS,	   and	   is	   known	   to	   interact	   with	   cognitive	   impairment	  
(Feinstein,	  2011;	  Feinstein	  et	  al.,	  1999;	  Sá,	  2008).	  	  
	  
6.4.4	  Issues	  with	  analyses	  
The	   modest	   sample	   sizes	   could	   have	   been	   an	   issue	   for	   the	   employed	   statistical	  
tests,	   and	   therefore	   the	   study	  was	   underpowered	   to	   detect	   differences	   between	  
conditions.	  However	  the	  majority	  of	  scales	  had	  normal	  distributions	  of	  scores,	  and	  
so	  parametric	  tests	  were	  performed.	  A	  potential	  limitation	  of	  the	  analyses	  was	  that	  
multiple	   t-­‐tests	   were	   performed,	   and	   interpreted	   without	   using	   the	   Bonferroni	  
correction;	   hence	   there	   is	   an	   increased	   likelihood	   that	   any	   significant	   differences	  
are	  due	  to	  chance.	   If	  the	  Bonferroni	  correction	  had	  been	  employed	  the	  difference	  
on	  the	  GHQ	  would	  have	  remained	  significant,	  however	  the	  daily	  diary	  would	  not.	  In	  
future	  studies	  with	  larger	  samples	  it	  is	  advised	  that	  ANOVAs	  are	  used,	  to	  avoid	  the	  
issues	  with	  multiple	  testing.	  Alternatively	  regression	  methods	  could	  be	  employed.	  
	  
Due	  to	  the	  crossover	  design,	  tests	  for	  carryover	  and	  period	  effects	  were	  performed.	  
However	   the	   Cochrane	   Handbook	   states	   that	   the	   statistical	   techniques	   to	  
demonstrate	   carryover	   are	   unsatisfactory	   and	   therefore	   the	   decision	   lies	   on	   the	  
researcher’s	   judgement	   (Higgins	  &	  Green,	  2011).	   If	   carryover	   is	  detected	  then	  the	  
two-­‐stage	   Grizzle	   approach,	   of	   comparing	   only	   condition	   1	   data	   is	   suggested	  
(Grizzle,	  1965).	  However	  this	  ‘two	  stage	  analysis’	  was	  not	  performed	  as	  it	  has	  been	  
discredited	  and	  using	   the	   first	  period	   removes	   the	  main	  strength	  of	   the	  crossover	  
design,	  ability	  to	  do	  within-­‐participant	  comparisons	  (Freeman,	  1989).	  
	  
Intention-­‐to-­‐treat	   analysis	   was	   used	   throughout	   the	   trial,	   where	   all	   data	   were	  
categorised	  as	   the	  group	   in	  which	  participants	  were	   randomised	   into.	  However	   t-­‐
tests	  only	   included	   full	  data	  sets.	  The	   imputation	  of	  missing	  values,	  and	   therefore	  
sensitivity	  analyses	  were	  not	  performed.	  However	   it	   could	  be	  argued	   that	   though	  
this	  would	  have	   increased	  the	  sample	  size,	   it	  would	  have	  probably	  dampened	  the	  
detection	   of	   any	   effect.	   Another	   common	   but	   controversial	   limitation	   in	   health	  
sciences,	  which	  is	  practiced	  here,	  is	  the	  liberal	  treatment	  of	  ordinal	  scales	  as	  though	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they	  were	  interval	  scales.	  Therefore	  it	  would	  be	  beneficial	  to	  consider	  using	  Rasch	  
analysis	  to	  convert	  scales	  to	  interval	  level	  data	  in	  future	  trials.	  	  
	  
The	  use	  of	  null	  hypothesis	  significance	  testing	  (NHST)	  has	  many	  pitfalls	  (Field,	  2013),	  
as	  the	  level	  of	  significance	  does	  not	  indicate	  the	  importance	  of	  an	  effect.	  Therefore	  
the	  effect	  size,	  in	  the	  form	  of	  Cohen’s	  d,	  was	  also	  reported,	  as	  recommended	  by	  the	  
American	  Psychological	  Association	  (Wilkinson,	  1999).	  The	  effect	  sizes	  calculated	  in	  
this	  study,	  complemented	  the	  p	  values,	  in	  the	  interpretation	  of	  findings.	  
	  
Qualitative	  analysis	  was	  performed	  by	  the	  researcher	  for	  the	  first	  time	  during	  this	  
study,	   however	   supervision	   from	   an	   experienced	   qualitative	   researcher	   ensured	  
quality	  in	  the	  development	  of	  the	  framework	  matrix	  and	  identification	  of	  themes.	  	  
	  
6.5	  Implications	  for	  practice	  
Everyday	  memory	  improvements	  were	  reported	  on	  the	  daily	  diary,	  but	  not	  on	  the	  
EMQ	  or	  AMEDO.	  These	  results	  partially	  support	  the	  recommendations	  of	  Cicerone	  
et	  al.	  (2011)	  and	  de	  Joode	  et	  al.	  (2010),	  to	  offer	  compensatory	  aids	  to	  people	  with	  
memory	  problems,	  and	  Jamieson’s	  conclusion	  that	  there	  is	  evidence	  for	  prospective	  
memory	   prompting	   devices	   for	   people	   with	   degenerative	   conditions.	   Therefore	  
there	   is	   some	   suggestion	   that	   people	   with	   MS	   can	   be	   supported	   by	   electronic	  
memory	  aids	  to	  improve	  achievement	  of	  target	  behaviours	  and	  improve	  mood.	  
	  
NeuroText	  is	  a	  service	  that	  is	  currently	  available,	  and	  these	  findings	  suggest	  that	  the	  
service	  could	  be	  useful	  for	  people	  with	  progressive	  neurological	  conditions,	  as	  well	  
as	  people	  with	  ABI.	  Furthermore	  this	  could	  indicate	  that	  rehabilitation	  approaches	  
commonly	   used	   for	   people	   with	   ABI	   could	   be	   translatable	   to	   people	   with	  
neurodegenerative	   conditions.	   The	   study	   was	   carried	   out	   over	   five	   sites,	   with	  
community-­‐based	   MS	   patients,	   and	   therefore	   the	   findings	   could	   be	   viewed	   as	  
generalisable.	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The	  aims	  of	   the	   interviews	  were	   to	  elicit	  and	  examine	   feedback	   from	  participants	  
who	  had	  taken	  part	  in	  the	  RCT	  comparing	  NeuroText	  with	  an	  active	  control,	  and	  to	  
provide	   suggestions	   for	   improvements.	   Patient	   partnership,	   such	   as	   this,	   is	   a	   key	  
feature	  in	  many	  NHS	  services	  (DoH,	  2001).	  The	  feedback	  provided	  some	  explanation	  
for	   the	   quantitative	   findings,	   for	   example,	   the	  maintenance	   of	  NeuroText	   benefit	  
into	  the	  control	  condition	  for	  some	  participants.	  Therefore	  indicating	  that	  for	  some	  
people	   with	   MS	   who	   have	   memory	   problems	   it	   may	   be	   viable	   to	   initially	   have	  
prompts	  containing	  reminder	  content;	  and	  then	   for	  some	  the	  routine	  will	   remain,	  
others	  will	  independently	  replace	  their	  reminders	  with	  an	  alternative,	  and	  some	  will	  
effectively	  respond	  to	  a	  simple	  prompt,	  such	  as	  an	  alarm.	  	  
	  
6.6	  Implications	  for	  research	  
The	   trial	   is	   a	   high	   quality	   RCT,	   that	   was	   designed	   in	   response	   to	   the	   call	   for	  
methodologically	   robust	   memory	   rehabilitation	   research	   in	   recent	   systematic	  
reviews	  (das	  Nair	  et	  al.,	  2012;	  Goodwin,	  Lincoln,	  das	  Nair,	  &	  Bateman,	  2015;	  Rosti-­‐
Otajärvi	  &	  Hämäläinen,	  2014).	  Therefore,	  the	  study	  adds	  to	  the	  evidence-­‐base,	  and	  
will	  be	  eligible	  for	  inclusion	  in	  future	  systematic	  reviews.	  
	  
The	   feasibility	  of	   the	   trial	  design	  was	  assessed,	  and	  many	   recommendations	   for	  a	  
definitive	  full-­‐powered	  RCT	  have	  been	  made.	  The	  main	  recommendations	  are,	  that	  
an	  alternative	   to	   the	  EMQ	  should	  be	  used	  as	   the	  primary	  outcome	  measure,	   and	  
that	   a	   prospective	   memory	   measure	   is	   employed;	   and	   that	   a	   parallel	   arm	   RCT	  
design	  would	  be	  preferable	  to	  the	  current	  crossover	  design.	  
	  
Two	  sample	  size	  estimates	  were	  calculated	  using	  the	  GHQ	  and	  the	  daily	  diary	  data;	  
the	   estimates	   were	   for	   119	   and	   37	   participants,	   respectively.	   These	   estimates	  
indicate	  that	  a	  full	  powered	  trial	  is	  achievable.	  The	  decision	  to	  use	  these	  measures	  
for	   the	   calculations	   was	   made	   in	   light	   of	   the	   issues	   found	   with	   the	   EMQ	   in	   this	  
study,	   and	   the	   recommendations	   to	   use	   a	   different	   measure	   in	   future	   studies.	  
Therefore	  the	  calculated	  sample	  sizes	  are	  indicative	  for	  the	  other	  measures	  used	  in	  
this	  study.	  Further	  research	  into	  developing	  the	  psychometric	  properties	  of	  memory	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rehabilitation	  outcome	  measures	  are	  strongly	  recommended,	  using	  techniques	  such	  
as	  Rasch	  analysis.	  
	  
Interviews	  offer	  qualitative	  information	  that	  outcome	  measures	  used	  in	  most	  trials	  
do	  not	  offer	  (das	  Nair	  &	  Lincoln,	  2013).	  The	  addition	  of	  a	  qualitative	  study	  has	  been	  
an	  important	  addition	  to	  better	  understand	  the	  quantitative	  results,	  and	  is	  the	  first	  
qualitative	  evaluation	  of	  NeuroPage	  in	  the	  literature.	  Future	  trials	  in	  the	  field	  should	  
include	   a	   qualitative	   element,	   to	   allow	   for	   the	   triangulation	   of	   evidence,	  
demonstrated	  in	  this	  study	  (Moffatt,	  White,	  Mackintosh,	  &	  Howel,	  2006).	  	  
	  
Previous	   studies	   on	   NeuroPage	   have	   compared	   the	   intervention	   to	   usual-­‐care	  
(Wilson	   et	   al.,	   2001;	  Wilson,	   Emslie,	  Quirk,	   et	   al.,	   2005;	  Wilson	   et	   al.,	   1997).	   This	  
study	  used	  an	  active	  control,	  containing	  non-­‐reminder	  content;	  which	  has	  allowed	  
more	   exploration	  of	   the	   active	   ingredient	   of	   the	   intervention,	   e.g.	   the	   content	   or	  
the	   prompting	   alert.	   If	   participants	   had	   reduced	   retrospective	   memory	   (RM)	  
functioning,	  as	  suggested	  by	  baseline	  neuropsychological	  profile	  of	  the	  sample,	  then	  
it	  would	  be	  expected	   that	  participants	  would	  not	  have	   remembered	   the	   intended	  
action	   without	   receiving	   the	   reminder	   content.	   This	   was	   reported	   in	   some	  
participants	   who	   lost	   the	   benefit	   of	   NeuroText	   when	   the	   condition	   finished.	  
However,	  many	  participants	   reported	  a	  maintained	  benefit	   of	  NeuroText	   into	   the	  
control	   condition,	   which	   is	   suggestive	   of	   intact	   RM	   as	   they	   could	   remember	   the	  
intended	   action.	   It	   is	   probable	   this	   subset	   of	   participants	   therefore	   had	   a	  
prospective/executive	   functioning	   problem,	   and	   so	   a	   prompt	   was	   sufficient	   to	  
trigger	   recollection	   of	   the	   content	   and	   perform	   the	   target	   behaviour.	   A	   further	  
subset	  reported	  that	  they	  had	  developed	  a	  routine,	  following	  NeuroText,	  and	  that	  
they	   no	   longer	   needed	   the	  messages,	   which	  would	   suggest	   that	   implicit	   learning	  
had	  occurred.	  Hence,	  it	  would	  seem	  that	  the	  most	  important	  element	  of	  NeuroText,	  
e.g.	   content	   or	   prompt,	   is	   dependent	   on	   the	   user’s	   individual	   impairments.	  
Therefore	  it	  is	  necessary	  to	  include	  an	  active	  control	  in	  future	  trials,	  such	  as	  the	  one	  
used	  in	  this	  study,	  rather	  than	  just	  comparing	  to	  usual-­‐care.	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However	  at	  this	  stage,	  interpretations	  should	  be	  viewed	  in	  light	  of	  the	  strengths	  and	  
weaknesses	   of	   the	   study,	   such	   as	   the	   study	   being	   underpowered	   to	   determine	  
effect.	  MRC	  Framework	  for	  complex	  interventions	  (Campbell,	  Fitzpatrick,	  Haines,	  &	  
Kinmonth,	   2000)	  would	   place	   this	   study	   as	   a	   phase	   II	   exploratory	   trial.	   The	   study	  
findings	  justify	  a	  full-­‐powered	  definitive	  RCT.	  
	  
6.7	  Future	  Directions	  
A	   full	   powered	   RCT	   should	   be	   undertaken,	   using	   the	   sample	   size	   estimation,	   and	  
considering	  the	  feasibility	  recommendations	  documented	  throughout	  this	  chapter.	  
Considering	  the	  limitations	  associated	  with	  the	  crossover	  design	  it	  is	  suggested	  that	  
a	  parallel	  arm	  RCT	  design	  is	  employed	  in	  this	  future	  trial.	  It	  is	  recommended	  that	  a	  
third	   arm	   containing	   a	   content-­‐free	  prompt	   is	   added,	   in	   light	   of	   the	   fact	   that	   the	  
current	   control	   was	   perceived	   by	   some	   as	   distracting	   them	   away	   from	   target	  
behaviours.	  Additionally	  this	  design	  would	  allow	  the	  observation	  of	  how	  useful	  the	  
content-­‐free	   prompts	   would	   be	   without	   the	   priming	   element	   of	   NeuroText	   first	  
seen	  in	  Group	  1	  in	  this	  trial.	  
	  
A	  further	  suggestion	  would	  be	  to	  assess	  the	  importance	  of	  therapeutic	  input	  in	  the	  
intervention,	   i.e.	   the	   clinician/researcher	   led	   identification	   of	   target	   intentions,	  
reminder	  content	  and	  frequency	  of	  prompt.	  Therefore	  a	  future	  study	  could	  assess	  
how	   beneficial	   this	   stage	   alone	  would	   be,	   where	   participants	   to	   implement	   their	  
own	   replacement	   memory	   aids.	   Another	   piece	   of	   research	   could	   look	   at	   the	  
relationship	  between	  baseline	  cognitive	  data,	  e.g.	  memory,	  attention	  and	  executive	  
functioning	   abilities,	   and	   their	   response	   to	   the	   intervention.	   For	   example,	   “do	  
people	  with	  MS	   and	   impaired	   baseline	   executive	   functioning,	   but	   intact	  memory,	  
experience	  benefit	  from	  content-­‐free	  cues?”,	  in	  line	  with	  the	  research	  of	  Fish	  et	  al.	  
(2008).	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7.0	  Conclusions	  
	  
Evidence	   on	   the	   effectiveness	   of	   external	   memory	   aids	   in	   MS	   was	   gathered	   by	  
conducting	   a	   systematic	   review	   on	   the	   area.	   Only	   one	   study	   was	   identified	   that	  
specifically	  evaluated	  the	  use	  of	  external	  memory	  aids	  with	  people	  with	  MS,	  despite	  
the	  inclusion	  of	  non-­‐randomised	  designs.	  It	  was	  concluded	  that	  the	  methodological	  
quality	  of	  studies	  was	  poor	  and	  that	  high	  quality	  trials	  were	  necessary	  in	  the	  field.	  
	  
In	  an	  attempt	   to	  address	   the	   lack	  of	  evidence	  observed	   in	   the	   literature,	  a	  single-­‐
blind	  multicentre	  RCT	  was	  conducted	  to	  examine	  the	  effectiveness	  of	  an	  electronic	  
memory	  aid,	  NeuroText.	  The	  aim	  of	  this	  study	  was	  to	  evaluate	  whether	  people	  with	  
MS	  who	  used	  NeuroText	  reminder	  messages	  reported	  reduced	  subjective	  reports	  of	  
memory	   problems	   in	   daily	   life;	   increased	   attainment	   of	   target	   behaviours;	   and	  
improved	   mood	   and	   quality	   of	   life,	   compared	   to	   control	   messages.	   A	   mixed-­‐
methods	  approach,	   incorporating	  both	  quantitative	  and	  qualitative	   information	   to	  
acquire	  a	  fuller	  understanding	  of	  the	  data	  was	  employed.	  Based	  on	  the	  quantitative	  
data,	  there	  was	  no	  evidence	  to	  suggest	  that	  NeuroText	  improved	  memory	  problems	  
in	  daily	  life,	  or	  quality	  of	  life.	  However	  there	  was	  evidence	  that	  NeuroText	  improved	  
attainment	   of	   target	   behaviours	   and	   mood.	   Interestingly,	   the	   qualitative	   data	  
suggested	  that	  participants	  found	  NeuroText	  to	  be	  useful	  across	  multiple	  aspects	  of	  
their	   everyday	   life,	   and	   some	   found	   the	   benefit	   remained	   after	   the	   intervention	  
stopped.	  
	  
Comparing	  NeuroText	  with	   an	   active	   control,	   rather	   than	   usual	   care,	   allowed	   the	  
observation	   of	   what	   element	   of	   the	   reminder	   service	   might	   be	   providing	   the	  
treatment	  effect.	  The	  content	  of	  NeuroText	  appears	  important	  to	  its	  effectiveness,	  
but	   further	   research	   is	   necessary	   to	   determine	   how	   people	   with	   different	  
neuropsychological	  profiles	  respond.	  
	  
Small	   sample	   size	   and	   lack	   of	   appropriate	   outcome	  measures	  may	   have	   affected	  
quantitative	   results.	   Findings	   should	   be	   interpreted	   with	   consideration	   for	   the	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strengths	   and	  weaknesses	   of	   the	   study.	   The	   trial	  was	   deemed	   feasible	   to	   deliver,	  
and	   recommendations	   for	   future	   trials	  were	  outlined.	   Therefore	  we	  are	  hopefully	  
one	   step	   closer	   to	  meeting	   the	   unmet	   needs	   of	   people	  with	  MS	  who	   experience	  
memory	  problems.	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Appendices	  
Appendix	  1:	  Systematic	  review	  search	  strategy	  
	  
1.	   Multiple	  sclerosis	  (exp)	  
2.	   (Demyelinating	   and	   autoimmune	   and	   disease)	   or	   (demyelination)	   or	  
(demyelinating	  and	  diseases)	  or	  (optic	  and	  neuritis)	  or	  (Myelitis	  and	  transverse)	  or	  
(Neuromyelitis	  and	  optica)	  or	  (Disseminated	  and	  sclerosis)	  or	  (Devics	  and	  disease)	  
3.	   1	  or	  2	  
	  
4.	   Memory	  disorder	  (exp)	  
5.	   Memory	  (exp)	  
6.	   Attention	  or	  Cognit*	  or	  (Cognit*	  and	  (disorders	  or	  impair*))	  or	  Concentrat*	  
or	  Distract*	   or	   Alert*	   or	   Amne?sia	   or	   (Planning	   and	   problem*)	   or	   Confabulat*	   or	  
Recall	   or	   (Coniti*	   and	   retention)	   or	   Recogni*	   or	   (Prospective	   and	   memory)	   or	  
Forget*	  or	   (Executive	  and	  function*)	  or	   (Executive	  and	  behavio?r)	  or	  dysexecutive	  
or	  planning	  
7.	   4	  or	  5	  or	  6	  	  
	  
8.	   (Assistive	   and	   technolog*)	   or	   (Assistive	   and	   technolog*	   and	   device)	   or	  
(Adaptive	   and	   technolog*)	   or	   (Assistive	   and	   device*)	   or	   pager*	   or	   (paging	   and	  
system*)	  or	   (Technolog*	  and	  aid*)	  or	   (pocket	  and	  (pc	  or	  computer))	  or	   (palm	  and	  
top)	  or	  (personal	  and	  digital	  and	  assistant)	  or	  PDA	  or	  (self	  and	  help	  and	  device*)	  or	  
(computer*	  and	  handheld)	  
9.	   (Memory	  and	  aid*)	  or	  (Memory	  and	  strateg*)	  or	  Compensat*	  or	  (Electronic	  
and	   aid*)	   or	   (External	   and	   aid*)	   or	   (External	   and	   compensat*)	   or	   (memory	   and	  
device*)	   or	   (remind*	   and	   system)	   or	   remind*	   or	   (cogniti*	   and	   prosthetic*)	   or	  
substitute*	  
10.	   8	  or	  9	  
• 	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11.	   Rehabilitation	  (exp)	  
12.	   Neurorehab*	   or	   Therap*	   or	   Treatment	   or	   Intervention	   or	   Strateg*	   or	  
Management	  or	  (Cogniti*	  and	  rehab*)	  or	  (Therap*	  and	  computer	  and	  assist*)	  
13.	   11	  or	  12	  
	  
14.	   3	  and	  7	  and	  10	  and	  13	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Appendix	  3:	  Letter	  of	  ethical	  approval	  
	  
	  
NRES Committee East Midlands - Northampton	  
The Old Chapel	  




Telephone: 0115 8839440 	  
22 October 2013	  
	  
Professor Nadina Lincoln	  
Professor of Clinical Psychology	  
University of Nottingham	  
Division or Rehabilitation and Ageing	  




Dear Professor Lincoln	  
	  
Study title:	  





IRAS project ID:	  
131028	  
	  
Thank you for your letter of 07 October 2013, responding to the Committee’s 
request for further information on the above research and submitting revised 
documentation.	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The further information has been considered on behalf of the Committee by the 
Chair. 	  
	  
We plan to publish your research summary wording for the above study on the 
NRES website, together with your contact details, unless you expressly withhold 
permission to do so.  Publication will be no earlier than three months from the date 
of this favourable opinion letter.  Should you wish to provide a substitute contact 
point, require further information, or wish to withhold permission to publish, please 
contact the REC Manager Ms Dawn Denton, nrescommittee.eastmidlands-
northampton@nhs.net.	  
	  
Confirmation of ethical opinion	  
	  
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 
supporting documentation as revised, subject to the conditions specified below.	  
	  




The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see "Conditions of the favourable opinion" below).	  
Non-NHS sites	  
	  
Notification(s) of no objection have been received from local assessors for the non-
NHS site(s) listed in the table below, following site-specific assessment (SSA).	  
	  
I am pleased to confirm that the favourable opinion applies to the following research 
site(s), subject to site management permission being obtained prior to the start of 
the study at the site (see under ‘Conditions of the favourable opinion below’).	  
 	  
Research Site 	  
Principal Investigator / Local Collaborator 	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 Division of Rehabilitation and Ageing 	  
Professor Nadina Lincoln 	  
 	  
Conditions of the favourable opinion	  
	  
The favourable opinion is subject to the following conditions being met prior to the 
start of the study.	  
	  
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned.	  
	  
Management permission ("R&D approval") should be sought from all NHS 
organisations involved in the study in accordance with NHS research governance 
arrangements.	  
	  
Guidance on applying for NHS permission for research is available in the Integrated 
Research Application System or at http://www.rdforum.nhs.uk.  	  
	  
Where a NHS organisation’s role in the study is limited to identifying and referring 
potential participants to research sites ("participant identification centre"), guidance 
should be sought from the R&D office on the information it requires to give 
permission for this activity.	  
	  
For non-NHS sites, site management permission should be obtained in accordance 
with the procedures of the relevant host organisation. 	  
	  
Sponsors are not required to notify the Committee of approvals from host 
organisations	  
	  
Registration of Clinical Trials	  
	  
All clinical trials (defined as the first four categories on the IRAS filter page) must be 
registered on a publically accessible database within 6 weeks of recruitment of the 
first participant (for medical device studies, within the timeline determined by the 
current registration and publication trees).  	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There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g when submitting an amendment.  We will audit the 
registration details as part of the annual progress reporting process.	  
	  
To ensure transparency in research, we strongly recommend that all research is 
registered but for non clinical trials this is not currently mandatory.	  
	  
If a sponsor wishes to contest the need for registration they should contact 
Catherine Blewett (catherineblewett@nhs.net), the HRA does not, however, expect 
exceptions to be made. Guidance on where to register is provided within IRAS.	  
	  
It is the responsibility of the sponsor to ensure that all the conditions are 





The final list of documents reviewed and approved by the Committee is as follows:	  
 	  
Document   	  
Version   	  
Date   	  
 Covering Letter 	  
 	  
06 August 2013 	  
 Evidence of insurance or indemnity 	  
 	  
31 July 2013 	  
 GP/Consultant Information Sheets 	  
1.0 	  
30 July 2013 	  
 Interview Schedules/Topic Guides 	  
Feedback 1.0 	  
30 July 2013 	  
 Interview Schedules/Topic Guides 	  
Interview assessment 1.0 	  
30 July 2013 	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 Investigator CV 	  
 	  
17 June 2013 	  
 Letter from Sponsor 	  
 	  
05 August 2013 	  
 Letter of invitation to participant 	  
Invitation to study 1.0 	  
30 July 2013 	  
 Letter of invitation to participant 	  
Invitation to feedback interview 1.0 	  
30 July 2013 	  
 Letter of invitation to participant 	  
1.0 	  
30 July 2013 	  
 Letter of invitation to participant 	  
2.0 	  
07 October 2013 	  
 Other: Non NHS SSI 	  
131028/486225/7/603/212521/278328 	  
12 August 2013 	  
 Other: CV - Andrew Bateman 	  
 	  
17 July 2013 	  
 Other: CV - Dr Nair 	  
 	  
24 July 2013 	  
 Other: CV - Rachel Goodwin 	  
 	  
28 May 2013 	  
 Other: EMQ - Relative/Friend 	  
1.0 	  
30 July 2013 	  
 Other: EMQ - Participant 	  
1.0 	  
30 July 2013 	  
 Other: Flowchart of protocol 	  
1.0 	  
30 July 2013 	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 Other: Letter from funder 	  
 	  
14 December 2012 	  
 Participant Consent Form 	  
1.0 	  
30 July 2013 	  
 Participant Consent Form: Relative/Friend 	  
1.0 	  
30 July 2013 	  
 Participant Consent Form 	  
2.0 	  
07 October 2013 	  
 Participant Consent Form: Relative/Friend 	  
2.0 	  
07 October 2013 	  
 Participant Information Sheet 	  
1.0 	  
30 July 2013 	  
 Participant Information Sheet 	  
2.0 	  
07 October 2013 	  
 Protocol 	  
1.0 	  
30 July 2013 	  
 Protocol 	  
2.0 	  
07 October 2013 	  
 Questionnaire: Relative/Friends  	  
1.0 	  
30 July 2013 	  
 Questionnaire: Participant 	  
1.0 	  
30 July 2013 	  
 REC application 	  
131028/486219/1/448 	  
12 August 2013 	  
 Response to Request for Further Information 	  
 	  
07 October 2013 	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Statement of compliance	  
	  
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK.	  
	  




The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including:	  
	  
  Notifying substantial amendments	  
  Adding new sites and investigators	  
  Notification of serious breaches of the protocol	  
  Progress and safety reports	  
  Notifying the end of the study	  
	  
The NRES website also provides guidance on these topics, which is updated in the 




You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure.  If you wish to 
make your views known please use the feedback form available on the website.	  
	  
Further information is available at National Research Ethics Service website > After 
Review	  
	  
13/EM/0324                          Please quote this number on all correspondence	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We are pleased to welcome researchers and R & D staff at our NRES committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/ 	  
	  











Enclosures:  “After ethical review – guidance for	  
   researchers” 	  
	  
Copy to:  Mr Paul Cartledge, Research Innovation Services 	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Appendix	  6:	  Invitation	  to	  study	  version	  2	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Appendix	  7:	  NeuroText	  timetable	  example	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Appendix	  8:	  Control	  timetable	  example	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Appendix	  10:	  Demographic	  Form	  
	  
	  	   	  234	  
	  
	  	   	  235	  







	   Date	  form	  completed:	  	   /	   /	  
	   D	   D	   M	   M	   M	   Y	   Y	   Y	   Y	  
	  
	   Your	  study	  ID:	   	   	  
	   	  
	  
Thank	   you	   in	   advance	   for	   completing	   this	   questionnaire.	   Please	   check	   that	   you	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Instructions	  
	  
For	  most	  of	  the	  questions	  all	  you	  need	  to	  do	  is	  tick	  a	  box	  or	  cicle	  the	  answer.	  	  
	  
If	  you	  need	  help	  filling	   in	  this	  questionnaire,	  please	  feel	  free	  to	  discuss	  this	  with	  a	  
relative	  or	  friend.	  But	  please	  make	  sure	  the	  answers	  are	  your	  own	  views.	  	  
	  
It	  may	  take	  you	  about	  25	  minutes	  to	  fill	  in,	  depending	  on	  how	  much	  time	  you	  wish	  
to	  spend	  on	   it.	  As	  you	  fill	   it	  out,	  don’t	  spend	  too	  much	  time	  on	  any	  one	  question.	  
There	  are	  no	  right	  or	  wrong	  answers.	  
	  
Your	  answers	  to	  the	  questions	  are	  extremely	  valuable	  for	  the	  successful	  completion	  of	  
the	   research.	   We	   also	   want	   to	   remind	   you	   that	   your	   answers	   will	   be	   kept	  
completely	  confidential.	  Therefore,	  your	  answers	  will	  in	  no	  way	  affect	  your	  care.	  
	  
Please	   check	   that	   you	   answer	   all	   questions	   and	   that	   no	   pages	   are	   missed	   by	  
accident.	  	  
	  
If	  you	  need	  any	  information	  then	  contact	  the	  research	  team	  on	  0758	  212	  9039.	  	  
	  
Everyday	  Memory	  Questionniare	  –	  Participant	  
	   	   237	  
	   	  
Everyday	  Memory	  Questionniare	  –	  Participant	  
	   	   238	  
	  
There	  are	  two	  sections	  to	  this	  questionnaire.	  
	  
Section	  1	  
Below	  are	  listed	  some	  examples	  of	  things	  that	  happen	  to	  people	  in	  everyday	  life.	  Some	  of	  them	  may	  happen	  frequently	  and	  some	  may	  
happen	  frequently	  and	  some	  may	  happen	  very	  rarely.	  We	  should	  like	  to	  know	  how	  often	  on	  average	  you	  think	  each	  one	  has	  happened	  
to	  you	  over	  the	  past	  month.	  For	  each	  item,	  tell	  us	  if	  you	  forgot	  it:	  
	  
Once	  or	  less	  in	  the	  last	  month/	  never	  	  	  	  	  	  
More	  than	  once	  a	  month	  but	  less	  than	  once	  a	  week	  	  	  	  	  	  	  	  	  
About	  once	  a	  week	  	  	  	  	  	  	  	  	  	  
More	  than	  once	  a	  week	  but	  less	  than	  once	  a	  day	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
Once	  or	  more	  a	  day	  
	  
Please	  tick	  one	  box	  for	  each	  item.	  
	  
Section	  2	  
Below	  is	  the	  same	  list	  from	  Section	  1	  of	  things	  that	  happen	  to	  people	  in	  everyday	  life.	  This	  time	  we	  should	  like	  to	  know	  how	  important	  
you	  think	  each	  item	  is	  for	  you.	  Tell	  us	  how	  important	  each	  item	  is	  for	  you	  by	  ticking	  one	  box	  for	  each	  item:	  
	  
Not	  at	  all	  important	  	  	  	  	  	  	  	  	  	  
Unimportant	  	  	  	  	  	  	  
Neither	  important	  or	  unimportant	  	  	  	  	  	  	  	  	  	  	  	  




Please	  make	  sure	  you	  complete	  both	  sections.	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Section	  1	   Tick	  one	  box	  below	  þ	  
Instructions:	   Read	   each	   statement	   below.	   Tick	   one	   box	   to	   the	  
right	  of	  the	  statement	  to	  indicate	  how	  often	  you	  experience	  this	  
problem	  
Once	  or	   less	  
in	   the	   last	  
month/	  
never	  
More	   than	  
once	   a	  
month	   but	  
less	   than	  
once	  a	  week	  
About	   once	  
a	  week	  
More	   than	  
once	  a	  week	  
but	   less	  
than	   once	   a	  
day	  
Once	   or	  
more	  a	  day	  
X	   Example	  item	   	   	   	   ü 	   	  
1	   Forgetting	  where	  you	  have	  put	  something.	  Losing	  things	  around	  the	  house	   	   	   	   	   	  
2	   Failing	  to	  recognise	  places	  that	  you	  are	  told	  you	  have	  often	  been	  to	  before	   	   	   	   	   	  
3	   Finding	  a	  television	  story	  difficult	  to	  follow	   	   	   	   	   	  
4	  
Not	  remembering	  a	  change	  in	  your	  daily	  routine,	  such	  as	  a	  change	  in	  the	  place	  where	  
something	   is	   kept,	   or	   a	   change	   in	   the	   time	   something	  happens.	   Following	   your	   old	  
routine	  by	  mistake	  
	   	   	   	   	  
5	   Having	  to	  go	  back	  and	  check	  whether	  you	  have	  done	  something	  that	  you	  meant	  to	  do	   	   	   	   	   	  
6	   Forgetting	   when	   it	   was	   that	   something	   happened;	   for	   example,	   whether	   it	   was	  
yesterday	  or	  last	  week	  
	   	   	   	   	  
7	   Completely	  forgetting	  to	  take	  things	  with	  you,	  or	  leaving	  things	  behind	  and	  having	  to	  
go	  back	  and	  fetch	  them	  
	   	   	   	   	  
8	   Forgetting	   that	   you	  were	   told	   something	   yesterday	   or	   a	   few	   days	   ago,	   and	  maybe	  
having	  to	  be	  reminded	  about	  it	  
	   	   	   	   	  
9	   Starting	   to	   read	   something	   (a	   book	   or	   an	   article	   in	   a	   newspaper,	   or	   a	   magazine)	  
without	  realising	  you	  have	  already	  read	  it	  before	  
	   	   	   	   	  
10	   Letting	  yourself	  ramble	  on	  to	  speak	  about	  unimportant	  or	  irrelevant	  things	   	   	   	   	   	  
11	   Failing	  to	  recognise,	  by	  sight,	  close	  relatives	  or	  friends	  that	  you	  meet	  frequently	   	   	   	   	   	  
12	   Having	  difficulty	  picking	  up	  a	  new	   skill.	   For	   example,	   finding	   it	   hard	   to	   learn	  a	  new	  
game	  or	  to	  work	  some	  new	  gadget	  after	  you	  have	  practised	  once	  or	  twice	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Instructions:	   Read	   each	   statement	   below.	   Tick	   one	   box	   to	   the	  
right	  of	  the	  statement	  to	  indicate	  how	  often	  you	  experience	  this	  
problem	  
Once	  or	   less	  
in	   the	   last	  
month/	  
never	  
More	   than	  
once	   a	  
month	   but	  
less	   than	  
once	  a	  week	  
About	   once	  
a	  week	  
More	   than	  
once	  a	  week	  
but	   less	  
than	   once	   a	  
day	  
Once	   or	  
more	  a	  day	  
13	   Finding	  that	  a	  word	  is	  'on	  the	  tip	  of	  your	  tongue'.	  You	  know	  what	  it	  is	  but	  you	  cannot	  
quite	  find	  it	  
	   	   	   	   	  
14	   Completely	  forgetting	  to	  do	  things	  you	  said	  you	  would	  do,	  and	  things	  you	  planned	  to	  
do	  
	   	   	   	   	  
15	   Forgetting	  important	  details	  of	  what	  you	  did	  or	  what	  happened	  to	  you	  the	  day	  before	   	   	   	   	   	  
16	   When	   talking	   to	   someone,	   forgetting	  what	   you	   have	   just	   said.	  Maybe	   saying	   'what	  
was	  I	  talking	  about?'	  
	   	   	   	   	  
17	   When	  reading	  a	  newspaper	  or	  magazine	  being	  unable	  to	  follow	  the	  thread	  of	  a	  story;	  
losing	  track	  of	  what	  it	  is	  all	  about	  
	   	   	   	   	  
18	   Forgetting	   to	   tell	   somebody	   something	   important.	   Perhaps	   forgetting	   to	   pass	   on	   a	  
message	  or	  remind	  someone	  of	  something	  
	   	   	   	   	  
19	   Forgetting	  important	  details	  about	  yourself,	  e.g.,	  your	  birth	  date	  or	  where	  you	  live	   	   	   	   	   	  
20	   Getting	  details	  of	  what	  someone	  has	  told	  you	  mixed	  up	  and	  confused	   	   	   	   	   	  
21	   Telling	  someone	  a	  story	  or	  joke	  that	  you	  have	  already	  told	  them	  once	  already	   	   	   	   	   	  
22	   Forgetting	   details	   of	   things	   you	   do	   regularly,	   whether	   at	   home	   or	   at	   work.	   For	  
example,	  forgetting	  details	  of	  what	  to	  do,	  or	  forgetting	  at	  what	  time	  to	  do	  it	  
	   	   	   	   	  
23	   Finding	   the	   faces	   of	   famous	   people	   seen	   on	   television	   or	   in	   photographs,	   look	  
unfamiliar	  
	   	   	   	   	  
24	   Forgetting	  where	  things	  are	  normally	  kept	  or	  looking	  for	  them	  in	  the	  wrong	  place	   	   	   	   	   	  
25	   Getting	  lost	  or	  turning	  in	  the	  wrong	  direction	  on	  a	  journey,	  on	  a	  walk	  or	  in	  a	  building	  
where	  you	  have	  OFTEN	  been	  before	  
	   	   	   	   	  
26	   Getting	  lost	  or	  turning	  in	  the	  wrong	  direction	  on	  a	  journey,	  on	  a	  walk	  or	  in	  a	  building	  
where	  you	  have	  ONLY	  BEEN	  ONCE	  OR	  TWICE	  before	  
	   	   	   	   	  
27	   Doing	  some	  routine	   thing	   twice	  by	  mistake.	  For	  example,	  putting	   two	   lots	  of	   tea	   in	  
the	  teapot,	  or	  going	  to	  brush/	  comb	  your	  hair	  when	  you	  have	  just	  done	  so	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28	   Repeating	   to	   someone	   what	   you	   have	   just	   told	   them	   or	   asking	   them	   the	   same	  
question	  twice	  
	   	   	   	   	  
	  
	   	  
Everyday	  Memory	  Questionniare	  –	  Participant	  
	   	   242	  
Section	  2	   Tick	  one	  box	  below	  þ	  
Instructions:	   Read	  each	   statement	  below.	   Tick	   one	  box	   to	   the	  
right	  of	  the	  statement	  to	  indicate	  how	  important	  this	  problem	  is	  
to	  you	  
Not	   at	   all	  








X	   Example	  item	   	   ü 	   	   	   	  
1	   Forgetting	  where	  you	  have	  put	  something.	  Losing	  things	  around	  the	  house	   	   	   	   	   	  
2	   Failing	  to	  recognise	  places	  that	  you	  are	  told	  you	  have	  often	  been	  to	  before	   	   	   	   	   	  
3	   Finding	  a	  television	  story	  difficult	  to	  follow	   	   	   	   	   	  
4	  
Not	  remembering	  a	  change	  in	  your	  daily	  routine,	  such	  as	  a	  change	  in	  the	  place	  where	  
something	   is	   kept,	   or	   a	   change	   in	   the	   time	   something	  happens.	   Following	   your	  old	  
routine	  by	  mistake	  
	   	   	   	   	  
5	   Having	  to	  go	  back	  and	  check	  whether	  you	  have	  done	  something	  that	  you	  meant	  to	  do	   	   	   	   	   	  
6	   Forgetting	   when	   it	   was	   that	   something	   happened;	   for	   example,	   whether	   it	   was	  
yesterday	  or	  last	  week	  
	   	   	   	   	  
7	   Completely	  forgetting	  to	  take	  things	  with	  you,	  or	  leaving	  things	  behind	  and	  having	  to	  
go	  back	  and	  fetch	  them	  
	   	   	   	   	  
8	   Forgetting	   that	   you	  were	   told	   something	   yesterday	   or	   a	   few	   days	   ago,	   and	  maybe	  
having	  to	  be	  reminded	  about	  it	  
	   	   	   	   	  
9	   Starting	   to	   read	   something	   (a	   book	   or	   an	   article	   in	   a	   newspaper,	   or	   a	   magazine)	  
without	  realising	  you	  have	  already	  read	  it	  before	  
	   	   	   	   	  
10	   Letting	  yourself	  ramble	  on	  to	  speak	  about	  unimportant	  or	  irrelevant	  things	   	   	   	   	   	  
11	   Failing	  to	  recognise,	  by	  sight,	  close	  relatives	  or	  friends	  that	  you	  meet	  frequently	   	   	   	   	   	  
12	   Having	  difficulty	  picking	  up	  a	  new	  skill.	   For	  example,	   finding	   it	   hard	   to	   learn	  a	  new	  
game	  or	  to	  work	  some	  new	  gadget	  after	  you	  have	  practised	  once	  or	  twice	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Instructions:	   Read	  each	   statement	  below.	   Tick	   one	  box	   to	   the	  
right	  of	  the	  statement	  to	  indicate	  how	  important	  this	  problem	  is	  
to	  you	  
Not	   at	   all	  








13	   Finding	  that	  a	  word	  is	  'on	  the	  tip	  of	  your	  tongue'.	  You	  know	  what	  it	  is	  but	  you	  cannot	  
quite	  find	  it	  
	   	   	   	   	  
14	   Completely	  forgetting	  to	  do	  things	  you	  said	  you	  would	  do,	  and	  things	  you	  planned	  to	  
do	  
	   	   	   	   	  
15	   Forgetting	  important	  details	  of	  what	  you	  did	  or	  what	  happened	  to	  you	  the	  day	  before	   	   	   	   	   	  
16	   When	   talking	   to	   someone,	   forgetting	  what	   you	  have	   just	   said.	  Maybe	   saying	   'what	  
was	  I	  talking	  about?'	  
	   	   	   	   	  
17	   When	  reading	  a	  newspaper	  or	  magazine	  being	  unable	  to	  follow	  the	  thread	  of	  a	  story;	  
losing	  track	  of	  what	  it	  is	  all	  about	  
	   	   	   	   	  
18	   Forgetting	   to	   tell	   somebody	   something	   important.	   Perhaps	   forgetting	   to	   pass	   on	   a	  
message	  or	  remind	  someone	  of	  something	  
	   	   	   	   	  
19	   Forgetting	  important	  details	  about	  yourself,	  e.g.,	  your	  birth	  date	  or	  where	  you	  live	   	   	   	   	   	  
20	   Getting	  details	  of	  what	  someone	  has	  told	  you	  mixed	  up	  and	  confused	   	   	   	   	   	  
21	   Telling	  someone	  a	  story	  or	  joke	  that	  you	  have	  already	  told	  them	  once	  already	   	   	   	   	   	  
22	   Forgetting	   details	   of	   things	   you	   do	   regularly,	   whether	   at	   home	   or	   at	   work.	   For	  
example,	  forgetting	  details	  of	  what	  to	  do,	  or	  forgetting	  at	  what	  time	  to	  do	  it	  
	   	   	   	   	  
23	   Finding	   the	   faces	   of	   famous	   people	   seen	   on	   television	   or	   in	   photographs,	   look	  
unfamiliar	  
	   	   	   	   	  
24	   Forgetting	  where	  things	  are	  normally	  kept	  or	  looking	  for	  them	  in	  the	  wrong	  place	   	   	   	   	   	  
25	   Getting	  lost	  or	  turning	  in	  the	  wrong	  direction	  on	  a	  journey,	  on	  a	  walk	  or	  in	  a	  building	  
where	  you	  have	  OFTEN	  been	  before	  
	   	   	   	   	  
26	   Getting	  lost	  or	  turning	  in	  the	  wrong	  direction	  on	  a	  journey,	  on	  a	  walk	  or	  in	  a	  building	  
where	  you	  have	  ONLY	  BEEN	  ONCE	  OR	  TWICE	  before	  
	   	   	   	   	  
27	   Doing	  some	  routine	   thing	   twice	  by	  mistake.	  For	  example,	  putting	   two	   lots	  of	   tea	   in	  
the	  teapot,	  or	  going	  to	  brush/	  comb	  your	  hair	  when	  you	  have	  just	  done	  so	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28	   Repeating	   to	   someone	   what	   you	   have	   just	   told	   them	   or	   asking	   them	   the	   same	  
question	  twice	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Please	  read	  this	  carefully:	  
	  
We	  should	  like	  to	  know	  if	  you	  have	  had	  any	  medical	  complaints,	  and	  how	  your	  health	  has	  been	  in	  
general,	   over	   the	   past	   few	   weeks.	   Please	   answer	   ALL	   the	   questions	   simply	   by	   underlining	   the	  
answer	   which	   you	   think	   most	   nearly	   applies	   to	   you.	   Remember	   that	   we	   want	   to	   know	   about	  
present	   and	   recent	   complaints,	   not	   those	   you	   had	   in	   the	   past.	   It	   is	   important	   that	   you	   try	   to	  
answer	  ALL	  the	  questions.	  
	  
Thank	  you	  very	  much	  for	  your	  co-­‐operation.	  
	  
HAVE	  YOU	  RECENTLY:	  
	  
1	  	  —	  	   been	  able	  to	  concentrate	  on	  	   Better	  than	   Same	  as	   Less	   than
	   Much	  less	  
	   whatever	  you're	  doing?	   usual	   usual	   usual
	   than	  usual	  
	  
2	  	  —	  	   lost	  much	  sleep	  over	  worry?	   Not	  at	  all	   No	  more	   Rather	   more	  
	   Much	  more	  
	   	   than	  usual	   than	  usual	   than	  usual	  
	  
3	  	  —	  	   been	  having	  restless,	  disturbed	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   nights?	   than	  usual	   than	  usual	   than	  usual	  
	  
4	  	  —	  	   been	  managing	  to	  keep	  yourself	   More	  so	   Same	  as	   Rather	   less
	   Much	  less	  
	   busy	  and	  occupied?	   than	  usual	   usual	   than	   usual
	   than	  usual	  
	  
5	  	  —	  	   been	  getting	  out	  of	  the	  house	  as	   More	  so	   Same	  as	   Less	   than
	   Much	  less	  
	   much	  as	  usual?	   than	  usual	   usual	   usual
	   than	  usual	  
	  
6	  	  —	  	   been	  managing	  as	  well	  as	  most	   Better	  than	   About	  the	   Rather	   less
	   Much	  less	  
	   people	  would	  in	  your	  shoes?	   most	   same	   well
	   well	  
	  
7	  	  —	  	   felt	  on	  the	  whole	  you	  were	  doing	   Better	  than	   About	  the	   Less	   well
	   Much	  less	  
	   things	  well?	   usual	   same	   than	   usual
	   well	  
	  
8	  	  —	  	   been	  satisfied	  with	  the	  way	  you've	   More	   About	  same	   Less	   satisfied	  
	   Much	  less	  
	   carried	  out	  your	  task?	   satisfied	   as	  usual	   than	   usual
	   satisfied	  
	  
9	  	  —	  	   been	  able	  to	  feel	  warmth	  and	  	   Better	  than	   About	  same	   Less	   well
	   Much	  less	  
	   affection	  for	  those	  near	  to	  you?	   usual	   as	  usual	   than	   usual
	   well	  
	  
10	  —	  	   been	  finding	  it	  easy	  to	  get	  on	  with	   Better	  than	   About	  same	   Less	   well
	   Much	  less	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   other	  people?	  	   usual	   as	  usual	   than	   usual
	   well	  
	  
11	  —	  	   spent	  much	  time	  chatting	  with	  	   More	  time	   More	  so	   Less	   time
	   Much	  less	  
	   people?	   than	  usual	   as	  usual	   than	   usual
	   than	  usual	  
	  
12	  —	  	   felt	  that	  you	  are	  playing	  a	  useful	  	   More	  so	   Same	  as	   Less	   useful
	   Much	  less	  
	   part	  in	  things?	   than	  usual	   usual	   than	   usual
	   useful	  
	  
13	  —	  	   felt	  capable	  of	  making	  decisions	  	   More	  so	   Same	  	   Less	   so
	   Much	  less	  
	   about	  things?	   than	  usual	   as	  usual	   than	   usual
	   capable	  
	  
	   	  
General	  Health	  Questionnaire	  
	   	  248	  
HAVE	  YOU	  RECENTLY:	  
	  
14	  —	  	   felt	  constantly	  under	  strain?	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
15	  —	  	   felt	  you	  couldn’t	  overcome	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   your	  difficulties?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
16	  —	  	   been	  finding	  life	  a	  struggle	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   all	  the	  time?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
17	  —	  	   been	  able	  to	  enjoy	  your	  normal	   More	  so	   Same	  as	   Less	   so	   than
	   Much	  less	  
	   day-­‐to-­‐day	  activities?	   than	  usual	   usual	   usual
	   than	  usual	  
	  
18	  —	  	   been	  taking	  things	  hard?	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
19	  —	  	   been	  getting	  scared	  or	  panicky	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   for	  no	  good	  reason?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
20	  —	  	   been	  able	  to	  face	  up	  to	  your	   More	  so	   Same	  as	   Less	   able	   than
	   Much	  less	  
	   problems?	   than	  usual	   usual	   usual
	   able	  
	  
21	  —	  	   found	  everything	  getting	  on	  top	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   of	  you?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
22	  —	  	   been	  feeling	  unhappy	  and	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   depressed?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
23	  —	  	   been	  losing	  confidence	  in	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   yourself?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
24	  —	  	   been	  thinking	  of	  yourself	  as	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   a	  worthless	  person?	   	   than	  usual	   than	   usual
	   than	  usual	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25	  —	  	   felt	  that	  life	  is	  entirely	  hopeless?	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
26	  —	  	   been	  feeling	  hopeful	  about	  your	   More	  so	   About	  same	   Less	   so	   than
	   Much	  less	  
	   own	  future?	   than	  usual	   as	  usual	   usual
	   hopeful	  
	  
27	  —	  	   been	  feeling	  reasonably	  happy,	   More	  so	   About	  same	   Less	   so
	   Much	  less	  
	   all	  things	  considered?	   than	  usual	   as	  usual	   than	   usual
	   than	  usual	  
	  
28	  —	  	   been	  feeling	  nervous	  and	  	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   strung-­‐up	  all	  the	  time?	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
29	  —	  	   felt	  that	  life	  isn’t	  worth	  living?	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   	   	   than	  usual	   than	   usual
	   than	  usual	  
	  
30	  —	  	   found	  at	  times	  you	  couldn’t	   Not	  at	  all	   No	  more	   Rather	   more
	   Much	  more	  
	   do	  anything	  because	  your	  nerves	   	   than	  usual	   than	   usual
	   than	  usual	  
	   were	  too	  bad?	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This is a set of questions about how you think you cope with your 
memory problems. There are no right or wrong answers. Please 
take your time and answer all questions. Tick the answer you feel 
best applies to you: 
 
Part A 
1. I have had enough information on why I have memory 
problems.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
2. I understand how memory works.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
3. I find it difficult to come to terms with my memory 
problems. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
4. I know how to use the strong aspects of my memory to 
compensate  
    for the weaker aspects.  
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
5. I understand why I remember some things more easily 
than others.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
 
 
6. I am well organised in how I cope with my memory 
problems. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
7. I have been doing things that I believe will improve my 
memory.  
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    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
 
8. I have little control over my memory ability.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
9. There are ways to cope with my memory difficulties.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                                Agree                    Disagree 
 
10. I rely on other people to remind me of what I have to 
do.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
11. I am confident that I can cope with my memory 
difficulties. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
12. It upsets me when others notice my memory problems. 
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
13. I am anxious about my memory problems. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
14. My memory problems make me feel embarrassed.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
15. I panic when I forget something important. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
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                               Agree                     Disagree 
 
Part B.                              MEMORY AIDS 
Memory aids are strategies we may all use to help us 
remember things. They can be external or internal: 
 
B1. External memory aids: can be objects or other cues in our 
surroundings to help us remember things without relying on our 
memory.  
 
16. The following is a list of external memory aids. Please 
indicate which of these you are using. If you are NOT using 
any external memory aids please go to question 21 on the 
next page. 
 










Dictaphone/ tape recorder 
 
Post it notes 
 






Object placement  
e.g. putting things in an obvious place where you will notice them 
/putting things at the same place all the time 
 
Following a routine 
e.g. doing specific things at specific times 
 
Ask someone else to remind you of things to do 
 
Any others:  
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Please consider the external memory aids you are using and 
complete the following questions:  
 
 
17. I believe that I make the most of the external memory 
aids I am  
      using.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
18. I know which external memory aids work best for me.  
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
19. The external memory aids I am using are effective.   
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
20. I have a range of external memory aids that I can use 
for different  
      tasks. 
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
 
21. If you are NOT using any external memory aids please 
indicate the reasons by ticking one or more of the boxes: 
 
 
-I have never tried to use them                                   
 
-I feel embarrassed to use them 
 
-I have tried but found them too complicated  
 
-I have tried but they don’t work for me 
 
 
Any other reasons:  
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B2.	   	   Internal memory aids are “tricks” to help us remember 
things when we only have our memory to rely on. 	  
 
22. The following is a list of internal memory aids. Please 
indicate which of these you are using. If you are NOT using 
any internal memory aids please go to question 27 on the 
next page. 
 
Tick as many as applicable: 
 




Putting similar things into groups  
(e.g. things you want to buy into vegetables, clothes, stationary etc.)  
 
 
Relating what you want to remember with something  
you already know 
(e.g. a friend’s name on the 26th December as one day after Christmas) 
 
 
Making a picture in your mind of things you want to 
remember 
(e.g. to remember the name Victoria Waters picture  
Queen Victoria by a waterfall) 
 
 




Paying attention to details (e.g. when parking the car try to observe  
the surroundings and watch for a landmark) 
 
 
Blocking information into chunks that make sense for you 




(e.g. lists of groceries      MEMORY: milk, eggs, matches, olives, rice, yeast) 
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Please consider the internal memory aids you are using and 
complete the following questions:  
 
23. I believe that I make the most of the internal memory 
aids I am  
      using.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
 
24. I know which internal memory aids work best for me.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
 
25. The internal memory aids I am using are effective.  
  
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
 
26. I have a range of internal memory aids that I can use for 
different  
      tasks. 
 
    Agree                        Slightly                   Slightly                  Disagree                                                                                                                         
                               Agree                     Disagree 
 
 
27. If you are NOT using any internal memory aids please 
indicate the reasons by ticking one or more of the boxes: 
 
-I have never tried to use them                                   
 
-I feel embarrassed to use them 
 
-I have tried but found them too complicated  
 
-I have tried but they don’t work for me 
 
Any other reasons:  
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By placing a tick in one box in each group below, please indicate which 
statements best describe your own health state today. 
 
Mobility	  
a)	  I	  have	  no	  problems	  in	  walking	  about	  
b)	  I	  have	  some	  problems	  in	  walking	  about	  
c)	  I	  am	  confined	  to	  bed	  
	  
Self-­‐Care	  
	   a)	  I	  have	  no	  problems	  with	  self	  care	  
	   b)	  I	  have	  some	  problems	  washing	  or	  dressing	  myself	  




 a) I have no problems with performing my usual  
   activities (e.g. work, study, housework, family  
   or leisure activities) 
	   b)	  I	  have	  some	  problems	  with	  performing	  my	  usual	  	  
	  	  	  	  activities	  
	   c)	  I	  am	  unable	  to	  perform	  my	  usual	  activities	  
	  
Pain/Discomfort	  
 a)	  I	  have	  no	  pain	  or	  discomfort 
	   b)	  I	  have	  moderate	  pain	  or	  discomfort	  
	  	  	  c)	  I	  have	  extreme	  pain	  or	  discomfort	  
	  
Anxiety/Depression	  
	   a)	  I	  am	  not	  anxious	  or	  depressed	  
	   b)	  I	  am	  moderately	  anxious	  or	  depressed	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To help people say how good or bad a health state is, we have drawn a 
scale (rather like a thermometer) on which the best state you can imagine 
is marked by 100 and the worst you can imagine is marked by 0. 
	  
We	   would	   like	   you	   to	   indicate	   on	   this	   scale	   how	  
good	   or	   bad	   is	   your	   own	   health	   today,	   in	   your	  
opinion.	  Please	  do	  this	  by	  drawing	  a	   line	  from	  the	  
box	   below	   to	   whichever	   point	   on	   the	   scale	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Thank	  you	  for	  your	  help	  
	  
	  




University	  of	  Nottingham	  
Division	  of	  Rehabilitation	  and	  Ageing	  
Medical	  School	  




If	  you	  would	  like	  to	  discuss	  this	  questionnaire,	  or	  any	  further	  information	  please	  
contact	  the	  Research	  Team:	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Appendix	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  Feedback	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Appendix	   15:	   Skew	   data	   for	   baseline	   measures	   in	   full	  
feasibility	  dataset	  
Variable	   Skewness	   Std	  Error	  of	  skewness	  
Age	   -­‐0.10	   0.34	  
Time	  since	  diagnosis	   0.93	   0.34	  
Time	  since	  last	  relapse	   1.87	   0.41	  
EMQ	  Total	  Score	   0.58	   0.34	  
Doors	  &	  People	  Test	   	  
People	   0.14	   0.34	  
Doors	   -­‐0.01	   0.34	  
Shapes	   -­‐0.33	   0.34	  
Names	   -­‐0.57	   0.34	  
Overall	  Score	   2.07	   0.34	  
Combined	  visual	  memory	   0.22	   0.34	  
Combined	  verbal	  memory	   -­‐0.12	   0.34	  
Combined	  recall	   .043	   0.34	  
Combined	  recognition	   -­‐0.51	   0.34	  
Verbal	  forgetting	   -­‐0.60	   0.34	  
Visual	  forgetting	   -­‐1.41	   0.34	  
Hayling	  &	  Brixton	   	  
Hayling	  error	   -­‐1.03	   0.34	  
Hayling	  overall	   -­‐1.00	   0.34	  
Brixton	   -­‐1.33	   0.34	  
Test	  of	  Everyday	  Attention	   	  
Map	  search	  1	   -­‐1.43	   0.35	  
Map	  search	  2	   -­‐2.60	   0.35	  
Elevator	  counting	   -­‐1.96	   0.34	  
Elevator	   counting	   with	  
distraction	  
-­‐0.52	   0.34	  
Visual	  elevator	  1	   -­‐0.11	   0.35	  
Visual	  elevator	  2	   -­‐0.59	   0.35	  
Elevator	  counting	  with	  reversal	   0.23	   0.37	  
Telephone	  search	   -­‐0.57	   0.34	  
Telephone	   search	   while	  
counting	  
-­‐0.18	   0.34	  
Lottery	   -­‐0.29	   0.34	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Appendix	  16:	  Amendments	  approval	  from	  ethics	  committee	  
	  
	  
	  	   	  268	  
	  
	  	   	  269	  
	   	  
	  	   	  270	  
Appendix	  17:	  Skew	  data	  for	  baseline	  measures	  in	  RCT	  dataset	  	  
	  
Variable	   Skewness	   Std	  Error	  of	  skewness	  
Age	   0.11	   0.38	  
Time	  since	  diagnosis	   1.26	   0.38	  
Time	  since	  last	  relapse	   2.01	   0.44	  
EMQ	  Total	  Score	   0.56	   0.38	  
Doors	  &	  People	  Test	   	  
People	   0.01	   0.38	  
Doors	   0.08	   0.38	  
Shapes	   -­‐0.59	   0.38	  
Names	   -­‐0.48	   0.38	  
Overall	  Score	   2.12	   0.38	  
Combined	  visual	  memory	   0.10	   0.38	  
Combined	  verbal	  memory	   -­‐0.08	   0.38	  
Combined	  recall	   -­‐0.14	   0.38	  
Combined	  recognition	   0.03	   0.38	  
Verbal	  forgetting	   -­‐0.68	   0.38	  
Visual	  forgetting	   -­‐1.64	   0.38	  
Hayling	  &	  Brixton	   	  
Hayling	  error	   -­‐1.43	   0.38	  
Hayling	  overall	   -­‐1.27	   0.38	  
Brixton	   -­‐0.41	   0.38	  
Test	  of	  Everyday	  Attention	   	  
Map	  search	  1	   -­‐0.23	   0.39	  
Map	  search	  2	   -­‐0.20	   0.39	  
Elevator	  counting	   -­‐1.69	   0.38	  
Elevator	   counting	   with	  
distraction	  
-­‐0.63	   0.38	  
Visual	  elevator	  1	   -­‐0.10	   0.39	  
Visual	  elevator	  2	   -­‐0.52	   0.39	  
Elevator	  counting	  with	  reversal	   -­‐0.15	   0.41	  
Telephone	  search	   -­‐0.76	   0.38	  
Telephone	   search	   while	  
counting	  
-­‐0.42	   0.38	  
Lottery	   -­‐0.43	   0.38	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Appendix	   18:	   Skew	   data	   for	   outcome	   measures	   in	   RCT	  
dataset	  	  
Variable	   Skewness	   Std	  Error	  of	  skewness	  
EMQ	   Frequency	   Participant	  
total	  condition	  1	  
-­‐0.94	   0.43	  
EMQ	   Importance	   Participant	  
total	  condition	  1	  
-­‐0.67	   0.47	  
GHQ	  total	  condition	  1	   0.88	   0.46	  
AMEDO	  Part	  A	  total	  condition	  1	   -­‐0.34	   0.47	  
AMEDO	  Part	  B1	  condition	  1	   -­‐1.95	   0.46	  
AMEDO	  Part	  B2	  condition	  1	   -­‐0.63	   0.50	  
EQ5d	  1	  condition	  1	   -­‐0.22	   0.47	  
EQ5d	  2	  condition	  1	   -­‐0.09	   0.47	  
EQ5d	  3	  condition	  1	   -­‐0.22	   0.47	  
EQ5d	  4	  condition	  1	   -­‐0.03	   0.47	  
EQ5d	  5	  condition	  1	   -­‐0.15	   0.47	  
EQ5d	  VAS	  condition	  1	   0.25	   0.47	  
EMQ	   Frequency	   Relative	   total	  
condition	  1	  
0.90	   0.49	  
EMQ	   Importance	  Relative	   total	  
condition	  1	  
-­‐0.42	   0.49	  
EMQ	   Frequency	   Participant	  
total	  condition	  2	  
0.22	   0.46	  
EMQ	   Importance	   Participant	  
total	  condition	  2	  
-­‐0.01	   0.47	  
GHQ	  total	  condition	  2	   0.78	   0.47	  
AMEDO	  Part	  A	  total	  condition	  2	   -­‐0.08	   0.47	  
AMEDO	  Part	  B1	  condition	  2	   -­‐0.69	   0.47	  
AMEDO	  Part	  B2	  condition	  2	   -­‐0.67	   0.49	  
EQ5d	  1	  condition	  2	   0.00	   0.48	  
EQ5d	  2	  condition	  2	   0.16	   0.47	  
EQ5d	  3	  condition	  2	   0.01	   0.47	  
EQ5d	  4	  condition	  2	   -­‐0.54	   0.47	  
EQ5d	  5	  condition	  2	   0.28	   0.47	  
EQ5d	  VAS	  condition	  2	   0.22	   0.48	  
EMQ	   Frequency	   Relative	   total	   0.57	   0.54	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condition	  2	  
EMQ	   Importance	  Relative	   total	  
condition	  2	  
-­‐0.30	   0.54	  
	  
	  
